You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Società Italiana<br />
di Farmacologia<br />
34° Congresso Nazionale<br />
della Società Italiana di Farmacologia<br />
<strong>PROGRAMMA</strong><br />
14-17 ottobre 2009<br />
Rimini, Palacongressi
Con l’Alto Patronato del Presidente della Repubblica<br />
e con il patricinio di:<br />
Regione Emilia Romagna<br />
Provincia di Rimini<br />
Comune di Rimini<br />
Alma Mater Studiorum Università di Bologna<br />
Polo Scientifico Didattico di Rimini<br />
Federazione Nazionale degli Ordini dei Medici Chirurghi e<br />
degli Odontoiatri<br />
Federazione Ordini Farmacisti Italiani<br />
Ordine Nazionale dei Biologi<br />
Società Italiana<br />
di Farmacologia<br />
<strong>PROGRAMMA</strong><br />
34° Congresso Nazionale<br />
della Società Italiana di Farmacologia<br />
14-17 ottobre 2009<br />
Rimini, Palacongressi<br />
I
II III<br />
L<br />
a ricerca farmacologica ha conseguito innumerevoli conquiste<br />
in campo medico, nonostante ciò nel corso degli anni è<br />
cambiato l’atteggiamento nei confronti del farmaco.<br />
In passato, ogni piccolo passo avanti veniva accolto con un entusiasmo<br />
tale da fare da viatico al passo successivo (piccolo o grande<br />
che fosse) e la disponibilità limitata di terapie farmacologiche<br />
portava a considerarle in tutto il loro valore.<br />
Oggi invece, il “bene farmaco” ha subito una notevole inflazione<br />
che riconosce le sue cause in un’eccessiva medicalizzazione, in una<br />
pressante richiesta di trattamenti anche per condizioni prima non<br />
considerate patologiche, in una babele di informazioni e disinformazioni<br />
e nella perdita dell’entusiasmo.<br />
Per risanare la nostra economia (la farmacologia) e dar nuovo<br />
corso alle nostre monete (i farmaci) è necessario contrastare questa<br />
inflazione incipiente. Come?<br />
Portando avanti una “rivoluzione culturale” che faccia nuovamente<br />
prender coscienza del valore dei farmaci, di quanto essi possano<br />
essere utili, ma anche di quanto possano essere dannosi, di<br />
quali altri progressi possano essere capaci e di quali lezioni possano<br />
impartire.<br />
La vita di un farmaco non è poi così dissimile da quella di un<br />
uomo: la nascita porta con sé dolore, fatica ed aspettativa, la crescita<br />
avviene tra esami ed ostacoli continui ed ogni impedimento<br />
affrontato e superato porta con sé maturità, esperienza e forza.<br />
Così è un farmaco dalla sua sintesi alla sperimentazione premarketing<br />
fino al lungo iter della ricerca post-marketing, così sono<br />
i giovani ricercatori rafforzati dalle difficoltà quotidiane, così sono i<br />
loro maestri che traggono dal confronto continuo l’entusiasmo, lo<br />
stesso entusiasmo del passato che non dovrà mai affievolirsi.<br />
Tutto questo è il nostro Congresso.<br />
Achille Patrizio Caputi
Consiglio Direttivo e Comitato Organizzatore Scientifico<br />
Consiglio Direttivo<br />
Presidente: Achille Patrizio Caputi (Messina)<br />
Presidente-eletto: Carlo Riccardi (Perugia)<br />
Segretario: Pier Luigi Canonico (Novara)<br />
Consiglieri: Elisabetta Cerbai (Firenze)<br />
Alessandra Concas (Cagliari)<br />
Diana Conte Camerino (Bari)<br />
Filippo Drago (Catania)<br />
Giorgio Racagni (Milano)<br />
Marco Scatigna (Milano)<br />
Past President: Giovanni Biggio (Cagliari)<br />
Comitato Organizzatore Scientifico<br />
Giorgio Cantelli Forti (Bologna)<br />
Giuseppe Cirino (Napoli)<br />
Giovanni Umberto Corsini (Pisa)<br />
Vincenzo Cuomo (Roma)<br />
Gianni De Crescenzo (Roma)<br />
Giovambattista De Sarro (Catanzaro)<br />
Sergio Dompé (Roma)<br />
Roberto Fantozzi (Torino)<br />
Flavia Franconi (Sassari)<br />
Guido Fumagalli (Verona)<br />
Corrado Galli (Milano)<br />
Maurizio Massi (Camerino)<br />
Gabriela Mazzanti (Roma)<br />
Alessandro Mugelli (Firenze)<br />
Rodolfo Paoletti (Milano)<br />
Carlo Patrono (Roma)<br />
Francesco Rossi (Napoli)<br />
Domenicantonio Rotiroti (Catanzaro)<br />
Francesco Scaglione (Milano)<br />
Cesare Sirtori (Milano)<br />
Gian Pietro Sgaragli (Siena)<br />
Maurizio Taglialatela (Campobasso)<br />
Michele Vacca (Chieti)<br />
Francesco Visioli (Parigi)<br />
Ilario Viano (Novara)<br />
Si ringraziano per la preziosa collaborazione<br />
Gold sponsors<br />
Abbott<br />
Amgen Dompé<br />
Astellas Pharma<br />
AstraZeneca<br />
Boehringer Ingelheim<br />
Bristol Myers Squibb<br />
Eli Lilly Italia<br />
GlaxoSmithKline<br />
Grünenthal-Italia<br />
Innova Pharma<br />
Novartis Farma<br />
Nycomed<br />
Pfizer Italia<br />
Roche<br />
Rottapharm Madaus<br />
Sanofi-Aventis<br />
Wyeth Lederle<br />
IV V<br />
Silver sponsors<br />
Un particolare ringraziamento a<br />
2Biological Instruments<br />
A. Menarini<br />
Allevamenti Plaisant<br />
Assogenerici<br />
Baxter<br />
Bayer<br />
Biomedica Mangoni<br />
Charles River Laboratories Italia<br />
Chiesi Farmaceutici<br />
Daiichi Sankyo Italia<br />
DiaTech<br />
Ebewe Italia<br />
Edizioni Minerva Medica<br />
Harlan Laboratories<br />
Italfarmaco<br />
Janssen-Cilag<br />
Lundbeck Italia<br />
Novo Nordisk Farmaceutici<br />
Siena Biotech<br />
Tecniplast<br />
Thomson Reuters<br />
Ugo Basile<br />
British Pharmacological Society<br />
EPHAR<br />
Farmindustria<br />
Fondazione per la Ricerca Farmacologica “Gianni Benzi” onlus<br />
Ringraziamenti
Informazioni Generali<br />
INFORMAZIONI GENERALI<br />
Segreteria Organizzativa<br />
AIM Group - Sede di Firenze<br />
Viale G. Mazzini, 70 - 50132 Firenze<br />
Tel. 055 233881 • Fax 055 2480246<br />
Informazioni generali: sif2009@aimgroup.it<br />
Registrazioni: sif2009.reg@aimgroup.it<br />
Hotel: sif2009.hotel@aimgroup.it<br />
Sede del Congresso<br />
Palacongressi<br />
Via della Fiera, 52 - 47900 Rimini<br />
Come raggiungerci<br />
IN TRENO<br />
STAZIONE FF. SS. di Rimini<br />
Piazzale Cesare Battisti, 1 - 47921 Rimini - tel. 0541 892021<br />
Orari di apertura biglietteria: 07.00 – 21.00 tutti i giorni<br />
Dalla Stazione FF SS con il bus di linea n.7 in circa 10 minuti si<br />
raggiunge il Palacongressi. Costo del biglietto per i bus di linea è<br />
di € 1,00 ed ha validità 60 minuti<br />
IN AEREO<br />
AEROPORTO INTERNAZIONALE FEDERICO FELLINI<br />
Via Flaminia, 409 – Miramare di Rimini<br />
Tel. 0541 715711 fax. 0541 373649<br />
E-mail: info@riminiairport.com - www.riminiairport.com<br />
Per raggiungere il Palacongressi (l’aeroporto dista 6 km) è possibile<br />
servirsi dell’Autobus di linea Tram Servizi: il bus di linea n. 9<br />
collega l’Aeroporto e la Stazione FF SS ogni 30 minuti circa ed<br />
ha una percorrenza di 25 minuti circa; dal terminal dei bus di<br />
linea presso la Stazione FF SS si raggiunge in 10 minuti circa il<br />
Palacongressi utilizzando il bus di linea n. 7. Costo del biglietto<br />
per i bus di linea è € 1,00 ed ha validità 60 minuti.<br />
In alternativa si può usufruire del servizio di RadioTaxi –<br />
tel. 0541 50020. Al fine di assicurare all’utenza una maggiore<br />
correttezza e trasparenza, la tariffa massima (individuata come<br />
fascia territoriale) esigibile per il tragitto Aeroporto – Rimini Centro<br />
è di € 17,00.<br />
IN AUTOMOBILE<br />
Rimini è collegata alle principali reti autostradali d’Italia. Si trova<br />
sulla Autostrada A14 Milano-Bari ed è servita da due uscite: Rimini<br />
Nord e Rimini Sud.<br />
Con la A14 Rimini si collega agevolmente alla Autostrada A4 per<br />
Venezia, alla Autostrada A1 per Milano, Firenze, Roma, Napoli ed<br />
alla Autostrada A22 per il passo del Brennero.<br />
Per raggiungere il Palacongressi di Rimini l’uscita autostradale<br />
più agevole è Rimini Sud; proseguendo sulla SS16 in direzione<br />
Ravenna - Bologna si giunge a Via della Fiera, sulla destra, dopo<br />
circa 1 km.<br />
Siti Web<br />
www.sifweb.org<br />
www.aimgroup.eu/2009/sif<br />
Segreteria in sede congressuale<br />
La Segreteria Organizzativa è a disposizione dei partecipanti in sede<br />
congressuale durante i seguenti orari:<br />
Mercoledì 14 ottobre 2009 10.00 - 19.30<br />
Giovedì 15 ottobre 2009 08.00 - 19.00<br />
Venerdì 16 ottobre 2009 08.00 - 19.00<br />
Sabato 17 ottobre 2009 08.00 - 13.30<br />
Iscrizione in sede congressuale<br />
Soci <strong>SIF</strong> € 480,00<br />
Non soci <strong>SIF</strong> € 660,00<br />
Soci <strong>SIF</strong> non strutturati<br />
di età inferiore ai 38 anni*<br />
Non soci <strong>SIF</strong> non strutturati<br />
di età inferiore ai 38 anni*<br />
€ 90,00<br />
€ 180,00<br />
Cena Sociale € 75,00<br />
* al momento dell’iscrizione è necessario presentare fotocopia della carta di identità<br />
e dichiarazione del Direttore di Dipartimento.<br />
La quota comprende:<br />
• partecipazione ai lavori scientifici • kit congressuale • attestato di<br />
partecipazione • colazioni di lavoro a buffet<br />
VI VII<br />
Informazioni Generali
Informazioni Generali<br />
Pagamento quota di partecipazione<br />
Le quote di iscrizione possono essere pagate tramite:<br />
• contanti<br />
• assegno bancario o circolare intestato ad AIM Congress srl<br />
• carta di credito (Visa - Mastercard/Eurocard)<br />
Badge<br />
A ciascun partecipante regolarmente iscritto viene consegnato un<br />
badge nominativo che deve essere sempre esibito per poter accedere<br />
alle Aule dove si svolgono le sessioni scientifiche.<br />
Guardaroba<br />
Per i partecipanti del Congresso è disponibile un guardaroba custodito<br />
che osserva gli orari dei lavori. Si prega pertanto di ritirare i<br />
propri effetti personali entro l’orario di chiusura.<br />
Internet Point<br />
Due Internet Point gratuiti saranno disponibili nell’Area Poster per<br />
tutto il periodo del Congresso.<br />
Programma Sociale<br />
Mercoledì 14 ottobre, ore 19.45<br />
Mercoledì 14 ottobre 2009, è prevista, nella sala Arcobaleno, la<br />
Cerimonia di Apertura del Congresso, alla quale seguirà un Cocktail<br />
di Benvenuto per i partecipanti al Congresso.<br />
Venerdì 16 ottobre 2009, ore 20.30<br />
La cena Sociale si svolgerà presso le Sale Quattro Colonne e Veranda<br />
del Grand Hotel Rimini (Parco Federico Fellini, 1 – Rimini)<br />
INFORMAZIONI SCIENTIFICHE<br />
Contributi scientifici<br />
COMUNICAZIONI ORALI<br />
Sono previste 24 Sessioni di Comunicazioni Orali, suddivise in 14<br />
tematiche, per un totale di 186 interventi.<br />
Si raccomanda di rispettare il tempo di 15 minuti a disposizione per<br />
ciascuna comunicazione.<br />
I files delle presentazioni devono essere realizzati in Power Point<br />
(Sistema Operativo Windows) e devono essere consegnati al<br />
Centro Proiezioni con largo anticipo.<br />
POSTER<br />
Sono previste 2 sessioni in cui i 416 Poster accettati, suddivisi in<br />
18 tematiche, potranno essere discussi. Le sessioni si svolgeranno<br />
nell’Area Poster nei seguenti orari:<br />
Giovedì 15 ottobre P-1 Ore 14.00–16.00<br />
tematiche:<br />
P-1/1 Farmacologia del Sistema Nervoso<br />
P-1/2 Recettori e meccanismi di trasduzione del segnale<br />
P-1/3 Farmacologia dei canali ionici e della trasmissione sinaptica<br />
P-1/4 Morte e proliferazione cellulare<br />
P-1/5 Farmacologia del dolore<br />
P-1/6 Sostanze d’abuso<br />
P-1/7 Invecchiamento, comportamento e tossicologia<br />
Venerdì 16 ottobre P-2 Ore 14.00-16.00<br />
tematiche:<br />
P-2/1 Farmacologia Cardiovascolare e della funzione respiratoria<br />
P-2/2 Farmacologia dell’apparato digerente<br />
P-2/3 Farmacologia del metabolismo, del sistema endocrino e<br />
della disfunzione erettile<br />
P-2/4 Chemioterapia<br />
P-2/5 Farmacologia dell’infiammazione<br />
P-2/6 Immunofarmacologia<br />
P-2/7 Farmacoepidemiologia, Farmacovigilanza, Farmacoeconomia,<br />
Informazione sul farmaco, Vaccini<br />
P-2/8 Medicine complementari<br />
P-2/9 Farmaci innovativi e biotecnologici<br />
P-2/10 Farmacogenetica<br />
P-2/11 Sperimentazione clinica dei farmaci<br />
VIII IX<br />
Informazioni Scientifiche<br />
Informazioni Scientifiche
Informazioni Scientifiche<br />
I Poster dovranno essere redatti in lingua inglese e non superare i<br />
160 cm di altezza e i 90 cm di larghezza. Dovranno essere affissi<br />
sul pannello corrispondente al numero assegnato a partire dalle ore<br />
8.00 del giorno della discussione e dovranno essere rimossi entro le<br />
ore 18.00 dello stesso giorno. La segreteria non custodirà eventuali<br />
poster non rimossi entro i termini stabiliti.<br />
Gli Abstract di tutti i lavori accettati come comunicazioni orali e<br />
poster sono consultabili nella pendrive all’interno del kit congressuale.<br />
Premi Poster<br />
Saranno assegnati 25 premi per i migliori Poster.<br />
Le commissioni discuteranno con i presentatori i loro poster e poi<br />
decideranno collegialmente, a chi assegnare i premi.<br />
Assemblea dei Soci<br />
In occasione del Congresso, l’Assemblea generale dei Soci della<br />
Società Italiana di Farmacologia è convocata venerdì 16 ottobre,<br />
presso la sala Arcobaleno, alle ore 18.45.<br />
Allestimenti tecnici e centro proiezioni<br />
Ogni sala è dotata di videoproiettore collegato a computer e tutte<br />
le presentazioni saranno trasferite via LAN ai computer di sala per<br />
la proiezione.<br />
Al fine di evitare problemi di compatibilità tra i portatili dei relatori<br />
e i proiettori delle sale e per rendere più veloce il susseguirsi delle<br />
relazioni non è possibile collegare i propri computer nelle sale.<br />
I relatori devono recarsi al Centro Proiezioni (ubicato al pianterreno,<br />
accanto alle Registrazioni) almeno due ore prima dell’intervento<br />
per permettere ai tecnici di duplicare la presentazione e inoltrarla<br />
via LAN alle sale di pertinenza.<br />
Informazioni Scientifiche<br />
Informazioni Scientifiche<br />
Crediti di Educazione Continua in Medicina<br />
Per le giornate congressuali del 15, 16 e 17 ottobre è stata inoltrata<br />
domanda di accreditamento presso la Commissione Nazionale per la<br />
Formazione Continua in Medicina (ECM) del Ministero della Salute<br />
per le figure di Medico Chirurgo, Farmacista ed Infermiere, che hanno<br />
ottenuto i seguenti crediti:<br />
15 ottobre<br />
• medico chirurgo (n. 5362-9028219) : crediti 5<br />
• farmacista (n. 5362-9028220): crediti 5<br />
• infermiere (n. 5362-9028221): in attesa di assegnazione<br />
16 ottobre<br />
• medico chirurgo (n. 5362-9028232): crediti 4<br />
• farmacista (n. 5362-9028233): crediti 5<br />
• infermiere (n. 5362-9028234): crediti 4<br />
17 ottobre<br />
• medico chirurgo (n. 5362-9028243): crediti 4<br />
• farmacista (n. 5362-9028244): crediti 4<br />
• infermiere (n. 5362-9028245): in attesa di assegnazione<br />
Per ottenere i Crediti è necessario per il partecipante:<br />
• Essere iscritti al congresso<br />
• Compilare la scheda di valutazione, il questionario di apprendimento<br />
e la scheda recapiti partecipanti presente all’interno della<br />
borsa congressuale.<br />
• Partecipare nella misura del 100% ai lavori scientifici<br />
• Al termine dell’evento riconsegnare, presso l’apposito Desk ECM,<br />
tutta la documentazione debitamente compilata e firmata<br />
Controllo Presenze<br />
L’accreditamento del Congresso rende necessario un controllo delle<br />
presenze che viene effettuato tramite sistema elettronico.<br />
Ai partecipanti viene consegnato, insieme al badge nominativo, un<br />
badge elettronico che, funzionando in radiofrequenza e mediante il<br />
passaggio del partecipante attraverso il portale, è in grado di registrarne<br />
l’effettiva presenza.<br />
I partecipanti possono rivolgersi in qualsiasi momento al Desk ECM<br />
per verificare personalmente con il proprio badge magnetico le ore<br />
di presenza accumulate. La perdita o la mancata consegna del badge<br />
magnetico comporta l’addebito per il partecipante pari a € 7,00.<br />
X XI<br />
Informazioni Scientifiche
Informazioni Scientifiche<br />
Attestati ECM<br />
Gli attestati ECM verranno inviati, entro 90 giorni dal termine<br />
dell’evento, a tutti coloro che avranno partecipato interamente alle<br />
singole giornate congressuali e che avranno riconsegnato la documentazione<br />
debitamente compilata e firmata.<br />
Attestato di partecipazione<br />
L’attestato di partecipazione verrà rilasciato a tutti gli iscritti che ne<br />
faranno richiesta alla Segreteria in Sede Congressuale, al termine<br />
dei lavori scientifici.<br />
Esposizione tecnica farmaceutica<br />
Nell’ambito del Congresso è allestita un’esposizione Tecnico-Scientifica,<br />
che osserva gli orari dei lavori Congressuali.<br />
XII<br />
Informazioni Scientifiche<br />
Scientific Program
2.30<br />
pm<br />
3.15<br />
pm<br />
3.45<br />
pm<br />
WEDNESDAY, October 14, 2009<br />
Sala Arcobaleno<br />
Welcome Ceremony<br />
OPENING REMARKS<br />
Caputi A. P., President, <strong>SIF</strong><br />
Cantelli Forti G., President, Scientific Didactic Rimini Unit<br />
Alessandra BITTO<br />
Department of Clinical and<br />
Experimental Medicine and<br />
Pharmacology<br />
University of Messina<br />
PRESIDENT’S REPORT<br />
Caputi A. P. (Messina)<br />
Award Ceremony: FARMINDUSTRIA-<strong>SIF</strong> AWARDS<br />
Caputi A. P. (Messina) – Stefanelli E. (Rome)<br />
5 Awards for <strong>SIF</strong> Members (35 years old maximum)<br />
Ornella CUOMO<br />
Department of Neurosciences<br />
University of Naples<br />
“Federico II”<br />
Daniele DE FILIPPIS<br />
Department of Experimental<br />
Pharmacology<br />
University of Naples<br />
“Federico II”<br />
Luigia DI FRANCESCO<br />
Department of Medicine and<br />
Ageing Science<br />
University of Chieti “G.<br />
d'Annunzio”<br />
Francesco Mattia NOÉ<br />
Mario Negri Research<br />
Institute, Milan<br />
Bitto A, et al.: Polydeoxyribonucleotide improves<br />
angiogenesis and wound healing in experimental<br />
thermal injury. Crit Care Med 2008; 36:1594-602.<br />
Cuomo O, et al.: “A Critical Role for the Potassium-<br />
Dependent Sodium/Calcium Exchanger NCKX2 in<br />
Protection Against Focal Ischemic Brain Damage” J<br />
Neurosci 2008; 28:2053-63.<br />
De Filippis D, et al. Melatonin reverses<br />
lipopolysaccharide-induced gastro-intestinal motility<br />
disturbances through the inhibition of oxidative stress.<br />
J Pineal Res 2008; 44:45-51.<br />
Di Francesco L et al: Induction of Prostacyclin by<br />
Steady Laminar Shear Stress Suppresses Tumor<br />
Necrosis Factor- Biosynthesis via Heme Oxygenase-1<br />
in Human Endothelial Cells. Circ Res 2009;104:506-<br />
13. (accepted 2008)<br />
Noè F, et al.: Neuropeptide Y gene therapy decreases<br />
chronic spontaneous seizures in a rat model of<br />
temporal lobe epilepsy. Brain 2008; 131:1506-1515.<br />
1<br />
WEDNESDAY, October 14, 2009
WEDNESDAY, October 14, 2009<br />
5 Awards for Pharmaceutical Industry Researchers (40 years old maximum)<br />
Paola BOGANI<br />
Novartis Pharma<br />
Paolo CAPPELLA<br />
Nerviano Medical Sciences<br />
Claudia PATRIGNANI<br />
Merck Serono<br />
Emiliano TOSO<br />
Merck Serono<br />
Claudio VALENTI<br />
Menarini Ricerche<br />
Bellosta S, Bogani P, et al.: Mediterranean diet and<br />
cardioprotection: wild artichoke inhibits<br />
metalloproteinase 9. Mol Nutr Food Res. 2008;<br />
52:1147-52.<br />
Cappella P, et al:. A novel method based on click<br />
chemistry, which overcomes limitations of cell cycle<br />
analysis by classical determination of BrdU<br />
incorporation, allowing multiplex antibody staining.<br />
Cytometry A. 2008; 73:626-36.<br />
Patrignani C, et al.: Knockout mice reveal a role for<br />
protein tyrosine phosphatase H1 in cognition. Behav<br />
Brain Funct. 2008; 4:36:1–14<br />
Toso E. Genotypic Characterisation Studies of<br />
Recombinant Cell Lines. Keeping Genetic Stability<br />
under Control. BIOforum Europe 9/2008.<br />
Valenti C, et al.:. MEN16132, a kinin B2 receptor<br />
antagonist, prevents the endogenous bradykinin<br />
effects in guinea-pigs airways. Eur J Pharmacol.<br />
2008; 579:350-356.<br />
2<br />
4.00<br />
pm<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.15<br />
pm<br />
6.35<br />
pm<br />
6.55<br />
pm<br />
7.15<br />
pm<br />
7.45<br />
pm<br />
THE VALUE OF SAFETY<br />
Stricker B. (Rotterdam)<br />
WEDNESDAY, October 14, 2009<br />
Sala Arcobaleno<br />
Plenary Lecture<br />
Introduction: Caputi A. P. (Messina)<br />
Round Table<br />
SCIENTIFIC ACTIVITY PUBLIC FUNDING AND GLOBAL ECONOMIC<br />
CRISIS: INDIVIDUAL MEASURES AND THEIR INTEGRATION<br />
Chairpersons: Maggi A. (Milan),<br />
Riccardi C. (Perugia), Rossi F. (Naples)<br />
EU SEVENTH FRAMEWORK PROGRAMME (FP7)<br />
Serafini L. (Brussels)<br />
INNOVATIVE MEDICINE INITIATIVE<br />
Ruberti G. (Monterotondo)<br />
INDUSTRY 2015<br />
Cavazza C. (Pomezia)<br />
INTEGRATION OF NATIONAL AND EUROPEAN ENTERPRISES<br />
Gaviraghi G. (Siena)<br />
PHARMACEUTICAL POSITION<br />
Stefanelli E. (Rome)<br />
PUBLIC FUNDING FOR SCIENTIFIC RESEACH IN THE CRISIS<br />
PERIOD: THE BIOTECH INDUSTRY POSITION<br />
Gradnik R. (Milan)<br />
Welcome Cocktail<br />
Commentary<br />
NEW PROPOSALS FROM CUN<br />
Cuomo V. (Rome)<br />
3<br />
WEDNESDAY, October 14, 2009
THURSDAY, October 15, 2009<br />
THURSDAY, October 15, 2009<br />
Sala Arcobaleno – 8.30-10.30 am<br />
Oral Communications<br />
PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 1)<br />
Chairpersons: Concas A. (Cagliari), Racagni G. (Milan)<br />
8.30 am ENDOCANNABINOIDS IN THE RAT BASOLATERAL<br />
AMYGDALA ENHANCE MEMORY CONSOLIDATION AND<br />
ENABLE GLUCOCORTICOID MODULATION OF MEMORY<br />
Campolongo P., Trezza V., Roozendaal B., Hauer D.,<br />
Schelling G., McGaugh J., Cuomo V. (Rome, Groningen,<br />
Munich, Irvine)<br />
8.45 am NEUROSTEROIDS AND SENSITIVITY TO STRESS IN<br />
SOCIALLY ISOLATED OFFSPRING<br />
Pisu M., Dore R., Biggio G., Serra M. (Cagliari)<br />
9.00 am REDUCED ADULT NEUROGENESIS AND ALTERED<br />
EMOTIONAL BEHAVIOURS IN AUTOIMMUNE-PRONE BAFF<br />
TRANSGENIC MICE<br />
Crupi R., Cambiaghi M., Spatz L., Hen R., Vita G., Spina<br />
E., Battaglia F. (Messina, New York, Milan)<br />
9.15 am MICRODIALYSIS STUDY OF STRIATAL DOPAMINE<br />
CHANGES IN A A-SYNUCLEIN-GENERATED RAT MODEL OF<br />
PARKINSON’S DISEASE<br />
Bazzu G., Negro A., Grigoletto J., Giusti P., Serra P.,<br />
Desole M., Miele E. (Sassari, Padua)<br />
9.30 am MATHERHOOD INCREASES BDNF, ARC AND LONG-TERM<br />
POTENTIATION IN THE RAT BRAIN: REVERSAL BY THE<br />
OFFSPRING SEPARATION<br />
Mostallino M., Secci P., Mura M., Maciocco E., Murru L.,<br />
Sanna E., Biggio G. (Cagliari)<br />
9.45 am ACUTE BEHAVIOURAL STRESS INCREASES GLUTAMATE<br />
RELEASE AND PRESYNAPTIC SNARE COMPLEX<br />
ACCUMULATION IN PREFRONTAL/FRONTAL CORTEX. THE<br />
DAMPENING ACTION OF ANTIDEPRESSANTS<br />
Tardito C., Musazzi L., Milanese M., Farisello P., Barbiero<br />
V., Zappettini S., Bonifacino T., Mallei A., Baldelli P.,<br />
Racagni G., Raiteri M., Benfenati F., Bonanno G., Popoli M.<br />
(Milan, Genoa)<br />
10.00 am 17ß-ESTRADIOL MINIMIZES INTRAVITREAL GLUTAMATE<br />
INCREASE AFTER TRANSIENT ISCHEMIA/REPERFUSION IN<br />
4<br />
RAT<br />
Cavaliere F., Russo R., Varano G., Rombolà L., Corasaniti<br />
M., Bagetta G., Morrone L. (Cosenza, Catanzaro)<br />
10.15 am RANTES MODULATES CENTRAL GLUTAMATERGIC<br />
NEUROTRANSMISSION IN HUMAN AND MOUSE NEOCORTEX<br />
Summa M., Musante V., Severi P., Raiteri M., Pittaluga A.<br />
(Genoa)<br />
5<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Azzurra – 8.30-10.30 am<br />
Symposium<br />
VARIABILITY OF THE RESPONSE TO ANTIPLATELET DRUGS:<br />
CAUSES, EVIDENCE AND FUTURE PERSPECTIVES<br />
Chairpersons: Patrono C. (Rome), Tremoli E. (Milan)<br />
VARIABILITY, NOT RESISTANCE, IN THE RESPONSE TO ASPIRIN:<br />
METHODS AND EVIDENCE<br />
Rocca B. (Rome)<br />
PHARMACOKINETICS AND PHARMACOGENOMIC VARIABILITY IN<br />
THE RESPONSE TO P2Y12 BLOCKERS<br />
Cattaneo M. (Milan)<br />
ENVIRONMENT AND LIFE STYLE: CAN THEY AFFECT THE<br />
RESPONSE TO THE ANTIPLATELET AGENTS?<br />
De Gaetano G. (Campobasso)<br />
FUTURE PERSPECTIVES: NEW HYPOTHESES FOR THE OLD DRUGS<br />
AND NEW ANTIPLATELET AGENTS: STRATEGIES AGAINST<br />
VARIABILITY?<br />
Patrignani P. (Chieti)<br />
(Educational support from Eli Lilly Italia and Daiichi Sankyo)<br />
6<br />
THURSDAY, October 15, 2009<br />
Sala Blu – 8.30-10.30 am<br />
Oral Communications<br />
PHARMACOLOGY OF DEATH AND CELL PROLIFERATION<br />
(SESSION 1)<br />
Chairpersons: Cantoni O. (Urbino), Grilli M. (Novara)<br />
8.30 am THE GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ)<br />
AND ITS NEW ISOFORM L-GILZ INHIBIT MYOGENIC<br />
TERMINAL DIFFERENTIATION AND MEDIATE ANTI-<br />
MYOGENIC EFFECTS OF GLUCOCORTICOIDS<br />
Bruscoli S., Donato V., Velardi E., Di Sante M., Coppo M.,<br />
Bastianelli A., Bereshchenko O., Canarile L., Riccardi C.<br />
(Perugia)<br />
8.45 am NF-kappa1 GENE DISRUPTION RESULTS IN SELECTIVE<br />
DEFICITS IN ADULT HIPPOCAMPAL NEUROGENESIS AND<br />
IN SHORT-TERM MEMORY IMPAIRMENT<br />
Dellarole A., Francese M., Bortolotto V., Crociara P.,<br />
Quadrato G., Canonico P. L., Orsetti M., Ghi P., Memo M.,<br />
Sara Anna B., Ferrari Toninelli G., Denis-Donini S., Grilli M.<br />
(Novara, Turin, Brescia, Milan)<br />
9.00 am ACID SPHINGOMYELINASE, NITRIC OXIDE AND SYNTAXIN<br />
4: AN IMPORTANT LINK BETWEEN APOPTOSIS AND<br />
EXOCYTOSIS<br />
Perrotta C., Bizzozero L., Morlacchi S., Cazzato D.,<br />
Gulbins E., Bassi M., Rosa P., Clementi E. (Milan, Essen)<br />
9.15 am PIVOTAL ROLE OF 12-LIPOXYGENASE IN THE REGULATION<br />
OF ASTROCYTE SURVIVAL TO PEROXYNITRITE<br />
Palomba L., Cerioni L., Cantoni O. (Urbino)<br />
9.30 am R-ROSCOVITINE SENSITIZES ANAPLASTIC THYROID<br />
CARCINOMA CELLS TO TRAIL-INDUCED APOPTOSIS VIA<br />
REGULATION OF IKK/NF-KB PATHWAY<br />
Festa M., Petrella A., Alfano S., Parente L. (Fisciano)<br />
9.45 am ACTIVATION OF mGLU3 RECEPTORS STIMULATES THE<br />
PRODUCTION OF GDNF IN STRIATAL NEURONS<br />
Traficante A., Battaglia G., Molinaro G., Riozzi B., Storto<br />
M., Busceti C., Spinsanti P., Bucci D., Di Liberto V., Mudò<br />
G., Corti C., Corsi M., Nicoletti F., Belluardo N., Bruno V.<br />
(Pozzilli, Rome, Palermo, Verona)<br />
7<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
10.00 am AUTOPHAGY IN NEONATAL HYPOXIA-ISCHEMIA INDUCED<br />
BRAIN INJURY<br />
Balduini W., Carloni S., Girelli S., Buonocore G. (Urbino,<br />
Siena)<br />
10.15 am CANNABIDIOL, A NON-PSYCHOACTIVE CANNABINOID<br />
COMPOUND, INHIBITS HUMAN GLIOMA CELL MIGRATION<br />
AND INVASIVENESS<br />
Valenti M., Massi P., Bolognini D., Solinas M., Parolaro D.<br />
(Varese, Milan)<br />
8<br />
8.30<br />
am<br />
8.50<br />
am<br />
9.10<br />
am<br />
9.30<br />
am<br />
9.50<br />
am<br />
10.10<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Giardino d’Inverno – 8.30-10.30 am<br />
Symposium<br />
PATHOGENIC MECHANISMS AND DRUGABLE TARGETS IN POST-<br />
ISCHEMIC BRAIN INJURY<br />
Chairpersons: Pellegrini-Giampietro D. (Florence),<br />
Pizzi M. (Brescia)<br />
TEMPORAL AND BRAIN REGIONAL DEFINITION OF THE<br />
NEUROINFLAMMATORY RESPONSE TO TRANSIENT FOCAL<br />
CEREBRAL ISCHEMIA IN RAT<br />
Amantea D. (Castrolibero)<br />
ROLE OF THE AKAP SCAFFOLDS AND THE UBIQUITIN-<br />
PROTEASOME PATHWAY IN THE PHYSIOLOGICAL RESPONSE TO<br />
BRAIN ISCHEMIA<br />
Feliciello A. (Naples)<br />
BRAIN ISCHEMIC POSTCONDITIONING EXERTS ITS<br />
NEUROPROTECTIVE EFFECT BY MODULATING ASIC1A AND NCX3<br />
EXPRESSION IN THE ISCHEMIC PENUMBRA REGION<br />
Pignataro G. (Naples)<br />
PRE-CONDITIONING AND POST-CONDITIONING AGAINST<br />
CEREBRAL ISCHEMIA: FROM EXPERIMENTAL STRATEGIES TO<br />
CLINICAL USE<br />
Gerace E. (Florence)<br />
TARGETING NF-KB AND EPIGENETIC CHROMATIN REMODELLING<br />
IN THE THERAPY OF POST-ISCHEMIC BRAIN INJURY<br />
Sarnico I. (Brescia)<br />
ENDOGENOUS NEURAL STEM CELL-BASED THERAPIES FOR<br />
STROKE: FOCUS ON GPR17, A NEW DUAL PURINERGIC/<br />
CYSTEINYL-LEUKOTRIENE RECEPTOR<br />
Abbracchio M. P. (Milan)<br />
9<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Viola – 8.30-10.30 am<br />
Symposium<br />
HUNTINGTON DISEASE - AN ORPHAN ILLNESS WITH HIGH<br />
MEDICAL NEED<br />
Chairpersons: Gaviraghi G. (Siena), Pepeu G. (Florence)<br />
KNOCKING DOWN THE DRUGGABLE GENOME FOR HD TARGET<br />
DISCOVERY<br />
Caricasole A. (Siena)<br />
TRANSLATIONAL RESEARCH AND THE CHALLENGE OF DISEASE<br />
ANIMAL MODELS<br />
Palfi S. (Creteil)<br />
STEM CELLS AS A TOOL FOR DRUG DISCOVERY AND POTENTIAL<br />
THERAPEUTICS IN HUNTINGTON'S DISEASE<br />
Zuccato C. (Milan)<br />
DEVELOPMENT OF NOVEL PHARMACO-THERAPIES FOR HD<br />
Terstappen G. C. (Siena)<br />
(Educational support from Siena Biotech)<br />
10<br />
8.30<br />
am<br />
8.50<br />
am<br />
9.10<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Arancione – 8.30-10.30 am<br />
Symposium<br />
PALMITOYLETHANOLAMIDE ANTINFLAMMATORY/ NEURO-<br />
PROTECTIVE PROPERTIES: THE PHARMACOLOGICAL BASES FOR<br />
NOVEL PUTATIVE THERAPEUTIC AGENTS<br />
Chairpersons: Skaper S. (Harlow), Steardo L. (Rome)<br />
PALMITOYLETHANOLAMIDE CONTROL OF MAST CELL MEDIATOR<br />
RELEASE: NEW PROSPECTIVE IN CHRONIC INFLAMMATION<br />
Iuvone T. (Naples)<br />
PEA ANTIALLODYNIC AND ANTIHYPERALGESIC EFFECTS IN A<br />
MURINE MODEL OF NEUROPATHIC PAIN<br />
Costa B. (Milan)<br />
EFFECTS OF PALMITOYLETHANOLAMIDE ON THE DEVELOPMENT<br />
OF SPINAL CORD INJURY<br />
Cuzzocrea S. (Messina)<br />
ANTINFLAMMATORY/NEUROPROTECTIVE PROPERTIES OF<br />
PALMITOYLETHANOLAMIDE IN A MODEL OF ALZHEIMER’S<br />
DISEASE<br />
Scuderi C. (Rome)<br />
ANTI-INFLAMMATORY PROPERTIES OF<br />
PALMITOYLETHANOLAMIDE: IMPLICATIONS IN EXPERIMENTAL<br />
MULTIPLE SCLEROSIS<br />
Guaza C. (Madrid)<br />
11<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Bianca – 8.30-10.30 am<br />
Symposium<br />
TRP CHANNELS IN HEALTH AND DISEASE<br />
Chairpersons: Geppetti P. (Florence), Trevisani M. (Ferrara)<br />
TRPC CHANNELS AND HYPOXIA SIGNALING<br />
Gudermann T. (Munich)<br />
TRP CHANNELS IN THE GASTROINTESTINAL TRACT WITH<br />
SPECIAL REFERENCE TO PANCREATIC Β-CELLS<br />
Oberwinkler J. (Homburg)<br />
THE RISING ROLE OF TRPA1 IN ASTHMA<br />
Patacchini R. (Parma)<br />
TRP CHANNELS: FROM PLANTS TO MAMMALS<br />
Appendino G. (Novara)<br />
(Educational support from Chiesi Farmaceutici)<br />
12<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Verde – 8.30-10.30 am<br />
Symposium<br />
NON-INVASIVE METHODS AND BIOMARKERS FOR ASSESSING<br />
PHARMACOLOGICAL THERAPY OF CHRONIC OBSTRUCTIVE<br />
PULMONARY DISEASE<br />
Chairpersons: Folco G. C. (Milan), Olivieri D. (Parma)<br />
METABOLOMICS OF EXHALED BREATH CONDENSATE<br />
Montuschi P. (Rome)<br />
EXHALED NITRIC OXIDE<br />
Clini E. (Pavullo)<br />
ANALYSIS OF SPUTUM INDUCTION<br />
Aiello M., Nicolini G., Olivieri D. (Parma)<br />
LIPIDS AS PRO-AND ANTI-INFLAMMATORY AGENTS<br />
Sala A. (Milan)<br />
(Educational support from PRIN)<br />
13<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
THURSDAY, October 15, 2009<br />
Sala Rossa – 8.30-10.30 am<br />
Oral Communications<br />
PHARMACOGENETICS<br />
Chairpersons: Fornasari D. (Milan),<br />
Genazzani A. (Novara)<br />
8.30 am ASSOCIATION BETWEEN GENOTYPES AND RESPONSE TO<br />
IMATINIB MESYLATE TREATMENT IN A SUBSET OF<br />
PREVIOUSLY UNTREATED PATIENTS AFFECTED BY<br />
GASTROINTESTINAL STROMAL TUMOURS<br />
Angelini S., Pantaleo M., Turrini E., Di Battista M., Biasco<br />
G., Cantelli Forti G., Hrelia P. (Bologna)<br />
8.45 am DIFFERENT RESPONSE TO DRUG THERAPY FROM<br />
OSTEOPOROTIC PATIENTS<br />
Conti V., Rinaldi B., Russomanno G., Toro A., Tripodi F.,<br />
Ciaramella N., Ruggiero F., Rossi F. (Naples, Mercato San<br />
Severino)<br />
9.00 am ADVERSE REACTIONS TO COMT INHIBITORS IN<br />
PARKINSON’S DISEASE PATIENTS: POSSIBLE<br />
ASSOCIATION WITH THE UGT1A9 GENE HAPLOTYPE<br />
Ferrari M., Loraschi A., Marino F., Riboldazzi G., Zangaglia<br />
R., Pianezzola C., Bono G., Lecchini S., Nappi G., Martignoli<br />
E., Cosentino M. (Varese, Pavia, Veruno, Rome)<br />
9.15 am EFFECTS OF CELECOXIB ON PROSTANOID BIOSYNTHESIS<br />
AND INFLAMMATORY AND ANGIOGENIC BIOMARKERS IN<br />
PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS<br />
Tacconelli S., Capone M., Dovizio M., Bruno A., Sciulli M.,<br />
Sala P., Signorini S., Bertario L., Dixon D., Lawson J.,<br />
FitzGerald G., Patrignani P. (Chieti, Milan, Columbia,<br />
Philadelphia)<br />
9.30 am IMPACT OF CYP2C9 AND VKORC1 POLYMORPHISMS ON<br />
PHARMACOKINETICS AND PHARMACODYNAMICS OF<br />
WARFARIN IN PATIENTS ON ANTICOAGULANT THERAPY<br />
Nisi A., Schiavon S., Zambon C., De Rosa G., Basso D.,<br />
Pengo V., Gusella M., Plebani M., Padrini R. (Padua,<br />
Rovigo)<br />
9.45 am EVALUATION OF DRUG RESPONSES IN NON-<br />
TRANSFORMED CELLS CARRYING CANCER ALLELES<br />
Gallicchio M., Di Nicolantonio F., Arena S., Zecchin D.,<br />
Martini M., Flonta S., Stella G., Lamba S., Cancelliere C.,<br />
14<br />
Russo M., Geuna M., Appendino G., Fantozzi R., Medico E.,<br />
Bardelli A. (Turin, Candiolo, Pavia, Novara, Milan)<br />
10.00 am ANALYSIS OF SEROTONIN TRANSPORTER 5HTTLPR AND<br />
CHOLECYSTOKININ TYPE 1 RECEPTOR GENE<br />
POLYMORPHISMS, CLINICAL VARIANTS AND SYMPTOM<br />
SEVERITY IN PATIENTS WITH IRRITABLE BOWEL<br />
SYNDROME<br />
Ghisu N., Colucci R., Bellini M., Rossi G., Gambaccini D.,<br />
Blandizzi C., Costa F., Marchi S., Del Tacca M. (Pisa)<br />
10.15 am GENETIC FACTORS INCREASE SUSCEPTIBILITY TO TAU<br />
PROTEIN HYPERPHOSPHORYLATION IN THE BRAIN OF<br />
MICE TREATED WITH 3,4-<br />
METHYLENDIOXYMETHAMPHETAMINE (“ECSTASY”)<br />
Biagioni F., Busceti C., Bucci D., Mastroiacovo F., Riozzi<br />
B., Battaglia G., Bruno V., Cassano T., Cuomo V., Fornai<br />
F., Nicoletti F. (Pozzilli, Rome, Foggia, Pisa)<br />
15<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
10.45<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Azzurra – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Paoletti R. (Milan)<br />
INNOVATION IN ANTIHYPERTENSIVE THERAPY: ALISKIREN<br />
Corsini A. (Milan)<br />
(Educational support from Novartis Farma)<br />
16<br />
10.45<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Blu – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Mazzei T. (Florence)<br />
AS04: THE BENEFITS OF THE NEW ADJUVANT SYSTEM FOR<br />
PREVENTION OF CERVICAL CANCER<br />
Scaglione F. (Milan)<br />
(Educational support from GlaxoSmithKline)<br />
17<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
10.45<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Giardino d’Inverno – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Danesi R. (Pisa)<br />
FIGHTING CANCER ON MULTIPLE FRONTS: THE AMGEN<br />
ONCOLOGY AND HAEMATOLOGY PIPELINE<br />
Suto T. (Zug)<br />
(Educational support from Amgen Dompé)<br />
18<br />
10.45<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Viola – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Fantozzi R. (Turin)<br />
SAFETY AND EFFICACY OF CANAKINUMAB (ACZ885) IN<br />
CHILDREN WITH CRYOPYRIN ASSOCIATED PERIODIC FEVER<br />
SYNDROME (CAPS): RESULTS OF A MULTICENTRE, RANDOMIZED<br />
DOUBLE BLIND, PHASE III STUDY<br />
Gattorno M. (Genoa)<br />
(Educational support from Novartis Farma)<br />
19<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
10.45<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Bianca – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Preziosi P. (Rome)<br />
CRITICALITIES ABOUT GENERIC DRUGS<br />
Navarra P. (Rome)<br />
(Educational support from Wyeth Lederle)<br />
20<br />
11.15<br />
am<br />
11.45<br />
am<br />
12.15<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Azzurra – 11.15 am-1.15 pm<br />
Symposium<br />
BEYOND THE CARDIOVASCULAR RISK<br />
Chairperson: Catapano A. (Milan)<br />
FOCUS ON ROSUVASTATIN: EFFICACY ON THE COMPREHENSIVE<br />
LIPID PROFILE AND INFLAMMATION<br />
Bernini F. (Parma)<br />
INFLAMMATION, LIPOPROTEINS AND ATHEROSCLEROSIS: THE<br />
NEW MARKERS<br />
Urbinati S. (Bologna)<br />
(Educational support from AstraZeneca)<br />
LECTURE<br />
Introduction: Rossi F. (Naples)<br />
THE LATE INAS: A NEW THERAPEUTIC TARGET IN ANGINA<br />
Mugelli A. (Florence)<br />
(Educational support from A. Menarini)<br />
21<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
11.15<br />
am<br />
11.45<br />
am<br />
12.15<br />
pm<br />
12.45<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Blu – 11.15 am-1.15 pm<br />
Symposium<br />
THERAPEUTIC APPROACH AND OPTIMIZATION OF RESOURCES IN<br />
RHEUMATIC DISEASES<br />
Chairpersons: Giusti P. (Padua), Riccardi C. (Perugia)<br />
CELLULAR AND MOLECULAR MECHANISMS UNDERLYING<br />
RHEUMATIC DISEASES<br />
Nocentini G. (Perugia)<br />
PHARMACOLOGY OF BIOLOGIC DRUGS USED IN THE TREATMENT<br />
OF RHEUMATIC DISORDERS<br />
Debetto P. (Padua)<br />
THERAPEUTIC STRATEGIES FOR CHRONIC IDIOPATHIC<br />
ARTHRITIS<br />
Montecucco C. (Pavia)<br />
RHEUMATIC DISEASES: A STUDY TO EVALUATE SOCIAL COSTS<br />
IN THE NEXT 30 YEARS IN DIFFERENT ITALIAN REGIONS<br />
Cicchetti A. (Rome)<br />
(Educational support from Abbott)<br />
22<br />
11.15<br />
am<br />
11.35<br />
am<br />
11.55<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Giardino d’Inverno – 11.15 am -0.15 pm<br />
Symposium<br />
PATIENT NEED AND OPTIMIZATION OF OSTEOPOROSIS<br />
MANAGEMENT<br />
Chairpersons: Adami S. (Verona), Canonico P. L. (Novara)<br />
POSTMENOPAUSAL OSTEOPOROSIS: CLINICAL EVALUATION,<br />
THERAPEUTIC STRATEGIES AND UNMET NEEDS<br />
Bianchi G. (Genoa)<br />
NEW PERSPECTIVES IN THE TREATMENT OF OSTEOPOROSIS<br />
Sinigaglia L. (Novara)<br />
NEW THERAPEUTIC PERSPECTIVES IN OSTEOPOROSIS: FROM<br />
MECHANISM OF ACTION TO CLINICAL CARE<br />
Adami S. (Verona)<br />
(Educational support from Amgen Dompé)<br />
23<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
11.15<br />
am<br />
11.35<br />
am<br />
11.55<br />
am<br />
12.15<br />
pm<br />
12.35<br />
pm<br />
12.55<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Viola – 11.15 am -1.15 pm<br />
<strong>SIF</strong>-<strong>SIF</strong>O Symposium<br />
INDEPENDENT DRUG INFORMATION AS A TOOL FOR AN<br />
APPROPRIATED AND SAFER USE OF MEDICINES<br />
Chairpersons: Fantozzi R. (Turin), Piacentini P. (Milan)<br />
INFORMATION AS A TOOL FOR AN APPROPRIATED AND SAFER<br />
USE OF MEDICINES<br />
Miracapillo R. (Bari)<br />
PROVIDING INDEPENDENT DRUG INFORMATION IN A UK<br />
HOSPITAL<br />
Proudlove C. (London)<br />
PROVIDING INDEPENDENT DRUG INFORMATION IN AN ITALIAN<br />
HOSPITAL<br />
Polidori P. (Palermo)<br />
INDEPENDENT DRUG INFORMATION AS A TOOL FOR A BETTER<br />
PRESCRIBING APPROPRIATENESS: THE EXPERIENCE OF<br />
“FARMACI IN EVIDENZA” A NEWSLETTER FROM THE ITALIAN<br />
SOCIETY OF PHARMACOLOGY<br />
Rosa A. C. (Turin)<br />
DRUG INFORMATION AT A REGIONAL LEVEL<br />
Venturini F. (Verona)<br />
THE ROLE OF THE ITALIAN REGULATORY AGENCY<br />
Addis A. (Rome)<br />
(Educational support from Thomson Reuters, provider of MICROMEDEX)<br />
24<br />
11.15<br />
am<br />
11.35<br />
am<br />
11.55<br />
am<br />
12.15<br />
pm<br />
12.35<br />
pm<br />
12.55<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Arancione – 11.15 am -1.15 pm<br />
Symposium<br />
PRINCIPLES OF PSYCHOTROPIC DRUG INTERACTIONS<br />
Chairpersons: Drago F. (Catania), Palmieri G. (Milan),<br />
Racagni G. (Milan)<br />
INTRODUCTION<br />
Palmieri G. (Milan)<br />
PRINCIPLES OF PHARMACOLOGICAL INTERACTIONS<br />
Racagni G. (Milan)<br />
PHARMACOVIGILANCE AND ADVERSE EVENT REPORTING<br />
Drago F. (Catania)<br />
PSYCHOTROPIC DRUG-DRUG INTERACTIONS IN PSYCHIATRY<br />
Caraci F. (Catania)<br />
PSYCHOTROPIC DRUG-DRUG INTERACTIONS IN NEUROLOGICAL<br />
SETTING<br />
Brunello N. (Modena)<br />
INTERACTIONS BETWEEN PSYCHOTROPIC AGENTS AND DRUGS<br />
USED IN INTERNAL MEDICINE<br />
Spina E. (Messina)<br />
(Educational support from Innova Pharma)<br />
25<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
11.15<br />
am<br />
12.00<br />
pm<br />
12.45<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Bianca – 11.15 am-1.15 pm<br />
Symposium<br />
GENERIC DRUGS: THE ITALIAN STATUS<br />
Chairpersons: Navarra P. (Rome), Saffi-Giustini E. (Pontedera)<br />
EVOLUTION OF GENERICS MARKET IN ITALY AND WORLD-WIDE<br />
Foresti G. (Milan)<br />
GENERICS AND POTENTIAL DRUG EXPENSES REDUCTION FOR<br />
NHS<br />
Giorni L. (Florence)<br />
GENERICS AND QUALITY ISSUES<br />
Tonini M. (Pavia)<br />
(Educational support from ASSOGENERICI)<br />
26<br />
11.15<br />
am<br />
11.35<br />
am<br />
11.55<br />
am<br />
THURSDAY, October 15, 2009<br />
Sala Verde – 11.15 am -12.15 pm<br />
Symposium<br />
ROFLUMILAST: A NEW THERAPEUTIC APPROACH TO COPD<br />
Chairpersons: Cirino G. (Naples), Folco G. C. (Milan),<br />
AN OVERVIEW ON PDE4 INHIBITORS<br />
Cirino G. (Naples)<br />
PATHOGENESIS OF COPD: WHICH ROLE FOR PDE4 INHIBITORS?<br />
Luisetti M. (Pavia)<br />
ROFLUMILAST, A NOVEL PDE4 INHIBITOR: PRECLINICAL PROFILE<br />
Lungarella G. (Siena)<br />
(Educational support from Nycomed)<br />
27<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
THURSDAY, October 15, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-1/1/1<br />
P-1/1/2<br />
P-1/1/3<br />
P-1/1/4<br />
P-1/1/5<br />
Poster Session<br />
P-1/1: PHARMACOLOGY OF NERVOUS SYSTEM<br />
Poster Commission Members:<br />
President: Spano P. F. (Brescia)<br />
Members: Brunello N. (Milan), Bruno V. (Rome), Di<br />
Luca M. (Milan), Pellegrini-Giampietro D. (Florence),<br />
Serra M. (Cagliari), Sortino M.A. (Catania)<br />
OSTEOPENIA BY RISPERIDONE-INDUCED<br />
HYPERPROLACTINEMIA: A CASE REPORT<br />
Capasso A., Milan W., Milan L., Siano C., Petrella C.<br />
(Fisciano)<br />
THE GHB ANALOGUE N-(4-TRIFLUOROMETHYL)-4-<br />
METHOXYBUTANAMIDE PREVENTS THE BEHAVIORAL AND<br />
NEURODEGENERATIVE CONSEQUENCES OF REPEATED<br />
EPISODES OF ALCOHOL WITHDRAWAL, IN RATS<br />
Tacchi R., Spaccapelo L., Maccio L., Ferrari A., Rivasi F.,<br />
Bertolini A. (Modena)<br />
LIGHT AND SHADE OF THERAPEUTIC DRUG MONITORING<br />
OF ANTIEPILEPTIC DRUGS<br />
Furlanut M., Cojutti P., Franceschi L. (Udine)<br />
SEROTONIN2C RECEPTORS IN THE MEDIAL PREFRONTAL<br />
CORTEX FACILITATE COCAINE-INDUCED DOPAMINE<br />
RELEASE IN THE RAT NUCLEUS ACCUMBENS<br />
Leggio G., Cathala A., Moison D., Cunningham K., Piazza<br />
P., Spampinato U. (Bordeaux, Catania, Galveston)<br />
ASSOCIATION STUDY BETWEEN MEDICATION OVERUSE<br />
HEADACHE AND POLYMORPHIC VARIANTS OF<br />
SEROTONERGIC GENES<br />
Terrazzino S., Sances G., Cereda C., Viana M., Nappi G.,<br />
Rinaldi M., Canonico P. L., Genazzani A. (Novara, Pavia)<br />
P-1/1/6 OPPOSITE REGULATION OF CB1-MEDIATED EFFECTS BY<br />
28<br />
P-1/1/7<br />
P-1/1/8<br />
P-1/1/9<br />
P-1/1/10<br />
P-1/1/11<br />
P-1/1/12<br />
P-1/1/13<br />
PRE- AND POST-SYNAPTIC ADENOSINE A2A RECEPTORS IN<br />
THE STRIATUM<br />
Tebano M., Martire A., Kofalvi A., Chiodi V., Domenici M.,<br />
Pepponi R., Ferreira S., Ferrante A., Chen J., Cunha R.,<br />
Popoli P. (Rome, Boston, Coimbra)<br />
DEATH RESISTANT NEURAL STEM CELLS REGENERATE<br />
NEURONAL TISSUE AND PROMOTE FUNCTIONAL<br />
RECOVERY AFTER TRANSPLANTATION IN A SPINAL CORD<br />
INJURY MODEL<br />
Marfia G., Madaschi L., Merli D., Menarini M., Marra F.,<br />
Gualeni A., Naselli F., Carelli S., Di Giulio A., Gorio A.<br />
(Milan, Rozzano, Imola)<br />
DEATH RESISTANT NEURAL PROGENITORS YIELD MOSTLY<br />
NEURONS: AN ERYTHROPOIETIN-DEPENDENT PROCESS<br />
Marra F., Marfia G., Madaschi L., Merli D., Bottai D.,<br />
Carelli S., Menarini M., Di Giulio A., Gorio A. (Milan, Imola,<br />
Rozzano)<br />
ERYRHROPOIETIN INCREASES NEURONAL<br />
DIFFERENTIATION OF NEURAL STEM CELLS AND DEATH<br />
RESISTANT NEURAL STEM CELLS<br />
Gualeni A., Naselli F., Merli D., Menarini M., Marra F.,<br />
Gervasi N., Carelli S., Madaschi L., Marfia G., Di Giulio A.,<br />
Gorio A. (Milan, Imola, Rozzano)<br />
FAILURE OF THE CB1 RECEPTOR ANTAGONIST SR141716A<br />
(RIMONABANT) TO INDUCE ANTIDEPRESSANT-LIKE<br />
EFFECT IN THE RAT FORCED SWIMMING TEST<br />
Bogliolo V., Garzia A., Serra G., D'Aquila P., Serra G.<br />
(Sassari, Rome)<br />
MAGNETIC AND FLUORESCENCE LABELLING FOR IN VIVO<br />
NEURAL STEM CELL TRANSPLANTATION MONITORING<br />
Merli D., Lui R., Marfia G., Clerici M., Ottobrini L.,<br />
Lucignani G., Carelli S., Marra F., Di Giulio A., Gorio A.<br />
(Milan, Rozzano)<br />
PALMITOYLTHENOLAMIDE CONTROLS THE PRO-<br />
ANGIOGENIC PATHWAY INDUCED BY BETA AMYLOID IN<br />
GLIAL CELLS<br />
Cipriano M., Scuderi C., De Filippis D., Esposito G., Di<br />
Marzo V., Steardo L., Iuvone T. (Naples, Rome)<br />
HMGB1-EVOKES GLUTAMATE RELEASE FROM GLIOSOMES<br />
FRESHLY PREPARED FROM ADULT MOUSE BRAIN<br />
Milanese M., Bonifacino T., Zappettini S., Pedrazzi M.,<br />
Passalacqua M., Sparatore B., Melloni E., Bonanno G.<br />
(Genoa)<br />
29<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/1/14<br />
P-1/1/15<br />
P-1/1/16<br />
P-1/1/17<br />
P-1/1/18<br />
P-1/1/19<br />
P-1/1/20<br />
P-1/1/21<br />
ABSENCE OF ENDOGENOUS INTERLEUKIN-10 ENHANCES<br />
SECONDARY INFLAMMATORY PROCESS AFTER SPINAL<br />
CORD COMPRESSION INJURY IN MICE<br />
Genovese T., Esposito E., Mazzon E., Di Paola R.,<br />
Caminiti R., Bramanti P., Cappelani A., Cuzzocrea S.<br />
(Messina, Naples, Catania)<br />
INTRAVENOUS MESENCHYMAL STEM CELLS<br />
ADMINISTRATION INDUCES SURVIVAL AND SYMPTOM<br />
AMELIORATION IN MUTANT SOD1 G93A MICE<br />
Bonifacino T., Zappettini S., Milanese M., Casazza S.,<br />
Caponnetto C., Uccelli A., Bonanno G. (Genoa)<br />
FAILURE OF ATYPICAL ANTIPSYCHOTICS TO INDUCE<br />
ANHEDONIA: BEHAVIOURAL EVIDENCE FOR THE ROLE OF<br />
5-HT2 RECEPTORS<br />
D'Aquila P., Cabras M., Modde C., Rassu C., Serra G.<br />
(Sassari)<br />
NEUROPROTECTIVE EFFECT OF<br />
DEYDROEPIANDROSTERONE IN HEPATIC<br />
ENCEPHALOPATHY: POSSIBLE INVOLVEMENT OF PROTEIN<br />
KINASE C, EPSILON ISOFORM<br />
Geminiani E., Corsi L., Carnevale G., Zanoli P., Baraldi M.<br />
(Modena)<br />
BB 16 AS NEW COMPOUND FOR MEMORY RELATED<br />
DISORDERS<br />
Di Viesti V., Carnevale G., Zavatti M., Zanoli P., Cannazza<br />
G., Braghiroli D., Baraldi M. (Modena)<br />
PHENOTYPICAL CHARACTERIZATION OF THIRD<br />
TRIMESTER HUMAN AMNIOTIC FLUID CELLS: A NEW<br />
RESERVOIR OF STEM CELLS?<br />
Bottai D., Cigognini D., Nicora E., Ripamonti E., Adami R.,<br />
Abrignani S., Moro M., Rebulla P., Menarini M., Di Giulio<br />
A., Gorio A. (Milan, Imola)<br />
THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS WITH<br />
POTENTIAL FOR THERAPY IN NEURODEGENERATIVE<br />
DISORDERS<br />
Cigognini D., Nicora E., Ripamonti E., Adami R., Menarini<br />
M., Di Giulio A., Bottai D., Gorio A. (Milan, Imola)<br />
ROLE OF MATRIX METALLOPROTEINASES IN RETINAL<br />
GANGLION CELLS (RGCS) LOSS INDUCED BY RETINAL<br />
ISCHEMIA/REPERFUSION<br />
Russo R., Cavaliere F., Varano G., Rombola' L., Corasaniti<br />
M., Bagetta G., Morrone L. (Cosenza, Catanzaro)<br />
P-1/1/22 MELANOCORTINS PROTECT AGAINST CENTRAL AND<br />
30<br />
P-1/1/23<br />
P-1/1/24<br />
P-1/1/25<br />
P-1/1/26<br />
P-1/1/27<br />
P-1/1/28<br />
P-1/1/29<br />
P-1/1/30<br />
PERIPHERAL DAMAGE FOLLOWING CEREBRAL ISCHEMIA<br />
THROUGH A VAGUS NERVE-MEDIATED MECHANISM<br />
Giuliani D., Ottani A., Galantucci M., Minutoli L., Bitto A.,<br />
Di Stefano V., Altavilla D., Squadrito F., Guarini S.<br />
(Modena, Messina)<br />
ROLE OF ENDOCANNABINOID SYSTEM AND VANILLOID<br />
TRPV1 CHANNELS IN THE PHENOTYPE OF DOPAMINE D3<br />
RECEPTOR KNOCK-OUT "D3(-/-)" MICE<br />
Micale V., Cristino L., Tamburella A., Petrosino S., Leggio<br />
G., Di Marzo V., Drago F. (Catania, Pozzuoli)<br />
NOOTROPICS: "SMART DRUGS"?<br />
Runci F., Fiaschi A., Barberi L., Passarello F.,<br />
Montefrancesco G., Giorgi G. (Siena)<br />
MOLECULES ACTING ON CB1 RECEPTOR AND THEIR<br />
EFFECTS ON MORPHINE WITHDRAWAL IN VITRO<br />
Festa M., Capasso A. (Salerno)<br />
COMPARISON OF THE ANTIEPILEPTOGENIC EFFECTS OF<br />
AN EARLY LONG-TERM TREATMENT WITH ETHOSUXIMIDE<br />
OR LEVETIRACETAM IN A GENETIC ANIMAL MODEL OF<br />
ABSENCE EPILEPSY<br />
Russo E., Citraro R., Scicchitano F., Marra R., Donato Di<br />
Paola E., De Fazio S., De Sarro G. (Catanzaro)<br />
NEUROCHEMICAL AND BEHAVIORAL EFFECTS OF<br />
CARVACROL<br />
Zotti M., Avato P., Trabace L. (Foggia, Bari)<br />
-LACTOALBUMIN, A WHEY PROTEIN RICH IN<br />
TRYPTOPHAN, SHOWS EFFICACY IN RODENT MODELS OF<br />
EPILEPSY<br />
Citraro R., Russo E., Scicchitano F., De Fazio S., Marra R.,<br />
Mainardi P., Perucca E., De Sarro G. (Catanzaro, Genoa,<br />
Pavia)<br />
LONG TERM ANTIEPILEPTIC DRUGS TREATMENT,<br />
ABSENCE EPILEPSY AND DEPRESSION: A CORRELATION<br />
STUDY<br />
De Fazio S., Russo E., Citraro R., Scicchitano F., De Fazio<br />
P., Segura Garcia C., Gareri P., De Sarro G. (Catanzaro)<br />
EFFECTS OF FLAVONOIDS GENISTEIN AGLYCONE AND<br />
FLAVOCOXID IN THE EXPERIMENTAL MOUSE MODEL OF<br />
DUCHENNE MUSCULAR DYSTROPHY<br />
Bitto A., Polito F., Irrera N., Messina S., Altavilla D.,<br />
Guarini S., Caputi A. P., Squadrito F. (Messina, Modena)<br />
P-1/1/31 MELATONIN REGULATES MATRIX METALLOPROTEINASE-2<br />
31<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/1/32<br />
P-1/1/33<br />
P-1/1/34<br />
P-1/1/35<br />
P-1/1/36<br />
P-1/1/37<br />
P-1/1/38<br />
AND -9, AND REDUCES STRESS-ACTIVATED/MITOGEN-<br />
ACTIVATED PROTEIN KINASES IN SPINAL CORD INJURY<br />
Esposito E., Genovese T., Caminiti R., Bramanti P., Meli<br />
R., Cuzzocrea S. (Messina, Naples)<br />
PRESYNAPTIC NICOTINIC AND D2 RECEPTORS<br />
FUNCTIONALLY INTERACT ON DOPAMINERGIC NERVE<br />
ENDINGS OF RAT AND MOUSE NUCLEUS ACCUMBENS<br />
Zappettini S., Grilli M., Lagomarsino F., Zoli M., Marchi M.<br />
(Genoa, Modena)<br />
MK801, A N-METHYL-D-ASPARTATE (NMDA) RECEPTOR<br />
ANTAGONIST, REDUCES SIGNALING PATHWAYS<br />
INVOLVED IN AN EXPERIMENTAL MODEL OF SPINAL CORD<br />
TRAUMA<br />
Paterniti I., Esposito E., Genovese T., Mazzon E.,<br />
Galuppo M., Bramanti P., Cuzzocrea S. (Messina)<br />
GSK3β INHIBITION PROTECTS MOUSE CORTICAL<br />
NEURONS AGAINST OXYGEN-GLUCOSE DEPRIVATION<br />
INJURY<br />
Delbarba A., Bertolotti P., Dossena M., Nisoli E., Valerio<br />
A. (Milan, Brescia)<br />
HEPATIC MITOCHONDRIA OBTAINED FROM 6-OHDA-<br />
LESIONED PARKINSONIAN RATS EXHIBIT DECREASED<br />
ENERGY CAPACITY AND MEMBRANE POTENTIAL<br />
Ferrigno A., Armentero M., Rizzo V., Ambrosi G., Richelmi<br />
P., Blandini F., Vairetti M. (Pavia)<br />
POSSIBLE ROLE OF TUNNELING NANOTUBES IN<br />
NEURODEGENERATIVE DISEASES: INTERCELLULAR<br />
TRANSFER OF MITOCHONDRIA, APP AND α-SYNUCLEIN<br />
Carone C., Genedani S., Agnati L., Filaferro M., Pederzoli<br />
F., Leo G. (Modena)<br />
β-AMYLOID FIBRILLATION AND/OR<br />
HYPERHOMOCYSTEINEMIA MODIFY STRIATAL PATTERNS<br />
OF GLYCOSAMINOGLYCANS: POSSIBLE ROLE IN THE<br />
PATHOGENESIS OF ALZHEIMER’S DISEASE<br />
Pederzoli F., Genedani S., Volpi N., Agnati L., Leo G.,<br />
Buzzega D., Maccari F., Carone C., Andreoli N., Filaferro M.<br />
(Modena)<br />
CHF5074 REDUCES BRAIN β-AMYLOID BURDEN IN A<br />
MOUSE MODEL OF ALZHEIMER’S DISEASE BY<br />
MODULATING APP AND PS1 INTERACTION<br />
Lanzillotta A., Sarnico I., Hutter-Paier B., Imbimbo B.,<br />
Windisch M., Pizzi M. (Brescia, Parma, Graz)<br />
P-1/1/39 STEERED MOLECULAR DYNAMICS SIMULATIONS TO<br />
32<br />
P-1/1/40<br />
P-1/1/41<br />
P-1/1/42<br />
P-1/1/43<br />
P-1/1/44<br />
P-1/1/45<br />
P-1/1/46<br />
INVESTIGATE THE DUAL PHARMACOLOGY OF THE NOVEL<br />
NUCLEOTIDES/LEUKOTRIENES RESPONDING RECEPTOR<br />
GPR17<br />
Parravicini C., Ranghino G., Fantucci P., Abbracchio M. P.<br />
(Milan, Bresso)<br />
SEIZURE SUSCEPTIBILITY OF HIV-1 TAT-TRANSGENIC<br />
MICE: IMPLICATIONS FOR THE ROLE OF TAT IN HIV-1<br />
ASSOCIATED NEUROPATHY (HAN)<br />
Zucchini S., Caputo A., Altavilla G., Brocca Cofano E.,<br />
Pittaluga A., Corallini A., Simonato M. (Ferrara, Padua,<br />
Bethesda, Genoa)<br />
ADENOSINE A2A RECEPTORS MODULATE ACTIVATION OF<br />
P38 MITOGEN ACTIVATED PROTEIN KINASE IN MURINE<br />
BV-2 CELLS<br />
Corti F., Cipriani S., Saura J., Lluis C., Serratosa J.,<br />
Franco R., Pedata F. (Florence, Barcelona)<br />
OXIDATIVE STRESS AND EFFECTS OF ANTIOXIDANT<br />
TREATMENT IN DISUSED SKELETAL MUSCLES OF<br />
HINDLIMB-UNLOADED MICE<br />
Digennaro C., Pierno S., Liantonio A., Giannuzzi V.,<br />
Camerino G., Dinardo M., Brocca L., Pellegrino M.,<br />
Bottinelli R., Desaphy J., Conte Camerino D. (Bari, Pavia)<br />
DISUSE-INDUCED SLOW-TWITCH MUSCLE IMPAIRMENT IS<br />
AMELIORATED BY IGF-1 OVEREXPRESSION IN HINDLIMB-<br />
UNLOADED TRANSGENIC MICE<br />
Pierno S., Liantonio A., Desaphy J., Digennaro C.,<br />
Giannuzzi V., Gramegna G., Dobrowolny G., Magnani E.,<br />
Rizzuto E., Musarò A., Conte Camerino D. (Bari, Rome)<br />
PHARMACOLOGICAL MODULATION OF THE ENZYMATIC<br />
PATHWAYS INVOLVED IN H2O2 ELEVATION LEADS TO<br />
NEUROPROTECTION IN EXPERIMENTAL ISCHEMIA<br />
Armogida M., Amantea D., Cucchiaroni M., Piccirilli S.,<br />
Guatteo E., Bagetta G., Mercuri N., Nistico R. (Rome,<br />
Rende)<br />
THE P2Y-LIKE GPR17 RECEPTOR PARTICIPATES IN<br />
OLIGODENDROCYTE POSTNATAL MATURATION AND<br />
REACTION TO ACUTE AND CHRONIC BRAIN INJURY<br />
Boda E., Mantovan T., Rosa P., Tempia F., Abbracchio<br />
MP., Buffo A. (Turin, Milan)<br />
THE CB1 AGONIST WIN55,212-2 REDUCES STRIATAL PKA<br />
HYPERACTIVITY AND TRPV1 RECEPTOR SENSITIVITY IN<br />
DYSKINETIC RATS<br />
Macheda T., Martinez A., Morgese M., Cassano T., Cuomo<br />
V., Giuffrida A. (San Antonio, Foggia, Rome)<br />
33<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/1/47<br />
P-1/1/48<br />
P-1/1/49<br />
P-1/1/50<br />
P-1/1/51<br />
P-1/1/52<br />
P-1/1/53<br />
P-1/1/54<br />
P-1/1/55<br />
MULTI-TARGET-DIRECTED LIGANDS: NEW HISTAMINE H3<br />
RECEPTOR ANTAGONISTS WITH ANTICHOLINESTERASE<br />
ACTIVITY<br />
Flammini L., Bertoni S., Saccani F., Incerti M., Morini G.,<br />
Ballabeni V., Barocelli E. (Parma)<br />
TEMPORAL ANALYSIS OF 17β-ESTRADIOL<br />
NEUROPROTECTIVE ACTIVITY AGAINST β-AMYLOID-<br />
INDUCED CELL DEATH IN ORGANOTYPIC HIPPOCAMPAL<br />
CULTURES<br />
Merlo S., Spampinato S., Canonico P. L., Sortino M.<br />
(Catania, Novara)<br />
APP OVEREXPRESSION AND ITS GRB2-MEDIATED<br />
SIGNALLING MODULATES MAPK ACTIVATION<br />
Nizzari M., Musso A., PasTurin M., Russo C., Florio T.<br />
(Genoa, Campobasso)<br />
PHARMACOLOGICAL ACTIVATION OF METABOTROPIC<br />
GLUTAMATE RECEPTOR SUBTYPE 1 DAMPENS SPIKE AND<br />
WAVE DISCHARGES IN THE WAG/RIJ RAT MODEL OF<br />
ABSENCE EPILEPSY<br />
Santolini I., Simonyi A., Molinaro G., Mairesse J.,<br />
Battaglia G., Bruno V., van Luijtelaar G., Ngomba R.,<br />
Nicoletti F. (Rome, Columbia, Pozzilli, Donders)<br />
A NOVEL PHARMACOLOGICAL ACTIVITY FOR THE ALPHA2-<br />
DELTA LIGANDS PREGABALIN AND GABAPENTIN: IN<br />
VITRO MODULATION OF ADULT NEUROGENESIS<br />
Valente M., Meneghini V., Francese M., Carraro L.,<br />
Canonico P. L., Grilli M. (Novara)<br />
BIOTELEMETRIC MONITORING OF STRIATAL<br />
NEUROCHEMISTRY AND BEHAVIOUR IN MPTP-INDUCED<br />
RAT MODEL OF PARKINSON’S DISEASE<br />
Puggioni G., Bazzu G., Spissu Y., Rocchitta G., Calia G.,<br />
Migheli R., Serra P. (Sassari)<br />
A NOVEL ROLE FOR THE RAGE-NF-KAPPAB AXIS IN ADULT<br />
SVZ NEUROGENESIS<br />
Meneghini V., Francese M., Carraro L., Valente M., Grilli<br />
M. (Novara)<br />
PROTECTIVE EFFECT OF TAT-PARKIN ON NEURONAL<br />
CELLS<br />
Grigoletto J., Zusso M., Debetto P., Negro A. (Padua)<br />
EFFECT OF REPEATED MPTP ADMINISTRATION ON<br />
STRIATAL ENERGY METABOLISM IN FREELY MOVING RATS<br />
Calia G., Migheli R., Rocchitta G., Puggioni G., Spissu Y.,<br />
Serra P. (Sassari)<br />
34<br />
P-1/1/56<br />
P-1/1/57<br />
P-1/1/58<br />
P-1/1/59<br />
P-1/1/60<br />
P-1/1/61<br />
P-1/1/62<br />
P-1/1/63<br />
P-1/1/64<br />
CYCLO-OXYGENASE ACTIVITY IN IMMORTALIZED<br />
HYPOTHALAMIC NEURONS GT1-7<br />
Mores N., Petrucci G., Errico S., Rugia S. (Rome, Chieti)<br />
DOMINANT ROLE OF INWARD RECTIFIERK + CHANNELS IN<br />
THE REGULATION OF CARBACHOL-INDUCED<br />
EPILEPTIFORM ACTIVITY IN RAT ENTORHINAL CORTEX<br />
Cataldi M., Avoli M. (Naples, Montreal, Rome)<br />
EXPOSURE TO RESTRAINT STRESS INCREASES NOP<br />
RECEPTOR GENE EXPRESSION IN THE CENTRAL<br />
AMYGDALA AND INCREASES THE ANXIOLYTIC-LIKE<br />
ACTION OF NOCICEPTIN<br />
Ubaldi M., De Guglielmo G., Ruggeri B., Soverchia L.,<br />
Kallupi L., Barbaro G., Massi M., Ciccocioppo R.<br />
(Camerino)<br />
SURFACE-DECORATED NANOPARTICLES AS DRUG<br />
DELIVERY AGENTS TO THE BRAIN<br />
Badiali L., Vergoni A., Tosi G., Ruozi B., Costantino L.,<br />
Bertolini A., Vandelli M., Forni F. (Modena)<br />
IN VITRO AND IN VIVO PHARMACOLOGICAL<br />
CHARACTERIZATION OF THE NEUROPEPTIDE S RECEPTOR<br />
ANTAGONIST SHA 68<br />
Ruzza C., Camarda V., Rizzi A., Trapella C., Pelà M.,<br />
Guerrini R., Regoli D., Salvadori S., Calò G. (Ferrara)<br />
NEUROPEPTIDE S EVOKES ANXIOLYTIC-LIKE EFFECTS IN<br />
RATS VIA NPSR SELECTIVE ACTIVATION<br />
Ruggieri V., Filaferro M., Romeno M., Guerrini R., Trapella<br />
C., Salvadori S., Rizzi A., Calò G., Vitale G. (Modena,<br />
Ferrara)<br />
NEUROPROTECTIVE EFFECTS OF ß-AMYLOID MONOMERS<br />
Giuffrida M., Caraci F., Pignataro B., Cataldo S., De Bona<br />
P., Bruno V., Molinaro G., Pappalardo G., Messina A.,<br />
Palmigiano A., Garozzo D., Nicoletti F., Rizzarelli E., Copani<br />
A. (Catania, Palermo, Rome, Pozzilli)<br />
IN VITRO PHARMACOLOGICAL CHARACTERIZATION OF<br />
GF-4, A NOVEL NON-PEPTIDE ANTAGONIST FOR THE<br />
NOCICEPTIN/ORPHANIN FQ RECEPTOR<br />
Molinari S., Trapella C., Fischetti C., Camarda V., Guerrini<br />
R., Salvadori S., Regoli D., Calò G. (Ferrara)<br />
CONJUGATED LINOLEIC ACID ISOMERS INDUCE ABC<br />
HALF-TRANSPORTER RELATIVE GENE EXPRESSION AND<br />
MODIFY PROTEIN PROFILE IN X- LINKED<br />
ADRENOLEUKODYSTROPHY<br />
35<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/1/65<br />
P-1/1/66<br />
P-1/1/67<br />
P-1/1/68<br />
P-1/1/69<br />
P-1/1/70<br />
P-1/1/71<br />
P-1/1/72<br />
Cappiello L., Iannone A., Banni S., Blasevich M., Della<br />
Casa L., Rossi E., Giordano E., Cordeddu L., Petroni A.<br />
(Milan, Modena, Cagliari)<br />
INHIBITION OF ENDOGENOUS DIPEPTIDYL PEPTIDASE-4<br />
IN ALZHEIMER’S PRONE MICE<br />
Di Filippo C., Marfella R., Ferraraccio F., Paolisso G., Rossi<br />
F., D'Amico M. (Naples)<br />
THE PARAVENTRICULAR NUCLEUS OF THE<br />
HYPOTHALAMUS IS A NEUROANATOMICAL SUBSTRATE<br />
FOR THE INHIBITION OF PALATABLE FOOD INTAKE BY<br />
NEUROPEPTIDE S<br />
Cannella N., Cifani C., Fedeli A., Braconi S., Economidou<br />
D., Kallupi M., Massi M., Ciccocioppo R. (Camerino)<br />
CONGENIC DA.WOKW FEMALES COULD BE SUITABLE<br />
MODELS TO ELUCIDATE THE GENETICS OF BINGE<br />
EATING?<br />
Micioni Di Bonaventura M., Cifani C., Wilke B., Massi M.,<br />
Polidori C., Kloting I. (Camerino, Karlsburg)<br />
SP PROTECTS CEREBELLAR GRANULE CELLS AGAINST β-<br />
AMYLOID-INDUCED APOPTOSIS BY DOWN-REGULATION<br />
AND REDUCED ACTIVITY OF KV4 POTASSIUM CHANNELS<br />
Marolda R., Pieri M., Amadoro G., Carunchio I., Ciotti M.,<br />
Possenti R., Zona C., Petrella C., Severini C. (Rome)<br />
STUDY OF BRAIN DERIVED NEUROTROPHIC FACTOR<br />
(BDNF) CONTENT CHANGE IN AN EXPERIMENTAL MODEL<br />
OF CHRONIC RENAL FAILURE<br />
Stiaccini G., Mannari C., Guidi A., Silvano E., Migliori M.,<br />
Scalori V., Giovannini L. (Pisa, L'Aquila, Lido di Camaiore)<br />
NF-KB P50 REGULATES ADULT NEUROGENESIS IN THE<br />
HIPPOCAMPUS BUT NOT IN THE OLFACTORY BULB<br />
Bortolotto V., Dellarole A., Francese M., Denis-Donini S.,<br />
Grilli M. (Novara, Milan)<br />
AGE-RELATED MODIFICATIONS OF DISTRIBUTION,<br />
SIGNALLING AND FUNCTION OF A1 ADENOSINE<br />
RECEPTORS IN THE BRAIN OF A RAT MODEL OF ABSENCE<br />
EPILEPSY<br />
Torelli E., D'Alimonte I., Citraro R., Russo E., Nargi E.,<br />
Buccella S., Di Iorio P., Giuliani P., Romeno S., Ballerini P.,<br />
Caciagli F., De Sarro G., Ciccarelli R. (Chieti, Catanzaro)<br />
METABOLOMICS OF ENERGY-LINKED ENZYMES IN<br />
LYMPHOCYTES FROM ACUTE STROKE PATIENTS<br />
Villa R., Devecchi E., Brera F., Pero G., Gorini A. (Pavia,<br />
Lodi, Milan)<br />
36<br />
P-1/1/73<br />
P-1/1/74<br />
P-1/1/75<br />
P-1/1/76<br />
P-1/1/77<br />
P-1/1/78<br />
P-1/1/79<br />
PHARMACOLOGICAL MANIPULATION OF DOPAMINERGIC<br />
RECEPTORS AND mGLU5 METABOTROPIC GLUTAMATE<br />
RECEPTORS INCREASES THE NUMBER OF INTRASTRIATAL<br />
TYROSINE HYDROXYLASE-POSITIVE CELLS IN NEONATAL<br />
MOUSE STRIATUM<br />
Fardone E., Bucci D., Busceti C., Biagioni F., Trabucco A.,<br />
Mastroiacovo F., Riozzi B., Gradini R., Battaglia G., Bruno<br />
V., Fornai F., Nicoletti F. (Pozzilli, Rome, Pisa)<br />
mGLU4 METABOTROPIC GLUTAMATE RECEPTOR-LIKE<br />
IMMUNOREACTIVITY IN THE CEREBROSPINAL FLUID OF<br />
PATIENTS WITH MULTIPLE SCLEROSIS AND MICE WITH<br />
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS<br />
Notartomaso S., D'Amore V., Maione T., Fazio F.,<br />
Scarselli P., Di Costanzo A., Bellantonio P., Battaglia G.,<br />
Storto M., Bruno V., Gradini R., Ferraguti F., Nicoletti F.,<br />
Di Marco R. (Pozzilli, Campobasso, Rome, Innsbruck)<br />
PHARMACOLOGICAL ACTIVATION OF METABOTROPIC<br />
GLUTAMATE RECEPTOR SUBTYPE 4 IS PROTECTIVE<br />
AGAINST FOCAL TRANSIENT ISCHEMIA<br />
Bernabucci M., Mastroiacovo F., Moyanova S., Kortesca<br />
L., Mitreva R., Ngomba R., Battaglia G., Bruno V., Nicoletti<br />
F. (Pozzilli, Rome, Sofia)<br />
THE THALAMIC EXPRESSION OF CANNABINOID<br />
RECEPTORS IS REDUCED IN A RAT MODEL OF ABSENCE<br />
EPILEPSY<br />
Cianci S., Ngomba R., Gaetani S., van Rijn C., van<br />
Luijtelaar G., Colangeli R., Santolini I., Cuomo V., Nicoletti<br />
F. (Rome, Nijmegen, Pozzilli, Bari)<br />
AMITRIPTYLINE ANTIDEPRESSANT ACTIVITY IS MEDIATED<br />
BY ARTEMIN, A GLIAL NEUROTROPHIC-DERIVED FACTOR<br />
Ghelardini C., Vivoli E., Salvicchi A., Di Cesare Mannelli<br />
L., Schiavone N., Bartolini A. (Florence)<br />
SOCIAL MEMORY IMPAIRMENT IN A TRIPLE-TRANSGENIC<br />
MOUSE MODEL OF ALZHEIMER’S DISEASE IS<br />
ACCOMPAINED BY MONOAMINERGIC ALTERATIONS<br />
Romano A., Cassano T., Gaetani S., Laconca L., Macheda<br />
T., Righetti L., Cianci S., Morgese M., Mastrantonio T.,<br />
Oddo S., Laferla F., Cuomo V. (Rome, Foggia, San<br />
Antonio, Irvine, Bari)<br />
IDENTIFICATION AND IN VITRO CHARACTERIZATION OF<br />
THE NOVEL NEUROPEPTIDE S RECEPTOR ANTAGONIST<br />
[TBU-D-GLY 5 ]NPS<br />
Camarda V., Guerrini R., Marzola E., Trapella C., Rizzi A.,<br />
Ruzza C., Fiorini S., Reinscheid R., Regoli D., Salvadori S.,<br />
37<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/1/80<br />
P-1/1/81<br />
P-1/1/82<br />
P-1/1/83<br />
P-1/1/84<br />
P-1/1/85<br />
P-1/1/86<br />
P-1/1/87<br />
Calo' G. (Ferrara, Irvine)<br />
TRIMETHYLETHIAZOLINE-INDUCED ANXIETY AS A MODEL<br />
FOR THE STUDY OF THE MOLECULAR TARGETS OF<br />
PREGABALIN IN MICE<br />
Marchiafava M., Matrisciano F., Scaccianoce S., Busceti<br />
C., Biagioni F., Nasca C., Orlando R., Melchiorri D.,<br />
Nicoletti F. (Rome, Pozzilli, Catania)<br />
PRECONDITIONING BY NMDA AND DHPG INDUCES<br />
TOLERANCE WITH DIFFERENTIAL MECHANISMS IN RAT<br />
ORGANOTYPIC HIPPOCAMPAL SLICES EXPOSED TO<br />
EXCITOTOXICITY<br />
Scartabelli T., Gerace E., Zianni E., Landucci E., Gardoni<br />
F., Berlinguer-Palmini R., Mannaioni G., Moroni F., Di Luca<br />
M., Pellegrini-Giampietro D. (Florence, Milan)<br />
MICROARRAY ANALYSIS IN HIPPOCAMPUS OF RATS<br />
TREATED WITH ESCITALOPRAM IN THE CHRONIC ESCAPE<br />
DEFICIT MODEL OF DEPRESSION<br />
Caggia F., Alboni S., Valensisi C., Benatti C., Corsini D.,<br />
Ferrari F., Tagliafico E., Mendlewicz J., Tascedda F.,<br />
Brunello N. (Modena, Brussels)<br />
ROLE OF THE ENDOCANNABINOID SYSTEM IN A RAT<br />
ORGANOTYPIC HIPPOCAMPAL SLICE MODEL OF CEREBRAL<br />
ISCHEMIA<br />
Landucci E., Scartabelli T., Gerace E., Boscia F., Moroni<br />
F., Pellegrini-Giampietro D. (Florence, Naples)<br />
GUANOSINE INDUCES NEURONAL DIFFERENTIATION IN<br />
THE HUMAN NEUROBLASTOMA SH-SY5Y CELL LINE<br />
Zanette C., Dell'Ovo V., Traversa U., Florio C. (Trieste)<br />
GPR35 EXPRESSION AND MODULATION OF CAMP<br />
PRODUCTION AND INTRACELLULAR CA 2+<br />
CONCENTRATION IN CULTURED ASTROCYTES<br />
Masi A., Cavone L., Sili M., Cozzi A., Berlinguer Palmini<br />
R., Cosi C., Mannaioni G., Moroni F. (Florence)<br />
ACTIVATION OF TRPV4 CHANNELS REDUCE MIGRATION<br />
OF GN11 CELLS, A NEUROENDOCRINE MODEL FOR<br />
MIGRATION<br />
Fornarelli A., Zaninetti R., Tacchi S., Mesenzani O.,<br />
Ciarletta M., Distasi C., Cariboni A., Canonico P. L.,<br />
Caldarelli A., Genazzani A. (Novara, Milan)<br />
PPARγ MEDIATES CANNABIDIOL ANTIINFLAMMATORY AND<br />
NEUROPROTECTIVE EFFECTS IN AN IN VITRO MODEL OF<br />
ALZHEIMER’S DISEASE<br />
Scuderi C., Blasio A., Valenza M., Steardo A., De Filippis<br />
38<br />
P-1/1/88<br />
P-1/1/89<br />
P-1/1/90<br />
P-1/1/91<br />
P-1/1/92<br />
P-1/1/93<br />
P-1/1/94<br />
P-1/1/95<br />
D., Iuvone T., Esposito G., Steardo L. (Rome, Naples)<br />
LEPTOMENINGEAL STEM/PROGENITOR CELLS (LESC)<br />
FROM RATS OF DIFFERENT AGES: CHARACTERIZATION,<br />
IN VITRO EXPANSION AND ASSESSMENT OF NEURAL<br />
DIFFERENTIATION POTENTIAL<br />
Decimo I., Bifari F., Bersan E., Malpeli G., Bonetti B.,<br />
Pizzolo G., Krampera M., Chiamulera C., Fumagalli G.<br />
(Verona)<br />
ON THE ROLE OF POLY(ADP-RIBOSE)POLYMERASE-1 IN A<br />
IN VIVO MODEL OF BRAIN ISCHEMIC PRECONDITIONING<br />
Blasi F., Faraco G., Moroni F., Chiarugi A. (Florence,<br />
Rende)<br />
COMPARISON OF CIGUATOXINS AND BREVETOXINS<br />
POTENCY ON HUMAN VOLTAGE GATED SODIUM<br />
CHANNELS OF BRAIN AND PERIPHERAL SENSORY<br />
NEURONS EXPRESSED IN HUMAN EMBRYONIC KIDNEY<br />
CELLS<br />
Dell'Ovo V., Bottein M., Tubaro A., Ramsdell J. (Trieste,<br />
Charleston)<br />
CANNABINOID AND PPAR RECEPTORS: NOVEL TARGETS<br />
FOR THE TREATMENT OF LEVODOPA-INDUCED<br />
DYSKINESIAS<br />
Morgese M., Trabace L., Giuffrida A. (Foggia, San<br />
Antonio)<br />
SOLUBLE ΒETA-AMYLOID1-42 INDUCES DEPRESSIVE-LIKE<br />
BEHAVIOUR IN RATS<br />
Colaianna M., Tucci P., Cuomo V., Trabace L. (Foggia,<br />
Rome)<br />
SPECIFIC NPY-Y1 RECEPTOR DELETION IN Y5R<br />
CONTAINING NEURONS IMPAIRS ANXIOUS BEHAVIOUR<br />
BUT NOT FEEDING BEHAVIOUR<br />
Longo A., Oberto A., Bertocchi I., Mele P., Palanza P.,<br />
Sprengel R., Eva C. (Turin, Parma, Heidelberg)<br />
EFFECTS OF SYSTEMIC ADMINISTRATION OF THE<br />
ESSENTIAL OIL OF BERGAMOT ON GROSS BEHAVIOUR<br />
AND EEG POWER SPECTRA RECORDED FROM THE<br />
HIPPOCAMPUS AND CEREBRAL CORTEX OF RAT<br />
Rombolà L., Corasaniti M., Rotiroti D., Tassorelli C.,<br />
Sakurada S., Bagetta G., Morrone L. (Rende, Catanzaro,<br />
Pavia, Sendai)<br />
EFFECT OF LRRK2 PATHOLOGICAL MUTATION ON<br />
DOPAMINE METABOLISM IN PC12 CELLS<br />
Spissu Y., Rocchitta G., Iaccarino C., Crosio C., Galiotto<br />
39<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/1/96<br />
P-1/1/97<br />
M., Desole M., Migheli R. (Sassari)<br />
TRANSCRIPTIONAL SIGNATURES IN<br />
NEURODEGENERATIVE DISEASES<br />
Diamanti D., Pollio G., Tarditi A., Remelli R., Terstappen<br />
G., Caricasole A. (Siena)<br />
HIGH AFFINITY AND LOW AFFINITY N-METHYL-D-<br />
ASPARTATE AUTORECEPTORS FACILITATE RESPECTIVELY<br />
EXOCYTOSIS AND CARRIER-MEDIATED RELEASE OF<br />
GLUTAMATE IN RAT HIPPOCAMPUS<br />
Summa M., Musante V., Raiteri M., Pittaluga A. (Genoa)<br />
40<br />
THURSDAY, October 15, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-1/2/1<br />
P-1/2/2<br />
P-1/2/3<br />
P-1/2/4<br />
P-1/2/5<br />
Poster Session<br />
P-1/2: RECEPTORS AND SIGNAL TRANSDUCTION<br />
MECHANISMS<br />
Poster Commission Members:<br />
President: Clementi F. (Milan)<br />
Members: Pizzi M. (Brescia), Taglialatela M.<br />
(Campobasso)<br />
THIAZOLIDINEDIONES ACTIVATE THE GLUCOCORTICOID<br />
RECEPTOR<br />
Tersigni M., Matthews L., Berry A., Ray D., Ianaro A.<br />
(Naples, Manchester)<br />
SONIC HEDGEHOG (SHH) INDUCES PROLIFERATION OF<br />
NEURAL PROGENITOR CELLS ISOLATED FROM RAT<br />
POSTNATAL CEREBELLUM<br />
Barbierato M., Soffia S., Zusso M., Negro A., Skaper S.,<br />
Trevisan L., Debetto P., Giusti P. (Padua)<br />
DEFICIENCY OF POLYCYSTIC KIDNEY DISEASE-1 GENE<br />
(PKD1) EXPRESSION INCREASES A3 ADENOSINE<br />
RECEPTORS IN HUMAN RENAL CELLS<br />
Varani K., Aguiari G., Vincenzi F., Tosi A., Gessi S.,<br />
Sacchetto V., Bogo M., Del Senno L., Borea PA. (Ferrara)<br />
THERMODYNAMIC ANALYSIS IN DRUG-RECEPTOR<br />
BINDING: THE A3 ADENOSINE RECEPTOR<br />
Vincenzi F., Varani K., Targa M., Tosi A., Gessi S., Merighi<br />
S., Borea P. (Ferrara)<br />
PHARMACOLOGICAL CHARACTERIZATION OF NOVEL<br />
ALLOSTERIC ENHANCERS OF THE A1 ADENOSINE<br />
RECEPTORS<br />
Tosi A., Varani K., Romegnoli R., Vincenzi F., Targa M.,<br />
Preti D., Baraldi P., Borea PA. (Ferrara)<br />
P-1/2/6 A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-<br />
41<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/2/7<br />
P-1/2/8<br />
P-1/2/9<br />
P-1/2/10<br />
P-1/2/11<br />
P-1/2/12<br />
P-1/2/13<br />
INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN<br />
CANCER CELLS<br />
Simioni C., Merighi S., Gessi S., Varani K., Mirandola P.,<br />
Leung E., Maclennan S., Baraldi P., Borea PA. (Ferrara,<br />
Parma, Cary)<br />
L163,255, A SYNTHETIC GROWTH HORMONE<br />
SECRETAGOGUE, ALTERS CA 2+ HOMEOSTASIS AND<br />
MODULATES CELL VIABILITY OF SKELETAL MUSCLE<br />
Gramegna G., Liantonio A., Giannuzzi V., Conte Camerino<br />
D. (Bari)<br />
PERINATAL HYPOXIA IN NEONATAL AND ADULT BRAIN:<br />
P2X7 ACTIVITY AND GLUTAMATE RELEASE<br />
Barbieri R., Alloisio S., Cervetto C., Mazzotta M., Marcoli<br />
M., Maura G., Nobile M. (Genoa)<br />
ACTIVATION OF mGLU2/3 METABOTROPIC GLUTAMATE<br />
RECEPTORS NEGATIVELY REGULATES THE STIMULATION<br />
OF INOSITOL PHOSPHOLIPID HYDROLYSIS MEDIATED BY<br />
5-HT2A SEROTONIN RECEPTORS IN THE FRONTAL CORTEX<br />
OF LIVING MICE<br />
Molinaro G., Traficante A., Riozzi B., Di Menna L., Curto<br />
M., Pallottino S., Iacovelli L., Nicoletti F., Bruno V.,<br />
Battaglia G. (Perugia, Rome, Pozzilli)<br />
PRESYNAPTIC UROTENSIN RECEPTORS IN THE CERVICAL<br />
SPINAL MOTONEURONS: FACILITATION OF<br />
ACETYLCHOLINE RELEASE<br />
Cervetto C., Mazzotta M., Bruzzone F., Diaspro A.,<br />
Bianchini P., Vallarino M., Maura G., Leprince J., Vaudry<br />
H., Marcoli M. (Genoa, Mont-Saint-Aignan)<br />
C-TERMINAL DOMAIN REQUIREMENT FOR P2X7 RECEPTOR<br />
TO FUNCTION AS A CHANNEL/PORE FOR GLUTAMATE<br />
Mazzotta M., Cervetto C., Alloisio S., Nobile M., Maura G.,<br />
Marcoli M. (Genoa)<br />
SYNERGISTIC INHIBITION OF AGS GASTRIC CANCER CELL<br />
GROWTH BY COMBINED TREATMENT WITH SMALL<br />
MOLECULE RECEPTOR TYROSINE KINASE INHIBITORS<br />
AND/OR PROTEASOME INHIBITORS<br />
Damiano V., Troiani T., Piegari E., Russo R., Morgillo F.,<br />
Martinelli E., Ciardello F., Rossi F., Berrino L. (Naples)<br />
CYTOPLASMIC FES TYROSINE KINASE IS A DOWN-<br />
STREAM EFFECTOR OF THE INSULIN-LIKE GROWTH<br />
FACTORS (IGFS)/IGF-I RECEPTOR (IGF-IR) SYSTEM OF<br />
NEUROBLASTOMA CELLS<br />
Gnemmi I., Condorelli F., Canonico P. L. (Novara)<br />
42<br />
P-1/2/14<br />
P-1/2/15<br />
P-1/2/16<br />
IN NEUROBLASTOMA CELL LINES, CYTOPLASMIC FES<br />
TYROSINE KINASE LINKS THE INSULIN-LIKE GROWTH<br />
FACTOR-I RECEPTOR (IGF-IR) ACTIVATION TO STAT3-<br />
DEPENDENT ANTI-APOPTOTIC EFFECTS<br />
Sanzone S., Condorelli F., Canonico P. L. (Novara)<br />
CHARACTERIZATION OF THE ENZYME RESPONSIBLE FOR<br />
THE DEGRADATION OF THE SECOND MESSENGER NAADP<br />
Grolla A., Travelli C., Polzonetti V., Del Grosso E.,<br />
Billington R., Canonico P. L., Genazzani A. (Novara,<br />
Plymouth)<br />
A GENOME-SCALE RNAI SCREEN IDENTIFIES EFFECTORS<br />
OF FLT3-ITD IN ACUTE MYELOID LEUKEMIA<br />
Caldarelli A., Paskow-Rozas M., Mueller J., Koch S.,<br />
Kittler R., Genazzani A., Canonico P. L., Ding L., Kasper S.,<br />
Fisher T., Boehmer F., Buchholz F. (Novara, Dresden,<br />
Jena, Magdeburg)<br />
43<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
THURSDAY, October 15, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-1/3/1<br />
P-1/3/2<br />
P-1/3/3<br />
P-1/3/4<br />
P-1/3/5<br />
Poster Session<br />
P-1/3: PHARMACOLOGY OF ION CHANNELS AND<br />
SYNAPTIC TRANSMISSION<br />
Poster Commission Members:<br />
President: Clementi F. (Milan)<br />
Members: Pizzi M. (Brescia),<br />
Taglialatela M. (Campobasso)<br />
ALTERED REGULATION OF GLUTAMATE RELEASE BY<br />
CANNABINOIDS AND DECREASED FUNCTIONAL ACTIVITY<br />
AND EXPRESSION OF GLT1 AND GLAST GLUTAMATE<br />
TRANSPORTERS IN THE HIPPOCAMPUS OF ADOLESCENT<br />
RATS PERINATALLY EXPOSED TO Δ 9 -THC<br />
Castaldo P., Magi S., Cataldi M., Arcangeli S., Capeci W.,<br />
Ferraro L., Tomasini MC., Antonelli T., Cassano T., Cuomo<br />
V., Amoroso S. (Ancona, Rome, Foggia, Naples, Ferrara)<br />
MECHANISMS OF GLYCINE RELEASE FROM MOUSE SPINAL<br />
CORD AND HIPPOCAMPAL GLYCINERGIC NERVE<br />
TERMINALS IN RESPONSE TO IDENTICAL DEPOLARIZING<br />
STIMULI<br />
Romei C., Luccini E., Raiteri L. (Genoa)<br />
NEUROPEPTIDE S INHIBITS THE RELEASE OF 5-HT AND<br />
NORADRENALINE FROM MOUSE FRONTAL CORTEX<br />
SYNAPTOSOMES<br />
Luccini E., Romei C., Salvadori S., Raiteri L. (Genoa,<br />
Ferrara)<br />
L-ASPARTATE AS AN AMINO ACID NEUROTRANSMITTER:<br />
MECHANISMS OF THE DEPOLARIZATION-INDUCED<br />
RELEASE FROM CEREBROCORTICAL SYNAPTOSOMES<br />
Cavallero A., Marte A., Fedele E. (Genoa)<br />
ALTERATIONS OF GLUTAMATE RELEASE IN THE SPINAL<br />
CORD OF MICE AFFECTED BY EXPERIMENTAL<br />
AUTOIMMUNE ENCEPHALOMYELITIS<br />
44<br />
P-1/3/6<br />
P-1/3/7<br />
P-1/3/8<br />
P-1/3/9<br />
P-1/3/10<br />
P-1/3/11<br />
P-1/3/12<br />
P-1/3/13<br />
Marte A., Cavallero A., Raiteri M., Uccelli A., Morando S.,<br />
Fedele E. (Genoa)<br />
VOLUME-REGULATED ANION CHANNELS IN RAT CORTICAL<br />
ASTROCYTES: INHIBITION BY CARBENOXOLONE<br />
Cervetto C., Benfenati V., Caprini M., Nicchia G., Rossi A.,<br />
Dovizio M., Mazzotta M., Marcoli M., Maura G., Alloisio S.,<br />
Nobile M., Ferroni S. (Genoa, Bari, Bologna)<br />
STIMULUS-SELECTIVE NEUROMODULATORY ACTION OF<br />
BETA-AMYLOID<br />
Mura E., Govoni S., Preda S., Frattini P., Giudici D., Grilli<br />
M., Lagomarsino F., Marchi M. (Pavia, Genoa)<br />
TYPE 1 CANNABINOID RECEPTOR (CB1R) AGONISTS<br />
PROMOTE RAT CEREBELLAR NEURAL PROGENITOR CELL<br />
PROLIFERATION THROUGH ACTIVATION OF THE ERK AND<br />
AKT PATHWAYS<br />
Soffia S., Barbierato M., Zusso M., Skaper S., Giusti P.,<br />
Debetto P. (Padua)<br />
EXPOSURE TO AN ENRICHED ENVIRONMENT SELECTIVELY<br />
INCREASES THE FUNCTIONAL RESPONSE OF THE<br />
PRESYNAPTIC NMDA RECEPTORS WHICH MODULATE<br />
NORADRENALINE RELEASE IN MOUSE HIPPOCAMPUS<br />
Grilli M., Zappettini S., Zanardi A., Lagomarsino F.,<br />
Pittaluga A., Zoli M., Marchi M. (Genoa, Modena)<br />
CALCIUM ACTIVATED K + CHANNEL AS A TARGET OF<br />
PROMPT-TO-USE DRUGS IN NEUROMUSCULAR<br />
DISORDERS<br />
Mele A., Carbonara G., Fracchiolla G., Loiodice F., Latorre<br />
R., Conte Camerino D., Tricarico D. (Bari, Valparaìso)<br />
MODULATION OF GLYCINE EXOCYTOSIS FROM MOUSE<br />
SPINAL CORD AND HIPPOCAMPUS GLYCINERGIC NERVE<br />
TERMINALS BY PRESYNAPTIC GABAB RECEPTORS<br />
Raiteri L., Luccini E., Romei C. (Genoa)<br />
CPVT –RELATED RYR2 MUTATION: IMPACT OF AN<br />
ARRHYTHMOGENIC DISORDER ON THE MECHANICAL<br />
PROPERTIES OF MYOCARDIUM. INSIGHTS FROM A<br />
TRANSGENIC MOUSE MODEL<br />
Coppini R., Ferrantini C., Poggesi C., Cerbai E. (Florence)<br />
DIFFERENTIAL REGULATION OF EXCITATORY AND<br />
INHIBITORY NEUROTRANSMITTER RELEASE BY LARGE-<br />
CONDUCTANCE CA 2+ - AND VOLTAGE-ACTIVATED K +<br />
(BKCA) CHANNELS<br />
Martire M., Panza E., Barrese V., Iannotti F., D'Amico M.,<br />
Calciano S., Viggiano D., Taglialatela M. (Rome, Naples,<br />
45<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/3/14<br />
P-1/3/15<br />
P-1/3/16<br />
Campobasso)<br />
FUNCTIONAL CONSEQUENCES OF BFNS-CAUSING<br />
MUTATION IN THE VOLTAGE SENSOR OF KV7.2 CHANNELS<br />
AND GATING CURRENTS FROM NEURONAL KV7 CHANNELS<br />
Miceli F., Soldovieri M., Cilio M., Bezanilla F., Taglialatela<br />
M. (Naples, Rome, Campobasso, Chicago)<br />
KV7 (KCNQ1-5) POTASSIUM CHANNEL SUBUNITS<br />
CONTROL SKELETAL MUSCLE PROLIFERATION,<br />
DIFFERENTIATION, AND RESPONSE TO MYOTOXIC<br />
INSULTS<br />
Iannotti F., Panza E., Barrese V., Viggiano D.,<br />
Taglialatela M. (Naples, Campobasso)<br />
LARGE SCREENING OF NEWLY SYNTHESIZED MEXILETINE<br />
AND TOCANIDE ANALOGS AS POTENT USE-DEPENDENT<br />
BLOCKERS OF SKELETAL MUSCLE SODIUM CHANNELS:<br />
IDENTIFICATION OF THE STRUCTURAL REQUIREMENTS<br />
FOR IMPROVING ANTIMYOTONIC ACTIVITY<br />
De Bellis M., De Luca A., Conte Camerino D., Lentini G.,<br />
Carocci A., Corbo F., Franchini C. (Bari)<br />
46<br />
THURSDAY, October 15, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-1/4/1<br />
P-1/4/2<br />
P-1/4/3<br />
P-1/4/4<br />
P-1/4/5<br />
P-1/4/6<br />
Poster Session<br />
P-1/4: CELL DEATH AND PROLIFERATION<br />
Poster Commission Members:<br />
President: Pepeu G. (Florence)<br />
Members: Abbracchio M. P. (Milan), Florio T. (Genoa)<br />
INHIBITION OF APOPTOSIS-DRIVEN REGRESSION OF<br />
HAIR BULB<br />
Carelli S., Traversa M. V., Giuliani G., Marzani B.,<br />
Benedusi A., Di Giulio A., Gorio A. (Milan, Rozzano)<br />
SIGNALING PATHWAYS INVOLVED IN THE APOPTOTIC<br />
ACTION OF OUABAIN IN TWO DIFFERENT CANCER CELL<br />
LINES<br />
Trenti A., Cusinato F., Bertoldo A., Luciani S., Trevisi L.<br />
(Padua)<br />
NEMO-BINDING DOMAIN PEPTIDE INDUCES APOPTOSIS<br />
IN HUMAN MELANOMA CELLS: AN EFFECT ASSOCIATED<br />
TO INHIBITION OF CONSTITUTIVE NF-KB ACTIVATION<br />
Ianaro A., Tersigni M., Belardo G., Naplestano M.,<br />
Ascierto P., Ialenti A. (Naples, Rome)<br />
INHIBITION OF DBTRG PROLIFERATION AND MIGRATION<br />
IN VITRO BY THC AND CANNABIDIOL: A CELLULAR BASIS<br />
FOR THE EFFECTS OF CANNABIS SATIVA ON<br />
GLIOBLASTOMA<br />
Fiore G., Montefrancesco G., Fiaschi A., Giorgi G.,<br />
Cerretani D. (Siena)<br />
EFFECTS OF BERGAMOT ESSENTIAL OIL BERGAPTENE-<br />
FREE IN CARRAGEENAN-INDUCED PAW OEDEMA IN RAT<br />
Navarra M., Mannucci C., Trapasso E., Pergolizzi S., Miceli<br />
N., Calapai G. (Messina)<br />
THE mGLU(5) RECEPTOR ANTAGONIST 2-METHYL-6-<br />
(PHENYLETHYNYL)PYRIDINE (MPEP) PROTECTS RAT<br />
LIVERS AGAINST WARM AND COLD ISCHEMIA INJURY<br />
47<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/4/6<br />
P-1/4/7<br />
P-1/4/8<br />
P-1/4/9<br />
P-1/4/10<br />
P-1/4/11<br />
P-1/4/12<br />
P-1/4/13<br />
P-1/4/14<br />
Ferrigno A., Rizzo V., Storto M., Riozzo B., Gregotti C.,<br />
Richelmi P., Nicoletti F., Vairetti M. (Pavia, Pozzilli, Rome)<br />
PROMOTER METHYLATION OF TSC2 GENE IS IMPORTANT<br />
FOR PATHOGENESIS OF TSC AND LAM LESIONS<br />
Ancona S., Lesma E., Sirchia S., Grande V., Chiaramonte<br />
E., Di Giulio A., Gorio A. (Milan)<br />
METHYLGUANIDINE INCREASES THE OXIDATIVE STRESS<br />
APOPTOSIS IN RAT GLIOMA CELL LINE<br />
Marzocco S., Popolo A., Bianco G., Pinto A., Autore G.<br />
(Fisciano)<br />
ROLE OF HMG-COA REDUCTASE INHIBITORS IN<br />
CONTROLLING TSC2 -/- ASM CELL GROWTH AND<br />
PROLIFERATION<br />
Grande V., Lesma E., Ancona S., Chiaramonte E., Di<br />
Giulio A., Gorio A. (Milan)<br />
ROLE OF SESTRIN2 IN THE INDUCTION OF AUTOPHAGY<br />
Maiuri M. C., De Stefano D., Carnuccio R., Kroemer G.<br />
(Villejuif, Naples)<br />
EFFECT OF BOTH STATINS AND FARNESYLTRANSFERASE<br />
INHIBITORS ON PRIMARY CULTURES OF NON SMALL<br />
LUNG CANCER CELLS PROLIFERATION<br />
Gallelli L., Falcone D., Santoro L., Pelaia G., Maselli R.,<br />
Savino R., De Sarro G. (Catanzaro, Naples)<br />
EARLY DEFECT OF TRANSFORMING GROWTH FACTOR β-1<br />
FORMATION IN HUNTINGTON’S DISEASE<br />
Riozzi B., Cannella M., Battaglia G., Orobello S., Maat-<br />
Schieman M., Aronica E., Busceti C., Ciarmiello A.,<br />
Sassone J., Ciammola A., Pouladi M., Hayden M., Sipione<br />
S., Bruno V., Nicoletti F., Squitieri F. (Pozzilli, Leiden,<br />
Amsterdam, La Spezia, Milan, Vancouver, Edmonton,<br />
Rome)<br />
IN VITRO BIOLOGICAL EFFECTS OF PISTACIA LENTISCUS<br />
ESSENTIAL OIL<br />
Casarin E., Buriani A., Fortinguerra S., Carrara M.<br />
(Padua)<br />
EXPRESSION AND FUNCTION OF SDF1 AND CXCR4 IN<br />
HUMAN NORMAL PITUITARY AND PITUITARY ADENOMAS:<br />
AN INSIGHT TO PUTATIVE HYPOPHYSEAL TUMOR STEM<br />
CELLS<br />
Barbieri F., Bajetto A., Pattarozzi A., Gatti M., Wurth R.,<br />
Mannino E., Florio T. (Genoa)<br />
P-1/4/15 COUNTER REGULATORY EFFECTS OF PKC DELTA AND<br />
48<br />
P-1/4/16<br />
P-1/4/17<br />
P-1/4/18<br />
P-1/4/19<br />
P-1/4/20<br />
P-1/4/21<br />
P-1/4/22<br />
P-1/4/23<br />
EPSILON ON ENDOTHELIAL NOS AND CELL DYSFUNCTION<br />
Monti M., Donnini S., Giachetti A., Mochly Rosen D., Ziche<br />
M. (Siena, Stanford)<br />
ANTIPROLIFERATIVE EFFECTS OF BERGAMOT JUICE ON<br />
SH-SY5Y HUMAN NEUROBLASTOMA CELLS<br />
Trapasso E., Ursino Maria Rita M., Calapai G., Navarra M.,<br />
Bramanti P. (Messina)<br />
PROTECTIVE ROLE OF RAPAMYCIN IN NEONATAL<br />
HYPOXIA-ISCHEMIA INDUCED BRAIN INJURY<br />
Carloni S., Girelli S., Buonocore G., Marzocchi B., Balduini<br />
W. (Urbino, Siena)<br />
SIMVASTATIN REDUCES HYPOXIA-ISCHEMIA INDUCED<br />
BRAIN DAMAGE IN THE IMMATURE RAT VIA AKT<br />
ACTIVATION AND REDUCTION OF INFLAMMATORY CELL<br />
RECRUITMENT<br />
Girelli S., Carloni S., Buonocore G., Longini M., Balduini<br />
W. (Urbino, Siena)<br />
NGF TREATMENT DECREASES THE INVASIVE CAPABILITY<br />
OF METASTATIC PROSTATE CANCER CELL LINES<br />
THROUGH THE MODIFICATION OF PROTEINS INVOLVED<br />
IN CELL MOTILITY AND ADHESION<br />
Bodei S., Bedussi F., Arrighi N., Zani D., Missale C.,<br />
Simeone C., Cosciani Cunico S., Spano P. F., Sigala S.<br />
(Brescia)<br />
EFFECTS OF FR235222 IN PROLIFERATION AND<br />
APOPTOSIS OF HUMAN LEUKAEMIA CELL LINES: ROLE OF<br />
ANNEXIN A1 AND ITS MEMBRANE LOCALIZATION<br />
D'Acunto C., Festa M., Parente L., Petrella A. (Salerno)<br />
THE SELECTIVE ENHANCER OF TYPE-4 METABOTROPIC<br />
GLUTAMATE RECEPTORS, PHCCC, REDUCES<br />
PROLIFERATION OF CULTURED RAT PANCREATIC DUCTAL<br />
CELLS<br />
Grimaldi A., Spinsanti P., De Vita T., Anastasi E., Nicoletti<br />
F., Melchiorri D. (Rome, Pozzilli)<br />
DIFFERENTIATION-ASSOCIATED LOSS OF RYANODINE<br />
RECEPTORS: A STRATEGY ADOPTED BY<br />
MONOCYTES/MACROPHAGES TO PREVENT THE DNA<br />
SINGLE-STRAND BREAKAGE INDUCED BY PEROXYNITRITE<br />
Guidarelli A., Cerioni L., Fiorani M., Cantoni O. (Urbino)<br />
DICKKOPF-1, AN ENDOGENOUS ANTAGONIST OF THE<br />
WNT PATHWAY, IS INCREASED IN THE SERUM AFTER<br />
BRAIN ISCHEMIA<br />
Mastroiacovo F., Busceti C., Biagioni F., Riozzi B., Storto<br />
49<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/4/24<br />
P-1/4/25<br />
P-1/4/26<br />
P-1/4/27<br />
P-1/4/28<br />
P-1/4/29<br />
P-1/4/30<br />
M., Bucci D., Pallottino S., Ottaviani S., Gradini R.,<br />
Battaglia G., Bruno V., Sobrado M., Nicoletti F. (Pozzilli,<br />
Rome, Madrid)<br />
EFFECTS OF PRAMIPEXOLE ON NEUROSPHERES:<br />
DIFFERENTIATION TOWARD THE NEURONAL AND GLIAL<br />
LINEAGE<br />
Spampinato S., Merlo S., Buerger E., Canonico P. L.,<br />
Sortino M. (Catania, Novara, Biberach an der Riss)<br />
CELECOXIB SYNERGIZES THE ANTI-LEUKEMIC EFFECTS<br />
OF IMATINIB BY INDUCING ENDOPLASMIC RETICULUM<br />
STRESS (ERS)-DEPENDENT AUTOPHAGY VIA NON-COX2<br />
TARGETS<br />
De Dominici M., Riva B., Condorelli F., Canonico P. L.<br />
(Novara)<br />
CHARACTERIZATION OF FK866, A NOVEL ANTICANCER<br />
AGENT TARGETING NAD METABOLISM, AND OF NEWLY<br />
SYNTHESISED CHEMICAL ANALOGUES<br />
Travelli C., Colombano G., Billington R., Grolla A., Galli<br />
U., Tron G., Condorelli F., Canonico P. L., Genazzani A.<br />
(Novara, Plymouth)<br />
DOWN-REGULATION OF RYANODINE RECEPTORS: A<br />
NOVEL STRATEGY ADOPTED BY<br />
MONOCYTES/MACROPHAGES TO COPE WITH<br />
PEROXYNITRITE, BASED ON PREVENTION OF<br />
MITOCHONDRIAL H2O2 FORMATION<br />
Cerioni L., Guidarelli A., Cantoni O. (Urbino)<br />
GSH-DEPENDENT REGULATION OF CA2+ MOBILIZATION<br />
FROM THE RYANODINE RECEPTOR IS OF PIVOTAL<br />
IMPORTANCE FOR PREVENTION OF DNA STRAND<br />
SCISSION AND FOR SURVIVAL OF ASTROCYTES EXPOSED<br />
TO PEROXYNITRITE<br />
Amadori A., Guidarelli A., Palomba L., Giordano G., Costa<br />
L., Cantoni O. (Urbino)<br />
EXPLOITATION OF THE ESSENTIAL OIL OF BERGAMOT IN<br />
CELL-CYCLE PROGRESSION, CELL PROLIFERATION AND<br />
VIABILITY STUDIES IN CULTURED HUMAN SH-SY5Y<br />
NEUROBLASTOMA CELLS<br />
Ciociaro A., Maida S., Russo R., Berliocchi L., Ragusa S.,<br />
Rotiroti D., Bagetta G., Corasaniti M. (Catanzaro, Cosenza)<br />
A NOVEL PHARMACOLOGICAL TARGET FOR IMMUNE-<br />
MEDIATED VASCULAR DISEASES: GENDER DIFFERENCES<br />
IN OXIDATIVE STRESS AND APOPTOSIS INDUCED BY<br />
AUTOANTIBODIES SPECIFIC TO RLIP76<br />
Ascione B., Colasanti T., Margutti P., Matarrese P.,<br />
Vacirca D., Malorni W., Ortona E. (Rome)<br />
50<br />
THURSDAY, October 15, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-1/5/1<br />
P-1/5/2<br />
P-1/5/3<br />
P-1/5/4<br />
P-1/5/5<br />
P-1/5/6<br />
Poster Session<br />
P-1/5: PAIN PHARMACOLOGY<br />
Poster Commission Members:<br />
President: Navarra P. (Rome)<br />
Members: Grilli M. (Novara), Nicoletti F. (Rome)<br />
BASAL EXPRESSION OF ENDOGENOUS OPIOID GENES IN<br />
MICE NEURONAL TISSUES INVOLVED IN PAIN CONTROL<br />
D'Addario C., Romaudi P., Candeletti S. (Bologna)<br />
ST JOHN’S WORT INDUCES A PROLONGED PROTEIN<br />
KINASE C-MEDIATED, OPIOID-RELATED<br />
ANTINOCICEPTION IN MICE<br />
Vivoli E., Galeotti N., Ghelardini C., Salvicchi A., Bartolini<br />
A. (Florence)<br />
ANTIHYPERALGESIC PROPERTY OF ST JOHN’S WORT IN A<br />
RAT MODEL OF NEUROPATHIC PAIN THROUGH A<br />
HYPERICIN-MEDIATED INHIBITION OF THE PROTEIN<br />
KINASE C, G AND E ACTIVITY<br />
Salvicchi A., Galeotti N., Ghelardini C., Vivoli E., Bartolini<br />
A. (Florence)<br />
A RAT MODEL OF NARCOTIC BOWEL SYNDROME<br />
Agostini S., Eutamene H., Broccardo M., Improta G.,<br />
Petrella C., Theodorou V., Bueno L. (Rome, Toulouse)<br />
PERITONITIS INDUCED HYPERNOCICEPTION DEPENDS ON<br />
SYSTEMIC RELEASE OF ENDOGENOUS BV8/PK2<br />
Nicotra A., Canestrelli M., Giannini E., Balboni G.,<br />
Salvadori S., Lattanzi R. (Rome, Ferrara)<br />
INVOLVEMENT OF CB1 RECEPTORS ON THE<br />
ANTINOCICEPTIVE EFFECT OF ACETYLSALICYLIC ACID IN<br />
TWO PAIN TESTS IN THE RAT<br />
Sandrini M., Vitale G., Ruggieri V., Filaferro M., Frigeri C.,<br />
Pini L. (Modena)<br />
51<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/5/7<br />
P-1/5/8<br />
P-1/5/9<br />
P-1/5/10<br />
P-1/5/11<br />
P-1/5/12<br />
P-1/5/13<br />
P-1/5/14<br />
INVOLVEMENT OF OPIOID AND CANNABINOID<br />
RECEPTORS IN THE OXYTOCIN-INDUCED<br />
ANTIHYPERALGESIC EFFECT FOLLOWING ICV<br />
ADMINISTRATION<br />
Russo R., La Rana G., Sasso O., D'Agostino G., Calignano<br />
A. (Naples)<br />
OXALIPLATIN-INDUCED NEUROPATHIC PAIN: GLIAL<br />
ACTIVATION AND CHARACTERISTIC NERVOUS TISSUE<br />
ALTERATION<br />
Di Cesare Mannelli L., Pacini A., Carovani M., Ghelardini<br />
C., Bartolini A. (Florence)<br />
ROLE OF P2Y RECEPTORS IN NEURON-GLIA SIGNALLING<br />
AND IN PAIN TRANSMISSION IN THE SPINAL TRIGEMINAL<br />
SYSTEM<br />
Villa G., Ceruti S., Fumagalli M., Colombo L., Verderio C.,<br />
Bhargava A., Jasmin L., Ohara P., Abbracchio M. P. (Milan,<br />
San Francisco, Los Angeles)<br />
EPIGENETIC CONTROL OF CHRONIC PAIN MECHANISMS<br />
Zammataro M., Copani A., Nicolai R., Nicoletti F.,<br />
Chiechio S. (Catania, Pomezia, Rome, Pozzilli)<br />
TRIGEMINAL GANGLION SATELLITE GLIAL CELLS CAN BE<br />
ACTIVATED UNDER PRO-INFLAMMATORY STIMULI AND<br />
INFLUENCE TRIGEMINAL NEURON ACTIVITY: RESULTS<br />
FROM A “SIMPLIFIED” IN VITRO MODEL OF NEURON-GLIA<br />
INTERACTION<br />
Capuano A., De Corato A., Lisi L., Tringali G., Navarra P.,<br />
Dello Russo C. (Rome)<br />
FUNCTIONAL INTERACTION BETWEEN TRPV1 AND µ-<br />
OPIOID RECEPTORS IN DESCENDING ANTINOCICEPTIVE<br />
PATHWAY ACTIVATES GLUTAMATE TRANSMISSION AND<br />
INDUCES ANALGESIA<br />
Guida F., Migliozzi A., Palazzo E., Scafuro A., Rossi F., Di<br />
Marzo V., Maione S. (Naples)<br />
GROUP III mGLUR7 AND mGLUR8 IN THE AMYGDALA<br />
DIFFERENTIALLY MODULATE NOCIFENSIVE AND<br />
AFFECTIVE PAIN BEHAVIOUR<br />
Palazzo E., De Chiaro M., Marabese I., Neugebauer V., de<br />
Novellis V., Maione S. (Naples, Galveston)<br />
METABOTROPIC GLUTAMATE RECEPTOR SUBTYPES 7 AND<br />
8 MEDIATE OPPOSITE EFFECTS ON GLUTAMATE RELEASE<br />
IN THE STRIATUM AND DECREASE NOCICEPTIVE<br />
RESPONSES IN NEUROPATHIC RATS<br />
Marabese I., Palazzo E., Rossi C., De Chiaro M.,<br />
52<br />
P-1/5/15<br />
P-1/5/16<br />
Soukupova M., Scafuro M., Maione S., de Novellis V.<br />
(Naples, Prague)<br />
THE AGONIST OF N-FORMYL PEPTIDE RECEPTORS FMLF<br />
AFFECTED OPIOID TOLERANCE<br />
Mastriota M., Colucci M., Pieretti S., Di Giannuario A.<br />
(Rome)<br />
PROTECTIVE EFFECTS OF ANTIOXIDANTS IN NITRIC<br />
OXIDE/COX2 INTERACTION DURING ACUTE<br />
INFLAMMATORY PAIN: THE ROLE OF NITRATION<br />
Dagostino C., Di Girolamo F., Crispo G., Guadagni F.,<br />
Costa N., Casale F., Ventrice D., Rizzo M., Mollace V.,<br />
Muscoli C. (Catanzaro, Rome, Catania)<br />
53<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
THURSDAY, October 15, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-1/6/1<br />
P-1/6/2<br />
P-1/6/3<br />
P-1/6/4<br />
P-1/6/5<br />
P-1/6/6<br />
Poster Session<br />
P-1/6: DRUGS OF ABUSE<br />
Poster Commission Members:<br />
President: Navarra P. (Rome)<br />
Members: Grilli M. (Novara), Nicoletti F. (Rome)<br />
PRE-TREATMENT WITH K + CHANNEL BLOCKERS 4-AP AND<br />
TEA PREVENTS THE DEVELOPMENT OF OPIOID<br />
DEPENDENCE IN GUINEA-PIG ILEUM (GPI) UNMASKING<br />
OPIOID AND ADENOSINE A1 CONSTITUTIVE ACTIVITY<br />
Mhillaj E., Romenelli L., Valeri P., Palmery M. (Rome)<br />
BIOLOGICAL AND MOLECULAR EFFECTS OF HIGH DOSES<br />
OF ANABOLIC STEROIDS<br />
Piccione F., Abbadessa G., Cangemi L., De Francia S.,<br />
Esculapio P., Penna C., Tullio F., Portaleone P., Pagliaro P.,<br />
Di Carlo F., Racca S. (Orbassano, Turin)<br />
EFFECTS OF MDMA ON N/OFQ-NOPR SYSTEM USING IN<br />
VITRO AND IN VIVO APPROACHES<br />
Di Benedetto M., Cavina C., Candeletti S., Romualdi P.<br />
(Bologna)<br />
EFFECTS OF FENTANYL TREATMENT ON MOP AND NOP<br />
GENE EXPRESSION IN HUMAN NEUROBLASTOMA SH-SY5Y<br />
CELLS<br />
Cannarsa R., Candeletti S., Romualdi P. (Bologna)<br />
INDIVIDUALIZING NICOTINE REPLACEMENT THERAPY BY<br />
MEANS OF PLASMA NICOTINE AND COTININE ANALYSIS<br />
IN CIGARETTES’ SMOKERS<br />
Baraldo M., Feruglio M., Cojutti P., Savio S., Furlanut M.<br />
(Udine)<br />
INHIBITION OF FATTY ACID AMIDE HYDROLASE<br />
DIFFERENTIALLY AFFECT ETHANOL RELAPSE BEHAVIOUR<br />
IN WISTAR AND IN GENETICALLY SELECTED ALCOHOL<br />
54<br />
P-1/6/7<br />
P-1/6/8<br />
P-1/6/9<br />
P-1/6/10<br />
P-1/6/11<br />
P-1/6/12<br />
P-1/6/13<br />
P-1/6/14<br />
PREFERRING RATS<br />
Braconi S., Cippitelli A., Cannella N., Kallupi M., Ubaldi<br />
M., Salvucci C., Ciccocioppo R. (Camerino)<br />
NEUROPEPTIDE S FACILITATES ETHANOL SEEKING<br />
BEHAVIOUR THROUGH STIMULATION OF HYPOTHALAMIC<br />
HYPOCRETIN SYSTEM<br />
Cannella N., Kallupi M., Economidou D., Ruggeri B.,<br />
Ubaldi M., Massi M., Ciccocioppo R. (Camerino)<br />
REDUCTION OF ALCOHOL DRINKING AND ALCOHOL<br />
WITHDRAWAL-ASSOCIATED SYMPTOMS FOLLOWING<br />
ACTIVATION OF CENTRAL NOCICEPTIN/ORPHANIN FQ<br />
RECEPTORS<br />
Stopponi S., Braconi S., Economidou D., Cippitelli A.,<br />
Ubaldi M., Clementi S., Massi M., Ciccocioppo R.<br />
(Camerino)<br />
NEUROPETIDE S POTENTLY STIMULATES COCAINE-<br />
SEEKING BEHAVIOUR: AN EFFECT MEDIATED BY<br />
ACTIVATION OF THE HYPOTHALAMIC HYPOCRETIN<br />
SYSTEM<br />
Kallupi M., Cannella N., Economidou D., de Guglielmo G.,<br />
Ruggeri B., Massi M., Ciccocioppo R. (Camerino)<br />
NEUROPETIDE S RECEPTOR GENE EXPRESSION IN<br />
ALCOHOL WITHDRAWAL AND PROTRACTED ABSTINENCE<br />
IN POST-DEPENDENT RATS<br />
Ruggeri B., Braconi S., Cannella N., Kallupi M., Soverchia<br />
L., Ciccocioppo R., Ubaldi M. (Camerino)<br />
STRESS AND COCAINE INTERACT TO MODULATE BRAIN<br />
DERIVED NEUROTROPHIC FACTOR (BDNF) EXPRESSION<br />
IN RAT BRAIN<br />
Caffino L., Racagni G., Riva M., Fumagalli F. (Milan)<br />
CLINICAL MINIMAL INTERVENTION IN SMOKING<br />
CESSATION<br />
Russo G., Calzavara E., Carnì A., Mannucci C., Pieratti A.,<br />
Navarra M., Caputi A. P., Calapai G. (Messina)<br />
MODELING NATURAL RECOVERY FROM DRUG ABUSE<br />
Montefrancesco G., Mocenni C., Tiezzi S., Giorgi G.<br />
(Siena)<br />
THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-<br />
ALPHA AGONIST METHOLEOYLETHANOLAMIDE<br />
MODULATES NICOTINE EFFECTS IN THE BRAIN REWARD<br />
CIRCUIT IN THE RAT<br />
Lecca S., Luchicchi A., Carta S., Pillolla G., Pistis M.<br />
(Cagliari)<br />
55<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/6/15<br />
P-1/6/16<br />
DECLINE OF SMOKING AFTER A SMOKING BAN IN PUBLIC<br />
PLACES IN ITALY<br />
Grassi M., Enea D., Ferketich A., Lu B., Nencini P. (Rome)<br />
GROUP COUNSELING AND VARENICLINE FOR SMOKING<br />
CESSATION TREATMENT: A ONE-YEAR FOLLOW-UP STUDY<br />
Grassi M., Enea D., Pasquariello S., Marchetti R., Nencini<br />
P. (Rome)<br />
56<br />
THURSDAY, October 15, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-1/7/1<br />
P-1/7/2<br />
P-1/7/3<br />
P-1/7/4<br />
P-1/7/5<br />
P-1/7/6<br />
Poster Session<br />
P-1/7: AGING, BEHAVIOUR AND TOXICOLOGY<br />
Poster Commission Members:<br />
President: Cuomo V. (Rome)<br />
Members: Hrelia P. (Bologna), Marinovich M. (Milan)<br />
DULOXETINE IN THE TREATMENT OF BULIMIA NERVOSA:<br />
A CASE REPORT<br />
Capasso A., Siano C., Nolfe G., Petrella C., Milan L., Milan<br />
W. (Fisciano)<br />
CONFORMATIONALLY ALTERED P53: A POTENTIAL<br />
PREDICTIVE MARKER FROM MCI TO ALZHEIMER’S<br />
DISEASE?<br />
Stanga S., Lanni C., Uberti D., Mazzini G., Sinforiani E.,<br />
Memo M., Govoni S., Racchi M. (Pavia, Brescia)<br />
EFFECT OF ANTIOXIDANTS IN RATS TREATED WITH<br />
PYRETHROID INSECTICIDES<br />
Nasuti C., Gabbianelli R., Falcioni M., Sekar D.<br />
(Camerino)<br />
LIVER INJURY INDUCED BY TEUCRIUM CHAMAEDRYS<br />
INFUSION: AN ANALYSIS OF TWO RECIDIVOUS CASES<br />
Nencini C., Galluzzi P., Pippi F., Giorgi G., Micheli L.<br />
(Siena)<br />
NIVALENOL AND DEOXYNIVALENOL TRICHOTHECENES<br />
AFFECT J774A.1 MURINE MACROPHAGES VIABILITY<br />
Marzocco S., Russo R., Bianco G., Severino L., Autore G.<br />
(Fisciano, Naples)<br />
EFFECT OF AMYLOID-BETA PEPTIDES ON ZEBRAFISH<br />
(DANIO RERIO) EMBRYOS<br />
Cetti E., Solito R., Corti F., Santini R., Donnini S.,<br />
Giachetti A., Cotelli F., Ziche M. (Siena, Milan)<br />
57<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
P-1/7/7<br />
P-1/7/8<br />
P-1/7/9<br />
P-1/7/10<br />
P-1/7/11<br />
P-1/7/12<br />
P-1/7/13<br />
P-1/7/14<br />
IN VITRO EVALUATION ON THE ANTI-APOPTOTIC AND<br />
ANTI-OXIDANT EFFECT OF A SERIES OF NATURAL<br />
POLYPHENOLS ON UVB-IRRADIATED NORMAL HUMAN<br />
KERATINOCYTES AND MELANOCYTES<br />
Bruni E., Giudice S., Veratti E., Magnoni C., Benassi L.,<br />
Pellati F., Benvenuti S., Rossi T. (Modena)<br />
A MODEL OF BINGE EATING IN FEMALE RATS UNDER<br />
OPERANT SELF-ADMINISTRATION CONDITIONS<br />
Cifani C., Zanoncelli A., Tessari M., Righetti C., Di<br />
Francesco C., Micioni Di Bonaventura M., Ciccocioppo R.,<br />
Massi M., Melotto S. (Camerino, Verona)<br />
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL<br />
DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE<br />
Alghisi M., Baiguera C., Pinna A., De Luca M., Benarese<br />
M., Monfardini S., Sarnico I., Morelli M., Spano P. F., Pizzi<br />
M. (Brescia, Cagliari)<br />
EMBRYONIC STEM CELLS AS A MODEL TO STUDY THE<br />
EFFECT OF ANTINEOPLASTIC DRUGS<br />
Suffredini S., Sartiani L., Stillitano F., Mugelli A., Cerbai<br />
E. (Florence)<br />
DRUG METABOLISM AND ANTIOXIDANT DEFENSE<br />
MODULATION-BASED ANTICANCER STRATEGY: “5 A DAY<br />
FOR A BETTER HEALTH” ALIMENTARY PLAN VERSUS<br />
MONO-COLOR VEGETARIAN DIETS<br />
Bonamassa B., Canistro D., Longo V., Messina A.,<br />
Lubrano V., Sapone A., Andeotti C., Costa G., Biagi G.,<br />
Paolini M. (Bologna, Pisa)<br />
ANTIMUTAGENICITY OF A SECOISOPIMARANE<br />
DITERPENOID FROM SALVIA CINNABARINA M. MARTENS<br />
ET GALEOTTI IN AMES TEST AND MICRONUCLEUS ASSAY<br />
ON CULTURED HUMAN LYMPHOCYTES<br />
Di Sotto A., Carbone F., Maffei F., Hrelia P., Mazzanti G.<br />
(Rome, Bologna)<br />
ACUTE ADMINISTRATION OF OLEOYLETHANOLAMIDE<br />
AFFECTS BEHAVIORAL SATIETY SEQUENCE IN MICE: A<br />
COMPARATIVE STUDY WITH RIMONABANT EFFECTS<br />
Righetti L., Romano A., Coccurello R., Dipasquale P.,<br />
Bellantuono S., D’Amato F., Cuomo V., Moles A., Gaetani<br />
S. (Rome)<br />
EFFECTS OF ESTROGENS AND GENISTEIN ON RAT<br />
URINARY BLADDER CONTRACTILITY AND THEIR<br />
NEUROPROTECTIVE ROLE AGAINST ISCHAEMIA AND<br />
REPERFUSION INJURY<br />
Valeri A., Sgaragli G., Valoti M., Pessina F. (Siena)<br />
58<br />
P-1/7/15<br />
P-1/7/16<br />
P-1/7/17<br />
P-1/7/18<br />
P-1/7/19<br />
P-1/7/20<br />
P-1/7/21<br />
P-1/7/22<br />
P-1/7/23<br />
P-1/7/24<br />
RAT INTESTINAL PRECISION-CUT SLICES AS TOOL TO<br />
STUDY XENOBIOTIC INTERACTIONS WITH TRANSPORT<br />
PROTEINS<br />
Franco G., Possidente M., Frosini M., Dragoni S., Valoti M.<br />
(Siena)<br />
TOXIC EFFECTS OF AIRBORNE PM10 ON PRIMARY<br />
CULTURE OF HUMAN CELLS<br />
Chirafisi J., Speciale A., Trombetta D., Cristani M.,<br />
Naccari C., Saija A., Cimino F. (Messina)<br />
THE MARINE TOXIN PALITOXIN EXERTS A POTENT<br />
CYTOTOXIC EFFECT ON HUMAN HACAT KERATINOCYTES<br />
Pelin M., Zanette C., Sosa S., Tubaro A., Florio C.<br />
(Trieste)<br />
ISOTHIOCYANATES AS POTENTIALS ALZHEIMER'S<br />
DISEASE-MODIFYING DRUGS<br />
Bolondi C., Tarozzi A., Merlicco A., Morroni F., Cantelli<br />
Forti G., Hrelia P. (Bologna)<br />
A NEW METHOD FOR NICOTINAMIDE MONONUCLEOTIDE<br />
(NMN) DETECTION IN VITRO AND IN VIVO REVEALS NEW<br />
ASPECTS OF NAD BIOCHEMISTRY AND PHARMACOLOGY<br />
Pittelli M., Formentini L., Moroni F., Chiarugi A. (Florence)<br />
EFFECTS OF CARBON NANOTUBES ON RAT MICROGLIAL<br />
CELLS<br />
Russier J., Fiorito S., Togna A., Latina V., Togna G.<br />
(Rome)<br />
EVALUATION OF CARDIOVASCULAR BIOMARKERS IN<br />
GROUPS OF SMOKERS AFTER A DECADE OF SMOKING<br />
Calapai G., Mannucci C., Bassi A., Morandi S., Gregg E.,<br />
Nunziata A., Caputi A. P. (Messina, Rome, Perugia,<br />
Southampton)<br />
AN ANALYSIS OF SIDE EFFECTS OF NATURAL PRODUCTS<br />
INVOLVING THE IMMUNE SYSTEM<br />
Nunziata A., Andreini I., Andreoli C., Calapai G. (Messina)<br />
EFFECTS OF DIETARY CHOLINE DEPRIVATION ON MOTOR<br />
SKILLS AND COGNITIVE FUNCTION IN THE RAT<br />
Massaro A., Coluccia A., Borracci P., Renna G., Carratù M.<br />
(Bari)<br />
GESTATIONAL EXPOSURE TO ALL-TRANS RETINOIC ACID:<br />
A LONGITUDINAL STUDY ON MOTOR SKILLS IN THE<br />
OFFSPRING OF SPRAGUE-DAWLEY RATS<br />
Massaro A., Coluccia A., Borracci P., Belfiore D., Carratù<br />
M. (Bari)<br />
59<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
4.00<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Arcobaleno – 4.00-4.30 pm<br />
PLENARY LECTURE<br />
Introduction: Meldolesi J. (Milan)<br />
HIGHLIGHTS ON SECOND MESSENGERS<br />
Pozzan T. (Padua)<br />
60<br />
THURSDAY, October 15, 2009<br />
Sala Arcobaleno – 4.45-6.45 pm<br />
Oral Communications<br />
PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 2)<br />
Chairpersons: Amoroso S. (Ancona), Biggio G. (Cagliari)<br />
4.45 pm NEUROPEPTIDE S RECEPTOR LIGANDS<br />
Calò G., Salvadori S., Rizzi A., Regoli D., Guerrini R.<br />
(Ferrara)<br />
5.00 pm THE EFFECTS OF OLEOYLETHANOLAMIDE ON FEEDING<br />
BEHAVIOUR INVOLVE HYPOTHALAMIC OXYTOCIN<br />
NEURONS<br />
Dipasquale P., Gaetani S., Fu J., Cassano T., Romano A.,<br />
Righetti L., Cianci S., Laconca L., Giannini E., Scaccianoce<br />
S., Piomelli D., Cuomo V. (Rome, Irvine, Foggia)<br />
5.15 pm NEUROTOXIC EFFECTS OF ANABOLIC-ANDROGENIC<br />
STEROIDS<br />
Caraci F., Pistarà V., Musumeci T., Corsaro A., Sortino M.,<br />
Nicoletti F., Copani A. (Catania, Pozzilli, Rome)<br />
5.30 pm EFFECT OF ADJUNCTIVE DULOXETINE TREATMENT ON THE<br />
PLASMA CONCENTRATIONS OF CLOZAPINE, OLANZAPINE<br />
AND RISPERIDONE IN PATIENTS WITH PSYCHOTIC<br />
DISORDERS<br />
D'Arrigo C., Santoro V., Migliardi G., Micò U., Muscatello<br />
M., Pandolfo G., Spina E. (Messina)<br />
5.45 pm ZIF268 GENE INVOLVEMENT IN MELANOCORTIN-INDUCED<br />
LONG-LASTING FUNCTIONAL RECOVERY FROM ISCHEMIC<br />
STROKE<br />
Giuliani D., Ottani A., Minutoli L., Di Stefano V.,<br />
Galantucci M., Bitto A., Altavilla D., Zaffe D., Botticelli A.,<br />
Squadrito F., Guarini S. (Modena, Messina, Pavia)<br />
6.00 pm INVOLVEMENT OF THE NADPH OXIDASE NOX2 IN THE<br />
DEVELOPMENT OF BEHAVIORAL AND PATHOLOGICAL<br />
ALTERATIONS IN ISOLATED RATS<br />
Schiavone S., Cuomo V., Trabace L., Krause K. (Rome,<br />
Geneva, Foggia)<br />
6.15 pm TRPV1 CHANNELS CONTROL SYNAPTIC PLASTICITY IN THE<br />
DEVELOPING SUPERIOR COLLICULUS<br />
Migliozzi A., Cristino L., Palazzo E., Di Marzo V., Salt T.,<br />
Maione S. (Naples, Pozzuoli, London)<br />
61<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
6.30 pm PALMITOYLETHANOLAMIDE, AN ENDOGENOUS PPAR-α<br />
AGONIST, MODULATES NEUROSTEROIDS DE NOVO<br />
SYNTHESIS<br />
Sasso O., La Rana G., Vitiello S., Russo R., D'Agostino G.,<br />
Iacono A., Cuzzocrea S., Piazza P., Meli R., Calignano A.<br />
(Naples, Bordeaux, Messina)<br />
62<br />
THURSDAY, October 15, 2009<br />
Sala Azzurra – 4.45-6.45 pm<br />
Oral Communications<br />
RECEPTORS AND SIGNAL TRANSDUCTION MECHANISMS<br />
(SESSION 1)<br />
Chairpersons: Florio T. (Genoa), Ziche M. (Siena)<br />
4.45 pm OXYTOCIN STIMULATES IN VITRO ANGIOGENESIS VIA A<br />
PYK-2/SRC–DEPENDENT MECHANISM<br />
Cattaneo M., Mazzolini S., Vicentini L. (Milan)<br />
5.00 pm REGULATION OF MITOCHONDRIAL DYNAMICS BY NITRIC<br />
OXIDE IS A KEY EVENT IN MYOGENESIS<br />
De Palma C., Falcone S., Pisoni S., Bassi M., Scorrano L.,<br />
Moncada S., Brunelli S., Clementi E. (Milan, Bosisio Parini,<br />
Padua, London)<br />
5.15 pm THE SELECTIVE ENHANCER OF mGLU4 METABOTROPIC<br />
GLUTAMATE RECEPTORS, PHCCC, REGULATES DENDRITE<br />
FORMATION BY AMPLIFYING THE EXPRESSION OF ORC3<br />
PROTEINS IN CULTURED CEREBELLAR GRANULE CELLS<br />
Cappuccio I., Colapicchioni C, Santangelo V., Sale P.,<br />
Bonelli M., Niccolini C., Nicoletti F., Melchiorri D. (Pavia,<br />
Rome, Pozzilli)<br />
5.30 pm PHARMACOLOGICAL CHARACTERIZATION OF PURINE<br />
RECEPTORS IN BOVINE FIBROBLAST-LIKE SYNOVIOCYTES<br />
Varani K., Vincenzi F., Tosi A., De Mattei M., Gessi S.,<br />
Merighi S., Caruso A., Borea P. A. (Ferrara)<br />
5.45 pm ROLE OF THE AKAP SCAFFOLDS AND THE UBIQUITIN-<br />
PROTEASOME PATHWAY IN THE PHYSIOLOGICAL<br />
RESPONSE TO BRAIN ISCHEMIA<br />
Carlucci A., Adornetto A., Scorziello A., Viggiano D.,<br />
Cuomo O., Annunziato L., Feliciello A. (Naples)<br />
6.00 pm PGE2 SYNERGIZES WITH FGF-2/FGFR1 PATHWAY TO<br />
ANGIOGENESIS<br />
Donnini S., Finetti F., Bocci E., Morbidelli L., Ziche M.<br />
(Siena)<br />
6.15 pm THE ENDOVANILLOID/ENDOCANNABINOID SYSTEM IN<br />
HUMAN OSTEOCLASTS<br />
Rossi F., Bellini G., Siniscalco D., Luongo L., De Petrocellis<br />
L., Petrosino S., Torella M., Santoro C., Nobili B., Perrotta<br />
S., Di Marzo V., Maione S. (Naples, Pozzuoli)<br />
63<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.15<br />
pm<br />
6.45<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Blu – 4.45-7.00 pm<br />
Symposium<br />
TEACHING PHARMACOLOGY IN THE MODERN EUROPE<br />
Chairpersons: Drago F. (Catania), Moilanen E. (Tampere)<br />
PHARMACOLOGY: FROM BASIC PRINCIPLES TO TRANSLATIONAL<br />
MEDICINE TO CLINICAL PRACTICE<br />
Theoharides T. (Boston - Athens)<br />
HOW CAN WE BEST PREPARE MEDICAL STUDENTS TO BE SAFE<br />
AND EFFECTIVE PRESCRIBERS?<br />
Maxwell S. (Edinburgh)<br />
TWO STEP EDUCATION IN MEDICAL PHARMACOLOGY IN<br />
GERMANY: EFFECTIVE SYLLABUS OR WASTE OF TIME<br />
Forstermann U. (Mainz)<br />
THE TEACHING OF PHARMACOLOGY IN ITALY: CURRENT<br />
PROBLEMS AND FUTURE PERSPECTIVES<br />
Mugelli A. (Florence)<br />
(Educational support from Sanofi-Aventis)<br />
FINAL TEST<br />
64<br />
4.45<br />
pm<br />
5.30<br />
pm<br />
6.15<br />
pm<br />
6.45<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Giardino d’Inverno – 4.45-7.00 pm<br />
Symposium<br />
NEW THERAPEUTIC PERSPECTIVES IN THE TREATMENT OF<br />
INVASIVE FUNGAL INFECTIONS: FROM PHARMACOLOGY TO THE<br />
CLINICAL EVIDENCE<br />
Chairpersons: Caputi A. P. (Messina), Mazzei T. (Florence)<br />
PHARMACOKINETIC PROFILE AS A TOOL FOR RATIONAL<br />
PRESCRIBING<br />
Mazzei T. (Florence)<br />
EVOLUTION IN THE TREATMENT OF INVASIVE FUNGAL<br />
INFECTIONS: THE ROLE OF ANIDULAFUNGIN<br />
Menichetti F. (Pisa)<br />
ANIDULAFUNGIN: CLINICAL EXPERIENCE IN THE TREATMENT OF<br />
FUNGAL INFECTIONS IN CRITICALLY ILL PATIENT<br />
Sganga G. (Rome)<br />
(Educational support from Pfizer Italia)<br />
FINAL TEST<br />
65<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
THURSDAY, October 15, 2009<br />
Sala Viola – 4.45-6.45 pm<br />
Oral Communications<br />
IMMUNOPHARMACOLOGY<br />
Chairpersons: Brunelleschi S. (Novara),<br />
Sacerdote P. (Milan)<br />
4.45 pm THERAPEUTIC KYNURENINES IN INFLAMMATION AND<br />
AUTOIMMUNITY<br />
Pallotta MT, Grohmann U., Volpi C., Orabona C., Vacca C.,<br />
Bianchi R., Belladonna ML., Puccetti P., Fioretti MC,<br />
Fallarino F. (Perugia)<br />
5.00 pm mGLU4 METABOTROPIC GLUTAMATE RECEPTOR<br />
NEGATIVELY REGULATES TH17 CELL-DRIVEN IMMUNE<br />
RESPONSES: A NEW TARGET FOR THE EXPERIMENTAL<br />
TREATMENT OF NEUROINFLAMMATORY AUTOIMMUNE<br />
DISORDERS<br />
Fazio F., Fallarino F., Notartomaso S., Busceti C., Volpi C.,<br />
Vacca C., Battaglia G., Bruno V., Nicoletti F., Grohmann U.,<br />
Di Marco R. (Pozzilli, Rome, Perugia, Campobasso)<br />
5.15 pm GITR ABLATION IN DENDRITIC CELLS MAKES T CELLS<br />
UNRESPONSIVE TO ACTIVATION IN AN IL-10-DEPENDENT<br />
MANNER<br />
Ronchetti S., Petrillo M., Bianchini R., Cannarile L.,<br />
Nocentini G., Riccardi C. (Perugia)<br />
5.30 pm NON-CANONICAL NF-κB AS A NOVEL TARGET FOR<br />
IMMUNOSUPPRESSION<br />
Volpi C., Fallarino F., Grohmann U., Puccetti P., Fioretti M.<br />
(Perugia)<br />
5.45 pm GLYCOGEN SYNTHASE KINASE 3BETA AS A TARGET FOR<br />
THE THERAPY OF INFLAMMATION, TRAUMA AND<br />
ISCHEMIA/REPERFUSION INJURY<br />
Genovese T., Di Paola R., Esposito E., Cuzzocrea S.<br />
(Messina)<br />
6.00 pm B7H TRIGGERING INHIBITS ADHESION OF HUMBILICAL<br />
VASCULAR ENDOTHELIAL CELLS TO COLON CARCINOMA<br />
CELL LINES AND POLYMORPHONUCLEAR CELLS<br />
Minelli R., Dianzani C. (Turin)<br />
66<br />
6.15 pm INVOLVEMENT OF NUCLEAR FACTOR KB ACTIVATION IN<br />
MODULATION OF APOPTOSIS BY AZIDOTHYMIDINE<br />
Macchi B., Matteucci C., Minutolo A., Balestrieri E., Grelli<br />
S., Mastino A. (Rome, Messina)<br />
66 67<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
4.45<br />
pm<br />
5.00<br />
pm<br />
5.15<br />
pm<br />
5.30<br />
pm<br />
5.45<br />
pm<br />
6.00<br />
pm<br />
6.15<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Arancione – 4.45-7.00 pm<br />
Symposium<br />
ROLE OF PURINOCEPTOR IN ACUTE AND CHRONIC INJURIES AT<br />
THE CENTRAL NERVOUS SYSTEM<br />
Chairpersons: Abbracchio M. P. (Milan), Pedata F. (Florence)<br />
A ROLE FOR THE P2Y-LIKE RECEPTOR GPR17 IN THE<br />
DEVELOPMENT OF TISSUE DAMAGE AND IN<br />
REMODELLING/REPAIR PROCESSES: A NEW SENSOR OF DAMAGE<br />
AND A POTENTIAL PHARMACOLOGICAL TARGET IN SPINAL CORD<br />
INJURY<br />
Ceruti S. (Milan)<br />
ACTIVATION OF MICROGLIA BY AMYLOID β REQUIRES P2X7<br />
RECEPTOR EXPRESSION<br />
Ferrari D. (Ferrara)<br />
A SELECTIVE ADENOSINE A2A RECEPTOR ANTAGONIST REDUCES<br />
JNK MAPK ACTIVATION IN OLIGODENDROCYTES AFTER<br />
CEREBRAL ISCHEMIA “IN VIVO”<br />
Melani A. (Florence)<br />
THE PRO-INFLAMMATORY ACTION OF MICROGLIAL P2<br />
RECEPTORS IS ENHANCED IN SOD1 MODELS FOR AMYOTROPHIC<br />
LATERAL SCLEROSIS<br />
D’Ambrosi N. (Rome)<br />
REMODELING OF STRIATAL NMDA RECEPTORS BY CHRONIC A2A<br />
RECEPTOR ACTIVATION OR BLOCKADE IN HUNTINGTON’S<br />
DISEASE MICE<br />
Martire A. (Rome)<br />
NEUROPROTECTION BY A2A RECEPTOR INACTIVATION,: ROLE OF<br />
FOREBRAIN AND GLIAL A2A RECEPTORS IN THE MPTP MOUSE<br />
MODEL OF PARKINSON'S DISEASE<br />
Morelli M. (Cagliari)<br />
NEUROLOGICAL SYNDROMES AND PURINE DISMETABOLISMS:<br />
NEW INSIGHT<br />
Tozzi M. G. (Pisa)<br />
68<br />
6.30<br />
pm<br />
6.45<br />
pm<br />
MICROPARTICLE RELEASE FROM REACTIVE GLIAL CELLS:<br />
POSSIBLE ROLE IN THE CONTROL OF NEURONAL ACTIVITY<br />
Verderio C. (Milan)<br />
FINAL TEST<br />
68 69<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.05<br />
pm<br />
6.25<br />
pm<br />
6.45<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Bianca – 4.45-7.00 pm<br />
Symposium<br />
NEW INSIGHTS ON THE PHARMACOLOGY AND TOXICOLOGY OF<br />
CANNABINOIDS<br />
Chairpersons: Cuomo V. (Rome), Tanganelli S. (Ferrara)<br />
MODULATORY ROLE OF CANNABINOIDS IN THE RESPONSE TO<br />
EMOTIONAL CHALLENGES<br />
Cuomo V. (Rome)<br />
SHORT AND LONG-TERM CONSEQUENCES OF GESTATIONAL<br />
EXPOSURE TO CANNABINOIDS ON RAT GLUTAMATE<br />
TRANSMISSION AND COGNITIVE FUNCTIONS<br />
Ferraro L. (Ferrara)<br />
THERAPEUTIC POTENTIAL OF THE ENDOCANNABINOID SYSTEM<br />
IN MAJOR DEPRESSION<br />
Rubino T. (Varese)<br />
LIPID RAFTS AS A PLATFORM FOR ENDOCANNABINOID<br />
SIGNALING<br />
Maccarrone M. (Rome)<br />
CANNABIS ABUSE: CLINICAL AND PRECLINICAL ASPECTS<br />
Fattore L. (Cagliari)<br />
FINAL TEST<br />
70<br />
THURSDAY, October 15, 2009<br />
Sala Verde – 4.45-6.45 pm<br />
Oral Communications<br />
GASTROINTESTINAL PHARMACOLOGY<br />
Chairpersons: Blandizzi C. (Pisa), Crema F. (Pavia)<br />
4.45 pm TLQP-21, A VGF-DERIVED PEPTIDE, STIMULATES<br />
EXOCRINE PANCREATIC SECRETION IN THE RAT<br />
Petrella C., Agostini S., Severini C., Linari G., Possenti R.,<br />
Broccardo M., Improta G. (Rome, Toulose)<br />
5.00 pm CONTROL OF COLONIC NEUROMUSCULAR FUNCTIONS BY<br />
A3 PURINERGIC RECEPTORS IN NORMAL COLON AND IN<br />
EXPERIMENTAL COLITIS<br />
Antonioli L., Fornai M., Colucci R., Ghisu N., Tuccori M.,<br />
Giron M., Bin A., Zoppellaro C., Castagliuolo I., Gaion R.,<br />
Del Tacca M., Blandizzi C. (Pisa, Padua)<br />
5.15 pm THE NON-PEPTIDYL LOW MOLECULAR WEIGHT RADICAL<br />
SCAVENGER IAC PROTECTS RATS FROM DSS-INDUCED<br />
COLITIS<br />
Vasina V., Broccoli M., Ursino M., Soleti A., Paolini M., De<br />
Ponti F. (Bologna, Turin)<br />
5.30 pm IN VITRO ISCHAEMIA INCREASES PHOSPHORYLATION OF<br />
NMDA RECEPTOR NR1 SUBUNIT IN THE MYENTERIC<br />
PLEXUS OF THE GUINEA PIG ILEUM VIA PROTEIN KINASE C<br />
Giaroni C., Zanetti E., Oldrini R., Marchet S., Lorenzi T.,<br />
Moro E., Trinchera M., Crema F., Lecchini S., Frigo G.<br />
(Varese, Pavia)<br />
5.45 pm CANNABIDIOL CONTROLS INTESTINAL INFLAMMATION<br />
THROUGH THE MODULATION OF ENTERIC GLIAL CELLS.<br />
Iuvone T., De Filippis D., Esposito G., Cipriano M., Scuderi<br />
C., Cuomo R., De Man J., Steardo L. (Naples, Rome,<br />
Antwerp)<br />
6.00 pm EVALUATION OF ANTIULCER ACTIVITY OF THE<br />
ANTIOXIDANT COMPOUND IAC ON DIFFERENT<br />
EXPERIMENTAL ULCER MODELS IN RATS<br />
Carnevale G., Zanoli P., Corsi L., Geminiani E., Zavatti M.,<br />
Baraldi M. (Modena)<br />
6.15 pm A NEW MELANOCORTIN AGONIST REDUCES CERULEIN<br />
INDUCED PANCREATIC DAMAGE IN AN EXPERIMENTAL<br />
RAT MODEL<br />
71<br />
THURSDAY, October 15, 2009
THURSDAY, October 15, 2009<br />
Bitto A., Polito F., Minutoli L., Di Stefano V., Irrera N.,<br />
Altavilla D., Giuliani D., Guarini S., Ottani A., Caputi A. P.,<br />
Squadrito F. (Messina, Modena)<br />
6.30 pm EFFECT OF CANNABIDIOL, A NON-PSYCHOTROPIC<br />
INGREDIENT OF CANNABIS SATIVA, ON DNBS-INDUCED<br />
COLITIS IN MICE<br />
Aviello G., Borrelli F., Romeno B., Capasso R., Maiello F.,<br />
Guadagno F., Petrosino S., Di Marzo V., Izzo A. (Naples,<br />
Pozzuoli)<br />
72<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.05<br />
pm<br />
6.25<br />
pm<br />
6.45<br />
pm<br />
THURSDAY, October 15, 2009<br />
Sala Rossa – 4.45-7.00 pm<br />
Symposium<br />
PHARMACOGENETICS: STATE-OF-THE-ART AND FUTURE<br />
Chairpersons: Clementi E. (Milan), Filippelli A. (Naples)<br />
THERAPEUTIC INNOVATION, DRUG DEVELOPMENT AND<br />
PHARMACOGENETICS<br />
Recchia G. (Verona)<br />
PHARMACOGENETICS IN ONCOLOGY<br />
Danesi R. (Pisa)<br />
GENETIC TESTING, GENOMIC BIOMARKERS AND PHARMACO<br />
GENETICS<br />
Novelli G. (Rome)<br />
PHARMACOGENETICS OF TRANSPLANT MEDICINE<br />
Cattaneo D. (Milan)<br />
THE COMPANY ‘S ROLE IN THE PERSONALIZED THERAPY<br />
Biondi F. (Jesi)<br />
FINAL TEST<br />
(Educational support from DiaTech)<br />
73<br />
THURSDAY, October 15, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Sala Arcobaleno – 8.30-10.30 am<br />
Oral Communications<br />
PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 3)<br />
Chairpersons: Brunello N. (Modena), Pizzi M. (Brescia)<br />
8.30 am PPAR-β/δ-MEDIATED PROTECTION IN RAT ORGANOTYPIC<br />
MODEL OF SPINAL CORD DAMAGE<br />
Esposito E., Paterniti I., Genovese T., Galuppo M., Meli R.,<br />
Bramanti P., Cuzzocrea S. (Messina, Naples)<br />
8.45 am ANTIDEPRESSANT PROPERTIES OF THE 5-HT4 RECEPTOR<br />
PARTIAL AGONIST, SL65.0155: BEHAVIORAL AND<br />
NEUROCHEMICAL STUDIES IN RATS<br />
Tamburella A., Micale V., Navarra A., Drago F. (Catania)<br />
9.00 am CORTISTATIN DISPLAYS EFFECTS OPPOSITE TO<br />
SOMATOSTATIN ON THE PRODUCTION AND RELEASE OF<br />
PROSTANOIDS FROM RAT CORTICAL MICROGLIA AND<br />
ASTROCYTES<br />
Tringali G., Dello Russo C., Navarra P. (Rome)<br />
9.15 am PLASMA CONCENTRATIONS OF OLANZAPINE DURING<br />
ADJUNCTIVE VALPROATE TREATMENT IN PATIENTS WITH<br />
BIPOLAR OR SCHIZOAFFECTIVE DISORDER<br />
Spina E., D'Arrigo C., Santoro V., Muscatello M., Pandolfo<br />
G., Zoccali R., Diaz F., de Leon J. (Messina, Medellin,<br />
Lexington)<br />
9.30 am MEMANTINE: POWERFUL ANTIMANIC AND MOOD<br />
STABILIZING EFFECT IN BIPOLAR DISORDER RESISTANT<br />
PATIENTS<br />
Koukopoulos A., Serra G. (Sassari, Rome)<br />
9.45 am HIPPOCAMPAL TRANSCRIPTIONAL PROFILES ASSOCIATED<br />
WITH VULNERABILITY AND RESILIENCE TO STRESS IN A<br />
BEHAVIOURAL MODEL OF DEPRESSION<br />
Tascedda F., Valensisi C., Caggia F., Alboni S., Benatti C.,<br />
Guidotti G., Blom J., Brunello N. (Modena)<br />
10.00 am PHARMACOLOGICAL MODULATION OF THE<br />
EXTRACELLULAR GLUTAMATE CHANGES INDUCED BY<br />
RETINAL ISCHEMIA/REPERFUSION IN RAT: TARGETS TO<br />
MINIMIZE RETINAL DAMAGE<br />
Russo R., Cavaliere F., Varano G., Rombola' L., Corasaniti<br />
M., Bagetta G., Morrone L. (Cosenza, Catanzaro)<br />
74<br />
10.15 am PROTEIN KINASE C-DEPENDENT UP-REGULATION OF<br />
HUMAN MU-OPIOID RECEPTOR GENE (OPRM1)<br />
TRANSCRIPTION IS NEGATIVELY INFLUENCED BY THE<br />
TRANSCRIPTION FACTOR REST<br />
Bedini A., Baiula M., Spampinato S. (Bologna)<br />
75<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Sala Azzurra – 8.30-10.30 am<br />
Oral Communications<br />
CARDIOVASCULAR AND PULMONARY PHARMACOLOGY<br />
(SESSION 1)<br />
Chairpersons: Berrino L. (Naples), Geppetti P. (Florence)<br />
8.30 am OBESTATIN INDUCES CARDIOPROTECTION AND INHIBITS<br />
APOPTOSIS IN THE ISCHEMIC/REPERFUSED ISOLATED<br />
RAT HEART AND CULTURED CARDIOMYOCYTES<br />
Arnoletti E., Alloatti G., Ghè C., Muccioli G. (Turin)<br />
8.45 am PHARMACOLOGICAL DISSECTION OF SEXUAL HORMONES<br />
ACTIVITIES ON L-CYS/H2S PATHWAY IN ISOLATED RAT<br />
AORTA<br />
Bucci M., Vellecco V., De Gruttola L., Roviezzo F.,<br />
Brancaleone V., Cirino G. (Naples)<br />
9.00 am ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC<br />
BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL<br />
ATP-SENSITIVE POTASSIUM CHANNEL<br />
Calderone V., Testai L., Martelli A., Rapposelli S.,<br />
Digiacomo M., Balsamo A., Breschi M. (Pisa)<br />
9.15 am PLATELET BEHAVIOUR IN PATIENTS WITH DRUG-ELUTING<br />
STENTS AFTER THIENOPYRIDINE TREATMENT<br />
DISCONTINUATION<br />
Camera M., Trabattoni D., Villa D., Bartorelli A., Bogani<br />
P., Brambilla M., Tremoli E. (Milan)<br />
9.30 am OVEREXPRESSION OF CYCLO-OXYGENASE 2 (COX-2) IN<br />
ENDOTHELIUM MAY CONTRIBUTE TO VASCULAR<br />
PROTECTIVE EFFECTS OF ADIPONECTIN<br />
Nacci C., Tarquinio M., Addabbo F., Montagnani M. (Bari)<br />
9.45 am REDOX STATE, CELL FATE AND SEX DIFFERENCES IN<br />
VASCULAR SMOOTH MUSCLE CELLS<br />
Canu S., Straface E., Gambardella L., Vona R., Marino M.,<br />
Coinu R., Campesi I., Malorni W., Franconi F. (Rome,<br />
Sassari)<br />
10.00 am ROLE OF INFLAMMATION ON DENDRITIC CELL AND<br />
VASCULAR SMOOTH MUSCLE CELL INTERACTIONS<br />
Parenti A., Musilli C., Ledda F., Gerlini G., Borgognoni L.,<br />
Mugelli A. (Florence)<br />
76<br />
10.15 am MODULATORY ROLE OF THE NOCICEPTIN/ORPHANIN FQ-<br />
NOP RECEPTOR SYSTEM IN THE ALLERGEN-INDUCED<br />
AIRWAY HYPERRESPONSIVENESS<br />
Sullo N., Orlotti D., Matteis M., Russo M., D'Agostino B.,<br />
Rossi F. (Naples)<br />
77<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
9.50<br />
am<br />
10.10<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Blu – 8.30-10.30 am<br />
Symposium<br />
STEM CELLS FOR CARDIAC REPAIR: CURRENT STATUS AND<br />
FUTURE PERSPECTIVE<br />
Chairpersons: Cerbai E. (Florence), Rossi F. (Naples)<br />
STEM CELLS AND REGENERATIVE MEDICINE: POTENTIAL AND<br />
LIMITATIONS<br />
Galderisi U. (Naples)<br />
STRATEGIES FOR CARDIAC TISSUE REGENERATION AND<br />
ENGINEERING<br />
Jaconi M. (Geneva)<br />
EMBRYONIC STEM CELLS AS A MODEL FOR CARDIAC CELL<br />
DIFFERENTIATION AND MATURATION<br />
Sartiani L. (Florence)<br />
CARDIAC PROGENITOR CELLS AND DOXORUBICIN-INDUCED<br />
CARDIOMYOPATHY<br />
De Angelis A. (Naples)<br />
MESENCHYMAL STEM CELLS FOR CARDIAC REPAIR: FROM BENCH<br />
TO BEDSIDE<br />
Parini A. (Toulouse)<br />
(Educational support from Novartis Farma)<br />
78<br />
FRIDAY, October 16, 2009<br />
Sala Giardino d’Inverno – 8.30-10.30 am<br />
Oral Communications<br />
PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY<br />
(SESSION 1)<br />
Chairpersons: Caputi A. P. (Messina),<br />
Ferrazin F. (Rome)<br />
8.30 am RISK OF TORSADES DE POINTES WITH ANTIMICROBIALS:<br />
THE CONTRIBUTION FROM THE FDA ADVERSE EVENT<br />
REPORTING SYSTEM (AERS)<br />
Raschi E., Poluzzi E., Mortola D., Moretti U., De Ponti F.<br />
(Bologna, Verona)<br />
8.45 am ADVERSE DRUG REACTIONS INDUCED BY DRUG-DRUG<br />
INTERACTIONS: ANALYSIS OF A SPONTANEOUS<br />
REPORTING DATABASE<br />
Magro L., Conforti A., Moretti U., Donati M., Cutroneo P.,<br />
Moschini M., Motola D., Tuccori M., Leone R. (Verona,<br />
Messina, Florence, Bologna, Pisa)<br />
9.00 am PSYCHIATRIC SIDE EFFECTS OF PROTON PUMP<br />
INHIBITORS: A SIGNAL FROM THE ITALIAN<br />
PHARMACOVIGILANCE SYSTEM<br />
Cutroneo P., Russo A., Polimeni G., Borsellino L., Tuccori<br />
M., D'Incau P., Motola D., Scotto S., Venegoni M.,<br />
Sottosanti L., Pagano I., Conforti A., Caputi A. P. (Messina,<br />
Palermo, Pisa, Verona, Bologna, Milan, Rome)<br />
9.15 am SAFETY PROFILE OF FLUOROQUINOLONES: AN ANALYSIS<br />
ON ADVERSE DRUG REACTIONS (ADRS) RELATED TO<br />
PRESCRIPTION DATA<br />
Vannacci A., Motola D., Montanaro N., Tuccori M., Leoni<br />
O., Cocci A., Leone R., Conforti A., Mazzaglia G., Mugelli<br />
A., Lapi F., Mazzei T. (Bologna, Pisa, Milan, Cremona,<br />
Verona, Florence)<br />
9.30 am PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY: AN<br />
EFFECT OF IMMUNODEFICIENCY OR AN ADVERSE DRUG<br />
REACTION?<br />
Piccinni C., Sacripanti C., Poluzzi E., Motola D., Magro L.,<br />
Moretti U., Conforti A., Montanaro N. (Bologna, Verona)<br />
9.45 am VACCINES PHARMACOVIGILANCE: DATA FROM THE<br />
ITALIAN SPONTANEOUS REPORTING SYSTEM<br />
Costantini D., Magro L., Opri S., Russo A., Lapi F., Biagi<br />
79<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
C., Cocci A., Magistro L., Moretti U. (Verona, Messina,<br />
Florence, Bologna, Milan)<br />
10.00 am NON VACCINE-RELATED ADVERSE DRUG REACTIONS IN<br />
CHILDREN: DATA FROM THE ITALIAN SPONTANEOUS<br />
REPORTING SYSTEM<br />
Opri S., Costantini D., Magro L., Cutroneo P., Lapi F.,<br />
Motola D., Tuccori M., Scotto S., Rivolta A., Velo G.<br />
(Verona, Messina, Florence, Bologna, Pisa, Milan)<br />
10.15 am TRENDS IN SPONTANEOUS ADVERSE DRUG REACTION<br />
REPORTS TO THE ITALIAN PHARMACOVIGILANCE SYSTEM<br />
(2001-2008)<br />
Sottosanti L., Potenza S., Rossi F., Venegoni M. (Rome,<br />
Naples)<br />
80<br />
8.30<br />
am<br />
8.45<br />
am<br />
9.00<br />
am<br />
9.15<br />
am<br />
9.30<br />
am<br />
9.50<br />
am<br />
10.10<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Viola – 8.30-10.30 am<br />
Symposium<br />
PURINE ACTIVITY IN PERIPHERAL CELLS<br />
Chairpersons: Borea P. A. (Ferrara), Caciagli F. (Chieti)<br />
DESIGN, SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF<br />
NEW A2B ADENOSINE ANTAGONISTS<br />
Baraldi P. G. (Ferrara)<br />
SYNERGISTIC ANTI-FIBROTIC EFFECT OF PURINERGIC AND<br />
CANNABINOID SYSTEM MODULATION IN HUMAN SCLERODERMIC<br />
FIBROBLASTS<br />
Castrichini M. (Siena)<br />
TRANSCRIPTIONAL PROFILE OF GTP-MEDIATED<br />
DIFFERENTIATION OF C2C12 SKELETAL MUSCLE CELLS<br />
Pietrangelo T. (Chieti)<br />
MECHANISMS UNDERLYING THE ANTI-INFLAMMATORY EFFECTS<br />
OF ADENOSINE DEAMINASE INHIBITORS IN EXPERIMENTAL<br />
COLITIS<br />
Fornai M. (Pisa)<br />
DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF NEW P2X3<br />
RECEPTOR LIGANDS<br />
Volpini R. (Camerino)<br />
EXPRESSION PROFILE AND PHARMACOLOGICAL EFFECTS OF<br />
ADENOSINE RECEPTORS IN MACROPHAGES AND FOAM CELLS<br />
Gessi S. (Ferrara)<br />
INVOLVEMENT OF THE PROTEASOME SYSTEM ACTIVATION IN<br />
THE ANTI-APOPTOTIC ACTIVITY OF GUANINE-BASED PURINES<br />
Tarozzi A. (Bologna)<br />
81<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Sala Arancione – 8.30-10.30 am<br />
Oral Communications<br />
PHARMACOLOGY OF ION CHANNELS AND SYNAPTIC<br />
TRANSMISSION<br />
Chairpersons: Conte Camerino D. (Bari),<br />
Taglialatela M. (Campobasso)<br />
8.30 am MOLECULAR DETERMINANTS OF HUMAN VOLTAGE-GATED<br />
SODIUM CHANNELS BLOCKADE BY LUBELUZOLE<br />
Costanza T., Bruno C., Franchini C., Lentini G., Conte<br />
Camerino D., Desaphy JF. (Bari)<br />
8.45 am MASSIVE ENDOCYTOSIS (MEND) ACTIVATED BY CA 2+ AND<br />
POLYAMINES IN FIBROBLASTS AND CARDIAC MYOYCTES:<br />
DEPENDENCIES ON NUCLEOTIDES, PIP2, CHOLESTEROL,<br />
CLATHRIN, AND OTHER FACTORS<br />
Lariccia V., Hilgemann D. (Ancona, Dallas)<br />
9.00 am MASSIVE ENDOCYTOSIS (MEND) ACTIVATED BY CA 2+ AND<br />
POLYAMINES IN FIBROBLASTS AND CARDIAC MYOCYTES:<br />
OPTICAL STUDIES OF MEMBRANE AND NA + /CA 2+<br />
EXCHANGER (NCX1) INTERNALIZATION, THE POSSIBLE<br />
ROLE OF CA 2+ ACTIVATED TRANSGLUTAMINASE IN MEND,<br />
AND THE POSSIBLE FUNCTION OF MEND IN CARDIAC<br />
MYOCYTES<br />
Magi S., Yaradanakul A., Llaguno M., Lin M., Shen C., Fine<br />
M., Nicoll D., Hilgemann D. (Ancona, Dallas, Los Angeles)<br />
9.15 am SIGMA-1 (σ1) RECEPTOR MODULATION OF THE DOPAMINE<br />
TRANSPORTER (DAT) ACTIVITY IN A CELL MODEL<br />
Fazio N., Spampinato S. (Bologna)<br />
9.30 am SYNAPTIC LOCALIZATION OF GLUR1 IS REGULATED BY<br />
ADAM10 ACTIVITY AND N-CADHERIN CLEAVAGE<br />
Gardoni F., Malinverno M., Sala C., Carta M., Mulle C., Di<br />
Luca M. (Milan, Bordeaux)<br />
9.45 am MERGING AMYLOID-BETA CASCADE AND ACTIVITY-<br />
DEPENDENT PLASTICITY IN HIPPOCAMPUS: A POSSIBLE<br />
ROLE FOR ADAM10<br />
Marcello E., Gardoni F., Vara-Rivera H., Epis R., Cattabeni<br />
F., Giustetto M., Perez-Otaño I., Di Luca M. (Milan, Turin,<br />
Pamplona)<br />
10.00 am SYNAPTOPROTEOMIC ANALYSIS OF ANIMAL MODELS OF<br />
82<br />
DEPRESSION REVEALS INVOLVEMENT OF ENERGY<br />
METABOLISM PROTEINS<br />
Mallei A., Giambelli R., Tardito D., Mathè A., El K y A.,<br />
Gruber S., Vollmayr B., Gass P., Racagni G., Popoli M.<br />
(Milan, Stockholm, Heidelberg)<br />
83<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
8.30<br />
am<br />
9.15<br />
am<br />
10.00<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Bianca – 8.30-10.30 am<br />
SIC-<strong>SIF</strong> Symposium<br />
THE NEW ANTIMICROBIALS FULFILL THE NEEDS OF CLINICAL<br />
PRACTICE?<br />
Chairpersons: Mazzei T. (Florence), Scaglione F. (Milan)<br />
EPIDEMIOLOGY OF RESISTANCE: COMPARISION BETWEEN OLD<br />
AND NEW DRUGS<br />
Stefani S. (Catania)<br />
NEW ANTIBIOTICS: VALUE AND LIMITS<br />
Scaglione F. (Milan)<br />
THE NEW ANTIFUNGALS: VALUE AND LIMITS<br />
Novelli A. (Florence)<br />
84<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Verde – 8.30-10.30 am<br />
Symposium<br />
BRAIN DEVELOPMENT: INFLUENCE OF STRESS AND<br />
NEUROACTIVE STEROIDS<br />
Chairpersons: Concas A. (Cagliari), Serra M. (Cagliari)<br />
EFFECT OF DEVELOPMENTAL EXPOSURE TO LOW-DOSE<br />
ESTROGENIC ENDOCRINE DISRUPTORS ON EXPLORATION AND<br />
EMOTIONAL RESPONSES IN MICE<br />
Palanza P. (Parma)<br />
CHANGES IN NEUROACTIVE STEROID LEVELS, GABAA RECEPTOR<br />
PLASTICITY AND SENSITIVITY TO ANXIOLYTIC DRUGS INDUCED<br />
BY NEONATAL EXPOSURE TO ESTROGEN<br />
Concas A. (Cagliari)<br />
EFFECT OF MATERNAL CARE ON EMOTIONAL AND FEEDING<br />
BEHAVIOUR IN NPY-Y1R CONDITIONAL KNOCKOUT MICE<br />
Eva C. (Turin)<br />
CHANGES IN NEURONAL PLASTICITY AND ETHANOL SENSITIVITY<br />
BY JUVENILE SOCIAL ISOLATION STRESS<br />
Serra M. (Cagliari)<br />
85<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Sala Rossa – 8.30-10.30 am<br />
Oral Communications<br />
PHARMACOLOGY OF METABOLISM, ENDOCRINE SYSTEM<br />
AND ERECTILE DYSFUNCTION (SESSION 1)<br />
Chairpersons: Cella S. (Milan), Cocchi D. (Brescia)<br />
8.30 am PKCß/HUR/VEGF PATHWAY AND ITS IMPLICATION IN<br />
DIABETIC RETINOPATHY<br />
Bucolo C., Amadio M., Drago F., Govoni S., Pascale A.<br />
(Catania, Pavia)<br />
8.45 am PALMITOYLETHANOLAMIDE INDUCES NEUROSTEROIDS<br />
SYNTHESIS IN C6 CELLS TROUGH PPAR-ALPHA<br />
DEPENDENT MECHANISM<br />
Mattace Raso G., Esposito E., Iacono A., D'Agostino G.,<br />
La Rana G., Sasso O., Russo R., Calignano A., Meli R.<br />
(Naples, Messina)<br />
9.00 am EFFECTS OF SOY ISOFLAVONE GENISTEIN AGLYCONE ON<br />
SKIN CHANGES INDUCED BY EXPERIMENTAL MENOPAUSE:<br />
A COMPARISON WITH ESTRADIOL AND RALOXIFENE<br />
Polito F., Marini H., Bitto A., Minutoli L., Di Stefano V.,<br />
Irrera N., Altavilla D., Calò M., Caputi A. P., Squadrito F.<br />
(Messina)<br />
9.15 am BRAIN-BODY METABOLIC PROGRAMMING AND<br />
FUNCTIONAL DERANGEMENT IN A TYPE-2 DIABETES<br />
MODEL IN MALE MICE: THE ROLE EXERTED BY OPIOID<br />
AND HPA SYSTEMS<br />
Loizzo S., Campana G., Spampinato S., Capasso A.,<br />
Fortuna A., Franconi F., Renzi P., Loizzo A. (Rome,<br />
Bologna, Salerno, Sassari)<br />
9.30 am PTH1-34 STIMULATION OF EARLY BONE FRACTURE<br />
HEALING<br />
Marino S., Portigliatti Barbos M., Barberis A., Di Carlo F.,<br />
Mognetti B. (Orbassano)<br />
9.45 am CHRONIC TRYPTOPHAN DEFICIENCY IMPAIRS BONE<br />
METABOLISM AND REDUCES BONE ACCRUAL IN GROWING<br />
RATS<br />
Sibilia V., Pagani F., Greco A., Guidobono F. (Milan)<br />
10.00 am THE PHYTOESTROGEN FERUTININ COUNTERACTS THE<br />
BONE LOSS INDUCED BY OVARIECTOMY IN RATS<br />
86<br />
Zavatti M., Zanoli P., Carnevale G., Bertoni L., Resca E.,<br />
Cavani F., Benelli A., Ferretti M., Palumbo C. (Modena)<br />
10.15 am ESTROGEN RECEPTOR BETA-1 STIMULATION BY<br />
AGLYCONE GENISTEIN REDUCES ENDOMETRIAL<br />
HYPERPLASIA IN PRE-MENOPAUSAL WOMEN: A<br />
RANDOMIZED DOUBLE-BLIND PLACEBO AND<br />
PROGESTERONE CONTROLLED STUDY<br />
Bitto A., Altavilla D., D'Anna R., Marini H., Squadrito F.<br />
(Messina)<br />
87<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
10.45<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Blu – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Spano P. F. (Brescia)<br />
PHARMACOLOGICAL MODULATION OF ENDOGENOUS<br />
NEUROGENESIS: IMPACT ON FUTURE TREATMENT OF<br />
NEUROPSYCHIATRIC DISORDERS<br />
Grilli M. (Novara)<br />
(Educational support from Pfizer Italia)<br />
88<br />
10.45<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Giardino d’Inverno – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Caputi A. P. (Messina)<br />
NEXT GENERATION OF GLP-1 ANALOGUES: LIRAGLUTIDE<br />
Nicolucci A. (Chieti)<br />
(Educational support from Novo Nordisk Farmaceutici)<br />
89<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
10.45<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Viola – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Mini E. (Florence)<br />
INNOVATION NEVER STOPS: TOWARDS THE SECOND<br />
GENERATION OF TARGETED CANCER MEDICINES<br />
Hilberg F. (Vienna)<br />
(Educational support from Boehringer Ingelheim Italia)<br />
90<br />
10.45<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Arancione – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Pepeu G. (Florence)<br />
MULTIPLE SCLEROSIS: FTY 720 (FINGOLIMOD)<br />
Nicoletti F. (Rome)<br />
(Educational support from Novartis Farma)<br />
91<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
10.45<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Bianca – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Viano I. (Novara)<br />
ECHINOCANDINS: PHARMACOLOGY OF A NEW CLASS OF<br />
SYSTEMIC ANTIFUNGAL DRUGS<br />
Scaglione F. (Milan)<br />
(Educational support from Astellas Pharma)<br />
92<br />
11.15<br />
am<br />
11.40<br />
am<br />
12.05<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Azzurra – 11.15 am-12.35 pm<br />
Symposium<br />
PHARMACOLOGICAL THERAPY OF ATRIAL FIBRILLATION: OLD<br />
DISAPPOINTMENTS, NEW HOPES<br />
Chairpersons: Mugelli A. (Florence), Rossi F. (Naples)<br />
HISTORICAL PERSPECTIVE OF ANTIARRHYTHMIC DRUGS: THE<br />
UNMET NEEDS<br />
Cerbai E. (Florence)<br />
CURRENT PHARMACOLOGICAL AND NON-PHARMACOLOGICAL<br />
TREATMENT OF ATRIAL FIBRILLATION AND DRONEDARONE<br />
Capucci A. (Ancona)<br />
FUTURE PERSPECTIVES OF DRONEDARONE USE IN CLINICAL<br />
CARDIOLOGY<br />
Perrone Filardi P. (Napoli)<br />
(Educational support from Sanofi-Aventis)<br />
93<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
11.15<br />
am<br />
11.45<br />
am<br />
12.15<br />
pm<br />
12.45<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Blu – 11.15 am-1.15 pm<br />
SINPF-<strong>SIF</strong> Symposium<br />
NEUROBIOLOGY AND PHARMACOLOGY OF PSYCHOSIS<br />
Chairpersons: Biggio G. (Cagliari), Canonico P. L. (Novara)<br />
NEUROBIOLOGY OF COGNITIVE FUNCTIONS<br />
Biggio G. (Cagliari)<br />
PHARMACOLOGICAL CHARACTERISTICS OF ZIPRASIDONE: A<br />
STARTING POINT FOR CLINICIANS<br />
Pani L. (Cagliari)<br />
FROM CLINICAL TRIAL TO REAL WORLD: THE UNMET NEEDS OF<br />
ATYPICAL ANTIPSYCHOTIC THERAPY<br />
Mencacci C., Cerveri G. (Milan)<br />
COGNITIVE PROCESSES AND SCHIZOPHRENIA<br />
Aguglia E. (Catania)<br />
(Educational support from Pfizer Italia)<br />
94<br />
11.15<br />
am<br />
11.45<br />
am<br />
12.15<br />
pm<br />
12.35<br />
pm<br />
12.55<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Giardino d’Inverno – 11.15 am-1.15 pm<br />
Symposium<br />
TYPE 2 DIABETES: THE PANDEMIC OF XXI CENTURY<br />
Chairpersons: Caputi A. P. (Messina), Cricelli C. (Florence)<br />
DIABETES EPIDEMIOLOGY IN ITALY: REGIONAL DATA FROM MNS<br />
PROJECT<br />
Nicolucci A. (Chieti)<br />
TREATMENT GUIDELINES, STANDARD OF CARE AND UNMET<br />
MEDICAL NEEDS<br />
Consoli A. (Chieti)<br />
OLD DRUGS AND NEW DRUGS: NOVEL THERAPEUTIC OPTIONS<br />
Cucinotta D., Russo G. T. (Messina)<br />
INDICATORS AND STANDARD OF CARE IN DIABETOLOGY:<br />
COMPARISON BETWEEN NATIONAL AND INTERNATIONAL DATA<br />
Mazzaglia G. (Florence)<br />
DIABETES COSTS IN ITALY: AN ECONOMIC ANALYSIS<br />
Mantovani L. (Naples)<br />
(Educational support from Bristol Myers Squibb and AstraZeneca)<br />
95<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
11.15<br />
am<br />
11.45<br />
am<br />
FRIDAY, October 16, 2009<br />
Sala Viola – 11.15 am-0.15 pm<br />
Symposium<br />
HEALTH TECHNOLOGY ASSESSMENT AND GOVERNANCE<br />
Chairpersons: Caputi A. P. (Messina), Preziosi P. (Rome)<br />
PRESCRIBING APPROPRIATENESS IN CLINICAL PRACTICE<br />
Pagliaro L. (Palermo)<br />
HTA: A MULTIDISCIPLINARY APPROACH TO CLINICAL<br />
GOVERNANCE<br />
Zappia M. (Palermo)<br />
(Educational support from GlaxoSmithKline)<br />
96<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/1/1<br />
P-2/1/2<br />
P-2/1/3<br />
P-2/1/4<br />
P-2/1/5<br />
Poster Session<br />
P-2/1: CARDIOVASCULAR AND PULMONARY<br />
PHARMACOLOGY<br />
Poster Commission Members:<br />
President: Brunelleschi S. (Novara)<br />
Members: Montuschi P. (Rome), Sala A. (Milan),<br />
Trabace L. (Foggia)<br />
METABOLITE I OF ERDOSTEINE POSSESSES A FREE<br />
RADICAL SCAVENGING ACTIVITY: ELECTRON<br />
PARAMAGNETIC RESONANCE (EPR) SPECTROSCOPY<br />
ANALYSIS<br />
Braga P., Culici M., Dal Sasso M., Falchi M., Spallino A.<br />
(Milan)<br />
TREATMENT OF SPONTANEOUSLY HYPERTENSIVE RATS<br />
(SHR) WITH ROSIGLITAZONE AMELIORATES<br />
CARDIOVASCULAR PATHOPHYSIOLOGY VIA ANTI-<br />
OXIDANT MECHANISMS IN THE VASCULATURE<br />
Potenza M., Gagliardi S., De Benedictis L., Quon M.,<br />
Montagnani M. (Bari, Bethesda)<br />
INTERACTION BETWEEN ENDOTHELIAL PRECURSOR<br />
CELLS AND VASCULAR WALL CELLS<br />
Musilli C., Ledda F., Mugelli A., Parenti A. (Florence)<br />
KIDNEY CLC-K CHLORIDE CHANNELS AS NEW TARGETS<br />
FOR ANTIHYPERTENSIVE AND DIURETIC DRUGS: EFFECT<br />
OF ACUTE IN VIVO ADMINISTRATION OF CLC-K<br />
BLOCKERS IN RATS<br />
Liantonio A., Gramegna G., Laghezza A., Fracchiolla G.,<br />
Loiodice F., Camerino G., Dinardo M., Mastrofrancesco L.,<br />
Lasorsa D., Procino G., Svelto M., Valenti G., Conte<br />
Camerino D. (Bari)<br />
THE NOVEL MELANOCORTIN MC4 RECEPTOR AGONIST PG-<br />
931 REVERSES HEMORRHAGIC SHOCK AND PREVENTS<br />
MULTIPLE ORGAN DAMAGE<br />
97<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/1/6<br />
P-2/1/7<br />
P-2/1/8<br />
P-2/1/9<br />
P-2/1/10<br />
P-2/1/11<br />
P-2/1/12<br />
P-2/1/13<br />
Galantucci M., Giuliani D., Ottani A., Zaffe D., Botticelli<br />
A., Grieco P., Novellino E., Jochem J., Guarini S. (Modena,<br />
Pavia, Naples, Bytom)<br />
EVIDENCE OF TLR-4 AND PAR2 RECEPTORS CROSS-TALK<br />
IN RAT VASCULAR REACTIVITY<br />
Vellecco V., Mattace Raso G., Brancaleone V., Roviezzo<br />
F., Bucci M., Cirino G. (Naples)<br />
BIOSYNTHESIS OF HYDROGEN SULPHIDE IS IMPAIRED IN<br />
DIABETIC CONDITIONS<br />
Brancaleone V., Roviezzo F., Vellecco V., De Gruttola L.,<br />
Bucci M., Cirino G. (Naples)<br />
PPAR-β/D ACTIVATION PROTECTS AGAINST RENAL<br />
ISCHEMIA/REPERFUSION INJURY IN DIABETIC RATS<br />
Collino M., Benetti E., Miglio G., Castiglia S., Rosa A.,<br />
Thiemermann C., Fantozzi R. (Turin, London)<br />
PPAR STIMULATION PROTECTS HUMAN PODOCYTES FROM<br />
SERUM DEPRIVATION-INDUCED CELL DEATH<br />
Miglio G., Rosa A., Rattazzi L., Benetti E., Collino M.,<br />
Fantozzi R. (Turin)<br />
THERAPEUTIC DRUG MONITORING: HYDROQUINIDINE<br />
ADMINISTRATION IN A NEWBORN INFANT WITH SHORT<br />
QT SYNDROME. A CASE REPORT<br />
Pirro E., De Francia S., Banaudi E., Riggi C., De Martino<br />
F., Piccione F., Di Carlo F. (Orbassano, Turin)<br />
A NOVEL NITRIC OXIDE RELEASING ANTI-DIABETIC DUAL<br />
DRUG: FROM THE DESIGN TO THE CHARACTERIZATION<br />
OF THE PHARMACOLOGICAL PROFILE<br />
Martelli A., Breschi M., Testai L., Balsamo A., Digiacomo<br />
M., Rapposelli S., Marchetti P., Torri S., Calderone V.<br />
(Pisa)<br />
MELANOCORTIN-INDUCED CARDIOPROTECTION AGAINST<br />
ISCHEMIA/REPERFUSION INJURY IS ASSOCIATED WITH A<br />
COUNTERACTION OF INFLAMMATORY AND APOPTOTIC<br />
RESPONSES<br />
Ottani A., Giuliani D., Galantucci M., Zaffe D., Botticelli<br />
A., Guarini S. (Modena, Pavia)<br />
NEUTROPHIL-DEPENDENT CEREBRAL OEDEMA IN MALE<br />
RAT: ROLE OF TRANSCELLULAR SYNTHESIS OF<br />
CYSTEINYL LEUKOTRIENES AND CYSLT2 RECEPTOR<br />
ACTIVATION<br />
Brivio I., Buccellati C., Di Gennaro A., Folco G., Sala A.<br />
(Milan, Stockholm)<br />
98<br />
P-2/1/14<br />
P-2/1/15<br />
P-2/1/16<br />
P-2/1/17<br />
P-2/1/18<br />
P-2/1/19<br />
P-2/1/20<br />
P-2/1/21<br />
P-2/1/22<br />
PRO-ANGIOGENIC ACTIVITY OF UROTENSIN-II ON<br />
CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS<br />
Sorato E., Albertin G., Spinazzi R., Mascarin A.,<br />
Oselladore B., Guidolin D., Giusti P. (Padua)<br />
POSSIBLE ROLE OF HYDROGEN SULPHIDE (H2S) IN THE<br />
ANTIHYPERTENSIVE EFFECT OF ZOFENOPRIL<br />
Bucci M., Vellecco V., Brancaleone V., De Gruttola L.,<br />
Roviezzo F., Evangelista S., Cirino G. (Naples, Florence)<br />
NBD PEPTIDE, A SELECTIVE INHIBITOR OF NF-κB,<br />
REDUCES NEOINTIMAL FORMATION IN A RAT MODEL OF<br />
VASCULAR INJURY<br />
Grassia G., Maddaluno M., Maffia P., Musilli C., Parenti A.,<br />
De Stefano D., Carnuccio R., Ianaro A., Grieco P., Ialenti<br />
A. (Naples, Strathclyde, Florence)<br />
ENDOTHELIAL PROTECTIVE EFFECTS OF ACE INHIBITORS:<br />
WHAT’S BEYOND?<br />
Morbidelli L., Donnini S., Terzuoli E., Pezzatini S., Ziche<br />
M. (Siena)<br />
A BENZODIAZEPINE ANALOGUE PROMOTES FAECAL<br />
STEROL EXCRETION IN APOA-I OVEREXPRESSING MICE<br />
Zanotti I., Pedrelli M., Calabresi L., Kempen H., Bernini F.<br />
(Parma, Milan, Basel)<br />
PROBUCOL ABOLISHES MEMBRANE RUFFLING AND<br />
RESTORES CELLULAR MIGRATION INDUCED BY FREE<br />
CHOLESTEROL IN MACROPHAGES FOAM CELLS<br />
Favari E., Adorni M., Granata A., Corsini A., Ronda N.,<br />
Gatti R., Bernini F. (Parma, Milan)<br />
STATIN AND FIBRATE TIME-DEPENDENTLY AFFECT THE<br />
CLC-1 CHLORIDE CHANNEL FUNCTION AND EXPRESSION<br />
AND MODIFY THE PROTEOMIC PROFILE IN RAT SKELETAL<br />
MUSCLE<br />
Camerino G., Pierno S., Digennaro C., Dinardo M.,<br />
Pellegrino M., George A., Bottinelli R., Conte Camerino D.<br />
(Bari, Pavia, Nashville)<br />
PALMITOYLETHANOLAMIDE RELAXES THE BOVINE<br />
OPHTHALMIC ARTERY THROUGH PEROXISOME<br />
PROLIFERATOR-ACTIVATED RECEPTORS (PPARS) IN<br />
ENDOTHELIUM-INDEPENDENT MANNER<br />
Lograno M., Romeno MR. (Bari)<br />
CARDIAC DEVELOPMENT REGULATES MEMBRANE LIPID<br />
RAFTS AND HYPERPOLARIZATION-ACTIVATED CYCLIC<br />
NUCLEOTIDE GATED CHANNELS<br />
Spinelli V., Del Lungo M., Sartiani L., Cerbai E. (Florence)<br />
99<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/1/23<br />
P-2/1/24<br />
P-2/1/25<br />
P-2/1/26<br />
P-2/1/27<br />
P-2/1/28<br />
P-2/1/29<br />
P-2/1/30<br />
P-2/1/31<br />
ADENOSINE MODULATES NO RELEASE IN EXPERIMENTAL<br />
INFLAMMATION MODEL OF RAT VASCULAR SMOOTH<br />
MUSCLE CELLS<br />
Malorgio F., Cignarella A., Bolego C., Pelosi V., Gaion R.<br />
(Padua)<br />
EFFECT OF PROBUCOL DERIVATE SUCCINOBUCOL (AGI-<br />
1067) ON CELLULAR CHOLESTEROL EFFLUX PATHWAYS<br />
Adorni M., Stocker R., Bernini F., Favari E. (Parma,<br />
Sydney)<br />
PROTECTIVE EFFECT OF DMSO ON ACUTE MYOCARDIAL<br />
INFARCTION IN RATS<br />
Gargiulo L., Parisi A., Alfieri A., Mascolo N., Cicala C.<br />
(Naples)<br />
COX-1 AND COX-2 COOPERATE TOWARD THE SYNTHESIS<br />
OF PROSTACYCLIN IN HUMAN ENDOTHELIAL CELLS<br />
THROUGH THE MODIFICATION OF HYDROPEROXIDE TONE<br />
Bolego C., Buccellati C., Folco G., Gaion M., Sala A.<br />
(Padua, Milan)<br />
LOW-DOSE NAPROXEN AND THE ANTIPLATELET EFFECT<br />
OF ASPIRIN IN HEALTHY SUBJECTS<br />
Anzellotti P., Capone M., Tontodonati P., Grossi L., Bruno<br />
A., Tacconelli S., Patrignani P. (Chieti)<br />
DENTAL PULP DERIVED MESENCHYMAL STEM CELLS IN<br />
MYOCARDIAL INFARCTION EXPERIMENTAL MODELS:<br />
PRELIMINARY RESULTS<br />
Di Scipio F., Sprio A., Folino A., Salamone P., Rastaldo R.,<br />
Pagliaro P., Di Carlo F., Berta G. (Orbassano)<br />
RESIDUAL THROMBOXANE BIOSYNTHESIS IS<br />
ASSOCIATED WITH PLATELET ACTIVATION IN HIGH RISK<br />
PATIENTS TREATED WITH LOW-DOSE ASPIRIN<br />
Grossi L., Meneguzzi A., Capone M., Evangelista V.,<br />
Levantesi G., Porreca E., Di Febbo C., Ferraro R.,<br />
Tontodonati P., Manarini S., Moretta V., Fava C., Minuz P.,<br />
Patrignani P. (Chieti, Verona, Vasto, Santa Maria Imbaro)<br />
ANGIOTENSIN II SUBTYPE-2-RECEPTOR STIMULATION<br />
PROVIDES END-ORGAN PROTECTION IN STROKE-PRONE<br />
RATS<br />
Gelosa P., Pignieri A., Castiglioni L., Fandriks L., de<br />
Gasparo M., Hallberg A., Turolo L., Tremoli E., Sironi L.<br />
(Milan, Goteborg, Rossemaison, Uppsala)<br />
THE ACE INHIBITOR CAPTOPRIL PARTIALLY RESTORES<br />
THE EFFICACY OF POSTCONDITIONING IN HYPERTENSIVE<br />
100<br />
P-2/1/32<br />
P-2/1/33<br />
P-2/1/34<br />
P-2/1/35<br />
P-2/1/36<br />
P-2/1/37<br />
P-2/1/38<br />
P-2/1/39<br />
RAT HEARTS.<br />
Penna C., Marino S., Tullio F., Folino A., Moro F., Mognetti<br />
B., Pagliaro P. (Turin)<br />
REMODELING OF PERIPHERAL RESISTANCE ARTERIES IN<br />
MICE WITH HYPERTENSION INDUCED BY ANGIOTENSIN II<br />
INFUSION: ROLE OF CYCLOOXYGENASE-1<br />
Rugani I., Virdis A., Daghini E., Duranti E., Colucci R.,<br />
Fornai M., Basolo F., Blandizzi C., Del Tacca M., Taddei S.<br />
(Pisa)<br />
ROLE OF P2 RECEPTORS IN A CARDIOMYOCYTES<br />
ISCHEMIC HYPOXIA MODEL<br />
Cosentino S., Barcella S., Luo H., Burbiel J., Muller C.,<br />
Tremoli E., Banfi C., Abbracchio MP. (Milan, Bonn)<br />
ANTIARRHYTHMIC EFFECT OF ACUTE OXYGEN-OZONE<br />
ADMINISTRATION TO RATS<br />
Di Filippo C., di Ronza C., Rossi C., Cervone C., Marfella<br />
R., Lettieri B., Luongo C., Rossi F., D'Amico M. (Naples)<br />
MYOCARDIAL RECRUITMENT OF ENDOTHELIAL<br />
PROGENITOR CELLS FOLLOWING ADMINISTRATION OF<br />
OXYGEN/OZONE MIXTURE IN INFARCTED RAT HEART<br />
Di Filippo C., Rossi C., di Ronza C., Cervone C., Luongo<br />
C., Ferraraccio F., Lettieri B., Rossi F., D'Amico M. (Naples)<br />
LONG TERM INCUBATION WITH β-AMYLOID PEPTIDES<br />
IMPAIRS ENDOTHELIUM-DEPENDENT VASODILATATION<br />
AND eNOS PHOSPHORYLATION (AT SERINE 1177) IN<br />
ISOLATED RAT BASILAR ARTERY<br />
Salomone S., Chisari M., Merlo S., Sortino M. (Catania)<br />
ROLE OF CALPAIN IN DOXORUBICIN CARDIOTOXICITY IN<br />
VIVO: EFFECTS OF DIFFERENT EXPOSURE TIMES TO THE<br />
SAME CUMULATIVE DOSE<br />
Vitelli M., Piegari E., Leone L., Costantino S., Marino L.,<br />
Rossi F., Berrino L. (Naples)<br />
PERIPHERAL BLOOD BIOMARKERS OF METABOLIC<br />
SYNDROME: A GENDER PERSPECTIVE<br />
Straface E., Gambardella L., Gabrielli N., Metere A.,<br />
Mattatelli A., Labbadia A., Canali E., Agati L., Malorni W.<br />
(Rome)<br />
LOSARTAN COUNTERACTS THE HYPER-REACTIVITY TO<br />
ANGIOTENSIN II AND ROCK1 OVER-ACTIVATION IN<br />
AORTAS ISOLATED FROM STREPTOZOTOCIN-INJECTED<br />
DIABETIC RATS<br />
Failli P., Alfarano C., Mannucci E., Cerbai E., Mugelli A.,<br />
Raimondi L. (Florence)<br />
101<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/1/40<br />
P-2/1/41<br />
P-2/1/42<br />
P-2/1/43<br />
P-2/1/44<br />
P-2/1/45<br />
P-2/1/46<br />
P-2/1/47<br />
P-2/1/48<br />
PLASMA LEVELS OF ADIPONECTIN ARE AN INDEX OF<br />
UNBALANCED OXIDATIVE STRESS IN TYPE 1 DIABETIC<br />
RATS<br />
Lodovici M., Bigagli E., Tarantini F., Mannucci E., Alfarano<br />
C., Di Serio C., Raimondi L. (Florence)<br />
SMOOTH MUSCLE CELLS TRANSDIFFERENTIATION TO<br />
MACROPHAGE-LIKE CELLS<br />
Bellosta S., Canavesi M., Anelli C., Corsini A. (Milan)<br />
CHOLESTEROL MODULATION AFFECTS TISSUE FACTOR<br />
INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 IN<br />
ENDOTHELIAL CAVEOLAE<br />
Banfi C., Barcella S., Brioschi M., Pirillo A., Tremoli E.,<br />
Mussoni L. (Milan)<br />
FLUVASTATIN SYNERGISTICALLY IMPROVES THE<br />
ANTIPROLIFERATIVE EFFECT OF EVEROLIMUS ON RAT<br />
SMOOTH MUSCLE CELLS BY ALTERING P27 KIP1 /CYCLIN E<br />
EXPRESSION<br />
Ferri N., Granata A., Torti F., Pfister P., Dorent R., Corsini<br />
A. (Milan, Sophia Antipolis, Paris)<br />
EVEROLIMUS INHIBITS MONOCYTE MIGRATION AND<br />
THEIR ACCUMULATION IN CAROTID LESIONS OF<br />
CHOLESTEROL-FED RABBITS<br />
Baetta R., Granata A., Ferri N., Arnaboldi L., Canavesi M.,<br />
Bellosta S., Pfister P., Corsini A. (Milan, Basel)<br />
IN VITRO EFFECTS OF 2NTX-99, AN ANTI-<br />
ATHEROTHROMBOTIC AGENT IN LUNG PREPARATIONS<br />
Brivio I., Buccellati C., Pinna C., Casagrande C., Hodge J.,<br />
Folco G. (Milan, San Francisco)<br />
ANTI-AGGREGATING EFFECT OF CVM-01 A NOVEL HYBRID<br />
NITRIC OXIDE-RELEASING NONSTEROIDAL ANTI-<br />
INFLAMMATORY PRODRUG<br />
Coppo L., Velazquez C., Di Giuseppe D., Di Simplicio P.,<br />
Priora R. (Siena, Edmonton)<br />
MR IMAGING OF ATHEROSCLEROTIC PLAQUES IN<br />
BRACHIOCEPHALIC ARTERIES OF APOLIPOPROTEIN E<br />
KNOCKOUT MICE<br />
Parolini C., Rigamonti E., Marchesi M., Cabella C., Miragoli<br />
L., Poggi L., Valbusa G., Sirtori C., Chiesa G. (Milan,<br />
Colleretto Giacosa)<br />
ALLOGENIC BONE MARROW-DERIVED MESENCHYMAL<br />
STEM CELLS LIMIT STENOSIS PROGRESSION IN A MODEL<br />
OF RAT CAROTID ARTERIOTOMY: DISSECTING THEIR<br />
MECHANISMS OF ACTION<br />
102<br />
P-2/1/49<br />
P-2/1/50<br />
P-2/1/51<br />
P-2/1/52<br />
P-2/1/53<br />
P-2/1/54<br />
P-2/1/55<br />
P-2/1/56<br />
Forte A., Finicelli M., Grossi M., Cobellis G., De Feo M.,<br />
Cotrufo M., Berrino L., Rossi F., Cipollaro M., Galderisi U.<br />
(Naples)<br />
PHARMACOLOGICAL MODULATION OF NUMBER AND<br />
FUNCTION OF THE CD4 + CD25 + REGULATORY T CELLS<br />
POPULATION IN ATHEROSCLEROSIS<br />
Schembri L., Guasti L., Cosentino M., Maio R., Rasini E.,<br />
Legnaro M., De Bernardi S., Castiglioni L., Maroni L.,<br />
Venco A., Lecchini S. (Varese)<br />
REGULATION OF CELLULAR SIGNALS FROM CYANIDIN-3-<br />
O-GLUCOSIDE IN ENDOTHELIUM: A SPECIFIC ROLE<br />
BEYOND ANTIOXIDANT ACTIVITY<br />
Speciale A., Chirafisi J., Ermito S., Saija A., Morabito G.,<br />
Cimino F. (Messina)<br />
NITRIC OXIDE DONORS: ANTI-AGGREGATING EFFECTS<br />
AND INACTIVATION OF FIBRINOGEN RECEPTOR<br />
(ALPHAIIBBETA3)<br />
Priora R., Margaritis A., Coppo L., Frosali S., Di Giuseppe<br />
D., Aldinucci C., Maiorca S., Pessina G., Di Stefano A., Di<br />
Simplicio P. (Siena)<br />
ANABOLIC ANDROGENIC STEROIDS CARDIOTOXICITY:<br />
INVOLVEMENT OF THE NERVE GROWTH FACTOR SYSTEM<br />
Trefiletti G., Togna A., Scaccianoce S., Carretta M.,<br />
Togna G. (Rome)<br />
THREE-DIMENSIONAL IMAGING OF ATHEROSCLEROTIC<br />
PLAQUES IN APOLIPOPROTEIN E-DEFICIENT MICE<br />
Dever G., Rodolico G., Berrino L., McInnes I., Brewer J.,<br />
Garside P., Maffia P. (Glasgow, Naples)<br />
EFFECTS OF A NEW LOW MOLECULAR WEIGHT BIO-<br />
HEPARIN ON CARDIAC ISCHEMIA-REPERFUSION-INDUCED<br />
INJURY<br />
Lanzi C., Mastroianni R., Vinci M., Caterina U., Bani D.,<br />
Cinci L., Collino M., Masini E. (Florence, Turin)<br />
ROLE OF CARBON MONOXIDE IN HYPERDYNAMIC<br />
CIRCULATION IN CIRRHOTIC PATIENTS<br />
Mastroianni R., Tarquini R., Santosuosso U., La Villa G.,<br />
Laffi G., Masini E. (Florence)<br />
EFFECTS OF AMLODIPINE AND ZOFENOPRIL ON<br />
OXIDATIVE STRESS–INDUCED HYPERTENSION.<br />
De Gennaro Colonna V., Sitia S., Tomasoni L., Turiel M.<br />
(Milan)<br />
103<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/2/1<br />
P-2/2/2<br />
P-2/2/3<br />
P-2/2/4<br />
P-2/2/5<br />
Poster Session<br />
P-2/2: GASTROINTESTINAL PHARMACOLOGY<br />
Poster Commission Members:<br />
President: Tonini M. (Pavia)<br />
Members: Blandizzi C. (Pisa), Conte Camerino D. (Bari)<br />
NMDA RECEPTORS AND PROTEIN KINASE C MODULATE<br />
NITRIC OXIDE FORMATION IN THE GUINEA PIG ILEUM<br />
FOLLOWING IN VITRO ISCHAEMIA<br />
Crema F., Moro E., Oldrini R., Lorenzi T., Marchet S.,<br />
Zanetti E., Giaroni C., Lecchini S., Frigo G. (Pavia, Busto<br />
Arsizio)<br />
FLAVOCOXID, A DUAL INHIBITOR OF COX-2 AND 5-LOX,<br />
REDUCES PANCREATIC DAMAGE IN AN EXPERIMENTAL<br />
MODEL OF ACUTE PANCREATITIS<br />
Irrera N., Polito F., Minutoli L., Bitto A., Di Stefano V.,<br />
Altavilla D., Giuliani D., Guarini S., Ottani A., Caputi A. P.,<br />
Squadrito F. (Messina, Modena)<br />
ALTERATIONS IN NITRERGIC NEUROMUSCULAR<br />
TRANSMISSION OF ILEAL CIRCULAR MUSCLE FROM<br />
PATIENTS WITH CROHN’S DISEASE: EFFECT OF CR3294,<br />
NEW ANTI-INFLAMMATORY COMPOUND<br />
Trisolini P., Pezzolla F., Demma I., Caruso M., Letari O.,<br />
Caselli G., Maselli M. (Bari, Monza)<br />
NOCICEPTIN/ORPHANIN FQ CAUSES MUCOSAL MAST CELL<br />
ACTIVATION IN THE RAT GASTRIC FUNDUS<br />
Grandi D., Solenghi E., Massi M., Morini G. (Parma,<br />
Camerino)<br />
EFFECTS OF PERIPHERAL ADMINISTRATION OF THE NOP<br />
RECEPTOR ANTAGONIST, UFP101, ON MUCOSAL<br />
FUNCTIONS IN THE RAT STOMACH<br />
Grandi D., Solenghi E., Guerrini R., Massi M., Morini G.<br />
(Parma, Ferrara, Camerino)<br />
104<br />
P-2/2/6<br />
P-2/2/7<br />
P-2/2/8<br />
P-2/2/9<br />
P-2/2/10<br />
P-2/2/11<br />
P-2/2/12<br />
P-2/2/13<br />
P-2/2/14<br />
FUNCTIONAL ROLE OF EXOGENOUS AMP IN RAT<br />
INTESTINAL MOTOR ACTIVITY<br />
Bin A., Zoppellaro C., Castagliuolo I., Gaion R., Giron M.<br />
(Padua)<br />
SMALL BOWEL FUNCTIONAL ABNORMALITIES IN AN IN<br />
VIVO ANIMAL MODEL OF HERPES SIMPLEX VIRUS-1<br />
INFECTION OF THE ENTERIC NERVOUS SYSTEM<br />
Zoppellaro C., Brun P., Bin A., Gaion R., Castagliuolo I.,<br />
Giron M. (Padua)<br />
CANNABIDIOL, A NON PSYCHOTROPIC PLANT<br />
CANNABINOID, PREVENTS OXIDATIVE STRESS IN<br />
INTESTINAL EPITHELIAL CELLS<br />
Romano B., Aviello G., Capasso R., Capasso F., Izzo A.,<br />
Borrelli F. (Naples)<br />
GASTRIC EFFECTS OF HISTAMINE: ANY ROLE FOR H4<br />
RECEPTORS?<br />
Adami M., Pozzoli C., Smits R., Leurs R., Coruzzi G.<br />
(Parma, Amsterdam)<br />
CA ++ -DEPENDENT PKCS PARTICIPATE TO THE ADAPTIVE<br />
CHANGES OF M OPIOID PATHWAYS TO SYMPATHETIC<br />
DENERVATION IN THE GUINEA PIG COLON<br />
Oldrini R., Zanetti E., Pascale A., Marchet S., Amadio M.,<br />
Chiaravalli A., Giaroni C., Lecchini S., Frigo G. (Varese,<br />
Pavia)<br />
DETERMINATION OF INTESTINAL PERMEABILITY BY<br />
MEASURING NON-METABOLIZED SUGARS HAS BEEN<br />
USED TO ASSESS THE INTEGRITY OF INTESTINAL<br />
MUCOSA<br />
Fucile C., Isola L., Marini V., Martelli A., Mattioli F.<br />
(Genoa)<br />
ROLE OF THE CANNABINOID SYSTEM IN THE EXOCRINE<br />
PANCREAS<br />
Petrella C., Alemà S., Agostini S., Broccardo M., Casolini<br />
P., Giuli C., Improta G., Linari G. (Rome)<br />
IN VITRO STIMULATION OF GUINEA PIG ILEUM MOTILITY<br />
BY N-FORMYL-MET-LEU-PHE (FMLF): INVOLVEMENT OF<br />
NEUROTRANSMITTERS AND PROSTANOIDS AND<br />
INFLUENCE OF ADENOSINE AND OPIATE SYSTEMS IN THE<br />
FMLF-INDUCED TACHYPHYLAXIS<br />
Colucci M., Maione F., Mastriota M., Di Giannuario A.,<br />
Valeri P., Mascolo N., Pieretti S. (Rome, London, Naples)<br />
SYNTHESIS OF NEW COMPOUNDS STRUCTURALLY<br />
RELATED TO THE DITERPENOID SCB, ISOLATED FROM<br />
105<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
SALVIA CINNABARINA, WITH SEDATIVE AND<br />
ANTISPASMODIC ACTIVITY IN MICE<br />
Mastriota M., Colucci M., Bonito M., Di Giannuario A.,<br />
Romussi G., Mascolo N., Pieretti S. (Rome, Naples, Genoa)<br />
106<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/3/1<br />
P-2/3/2<br />
P-2/3/3<br />
P-2/3/4<br />
P-2/3/5<br />
Poster Session<br />
P-2/3: PHARMACOLOGY OF METABOLISM, ENDOCRINE<br />
SYSTEM AND ERECTILE DYSFUNCTION<br />
Poster Commission Members:<br />
President: Tonini M. (Pavia)<br />
Members: Blandizzi C. (Pisa), Conte Camerino D. (Bari)<br />
ARIPIPRAZOLE REDUCES RISPERIDONE-INDUCED<br />
HYPERPROLACTINEMIA: TWO CASE REPORTS<br />
Capasso A., Milan W., Milan L., Siano C., Petrella C.<br />
(Fisciano)<br />
ORAL DELIVERY OF INSULIN LOADED INTO PEPTIDE-<br />
CONJUGATED POLYMERIC NANOPARTICLES IN DIABETIC<br />
RATS<br />
Tosi G., Vergoni A., Ruozi B., Costantino L., Bondioli L.,<br />
Forni F., Vandelli M., Tacchi R., Ferrari A., Spaccapelo L.,<br />
Bertolini A. (Modena)<br />
EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED<br />
RECEPTORS (PPARS) RECEPTORS FOLLOWING CHRONIC<br />
EXPOSURE TO VEGETABLE OMEGA-3 AND OMEGA-6 FATTY<br />
ACIDS<br />
Campioli E., Avallone R., Rustichelli C., Baraldi M.<br />
(Modena)<br />
GHRELIN O-ACYLTRANSFERASE (GOAT) EXPRESSION AND<br />
PHARMACOLOGICAL MODULATION IN CULTURED<br />
CHONDROCYTES<br />
Gomez R., Bianco G., Autore G., Conte J., Lopez M.,<br />
Gomez-Reino J., Dieguez C., Lago F., Gualillo O. (Santiago<br />
de Compostela, Salerno)<br />
EFFECTS OF PDRN ON SPERMATOGENETIC ACTIVITY<br />
DURING THE PROGRESSION OF TESTICULAR ISCHEMIA<br />
AND REPERFUSION IN RATS<br />
Minutoli L., Antonuccio P., Squadrito F., Polito F., Bitto A.,<br />
107<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/3/6<br />
P-2/3/7<br />
P-2/3/8<br />
P-2/3/9<br />
P-2/3/10<br />
P-2/3/11<br />
P-2/3/12<br />
P-2/3/13<br />
Di Stefano V., Irrera N., Romeo C., Caputi A. P., Altavilla<br />
D. (Messina)<br />
EFFECTS OF THE 2-H-1,4 BENZOXAZINE DERIVATIVES ON<br />
PANCREATIC KATP CHANNEL: A MOLECULAR<br />
DETERMINANT RESPONSIBLE FOR THE SELECTIVITY OF<br />
THE 2-H-1,4 BENZOXAZINE DERIVATIVES ON THE<br />
PANCREATIC KATP CHANNELS VERSUS SKELETAL MUSCLE<br />
SUBTYPE<br />
Tricarico D., Rolland J., Cippone V., Mele A., Cannone G.,<br />
Laghezza A., Fracchiolla G., Loiodice F., Conte Camerino<br />
D. (Bari)<br />
EXPRESSION OF DETERMINANTS OF GLUCOCORTICOID<br />
SENSITIVITY IN ANDROGEN-DEPENDENT AND<br />
ANDROGEN-INDEPENDENT HUMAN PROSTATE CANCER<br />
CELL LINES<br />
Dovio A., Sartori M., De Francia S., Piccione F.,<br />
Abbadessa G., Racca S., Di Carlo F., Angeli A. (Orbassano)<br />
AMP-ACTIVATED PROTEIN KINASE (AMPK) IN THE<br />
ANTERIOR PITUITARY AND GH-IGF-1 AXIS ACTIVITY: IN<br />
VIVO AND IN VITRO STUDIES<br />
Tulipano G., Giovannini M., Giustina A., Cocchi D.<br />
(Brescia)<br />
STRESS-INDUCED CORTISOL SECRETION AND IN VIVO<br />
METABOLISM OF ARACHIDONIC ACID<br />
Simeoni S., Maccarrone P., Rocca B., Patacchioli F.<br />
(Rome)<br />
GENDER LONG TERM HPA ALTERATIONS INDUCED BY<br />
NEONATAL STRESS<br />
Campana G., Loizzo S., Loizzo A., Spampinato S.<br />
(Bologna, Rome)<br />
RAPID EFFECTS OF T3 AND T2 ON INTRACELLULAR<br />
CALCIUM AND NITRIC OXIDE IN PITUITARY GH3 CELLS<br />
Del Viscovo A., Secondo A., Esposito A., Moreno M.,<br />
Silvestri E., Lanni A., Goglia F., Canzoniero L. (Benevento,<br />
Naples, Caserta)<br />
ALTERED N-6 FATTY ACID METABOLISM IN DIFFERENT<br />
CYSTIC FIBROSIS CELL LINES<br />
Mauro N., Ghezzi S., Risè P., Melotti P., Assael B., Galli C.<br />
(Milan, Verona)<br />
EFFECTS OF SHORT-TERM TREATMENT WITH GHRELIN<br />
AND SYNTHETIC GHS IN AN ANIMAL MODEL OF CACHEXIA<br />
Rizzi L., Bresciani E., Caporali S., Frigerio E., Tamiazzo L.,<br />
Perissoud D., Locatelli V., Torsello A. (Monza, Frankfurt)<br />
108<br />
P-2/3/14<br />
LIMBIC NEUROPEPTIDE Y-Y1 RECEPTOR EXPRESSING<br />
NEURONS ARE MANDATORY FOR ANXIOLYTIC-RELATED<br />
BEHAVIOUR AND BODY WEIGHT CONTROL<br />
Bertocchi I., Oberto A., Longo A., Mele P., Palanza P.,<br />
Sprengel R., Eva C. (Turin, Parma, Heidelberg)<br />
109<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/4/1<br />
P-2/4/2<br />
P-2/4/3<br />
P-2/4/4<br />
P-2/4/5<br />
Poster Session<br />
P-2/4: CHEMOTHERAPY<br />
Poster Commission Members:<br />
President: Viano I. (Novara)<br />
Members: Bertazzoni Minelli E. (Verona),<br />
D’Alessandro N. (Palermo)<br />
THYMOL INHIBITS GARDNERELLA VAGINALIS ADHESION<br />
TO HUMAN VAGINAL CELLS<br />
Braga P., Dal Sasso M., Spallino A., Culici M., Sturla C.<br />
(Milan, Gallarate)<br />
NEW HPLC–MS METHOD FOR THE SIMULTANEOUS<br />
QUANTIFICATION IN HUMAN PLASMA OF THE<br />
ANTILEUKEMIA DRUGS IMATINIB, DASATINIB, AND<br />
NILOTINIB<br />
De Francia S., D’Avolio A., De Martino F., Pirro E.,<br />
Piccione F., Racca S., Di Carlo F. (Orbassano, Turin)<br />
MITOTANE: THE IMPORTANCE OF MONITORING IN<br />
ADRENOCORTICAL CANCER PATIENTS<br />
De Martino F., De Francia S., Pirro E., Piccione F., Terzolo<br />
M., Daffara D., Di Carlo F. (Orbassano)<br />
ANTI-ENDOTHELIAL EFFECTS OF LOW DOSE CERAMIDE<br />
ANALOGS IN VITRO AND IN VIVO<br />
Fioravanti A., Orlandi P., Di Desidero T., Canu B., Danesi<br />
R., Del Tacca M., Bocci G. (Pisa)<br />
IRINOTECAN AND AXITINIB SYNERGISTICALLY INHIBIT<br />
PANCREATIC CANCER IN VITRO AND IN VIVO BY<br />
MODULATING VEGFR-2, ABCG2 AND ATP7A GENE<br />
EXPRESSION AND TSP-1 SECRETION<br />
Canu B., Fioravanti A., Di Desidero T., Orlandi P., Danesi<br />
R., Del Tacca M., Bocci G. (Pisa)<br />
P-2/4/6 THE IGF1R INHIBITOR NVP-AEW541 DISRUPTS A PRO-<br />
110<br />
P-2/4/7<br />
P-2/4/8<br />
P-2/4/9<br />
P-2/4/10<br />
P-2/4/11<br />
P-2/4/12<br />
P-2/4/13<br />
P-2/4/14<br />
SURVIVAL AND PRO-ANGIOGENIC IGF-STAT3-HIF1<br />
PATHWAY IN HUMAN GLIOBLASTOMA CELLS<br />
Ravizza R., Molteni R., Monti E., Gariboldi M. (Busto<br />
Arsizio)<br />
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS<br />
BY A3 ADENOSINE RECEPTORS<br />
Gessi S., Sacchetto V., Fogli E., Merighi S., Varani K.,<br />
Baraldi P., Tabrizi M., Leung E., Mac Lennan S., Borea P.<br />
A. (Ferrara, Cary)<br />
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR<br />
BINDING DISCRIMINATES AGONISTIC FROM<br />
ANTAGONISTIC BEHAVIOUR<br />
Sacchetto V., Gessi S., Fogli E., Varani K., Merighi S.,<br />
Leung E., MacLennan S., Borea P. A. (Ferrara, Cary)<br />
GEMCITABINE-LOADED PEGYLATED UNILAMELLAR<br />
LIPOSOMES VS GEMZAR ® : BIODISTRIBUTION,<br />
PHARMACOKINETIC FEATURES AND IN VIVO ANTITUMOR<br />
ACTIVITY<br />
D’Agostino M., Paolino D., Cosco D., Celano M.,<br />
Racanicchi L., Trapasso E., Celia C., Iannone M., Puxeddu<br />
E., Costante G., Russo D., Fresta M. (Catanzaro, Milan,<br />
Messina, Roccelletta di Borgia, Perugia)<br />
CORRELATION BETWEEN IN VITRO AND IN VIVO<br />
CYTIDINE DEAMINASE PHENOTYPE AND GEMCITABINE<br />
PHARMACOKINETICS IN PATIENTS WITH SOLID TUMORS<br />
Gusella M., Modena J., Barile C., Toso S., Bononi A.,<br />
Menon D., Pasini F., Padrini R. (Rovigo, Padua)<br />
PRELIMINARY IN VITRO BIOLOGICAL EVALUATIONS OF<br />
NEW PRODRUGS DESIGNED AS ANTIMELANOMA AGENTS<br />
Nassi A., Ruzza P., Rosato A., Rondina M., Rossi C.,<br />
Floreani M., Quintieri L. (Padua)<br />
CURCUMIN INCREASES SENSITIVITY OF RESISTANT<br />
OVARIAN TUMOUR CELLS TO PLATINUM DRUGS:<br />
APOPTOTIC EFFECTS AND CELL-CYCLE ALTERATIONS<br />
Montopoli M., Ragazzi E., Froldi G., Dorigo P., Caparrotta<br />
L. (Padua)<br />
AN EVALUATION OF ANTIBIOTIC USE AND RESISTANCE IN<br />
AN ITALIAN UNIVERSITY HOSPITAL<br />
Silvani M., Poluzzi E., Motola D., Biagi C., Nanetti A.,<br />
Ambretti S., Fiacchi P., Puggioli C., Vaccheri A., Montanaro<br />
N. (Bologna)<br />
IN VITRO INVESTIGATION OF SULINDAC DERIVATIVES AS<br />
POTENTIAL ANTICANCER AGENTS<br />
111<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/4/15<br />
P-2/4/16<br />
P-2/4/17<br />
P-2/4/18<br />
P-2/4/19<br />
P-2/4/20<br />
Fogli S., Banti I., Digiacomo M., Macchia M., Lapucci A.,<br />
Breschi M. (Pisa)<br />
HPβCDS COMPLEXING RESVERATROL: A NOVEL<br />
APPROACH FOR CHEMOPREVENTION OF SQUAMOUS CELL<br />
CARCINOMA<br />
Salamone P., Sprio A., Di Scipio F., Marinos L., Cavalli R.,<br />
Carlotti M., Sapino S., Di Carlo F., Berta G. (Orbassano,<br />
Turin)<br />
HISTONE DEACETYLASE (HDAC) INHIBITION MODULATES<br />
INTRACELLULAR DEOXYNUCLEOTIDES (DNTP) POOLS AND<br />
POTENTIATES THE ANTITUMOR EFFECTS OF THE<br />
RIBONUCLEOTIDE REDUCTASE (RR) INHIBITOR 3’-<br />
METHYL-ADENOSINE (3’-ME-ADO) IN PROMYELOCITIC<br />
LEUKAEMIA CELL LINES<br />
Meli M., Tolomeo M., Grifantini M., Mai A., Cappellacci L.,<br />
Franchetti P., Saiko P., Dusonchet L. (Palermo, Camerino,<br />
Rome, Vienna)<br />
THE mGLU3 RECEPTOR ANTAGONIST, LY341495,<br />
ENHANCES CHEMOSENSITIVITY OF COLORECTAL CANCER<br />
STEM CELLS TO STANDARD CYTOTOXIC CHEMOTHERAPY<br />
Mosillo P., Turriziani B., Ricci-Vitiani L., Ciceroni C.,<br />
Cappuccio I., Spinsanti P., Sale P., Nicoletti F., Melchiorri<br />
D. (Rome, Pavia, Pozzilli)<br />
THERAPEUTIC DRUG MONITORING OF DAPTOMICYN:<br />
DEVELOPMENT, VALIDATION AND APPLICATION OF A<br />
HPLC METHOD<br />
Polillo M., Di Paolo A., Tascini C., Lastella M., Gemignani<br />
G., Ciofi L., Taddei R., Menichetti F., Danesi R., Del Tacca<br />
M. (Pisa)<br />
PHARMACOKINETICS AND TOXICITY OF AN EARLY SINGLE<br />
INTRAVESICAL INSTILLATION OF MITOMYCIN-C AFTER<br />
ENDOSCOPIC RESECTION OF SUPERFICIAL BLADDER<br />
CANCER<br />
Mattioli F., Campodonico F., Fucile C., Marini V.,<br />
Maffezzini M., Martelli A. (Genoa)<br />
DECOLONIZATION OF S. AUREUS CARRIERS IN<br />
ORTHOPEDIC SURGICAL TEAM MEMBERS: IMPACT ON<br />
SURGICAL SITE INFECTIONS<br />
Portigliatti Barbos M., Barberis A., Marino S., Pecoraro S.,<br />
Picco W., Veglio V., Di Carlo F., Mognetti B. (Orbassano,<br />
Turin)<br />
112<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/5/1<br />
P-2/5/2<br />
P-2/5/3<br />
P-2/5/4<br />
P-2/5/5<br />
P-2/5/6<br />
Poster Session<br />
P-2/5: PHARMACOLOGY OF INFLAMMATION<br />
Poster Commission Members:<br />
President: Patrono C. (Rome)<br />
Members: Tremoli E. (Milan), Ziche M. (Siena)<br />
ETHYL PYRUVATE REDUCES THE DEVELOPMENT OF<br />
ZYMOSAN-INDUCED GENERALIZED INFLAMMATION IN<br />
MICE<br />
Di Paola R., Mazzon E., Genovese T., Crisafulli C.,<br />
Bramanti P., Caminiti R., Esposito E., Fink M., Cuzzocrea<br />
S. (Messina, Naples, Waltham)<br />
MYRTUCOMMULONE FROM MYRTUS COMMUNIS EXHIBITS<br />
POTENT ANTI-INFLAMMATORY EFFECTIVENESS IN VIVO<br />
Rossi A., Di Paola R., Mazzon E., Pergola C., Koeberle A.,<br />
Werz O., Cuzzocrea S., Sautebin L. (Naples, Messina,<br />
Tuebingen)<br />
ROLE OF PALMITOYLETHANOLAMIDE ON MODULATION OF<br />
THE MAST CELL-T CELL INTERACTIONS: AN IN VITRO<br />
STUDY<br />
Valenti M., Massi P., Parolaro D. (Varese, Milan)<br />
HYDROGEN SULPHIDE INDUCES MOUSE HIND PAW<br />
OEDEMA<br />
Coletta C., d'Emmanuele di Villa Bianca R., Mitidieri E.,<br />
Bucci M., Cirino G., Sorrentino R. (Naples)<br />
A LIPID A FROM HALOMONAS MAGADIENSIS INHIBITS<br />
ENTERIC LPS-INDUCED TLR4 ACTIVATION IN HUMAN<br />
MONOCYTES<br />
Tersigni M., Ialenti A., Lanzetta R., Grant W., Ianaro A.<br />
(Naples, Leicester)<br />
POTENT ANTIOXIDANT PROFILE OF FLAVOCOXID, A<br />
NATURAL DUAL INHIBITOR OF CYCLOOXYGENASE AND 5-<br />
113<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/5/7<br />
P-2/5/8<br />
P-2/5/9<br />
P-2/5/10<br />
P-2/5/11<br />
P-2/5/12<br />
P-2/5/13<br />
P-2/5/14<br />
P-2/5/15<br />
LIPOXYGENASE<br />
Bitto A., Polito F., Minutoli L., Irrera N., Di Stefano V.,<br />
Altavilla D., Giuliani D., Guarini S., Ottani A., Caputi A. P.,<br />
Squadrito F. (Messina, Modena)<br />
HIGH MOBILITY GOUP BOX-1 EXPRESSION CORRELATES<br />
WITH OUTCOME IN CRITICAL ILL PATIENTS<br />
Bonaiuto A., Polito F., Bitto A., Minutoli L., Irrera N., Di<br />
Stefano V., Altavilla D., Giuliani D., Guarini S., Ottani A.,<br />
Caputi A. P., Squadrito F. (Messina, Modena)<br />
INFLUENCE OF GENDER IN THE MESENTERIC ISCHEMIA/<br />
REPERFUSION MODEL IN MICE<br />
Ghizzardi P., Gobbetti T., Bertoni S., Vegezzi G., Barocelli<br />
E. (Parma)<br />
G-NBD, A NOVEL CELL-PERMEABLE PEPTIDE, INHIBITS<br />
NF-κB ACTIVATION<br />
Maddaluno M., Grassia G., De Stefano D., Carnuccio R.,<br />
De Simone L., Neri E., Grieco P., Ialenti A. (Naples)<br />
ANTINFLAMMATORY PROPERTIES OF NOVEL 5-<br />
AMINO[1,2,4]-TRIAZOLO[4,3-A][1,8]NAPHTHYRIDINES-<br />
CAROBOXAMIDES DERIVATIVES<br />
Giorgio C., Tognolini M., Rome G., Di Braccio M.,<br />
Ballabeni V., Barocelli E. (Parma, Genoa)<br />
ANTI-INFLAMMATORY EFFECTS OF INDICAXANTHIN ON<br />
CARRAGEENIN-INDUCED RAT PLEURISY<br />
Tersigni M., Allegra M., Tesoriere L., Livrea M., Ianaro A.<br />
(Naples, Palermo)<br />
EVIDENCE FOR THE INVOLMENTE OF ADENOSINE A2A<br />
RECEPTOR IN CARRAGEENIN-INDUCED RAT PAW EDEMA<br />
Parisi A., Gargiulo L., Alfieri A., Cicala C. (Naples)<br />
LEUKOCYTE-DERIVED MICROPARTICLES (MP) DEEPLY<br />
AFFECT MONOCYTE/MACROPHAGE RESPONSIVENESS<br />
Bardelli C., Zeng H., Amoruso A., Fresu L., Palma A.,<br />
Brunelleschi S. (Novara)<br />
SMOKING AND RHEUMATOLOGIC DISEASES<br />
Calzavara E., Bartolone S., Russo G., Carnì A., Mannucci<br />
C., Pieratti A., Caputi A. P., Calapai G. (Messina)<br />
THE EFFICACY OF XILOIAL, A NEW ARTIFICIAL TEAR, IN<br />
AN EXPERIMENTAL MODEL OF DRY EYE IN RATS<br />
Mannari C., Guidi A., Stiaccini G., Scalori V., Sansò M.,<br />
Giovannini L. (Pisa)<br />
114<br />
P-2/5/16<br />
P-2/5/17<br />
P-2/5/18<br />
ANTI-INFLAMMATORY EFFECTS OF NCX 4040, A NITRIC<br />
OXIDE-DONATING ASPIRIN, BY INHIBITING IKB-ALPHA<br />
DEGRADATION IN HUMAN MONOCYTES<br />
Di Francesco L., Ricciotti E., Dovizio M., Anzellotti P.,<br />
Monopoli A., Patrignani P. (Chieti, Philadelphia, Bresso)<br />
ODN DECOY TO NF-KB RELEASED FROM RESPIRABLE<br />
PLGA LARGE POROUS PARTICLES: A POTENTIAL<br />
STRATEGY FOR TREATING CYSTIC FIBROSIS?<br />
De Stefano D., Giovino C., Ungaro F., Coletta C.,<br />
d’Emmanuele di Villa Bianca R., Sorrentino R., Quaglia F.,<br />
Carnuccio R. (Naples)<br />
EFFECT OF 1-PHENYL-6,7-DIHYDROXY-ISOCHROMEN ON<br />
LPS-INDUCED GLIAL ACTIVATION<br />
Latina V., Togna A., Trefiletti G., Marra C., Togna G.<br />
(Rome)<br />
115<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/6/1<br />
P-2/6/2<br />
P-2/6/3<br />
P-2/6/4<br />
P-2/6/5<br />
P-2/6/6<br />
Poster Session<br />
P-2/6: IMMUNOPHARMACOLOGY<br />
Poster Commission Members:<br />
President: Patrono C. (Rome)<br />
Members: Tremoli E. (Milan), Ziche M. (Siena)<br />
ACUTE PANCREATITIS IS REDUCED BY GENETIC OR<br />
PHARMACOLOGICAL INHIBITION OF GLUCOCORTICOID-<br />
INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR)<br />
Galuppo M., Nocentini G., Mazzon E., Esposito E., Di<br />
Paola R., Crisafulli C., Genovese T., Riccardi C., Cuzzocrea<br />
S. (Messina, Perugia, Naples)<br />
POST-TRANSLATIONAL MODIFICATION OF GILZ BY SUMO-<br />
1<br />
Pozzesi N., Riccardi C., Delfino D. (Perugia)<br />
GITR + CD25 - CELLS REPRESENT A HUMAN REGULATORY T<br />
CELLS SUBSET DEREGULATED IN SYSTEMIC LUPUS<br />
ERYTHEMATOSUS<br />
Bianchini R., Nocentini G., Petrillo M., Bistoni O., Alunno<br />
A., Ronchetti S., Bartoloni Bocci E., Gerli R., Riccardi C.<br />
(Perugia)<br />
EXPRESSION AND SIGNALLING OF PPAR-GAMMA IN SH-<br />
SY5Y, A HUMAN NEUROBLASTOMA CELL LINE<br />
Palma A., Amoruso A., Fresu L., Bardelli C., Brunelleschi<br />
S. (Novara)<br />
IMPACT OF TOBACCO SMOKE IN PPAR-GAMMA<br />
EXPRESSION IN MONOCYTE/MACROPHAGES ISOLATED<br />
FROM CORONARY HEART DISEASE (CHD) PATIENTS<br />
Amoruso A., Bardelli C., Fresu L., Palma A., Brunelleschi<br />
S. (Novara)<br />
MYCOPHENOLIC ACID THERAPEUTIC DRUG MONITORING<br />
BY MEANS OF A LIMITED SAMPLING STRATEGY IN ADULT<br />
116<br />
P-2/6/7<br />
P-2/6/8<br />
P-2/6/9<br />
P-2/6/10<br />
HEART TRANSPLANT PATIENTS<br />
Baraldo M., Feruglio M., Cojutti P., Tursi V., Livi U.,<br />
Furlanut M. (Udine)<br />
SULFATIDE AS AN ENDOGENOUS MODULATOR OF<br />
INDOLEAMINE 2,3-DIOXYGENASE IN ANTIGEN<br />
PRESENTING CELLS<br />
Fallarini S., Altomare E., Mossotti M., Panza L., Lombardi<br />
G. (Novara)<br />
ENDOGENOUS CATECHOLAMINES IN HUMAN NATURAL<br />
KILLER CELLS: BASIC EVIDENCE AND CLINICAL<br />
IMPLICATIONS<br />
Maio R., Bozzo L., Brunetta E., Bonaldo S., Marino F.,<br />
Mavilio D., Cosentino M. (Varese, Rozzano)<br />
POSSIBLE LINK BETWEEN HISTORY OF<br />
HYPERSENSITIVITY TO A SPECIFIC NON-STEROIDAL<br />
ANTI-INFLAMMATORY DRUG (NSAID) AND POSITIVE<br />
RESULTS FOLLOWING CHALLENGE TEST TO ALTERNATIVE<br />
NSAIDS<br />
Naccari C., Trombetta D., Imbesi S., Vita G., Isola S.,<br />
Minciullo P., Saija A., Gangemi S. (Messina)<br />
IMPAIRMENT OF DENDRITIC CELL FUNCTION IS CRUCIAL<br />
FOR PROTECTION AFFORDED BY PARP-1 INHIBITORS IN<br />
EXPERIMENTAL MODELS OF MULTIPLE SCLEROSIS<br />
Cavone L., Aldinucci A., Ballerini C., Biagioli T., Massacesi<br />
L., Moroni F., Chiarugi A. (Florence)<br />
117<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/7/1<br />
P-2/7/2<br />
P-2/7/3<br />
P-2/7/4<br />
P-2/7/5<br />
P-2/7/6<br />
Poster session<br />
P-2/7: PHARMACOEPIDEMIOLOGY, PHARMACOVIGILANCE,<br />
PHARMACOECONOMY, DRUG INFORMATION, VACCINES<br />
Poster Commission Members:<br />
President: De Sarro G. B. (Catanzaro)<br />
Members: De Ponti F. (Bologna), Spina E. (Messina)<br />
BILATERAL PAPILLEDEMA FOLLOWING HPV VACCINATION<br />
Rossi M., Pagano C., Pannini S., Barlocco E., Giorgi G.<br />
(Siena, Grosseto)<br />
MILIARY TUBERCULOSIS AFTER ENDOVESICAL<br />
INSTILLATION OF BACILLUS CALMETTE-GUÉRIN FOR<br />
BLADDER CANCER: A CASE-REPORT<br />
Parini F., Valenti L., Radaeli E., Spano P.F., Sigala S.<br />
(Brescia)<br />
EVALUATION OF THE USE OF PSYCHOTROPIC DRUGS IN<br />
TERMINALLY ILL CANCER PATIENTS<br />
Mussa M., Magnetti C., De Francia S., Pirro E., Piccione<br />
F., Dimonte V., Fantò F., Di Carlo F. (Turin, Orbassano)<br />
INFODOPING: A CONFIDENTIAL TELEPHONE SERVICE<br />
PROVIDING INFORMATION ON DRUGS AND SUBSTANCES<br />
IN SPORT AND SOCIETY<br />
Cojutti P., Furlanut M., Baraldo M. (Udine)<br />
ANTIDEPRESSANT DRUG (AD) PRESCRIBING PATTERNS<br />
DURING THE YEARS 1999-2008<br />
Mercanti G., Chinellato A., Terrazzani G., Bortolami A.,<br />
Debetto P., Giusti P. (Padua, Treviso)<br />
EU-ADR PROJECT: NOVEL SYSTEM FOR DETECTION OF<br />
DRUG SAFETY SIGNALS BY INTEGRATIVE MINING OF<br />
ELECTRONIC HEALTH CARE RECORDS AND BIOMEDICAL<br />
KNOWLEDGE<br />
Trifirò G., Sturkenboom M., Kors J., Diaz Acedo C., Boyer<br />
118<br />
P-2/7/7<br />
P-2/7/8<br />
P-2/7/9<br />
P-2/7/10<br />
P-2/7/11<br />
P-2/7/12<br />
S., Cantarutti L., Fourier-Reglat A., Gini R., Gurwitz D.,<br />
Herings R., Hippisley-Cox J., Loza M., Mazzaglia G.,<br />
Molokhia M., Oliveira J., Pedersen L., Romio S., Sanz F.,<br />
van der Lei J. (Messina, Rotterdam, Barcelona, Mölndal,<br />
Padua, Bordeaux, Florence, Tel Aviv, Utrecht, Nottingham,<br />
Santiago de Compostela, London, Aveiro, Aarhus, Milan)<br />
DATA MINING ON ELECTRONIC HEALTH RECORD<br />
DATABASES FOR SIGNAL DETECTION IN<br />
PHARMACOVIGILANCE: WHICH EVENTS TO MONITOR?<br />
Trifirò G., Pariente A., Coloma P., Kors J., Polimeni G.,<br />
Miremont-Salamé G., Catania M. A., Salvo F., David A.,<br />
Moore N., Caputi A. P., Sturkenboom M., Molokhia M.,<br />
Hippisley-Cox J., Diaz Acedo C., van der Lei J., Fourrier-<br />
Reglat A. (Messina, Rotterdam, Bordeaux, London,<br />
Nottingham, Barcelona)<br />
PROMOTING CONTINUING EDUCATION IN<br />
PHARMACOVIGILANCE: THE EXPERIENCE OF<br />
“PHARMASEARCH”, A NETWORK OF GENERAL<br />
PRACTITIONERS REPORTING ADVERSE DRUG REACTIONS<br />
Catania M. A., Salvo F., Oteri A., Polimeni G., Russo A.,<br />
Fava G., Giustini S., Sessa A., Tuccori M., Mattioli F.,<br />
Martelli A., Del Tacca M., Caputi A. P. (Messina, Pisa,<br />
Genoa)<br />
SAFETY PROFILES OF TICLOPIDINE AND CLOPIDOGREL: A<br />
CASE/NON CASE STUDY ON THE BASIS OF THE<br />
SPONTANEOUS ADRS REPORTING IN ITALY<br />
Motola D., Biagi C., Roberto G., Donati M., Lapi F., Salvo<br />
F., Leoni O., Montanaro N. (Bologna, Verona, Florence,<br />
Messina, Milan)<br />
DRUG SAFETY INFORMATION THROUGH THE INTERNET.<br />
THE EXPERIENCE OF AN ITALIAN WEBSITE<br />
Polimeni G., Russo A., Catania M. A., Sportiello L., Oteri<br />
A., Trifirò G., Calapai G., Sautebin L., Iacobelli M., Caputi<br />
A. P. (Messina, Naples, Milan)<br />
OBSERVATIONAL ITALIAN STUDY ON ANTENATAL<br />
DEPRESSION AND DRUG USE IN PREGNANCY<br />
Donati M., Imperadore G., Moretti U., Conforti A., Bisoffi<br />
G., D'Incau P., Leone R., Bellantuono C. (Verona,<br />
Ancona)<br />
ADVERSE REACTIONS TO ERLOTINIB: A CASE OF<br />
DERMATITIS BULLOSA<br />
Oteri A., Cattaneo M., Clementi E., Filippazzi V., Ferrario<br />
S., Gamabaro A., Isabella L., Radice S., Tosca N., Piazza<br />
E. (Milan, Messina)<br />
119<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/7/13<br />
P-2/7/14<br />
P-2/7/15<br />
P-2/7/16<br />
P-2/7/17<br />
P-2/7/18<br />
P-2/7/19<br />
P-2/7/20<br />
P-2/7/21<br />
MEDICINAL PLANTS AND HERBAL REMEDIES IN PATIENTS<br />
WITH MULTIPLE SCLEROSIS: A NATION-WIDE SURVEY IN<br />
ITALY<br />
Loraschi A., Bombelli R., Zaffaroni M., Ghezzi A., Marino<br />
F., Lecchini S., Comi G., Cosentino M. (Varese, Gallarate,<br />
Milan)<br />
DIETARY SUPPLEMENTS USE BY NON PROFESSIONAL<br />
ATHLETES: A PILOT STUDY IN NORTHERN ITALY<br />
Loraschi A., Caliari A., Cosentino M. (Varese)<br />
TRENDS IN ANTIBIOTIC THERAPY OF RESPIRATORY<br />
TRACT INFECTIONS: A PHARMACOEPIDEMIOLOGICAL<br />
SURVEY IN GENERAL PRACTICE IN NORTHERN ITALY AREA<br />
Cipolla G., Crema F., Moro E., Frigo G. (Pavia)<br />
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY: A<br />
REPORT OF TWO CASES IN PATIENTS WITH LYMPHOMAS<br />
ON MAINTENANCE THERAPY WITH RITUXIMAB<br />
Montagnani S., Tuccori M., Focosi D., Maggi F., Cosottini<br />
M., Meini B., Blandizzi C., Petrini M., Del Tacca M. (Pisa,<br />
Florence, Livorno)<br />
CEFTRIAXONE-INDUCED PANCREATITIS IN A PEDIATRIC<br />
PATIENT: A CASE REPORT<br />
Ruggiero S., Di Nardo R., Polimeno T., Rafaniello C.,<br />
Rossi F., Capuano A. (Naples)<br />
MANAGEMENT OF PAEDIATRIC PAIN RELATED TO VEIN<br />
CANNULATION: A SYSTEMATIC OVERVIEW<br />
Gallo M., Capuano A., Clavenna A., Rossi F., Bonati M.<br />
(Milan)<br />
ADHERENCE TO IRON-CHELATION THERAPY IN<br />
THALASSEMIC PATIENTS. A SURVEY ON PSYCHOSOCIAL<br />
ASPECTS<br />
Felisi M., Baiardi P., Padula R., Bonifazi D., Ceci A. (Pavia,<br />
Bari)<br />
AN OBSERVATIONAL STUDY OF ANTIPSYCHOTICS USE IN<br />
PATIENTS WITH BEHAVIOURAL AND PSYCHOLOGICAL<br />
SYMPTOMS OF DEMENTIA (BPSD)<br />
Potenza S., Formica R., Putaturo I., Scognamiglio M.,<br />
Forgione L., Postiglione A., Galdi M., De Martino G., Forte<br />
M., Rea G., Liquori G., Genovese T., Schipani G., Albano<br />
G., Scarpa R., Arcaro G., Ferrara F., Rabasca A., Di Maio<br />
G., De Angelis A., Caterino L., Irpino A., Rossi F., Capuano<br />
A. (Naples)<br />
DRUG-INDUCED TASTE AND SMELL ALTERATIONS: A<br />
CASE/NON-CASE STUDY ON AN ITALIAN DATABASE OF<br />
120<br />
P-2/7/22<br />
P-2/7/23<br />
P-2/7/24<br />
P-2/7/25<br />
P-2/7/26<br />
P-2/7/27<br />
P-2/7/28<br />
ADVERSE DRUG REACTIONS<br />
Tuccori M., Lapi F., Testi A., Cutroneo P., Leoni O.,<br />
Rivolta A., Costantini D., Opri S., Motola D., Venegoni M.,<br />
Santuccio C., Sottosanti L., Blandizzi C., Mugelli A., Del<br />
Tacca M. (Pisa, Florence, Messina, Milan, Verona, Bologna,<br />
Rome)<br />
PHARMACOKINETICS OF PROPOFOL DURING MONITORED<br />
ANAESTHESIA IN OBESE PATIENTS UNDERGOING<br />
BILIOPANCREATIC DIVERSION<br />
Fucile C., Di Noto A., Spagnolo L., Martelli A., Mattioli F.<br />
(Genoa)<br />
PHONE SURVEY ON DRUG RISK PERCEPTION IN GENERAL<br />
POPULATION: A FEASIBILITY STUDY<br />
Salvo F., Gentile M., Iannello C., Caputi A. P., Calapai G.<br />
(Messina)<br />
DRUG CARE NETWORK:INTERACTIVE MODELS<br />
PHYSICIAN- PHARMACIST- PATIENT<br />
Franceschini L., Sigala S., Brignoli O., Rastrelli F., Agabiti<br />
Rosei E., Spano P. F. (Brescia)<br />
HIGH LEVELS OF CHROMOGRANIN A AND SEROTONIN<br />
ASSOCIATED WITH ESOMEPRAZOLE TREATMENT IN A<br />
PATIENT ON FOLLOW-UP AFTER SURGERY FOR<br />
PANCREATIC NEURO-ENDOCRINE TUMOUR<br />
Gori G., Spinelli G., Spinelli C., Tuccori M., Blandizzi C.,<br />
Del Tacca M. (Pisa)<br />
CARDIOVASCULAR AND RESPIRATORY ADVERSE EVENTS<br />
DUE TO THE CHANGING INPOSITION DURING SPINAL<br />
ANAESTHESIA WITH 1% HYPERBARIC BUPIVACAINE<br />
Rafaniello C., Ianniello B., Riso C., Cillo B., Mercogliano<br />
A., Capodanno P., Delle Donne D., Di Bella O., Lettieri B.,<br />
Rossi F., Capuano A. (Naples)<br />
USE OF ANTIEPILEPTIC DRUGS IN AN ITALIAN SETTING<br />
OF ELDERLY OUTPATIENTS DURING THE YEARS 2004-<br />
2007: THE EFFECT OF HEALTH POLICY INTERVENTION<br />
Gagliostro M. S., Oteri A., Moretti S., Tari D., Caputi A.<br />
P., Spina E., Arcoraci V. (Messina, Caserta)<br />
PRESCRIBING PATTERN OF AROMATASE INHIBITORS AND<br />
SELECTIVE ESTROGEN RECEPTOR MODULATORS IN AN<br />
ITALIAN OUTPATIENT SETTING: A POPULATION-BASED<br />
STUDY DURING 2004-2007<br />
Cutroneo P., Gagliostro M. S., Oteri A., Moretti S., Tari<br />
D., Caputi A. P., Arcoraci V. (Messina, Caserta)<br />
P-2/7/29 SEVERE HYPOGLYCEMIA ASSOCIATED WITH<br />
121<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/7/30<br />
P-2/7/31<br />
P-2/7/32<br />
P-2/7/33<br />
P-2/7/34<br />
P-2/7/35<br />
LEVOFLOXACIN<br />
Giorgi G., Sbrilli M., Nencini C., Micheli L. (Siena)<br />
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES IN THE<br />
ITALIAN PAEDIATRIC POPULATION<br />
Baiardi P., Ceci A., Cantarutti L., Giaquinto C., Girotto S.,<br />
Felisi M., Padula R., Sturkenboom M., Baraldi E. (Pavia,<br />
Padua, Venezia, Rotterdam)<br />
SYSTEMATIC SURVEILLANCE OF ADVERSE DRUG EVENTS<br />
IN EMERGENCY DEPARTMENT IN LOMBARDIA REGION<br />
Oteri A., Conti V., Muserra G., Strippoli A., Ferri C.,<br />
Barrosi C., Vighi G. (Milan)<br />
“IN SILICO” COST/EFFECTIVENESS EVALUATION FOR<br />
TREATMENT WITH STATINS OF DIABETIC PATIENTS<br />
Cristani M., Monteleone D., Saija A., Tomaino A.<br />
(Messina)<br />
GOLDEN STANDARDS FOR QUALITY AND SAFETY IN THE<br />
PARENTERAL FORMULATIONS<br />
Martorana M., Arcoraci T., Saija A., Tomaino A. (Messina)<br />
ADVERSE REACTIONS OF MEDICINALS PRODUCTS: A<br />
SURVEY ON SICILIAN WOMEN<br />
Pieratti A., Calapai G., Crupi D., De Sarro A. (Messina)<br />
ACUTE LIVER FAILURE COMPLICATING TURP SYNDROME<br />
AFTER ABSORPTION OF IRRIGATION FLUID DURING<br />
TRANSURETHRAL RESECTION OF PROSTATE: A CASE<br />
REPORT<br />
Montagnani S., Tuccori M., Blandizzi C., Del Tacca M., Di<br />
Paolo M. (Pisa, Florence)<br />
122<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/8/1<br />
P-2/8/2<br />
P-2/8/3<br />
P-2/8/4<br />
P-2/8/5<br />
P-2/8/6<br />
Poster Session<br />
P-2/8: COMPLEMENTARY MEDICINES<br />
Poster Commission Members:<br />
President: Fantozzi R. (Turin)<br />
Members: Leone R. (Verona), Sautebin L. (Naples)<br />
USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE<br />
(CAM) BY PATIENTS WITH CHRONIC NON-MALIGNANT<br />
PAIN: COMPARISON BETWEEN PRIMARY HEADACHE AND<br />
RHEUMATIC DISEASE<br />
Spaccapelo L., Giuggioli D., Tacchi R., Ferrari A.<br />
(Modena)<br />
SUPERIORITY OF ENDOGENOUS VERSUS DIETARY<br />
ANTIOXIDANTS TO PREVENT OXIDATIVE DAMAGE IN RAT<br />
BRAIN<br />
Barone E., Guido P., Siciliano R., Lofaro A., Mancuso C.<br />
(Rome)<br />
GINKGO BILOBA EXTRACT, EGB 761, DECREASES LIPID<br />
PEROXIDATION AND IMPROVES COGNITIVE IMPAIRMENT<br />
IN PATIENTS WITH ISCHEMIC CEREBROPATHY<br />
Fiaschi A., Cerretani D., Fiore G., Cianchi C., Mancuso M.<br />
(Siena, Grosseto)<br />
OXIDATIVE STRESS AND SPA (SALUS PER AQUAM)<br />
THERAPY<br />
Costantino M., Filippelli A. (Naples)<br />
SCREENING OF ANTIOXIDANT PROPERTIES OF<br />
SPONTANEOUS ALLIUM SPECIES FROM ITALY<br />
Micheli L., Nencini C. (Siena)<br />
STUDIES IN VITRO OF PHARMACOLOGICAL PROPERTIES<br />
OF ECUADORIAN BLOOD-RED SAP FROM CROTON<br />
LECHLERI<br />
Froldi G., Montopoli M., Caparrotta L., Dorigo P. (Padua)<br />
123<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/8/7<br />
P-2/8/8<br />
P-2/8/9<br />
P-2/8/10<br />
P-2/8/11<br />
P-2/8/12<br />
P-2/8/13<br />
P-2/8/14<br />
USE OF COMPLEMENTARY/ALTERNATIVE MEDICATIONS<br />
AMONG PATIENTS UNDERGOING ANAESTHESIOLOGIC<br />
PREOPERATIVE ASSESSMENT<br />
Lapi F., Gallo E., Paoletti A., Di Pirro M., Pugi A., Vietri M.,<br />
Banchelli G., Moschini M., Cecchi E., Lupi P., La Torre M.,<br />
Diddi G., Gori L., Firenzuoli F., Mugelli A., Vannacci A.,<br />
Giommoni F. (Florence, Empoli, Prato)<br />
ATTITUDES TOWARDS HERBAL REMEDIES AMONG<br />
PHYSICIANS AND PATIENTS: A COMPARISON SURVEY IN<br />
FIVE TUSCANY HOSPITALS<br />
Pugi A., Gallo E., Paoletti A., Di Pirro M., Vietri M.,<br />
Banchelli G., Moschini M., Cecchi E., Fazzini A., Gori L.,<br />
Firenzuoli F., Mugelli A., Vannacci A., Lapi F. (Florence,<br />
Empoli)<br />
AN ANTI-HYPERTENSIVE HERBAL SUPPLEMENT<br />
CONTAINING NOT-DECLARED RESERPINE: A POSSIBLE<br />
RISK FOR PATIENTS' HEALTH<br />
Vannacci A., Giocaliere E., Paoletti A., Di Pirro M., Pugi<br />
A., Vietri M., Banchelli G., Moschini M., Cecchi E., Fazzini<br />
A., Gallo E., Pieraccini G., Moneti G., Gori L., Firenzuoli F.,<br />
Lapi F., Mugelli A. (Florence, Empoli)<br />
NATURAL PRODUCTS DURING PREGNANCY: ARE THEY<br />
SAFE?<br />
Vitalone A., Costa L. (Rome, Seattle)<br />
AN HEPATOTOXICITY STUDY AFTER PROLONGED ORAL<br />
ADMINISTRATION OF CASSIA ANGUSTIFOLIA L. IN<br />
WISTAR RATS<br />
Vitalone A., Di Sotto A., Franchitto A., Mammola C.,<br />
Mariani P., Mastrangelo S., Paoletti A., Mazzanti G. (Rome)<br />
DIFFERENCE OF FLAVONOIDS CONTENT AND<br />
ANTIOXIDANT ACTIVITY OF FRESH AND CANNED CHERRY<br />
TOMATO EXTRACTS<br />
Morabito G., Arcoraci T., Cristani M., Trombetta D.,<br />
Martorana M., Mancari F., Ferreri A. (Messina)<br />
A HUMAN “BIOREACTOR” MODEL TO UNDERSTAND THE<br />
BIOLOGICAL EFFECTS OF PLANT-DERIVED ACTIVE<br />
COMPOUNDS: A STUDY ON HUMAN ENDOTHELIAL CELLS<br />
Cimino F., Canali R., Virgili F., Saija A., Ricciardi E.,<br />
Chirafisi J., Speciale A. (Messina, Rome)<br />
BIOACCESSIBILITY OF PHENOLS FROM ALMOND SKINS<br />
USING AN “IN VITRO” DYNAMIC DIGESTION MODEL<br />
Arcoraci T., Mandalari G., Martorana M., Bisignano C.,<br />
Wickham M., Monteleone D., Bisignano G., Tomaino A.<br />
124<br />
P-2/8/15<br />
(Messina, Norwich)<br />
STUDY OF ANTIOXIDANT ACTIVITY AND PHENOLIC<br />
PROFILE OF PISTACHIO (PISTACIA VERA L. VAR. BRONTE)<br />
NUT<br />
Martorana M., Arcoraci T., Monteleone D., Giovinazzo C.,<br />
Saija A., Tomaino A. (Messina)<br />
125<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Poster Area<br />
Poster Display: for the duration of the day (8.30 am-6.45 pm)<br />
Author’s attendance at poster site: the author in bold will be available at the<br />
poster site between 2.00 and 4.00 pm<br />
Poster board<br />
No.:<br />
P-2/9/1<br />
P-2/9/2<br />
P-2/9/3<br />
P-2/9/4<br />
P-2/10/1<br />
Poster Session<br />
P-2/9, P-2/10 and P-2/11: INNOVATIVE AND<br />
BIOTECHNOLOGICAL DRUGS, PHARMACOGENETICS,<br />
CLINICAL TRIALS<br />
Poster Commission Members:<br />
President: Spina E. (Messina)<br />
Members: Danesi R. (Pisa), Genazzani A. (Novara)<br />
ADIPOSE-DERIVED STEM CELLS (ASCS) FOR THE<br />
TREATMENT OF OSTEOCHONDRAL DEFECTS:<br />
COMPARISON BETWEEN HUMAN AND PORCINE ASCS FOR<br />
FUTURE PRE-CLINICAL MODELS<br />
Arrigoni E., Lopa S., de Girolamo L., Stanco D., Brini A.<br />
(Milan)<br />
HUMAN ADIPOSE-DERIVED STEM CELLS (HASCS): A<br />
USEFUL TOOL TO SCREEN BIOMATERIALS FOR BONE<br />
REGENERATIOM<br />
Lopa S., Arrigoni E., de Girolamo L., Stanco D., Chiesa R.,<br />
Brini A. (Milan)<br />
DENTAL PULP MESENCHYMAL STEM CELLS PLASTICITY: A<br />
PROMISING TOOL IN DAMAGED TISSUES RESTORING<br />
Sprio A., Di Scipio F., Raimondo S., Salamone P., Folino<br />
A., Geuna S., Di Carlo F., Berta G. (Orbassano)<br />
PREFERENTIAL KILLING OF CANCER CELLS USING SIC<br />
QDS<br />
Barberis A., Marino S., Geloen A., Lysenko V., Mancardi<br />
D., Merlino A., Di Carlo F., Mognetti B. (Orbassano, Lyon)<br />
PHARMACOGENETICS OF CITALOPRAM IN PALLIATIVE<br />
CARE OF CANCER<br />
Schillani G., Giraldi T., Capozzo M., Conte M. (Trieste,<br />
San Vito al Tagliamento)<br />
P-2/10/2 DISTRIBUTION OF CB2 CANNABINOID RECEPTOR<br />
126<br />
P-2/10/3<br />
P-2/10/4<br />
P-2/10/5<br />
P-2/10/6<br />
P-2/10/7<br />
P-2/10/8<br />
P-2/10/9<br />
P-2/10/10<br />
POLYMORPHISMS IN AN ITALIAN POPULATION<br />
Minocci D., Martino A., Massei J., Rossi A., Nieri P. (Pisa)<br />
DRUG RELATED-GENE POLYMORPHISMS MAY PREDICT<br />
SURVIVAL IN ESOPHAGEAL CANCER PATIENTS RECEIVING<br />
NEO-ADJUVANT RADIO-CHEMOTHERAPY<br />
Bertolaso L., Gusella M., De Manzoni G., Bruscagin S.,<br />
Stievano L., Zanoni A., Ferrazzi E., Cordiano C., Padrini R.,<br />
Pasini F. (Rovigo, Verona, Padua)<br />
PRECLINICAL STUDIES OF COMBINATION OF<br />
GEMCITABINE AND VANDETANIB IN BLADDER<br />
TRANSITIONAL CANCER CELLS<br />
Mey V., Ricciardi S., Del Tacca M., Danesi R. (Pisa)<br />
SYNERGISTIC CYTOTOXICITY AND MOLECULAR<br />
INTERACTION ON DRUG TARGETS OF SORAFENIB AND<br />
GEMCITABINE IN HUMAN PANCREAS CANCER AND NSCLC<br />
CELL LINES<br />
Ricciardi S., Mey V., Pasqualetti G., Del Tacca M., Danesi<br />
R. (Pisa)<br />
ABCB1 POLYMORPHISMS ARE ASSOCIATED WITH<br />
CLOZAPINE PLASMA LEVELS IN PSYCHOTIC PATIENTS<br />
Lastella M., Consoli G., Polillo M., Ciapparelli A., Ciofi L.,<br />
Di Paolo A., Dell'Osso L., Del Tacca M., Danesi R. (Pisa)<br />
THIOPURINE S-METHYLTRANSFERASE<br />
PHARMACOGENETICS ON A LARGE-SCALE HEALTHY<br />
ITALIAN-CAUCASIAN POPULATION: DIFFERENCE IN<br />
ENZYME ACTIVITY<br />
Serpe L., Calvo P., Muntoni E., D'Antico S., Giaccone M.,<br />
Barbera C., Pera A., Ferretti C., Eandi M., Zara G.,<br />
Canaparo R. (Turin)<br />
ASSOCIATION BETWEEN SNPS IN CLOCK GENES AND<br />
ANTICANCER DRUG TOXICITY<br />
Caronno A., Pannacci M., Benfante R., Pirovano M.,<br />
Fornasari D., Scaglione F. (Milan)<br />
CYP3A5 POLYMORPHISMS AND CARBAMAZEPINE PLASMA<br />
LEVELS IN EPILEPTIC PATIENTS<br />
Magliulo L., Fallarini S., Viana M., Scordo M., Dahl M.,<br />
Monaco F., Lombardi G. (Novara, Uppsala)<br />
ROLE OF GENETIC POLYMORPHISMS IN THE CLINICAL<br />
RESPONSE TO GLUCOCORTICOIDS IN PEDIATRIC<br />
INFLAMMATORY BOWEL DISEASES<br />
De Iudicibus S., Londero M., Martelossi S., Stocco G.,<br />
Decorti G., Bartoli F., Ventura A. (Trieste)<br />
127<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
P-2/10/11<br />
P-2/10/12<br />
P-2/11/1<br />
P-2/11/2<br />
P-2/11/3<br />
GENETICS INTERACTIONS BETWEEN CITALOPRAM<br />
ANTIDEPRESSANT ACTIVITY AND MAO-A VNTR<br />
POLYMORPHISM IN PALLIATIVE CARE OF CANCER<br />
Era D., Schillani G., Capozzo M., Conte M., Giraldi T.<br />
(Trieste, San Vito al Tagliamento)<br />
A GENETIC PERSPECTIVE TO THE RESPONSE TO PT-<br />
BASED CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL<br />
LUNG CANCER (NSCLC) PATIENTS: TOWARD A<br />
CUSTOMIZED CHEMOTHERAPY<br />
Affatato A., Papi M., Valli M., Angelini S., Hrelia P.,<br />
Ravaioli A., Cantelli Forti G. (Bologna, Rimini)<br />
PHARMACOKINETIC AND PHARMACODINAMIC<br />
EVALUATIONS OF METRONOMIC CHEMOTHERAPY WITH<br />
ORAL URACIL/TEGAFUR (UFT), CYCLOPHOSPHAMIDE<br />
(CTX) AND CELECOXIB (CXB) IN PRETREATED PATIENTS<br />
WITH ADVANCED GASTROINTESTINAL CANCERS<br />
Di Desidero T., Allegrini G., Barletta M., Fioravanti A.,<br />
Orlandi P., Canu B., Di Paolo A., Danesi R., Falcone A.,<br />
Loupakis F., Masi G., Del Tacca M., Bocci G. (Pisa, Livorno,<br />
Pontedera)<br />
CLINICAL TRIALS ON “NON PHARMACEUTICAL<br />
PRODUCTS”, A NEW ASPECT OF EVIDENCE BASED<br />
MEDICINE<br />
Nunziata A., Bianco S. (Pomezia)<br />
RECURRENT URETHRAL STENOSIS: A PILOT CLINICAL<br />
STUDY OF LOCAL PACLITAXEL TREATMENT<br />
Robbiano L., Fucile C., Marini V., Gallo F., Giberti C.,<br />
Martelli A., Mattioli F. (Genoa, Savona)<br />
128<br />
4.00<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Arcobaleno – 4.00-4.30 pm<br />
PLENARY LECTURE<br />
Introduction: Drago F. (Catania)<br />
THE PHARMACOLOGICAL RESEARCH IN EUROPE: A BID FOR THE<br />
TWENTY-FIRST CENTURY<br />
Moilanen E. (Tampere)<br />
129<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Sala Arcobaleno – 4.45-6.45 pm<br />
Oral Communications<br />
PHARMACOLOGY OF NERVOUS SYSTEM (SESSION 4)<br />
Chairpersons: Pedata F. (Florence),<br />
Romualdi P. (Bologna)<br />
4.45 pm FUNCTIONAL CROSS-TALK BETWEEN INTERLEUKIN-1<br />
RECEPTOR AND NMDA RECEPTOR<br />
Gardoni F., Boraso M., Zianni E., Galli C., Cattabeni F.,<br />
Marinovich M., Di Luca M., Viviani B. (Milan)<br />
5.00 pm SELECTIVE ADENOSINE A2A RECEPTOR AGONISTS REDUCE<br />
THE APOPTOSIS IN AN EXPERIMENTAL MODEL OF SPINAL<br />
CORD TRAUMA<br />
Genovese T., Melani A., Esposito E., Mazzon E., Di Paola<br />
R., Bramanti P., Linden J., Pedata F., Cuzzocrea S.<br />
(Messina, Florence, Naples, Charlottesville)<br />
5.15 pm NOX2-DEFICIENCY PREVENTS KETAMINE-INDUCED<br />
BEHAVIOURAL AND BIOCHEMICAL ALTERATIONS IN MICE<br />
Sorce S., Schiavone S., Tucci P., Dubois-Dauphin M.,<br />
Trabace L., Krause K. (Geneva, Rome, Foggia)<br />
5.30 pm ADAM10/SAP97 ASSOCIATION IS DEFECTIVE IN<br />
ALZHEIMER DISEASE PATIENTS’ HIPPOCAMPUS<br />
Marcello E., Epis R., Gardoni F., Saraceno C., Cattabeni<br />
F., Borroni B., Padovani A., Di Luca M. (Milan, Brescia)<br />
5.45 pm ROLE OF PURINERGIC P2 RECEPTORS ON SYNAPTIC<br />
TRANSMISSION, NEURONAL SURVIVAL AND MAPK<br />
ACTIVATION DURING OXYGEN-GLUCOSE DEPRIVATION IN<br />
THE RAT CA1 HIPPOCAMPUS<br />
Traini C., Pugliese A., Cipriani S., Mello T., Andrea G.,<br />
Giovannini M., Pedata F. (Florence)<br />
6.00 pm NEW INSIGHT FOR A THERAPEUTICAL APPROACH TO<br />
ALCOHOLISM: STUDY OF TOXICITY, TOLERANCE AND<br />
ETHANOL DEPENDENCE MECHANISMS BY REGULATION OF<br />
TRANSCRIPTION, MOLECULAR IMAGING AND EPIGENETIC<br />
ANALYSIS<br />
D'Addario C., Caputi F., Candeletti S., Vukojevic V.,<br />
Ogren S., Terenius L., Romualdi P. (Bologna, Stockholm)<br />
6.15 pm CENTRAL INFUSION OF [NPHE 1 , ARG 14 , LYS 15 ] N/OFQ-NH2<br />
(UFP-101), A POTENT NOP RECEPTOR ANTAGONIST,<br />
130<br />
REVERSES BEHAVIOURAL EFFECTS IN A CHRONIC MODEL<br />
OF STRESS: CELLULAR AND MOLECULAR IMPLICATIONS<br />
Vitale G., Ruggieri V., Zucchini S., Frigeri C., Filaferro M.,<br />
Cifani C., Simonato M., Massi M. (Modena, Ferrara,<br />
Camerino)<br />
6.30 pm STRESS ENHANCES THE EXPRESSION OF THE WNT<br />
ANTAGONIST, DICKKOPF-1, IN THE MOUSE<br />
HIPPOCAMPUS: A KEY PROTEIN OF STRESS-INDUCED<br />
NEURODEGENERATION?<br />
Bucci D., Matrisciano F., Busceti C., Caruso A., Orlando<br />
R., Scaccianoce S., Biagioni F., Cappuccio I., Battaglia G.,<br />
Bruno V., Caraci F., Gradini R., Copani A., Melchiorri D.,<br />
Nicoletti F. (Pozzilli, Rome, Pavia, Catania)<br />
131<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.15<br />
pm<br />
6.45<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Azzurra – 4.45-7.00 pm<br />
Symposium<br />
FOCUS ON TARGETED ANTITUMOR DRUGS: ACTIVITY,<br />
RESISTANCE, CARDIOVASCULAR SAFETY<br />
Chairpersons: Menard S. (Milan), Minotti G. (Rome)<br />
TARGETED ANTI-TUMOR DRUGS: MOLECULAR MECHANISMS OF<br />
ACTIVITY AND RESISTANCE<br />
Menard S. (Milan)<br />
CLINICAL CORRELATES OF ACTIVITY AND RESISTANCE<br />
Di Maio M. (Naples)<br />
ANTINEOPLASTICS AND THE HEART: FROM ANTHRACYCLINES TO<br />
TARGETED DRUGS<br />
Minotti G. (Rome)<br />
CARDIOVASCULAR SAFETY OF TARGETED THERAPIES:<br />
TRASTUZUMAB AND OTHER CLINICAL PARADIGMS<br />
Gianni L., Bianchi G. (Milan)<br />
FINAL TEST<br />
132<br />
4.45<br />
pm<br />
5.05<br />
pm<br />
5.25<br />
pm<br />
5.45<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Blu – 4.45-6.00 pm<br />
Symposium<br />
ACTUAL AND FUTURE PERSPECTIVES IN PAIN THERAPY<br />
Chairperson: Canonico P. L. (Novara)<br />
THE USE OF THE OPIOIDS IN ITALY<br />
Navarra P. (Rome)<br />
RECENT ADVANCES IN THE MOLECULAR PHARMACOLOGY OF<br />
OPIOIDS ARE DRIVING TO A BETTER PAIN THERAPY<br />
Sacerdote P. (Milan)<br />
TAPENTADOL: A NOVEL µ OPIOID RECEPTOR AGONIST/<br />
NORADRENALINE REUPTAKE INHIBITOR WITH ANALGESIC<br />
PROPERTIES IN ACUTE NOCICEPTIVE AND CHRONIC<br />
NEUROPATHIC PAIN<br />
Jahnel U. (Aachen)<br />
(Educational support from Grünenthal-Italia)<br />
FINAL TEST<br />
133<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.05<br />
pm<br />
6.25<br />
pm<br />
6.45<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Giardino d’Inverno – 4.45-7.00 pm<br />
<strong>SIF</strong> Clinical Section Symposium<br />
PLACEBO AND CLINICAL TRIALS: UPDATE AND FUTURE ISSUES<br />
Chairpersons: Mugelli A. (Florence), Borea P. A. (Ferrara)<br />
THE PLACEBO EFFECTS<br />
Benedetti F. (Turin)<br />
PLACEBO AND CLINICAL TRIALS WITH CENTRAL NERVOUS<br />
SYSTEM DRUGS<br />
De Ponti F. (Bologna)<br />
PLACEBO AND CLINICAL TRIALS WITH CARDIOVASCULAR DRUGS<br />
Patrono C. (Rome)<br />
PLACEBO AND CLINICAL TRIALS IN ONCOLOGY<br />
Di Costanzo F. (Florence)<br />
DISCUSSION<br />
Geppetti P., Del Tacca M. (Florence, Pisa)<br />
FINAL TEST<br />
134<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.15<br />
pm<br />
6.45<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Viola – 4.45-7.00 pm<br />
Symposium<br />
CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY<br />
Chairpersons: Ceci A. (Bari), Conte Camerino D. (Bari)<br />
ANTITUMORAL CHEMOTHERAPIES WITH HIGH NEUROTOXIC<br />
POTENTIAL<br />
Mazzei T. (Florence)<br />
MOLECULAR MECHANISMS RESPONSIBLE FOR NEUROTOXICITY<br />
INDUCED BY CHEMOTHERAPEUTICS AND POSSIBLE<br />
THERAPEUTIC APPROACHES<br />
Desaphy J. F. (Bari)<br />
INDIVIDUATION OF RISK FACTORS AND DIAGNOSIS IN A<br />
MULTIDISCIPLINARY CONTEXT<br />
Cavaletti G. (Monza)<br />
THE CONTROL OF CHEMOTHERAPY-INDUCED NEUROPATHY IN<br />
CLINICAL PRACTICE<br />
Amadori D. (Forlì)<br />
(Educational support from “Gianni Benzi” Foundation)<br />
FINAL TEST<br />
135<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Sala Arancione – 4.45-6.45 pm<br />
Oral Communications<br />
CARDIOVASCULAR AND PULMONARY PHARMACOLOGY<br />
(SESSION 2)<br />
Chairpersons: Padrini R. (Padua), Sala A. (Milan)<br />
4.45 pm DETERMINANTS OF THE VARIABILITY OF THROMBOXANE<br />
INHIBITION BY ASPIRIN IN PATIENTS WITH<br />
CARDIOVASCULAR DISEASE<br />
Capone M., Grossi L, Anzellotti P, Evangelista V, Levantesi<br />
G., Porreca E., Di Febbo C., Moretta V., Meneguzzi A.,<br />
Ferraro R., Tontodonati P., Manarini S., Fava C., Minuz P.,<br />
Patrignani P. (Chieti, Verona, Santa Maria Imbaro)<br />
5.00 pm TIMING OF PHARMACOLOGICAL INTERVENTION AFTER<br />
OVARIECTOMY DICTATES THE VASOPROTECTIVE ACTIONS<br />
OF ESTROGEN RECEPTOR-α SELECTIVE AGONISTS<br />
Cignarella A., Pinna C., Sanvito P., Pelosi V., Gaion R.,<br />
Bolego C. (Padua, Milan)<br />
5.15 pm ROSUVASTATIN PREVENTS ENDOTHELIAL DYSFUNCTION<br />
IN MESENTERIC RESISTANCE ARTERIES FROM RATS WITH<br />
ANGIOTENSIN II-INDUCED HYPERTENSION<br />
Colucci R., Virdis A., Ghisu N., Antonioli L., Fornai M.,<br />
Duranti E., Blandizzi C., Taddei S., Del Tacca M. (Pisa)<br />
5.30 pm ELECTROPHYSIOLOGICAL EVALUATION OF NOVEL<br />
BLOCKERS OF IF CURRENT<br />
Del Lungo M., Melchiorre M., Sartiani L., Biel M., Varro A.,<br />
Mugelli A., Romenelli M., Cerbai E. (Florence, Munchen,<br />
Szeged)<br />
5.45 pm APOLIPOPROTEIN A-I DEGRADATION AFTER TREATMENT<br />
WITH ALTEPLASE AND TENECTEPLASE: IN VITRO AND IN<br />
VIVO STUDIES<br />
Gomaraschi M., Pozzi S., Sinagra G., Franceschini G.,<br />
Calabresi L. (Milan, Trieste)<br />
6.00 pm PPARS EXPRESSION IN MONOCYTE/MACROPHAGES: A<br />
POSSIBLE GENDER DIFFERENCE IN PATIENTS WITH<br />
CORONARY HEART DISEASE (CHD)<br />
Amoruso A., Bardelli C., Fresu L., Palma A., Brunelleschi<br />
S. (Novara)<br />
136<br />
6.15 pm BENEFICIAL EFFECTS OF A HEPARIN-LIKE SEMI-<br />
SYNTHETIC DERIVATIVE IN A RAT MODEL OF CEREBRAL<br />
ISCHEMIA/REPERFUSION INJURY<br />
Collino M., Castiglia S., Manoni M., Salsini L., Chini J.,<br />
Masini E., Fantozzi R. (Turin, Montale, Florence)<br />
6.30 pm A SELECTIVE H4R ANTAGONIST PREVENTS ANTIGEN-<br />
INDUCED AIRWAY INFLAMMATION IN GUINEA PIG: A<br />
PIVOTAL ROLE OF ANNEXIN-A1<br />
Vinci M., Lanzi C., Mastroianni R., Uliva C., Cinci L., Bani<br />
D., Thurmond R., Masini E. (Florence, San Diego)<br />
137<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
4.45<br />
pm<br />
5.15<br />
pm<br />
5.45<br />
pm<br />
6.15<br />
pm<br />
6.45<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Bianca – 4.45-7.00 pm<br />
SITOX-<strong>SIF</strong> Symposium<br />
NEW APPROACHES FOR ASSESSING SAFETY OF DRUG<br />
IMPURITIES<br />
Chairpersons: Galli C. L. (Milan), Hrelia P. (Bologna)<br />
DEFINITION OF THE SAFETY DOSE IN RISK CHARACTERIZATION<br />
Galli C. L. (Milan)<br />
APPLICATION OF THE TTC (THRESHOLD OF TOXICOLOGICAL<br />
CONCERN) TO DRUG IMPURITIES EVALUATION<br />
Marinovich M. (Milan)<br />
IN SILICO MODELS FOR GENOTOXICITY: THE APPROACH OF<br />
CAESAR AND OTHER INITIATIVES<br />
Benfenati E. (Milan)<br />
EMEA APPROACH IN THE NON CLINICAL EVALUATION OF<br />
POTENTIALLY GENOTOXIC IMPURITIES IN PHARMACEUTICAL<br />
DRUG SUBSTANCES<br />
Meneguz A. (Rome)<br />
FINAL TEST<br />
138<br />
4.45<br />
pm<br />
5.05<br />
pm<br />
5.25<br />
pm<br />
5.45<br />
pm<br />
6.05<br />
pm<br />
6.25<br />
pm<br />
6.45<br />
pm<br />
FRIDAY, October 16, 2009<br />
Sala Verde – 4.45-7.00 pm<br />
Symposium<br />
HDAC INHIBITORS: EMERGING DRUGS WITH PLEIOTYPIC<br />
THERAPEUTIC POTENTIAL<br />
Chairpersons: Chiarugi A. (Florence), Mascagni P. (Milan)<br />
TARGETING HISTONE DEACETYLASES: VORINOSTAT AND NOVEL<br />
CLASSES OF HDACI<br />
Steinkühler C. (Rome)<br />
HDACS AND APOPTOSIS: IS HDAC4 A GOOD TARGET?<br />
Brancolini C. (Udine)<br />
HDAC INHIBITORS AS NOVEL ANTI-INFLAMMATORY AGENTS<br />
Dinarello C. A. (Denver)<br />
EPIGENETIC BASIS OF MUSCLE REGENERATION IN MUSCULAR<br />
DYSTROPHY<br />
Puri P. L. (Rome)<br />
HISTONE DEACETYLASE INHIBITORS IN CANCER: GIVINOSTAT, A<br />
CASE STUDY<br />
Fossati G. (Milan)<br />
REGULATION OF SELF-RENEWAL IN CANCER STEM CELLS<br />
Pelicci P. G. (Milan)<br />
FINAL TEST<br />
139<br />
FRIDAY, October 16, 2009
FRIDAY, October 16, 2009<br />
FRIDAY, October 16, 2009<br />
Sala Rossa – 4.45-6.45 pm<br />
Oral Communications<br />
PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY<br />
(SESSION 2)<br />
Chairpersons: Sautebin L. (Naples), Velo G. P. (Verona)<br />
4.45 pm THE RISK OF CARDIAC VALVE REGURGITATION WITH<br />
ERGOT AND NON-ERGOT DERIVED DOPAMINE AGONIST<br />
USE IN PARKINSON’S DISEASE<br />
Trifirò G., Mokhles M., Dieleman J., van Soest E.,<br />
Mazzaglia G., Vehramme K., Lesaffre E., Colao A.,<br />
Haverkamp H., van Camp G., Schade R., Brusselle G.,<br />
Zanettini R., de Luise C., Sturkenboom M. (Messina,<br />
Rotterdam, Florence, Naples, Berlin, Brussels, Gent, Milan,<br />
New York)<br />
5.00 pm DRUG-INDUCED HEPATIC INJURY IN CHILDREN: ANALYSIS<br />
OF SPONTANEOUS REPORTS OF SUSPECTED ADVERSE<br />
DRUG REACTIONS IN THE WHO DATABASE<br />
Ferrajolo C., Capuano A., Verhamme K., Schuemie M.,<br />
Rossi F., Stricker B., Sturkenboom M. (Naples, Rotterdam)<br />
5.15 pm INDEPENDENT DRUG INFORMATION: THE <strong>SIF</strong> “FARMACI<br />
IN EVIDENZA” INPUT<br />
Luppino M. R., Rosa A. C., Casale F., Cerbai E., Fantozzi<br />
R. (Messina, Turin, Florence)<br />
5.30 pm SAFETY AND TOLERABILITY OF ADHD MEDICATIONS: AN<br />
INTENSIVE MONITORING PROGRAMME IN THE CAMPANIA<br />
REGION<br />
Basilicata G., Pascotto A., Bravaccio C., Grimaldi G.,<br />
Granato R., Gallo M., Rafaniello C., Ianniello B., Potenza<br />
S., Ruggiero S., Formica R., Rossi F., Capuano A. (Naples,<br />
Aversa)<br />
5.45 pm NOTIFICATION OF UNDESIRABLE EFFECTS OF COSMETICS<br />
AND TOILETRIES<br />
Sportiello L., Cammarota S., de Portu S., Sautebin L.<br />
(Naples)<br />
6.00 pm THE SOS PROJECT (SAFETY OF NSAIDS): PRELIMINARY<br />
RESULTS OF PUBLISHED META-ANALYSES REVIEW<br />
Salvo F., Pariente A., Gulmez S., Guillaume Y.,<br />
Castellsague J., Haag M., Sturkenboom M., Moore N.,<br />
Fourrier-Réglat A. (Messina, Bordeaux, Barcelona,<br />
140<br />
Rotterdam)<br />
6.15 pm HOSPITAL-BASED CASE-CONTROL NETWORKS FOR<br />
SURVEILLANCE OF ADVERSE DRUG REACTIONS: A CASE-<br />
CONTROL STUDY IN ITALY<br />
Loraschi A., Volontè A., Catherine K., Castelletti C., Tosi<br />
L., Malesci A., Monina G., Cosentino M. (Varese, Busto<br />
Arsizio, Pavia, Gallarate)<br />
6.30 pm ASSESSING THE RISK OF OSTEONECROSIS OF THE JAWS<br />
(ONJ) DUE TO BISPHOSPHONATES THERAPY IN THE<br />
SECONDARY PREVENTION OF OSTEOPOROTIC<br />
FRACTURES: A NESTED CASE-CONTROL STUDY USING<br />
REGIONAL CLAIMS DATABASES<br />
Lapi F., Corrao G., Montanaro N., Sturkenboom M.,<br />
Geppetti P., Gregori D., Carle F., Menna A., Vestri A.,<br />
Valenti M., Caputi A. P., Mazzaglia G. (Florence, Milan,<br />
Bologna, Rotterdam, Turin, Pescara, Rome, L'Aquila,<br />
Messina)<br />
141<br />
FRIDAY, October 16, 2009
SATURDAY, October 17, 2009<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Azzurra – 8.30-10.30 am<br />
Symposium<br />
PHARMACOEPIDEMIOLOGY FOR MONITORING OF DRUG SAFETY<br />
AND RATIONAL DRUG USE: A GOOD CASE FOR TRANSLATION<br />
MEDICINE<br />
Chairperson: Patrignani P. (Chieti)<br />
SELECTED EXAMPLES OF PHARMACOEPIDEMIOLOGIC STUDIES<br />
USING PRIMARY CARE DATABASES<br />
Garcia Rodriguez L. (Madrid)<br />
HOW TO DESIGN A PHARMACOEPIDEMIOLOGY STUDY<br />
ASSOCIATED WITH ANALYSIS OF GENETICS FOR ASSESSMENT<br />
OF GASTROINTESTINAL RISK AMONG USERS OF INDIVIDUAL<br />
TRADITIONAL NSAIDS AND SELECTIVE COX-2 INHIBITORS<br />
Lanas A. (Zaragoza)<br />
THE PROACTIVE MODEL IN PHARMACOVIGILANCE AND THE ROLE<br />
OF PRIMARY CARE DATABASES: THE CASE OF BIFAP IN SPAIN<br />
de Abajo F. (Madrid)<br />
THE PROACTIVE MODEL IN PHARMACOVIGILANCE AND THE ROLE<br />
OF INDEPENDENT RESEARCH FUNDING IN ITALY<br />
Traversa G. (Oleggio)<br />
(Sponsored by EPHAR with support from the British Pharmacological Society,<br />
educational support from Pfizer Italia)<br />
142<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Blu – 8.30-10.30 am<br />
Symposium<br />
INDIVIDUALIZATION OF DRUG THERAPY IN THE TREATMENT OF<br />
PSYCHIATRIC DISORDERS<br />
Chairpersons: Gennarelli M. (Brescia), Spina E. (Messina),<br />
FACTORS OF VARIABILITY IN THE RESPONSE TO PSYCHOTROPIC<br />
DRUGS<br />
Torta R. (Turin)<br />
USEFULNESS AND LIMITATIONS OF THERAPEUTIC DRUG<br />
MONITORING OF PSYCHOTROPIC DRUGS<br />
Spina E. (Messina)<br />
PHARMACOGENETICS OF PSYCHOTROPIC DRUGS: PHARMACO-<br />
KINETICS ASPECTS<br />
Fornasari D. (Milan)<br />
PHARMACOGENETICS OF PSYCHOTROPIC DRUGS: PHARMACO-<br />
DYNAMICS ASPECTS<br />
Gennarelli M. (Brescia)<br />
143<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Giardino d’Inverno – 8.30-10.30 am<br />
Symposium<br />
THE GLUTAMATERGIC SYNAPSE - A MAJOR SITE FOR DISEASE<br />
AND DRUG ACTION<br />
Chairpersons: Nicoletti F. (Rome), Nisticò R. (Rende)<br />
INTERACTION BETWEEN EPHRINS AND mGLU5 METABOTROPIC<br />
GLUTAMATE RECEPTORS IN THE INDUCTION OF LONG-TERM<br />
SYNAPTIC DEPRESSION IN THE HIPPOCAMPUS<br />
Piccinin S. (Rome)<br />
ROLES FOR KAINATE RECEPTORS IN SYNAPTIC TRANSMISSION<br />
AND PLASTICITY IN THE HIPPOCAMPUS<br />
Bortolotto Z. A., Collingridge G. L. (Bristol)<br />
PRESYNAPTIC MECHANISMS OF AUTO-REGULATION OF<br />
GLUTAMATE RELEASE IN MAMMALIAN BRAIN<br />
Pittaluga A. (Genoa)<br />
D-ASPARTATE, A NOVEL MODULATOR OF HIPPOCAMPAL<br />
SYNAPTIC PLASTICITY AND SPATIAL MEMORY<br />
Nisticò R. (Rende)<br />
144<br />
8.30<br />
am<br />
8.50<br />
am<br />
9.10<br />
am<br />
9.30<br />
am<br />
9.50<br />
am<br />
10.10<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Viola – 8.30-10.30 am<br />
Symposium<br />
WOMEN AGING: FROM BASIC RESEARCH NOVEL THERAPEUTIC<br />
OPPORTUNITIES<br />
Chairperson: Franconi F. (Sassari)<br />
ESTROGEN RECEPTOR FUNCTION AND CARDIOMETABOLIC RISK<br />
IN POST-MENOPAUSAL WOMEN<br />
Cignarella A. (Padua)<br />
TO FISH OUT PERIPHERAL BLOOD BIOMARKERS OF METABOLIC<br />
SYNDROME IN A GENDER PERSPECTIVE: A PILOT STUDY<br />
Straface E. (Rome)<br />
BIOTECHNOLOGICAL ANIMAL MODELS FOR THE STUDY OF NOVEL<br />
DRUGS<br />
Ciana P. (Milan)<br />
ROLE OF ESTROGEN IN THE REGULATION OF LUNG<br />
INFLAMMATION<br />
Cuzzocrea S. (Messina)<br />
A NOVEL, HIGHLY RELIABLE REPORTER MOUSE TO STUDY NF-KB<br />
ACTIVITY IN LIVING ANIMALS<br />
Rizzi N. (Sant'Angelo Lodigiano)<br />
ESTROGEN AND BRAIN INFLAMMATION: RESULTS FROM THE<br />
"EWA" EUROPEAN PROJECT ON ESTROGEN AND WOMEN AGING<br />
Vegeto E. (Milan)<br />
145<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
SATURDAY, October 17, 2009<br />
Sala Arancione – 8.30-10.30 am<br />
Oral Communications<br />
ANTIBACTERIAL, ANTIVIRAL AND ANTICANCER<br />
CHEMOTHERAPY<br />
Chairpersons: Giraldi T. (Trieste), Hrelia P. (Bologna)<br />
8.30 am CYTOTOXIC DRUGS REGULATE VEGF AND IL-8<br />
EXPRESSION IN HUMAN MELANOMA CELLS BY A2A AND<br />
A3 ADENOSINE RECEPTORS<br />
Merighi S., Simioni C., Mirandola P., Gessi S., Varani K.,<br />
Tabrizi M., Baraldi P., Borea P. A. A. (Ferrara, Parma)<br />
8.45 am CLINICAL AND PHARMACODYNAMIC EVALUATION OF<br />
METRONOMIC CYCLOPHOSPHAMIDE, CELECOXIB AND<br />
DEXAMETHASONE IN ADVANCED HORMONE-REFRACTORY<br />
PROSTATE CANCER<br />
Bocci G., Fontana A., Orlandi P., Fioravanti A., Galli L.,<br />
Galli C., Allegrini G., Fontana E., Antonuzzo A.,<br />
D'Arcangelo M., Danesi R., Falcone A., Del Tacca M. (Pisa,<br />
Livorno, Lucca)<br />
9.00 am IDENTIFICATION OF PHARMACOGENOMIC MARKERS OF 5-<br />
FLUOROURACIL-BASED CHEMOTHERAPY IN COLORECTAL<br />
CANCER<br />
Nobili S., Naples C., Landini I., Morganti M., Cianchi F.,<br />
Valanzano R., Tonelli F., Mazzei T., Mini E. (Florence)<br />
9.15 am 5-FLUOROURACIL INFLUENCES ITS OWN<br />
PHARMACOKINETICS: ASSOCIATION WITH TREATMENT<br />
TOLERABILITY<br />
Di Paolo A., Ibrahim T., Amatori F., Ravaioli E., Mercatali<br />
L., Lastella M., Del Tacca M., Danesi R., Amadori D. (Pisa,<br />
Meldola)<br />
9.30 am EFFECT OF HIF-1 MODULATION ON THE RESPONSE OF<br />
TWO- AND THREE-DIMENSIONAL CULTURES OF HUMAN<br />
COLON CANCER CELLS TO 5-FLUOROURACIL,<br />
OXALIPLATIN AND DOXORUBICIN<br />
Molteni R., Ravizza R., Gariboldi M., Monti E. (Busto<br />
Arsizio)<br />
9.45 am INFLUENCE OF TYMS GENE EXPRESSION AND GENOTYPE<br />
ON THE CLINICAL OUTCOME OF COLORECTAL CANCER<br />
PATIENTS TREATED WITH 5-FLUOROURACIL<br />
Vignoli M., Nobili S., Naples C., Putignano A., Morganti<br />
146<br />
M., Papi L., Valanzano R., Cianchi F., Tonelli F., Mazzei T.,<br />
Genuardi M., Mini E. (Florence, Sesto Fiorentino)<br />
10.00 am ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED<br />
ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION<br />
CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND<br />
CHEMOSENSITIZING ACTIVITIES<br />
Labbozzetta M., Baruchello R., Marchetti P., Gueli M.,<br />
Poma P., Notarbartolo M., Simoni D., D'Alessandro N.<br />
(Palermo, Ferrara)<br />
10.15 am CYTOTOXICITY OF HEMIDESMUS INDICUS EXTRACT IS<br />
ASSOCIATED WITH APOPTOSIS BY ACTIVATION OF<br />
MITOCHONDRIAL PATHWAY AND INTERRUPTION OF CELL-<br />
CYCLE PROGRESSION BY MODULATION OF CYCLIN A2<br />
AND P21 IN HUMAN JURKAT T CELLS<br />
Fimognari C., Lenzi M., Cantelli Forti G., Hrelia P.<br />
(Bologna)<br />
147<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
8.30<br />
am<br />
9.00<br />
am<br />
9.30<br />
am<br />
10.00<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Bianca – 8.30-10.30 am<br />
SITOX-<strong>SIF</strong> Symposium<br />
FOOD SUPPLEMENTS<br />
Chairpersons: Calapai G. (Messina), Galli C. L. (Milan)<br />
SAFETY ASSESSMENT OF BOTANICALS AND BOTANICAL<br />
PREPARATIONS USED AS FOOD SUPPLEMENTS<br />
Galli C. L. (Milan)<br />
PHARMACOLOGY OF NATURAL PRODUCTS<br />
Mazzanti G. (Rome)<br />
PHYTOTHERAPY: FROM TRADITIONAL MEDICINE TO CLINICAL<br />
EVIDENCE<br />
Firenzuoli F. (Florence)<br />
HERBAL MEDICINES: FOOD OR DRUGS?<br />
Calapai G. (Messina)<br />
148<br />
SATURDAY, October 17, 2009<br />
Sala Verde – 8.30 -10.30 am<br />
Oral Communications<br />
PAIN PHARMACOLOGY<br />
Chairpersons: Bartolini A. (Florence), Negri L. (Rome)<br />
8.30 am PPAR-ALPHA AND NF-KB ACTIVATION. IMPLICATION IN<br />
PAIN PRINCIPIATION AND CHRONIC PAIN<br />
ESTABLISHMENT<br />
D'Agostino G., La Rana G., Russo R., Sasso O., Iacono<br />
A., Esposito E., Meli R., Calignano A. (Naples)<br />
8.45 am INTRA-PERIAQUEDUCTAL GRAY GLYCINE AND D-SERINE<br />
EXERT DUAL EFFECTS ON ROSTRAL VENTROMEDIAL<br />
MEDULLA ON AND OFF CELL ACTIVITY AND<br />
THERMOCEPTIVE THRESHOLD IN THE RAT<br />
de Novellis V., Marabese I., Siniscalco D., Migliozzi A.,<br />
Guida F., Rossi F., Maione S. (Naples)<br />
9.00 am ANTI-HYPERALGESIC PROFILE OF PRAMIRACETAM IN<br />
MODELS OF NEUROPATHIC PAIN<br />
Ghelardini C., Galeotti N., Salvicchi A., Vivoli E., Bennett<br />
G., Bartolini A. (Florence, Montreal)<br />
9.15 am TARGETING BV8/PROKINETICIN RECEPTORS IN<br />
INFLAMMATORY PAIN<br />
Giannini E., Lattanzi R., Nicotra A., Balboni G., Salvadori<br />
S., Franchi S., Sacerdote P., Negri L. (Rome, Ferrara,<br />
Milan)<br />
9.30 am PERIPHERAL ANTINOCICEPTIVE ACTIVITY OF LOW DOSES<br />
OF NALOXONE: RESULTS FROM AN IN VIVO AND AN IN<br />
VITRO MODEL OF TRIGEMINAL NOCICEPTION<br />
Capuano A., De Corato A., Tringali G., Treglia M., Dello<br />
Russo C., Navarra P. (Rome)<br />
9.45 am MICROGLIA ACTIVATION IN NEUROPATHIC PAIN IS<br />
REGULATED BY CANNABINOID SYSTEM<br />
Luongo L., Giordano C., Gatta L., Marabese I., Palazzo E.,<br />
de Novellis V., Malcangio M., Rossi F., Maione S. (Naples,<br />
London)<br />
10.00 am THE PROTECTIVE EFFECT OF BERGAMOT DERIVED<br />
FLAVONOID ON THE POST-TRANSLATIONAL MODULATION<br />
OF GLUTAMATE TRANSMISSION: A NEW THERAPEUTIC<br />
APPROACH FOR OPIOID TOLERANCE<br />
149<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
Muscoli C., Dagostino C., Ventrice D., Goffredo B., Rizzo<br />
M., Casale F., Strongoli M., Vecchio I., Rotiroti D., Muraca<br />
M., Nisticò G., Mollace V. (Catanzaro, Rome, Catania)<br />
10.15 am HUMAN MESENCHYMAL STEM CELLS TRANSPLANTED IN<br />
THE CEREBRAL VENTRICLE ARE ABLE TO DECREASE<br />
NOCICEPTIVE BEHAVIOURS AND PAIN-ASSOCIATED<br />
CELLULAR AND MOLECULAR CHANGES IN NEUROPATHIC<br />
MICE<br />
Siniscalco D., Giordano C., Luongo L., de Novellis V.,<br />
Rossi F., Maione S. (Naples)<br />
150<br />
10.45<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Azzurra – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Drago F. (Catania)<br />
OLD AND NEW TARGETS FOR THE TREATMENT OF<br />
OSTEOARTHRITIS: PHARMACOLOGY AND CLINICAL<br />
PHARMACOLOGY<br />
Rovati L. (Monza)<br />
(Educational support from ROTTAPHARM MADAUS)<br />
151<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
10.45<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Blu – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Bertazzoni Minelli E. (Verona)<br />
ROLE OF M-TOR INHIBITION ON ANTITUMOUR THERAPY<br />
Danesi R. (Pisa)<br />
(Educational support from Novartis Farma)<br />
152<br />
10.45<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Giardino d’Inverno – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Patrono C. (Rome)<br />
HEMOPHILIA: PAST, PRESENT AND FUTURE<br />
Mannucci P. M. (Milan)<br />
(Educational support from Wyeth Lederle)<br />
153<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
10.45<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Viola – 10.45-11.15 am<br />
LECTURE<br />
Introduction: Rossi F. (Naples)<br />
THE RECURRENT IDIOPATHIC PERICARDITIS: A NEW TREATMENT<br />
FOR AN OLD DISEASE<br />
Palmieri G. (Milan)<br />
154<br />
11.15<br />
am<br />
SATURDAY, October 17, 2009<br />
Sala Arcobaleno – 11.15-11.45 am<br />
LECTURE<br />
Introduction: Scaglione F. (Milan)<br />
PANDEMIC INFLUENZA H1N1: GUIDANCE FOR PREVENTION AND<br />
TREATMENT<br />
Rizzardini G. (Milan)<br />
155<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
11.15<br />
am<br />
12.00<br />
pm<br />
12.45<br />
pm<br />
1.15<br />
pm<br />
1.45<br />
pm<br />
2.15<br />
pm<br />
2.30<br />
pm<br />
SATURDAY, October 17, 2009<br />
Sala Azzurra – 11.15 am-2.30 pm<br />
Gender Pharmacology <strong>SIF</strong> Group Symposium<br />
GENDER AND EQUITY IN HEALTHCARE<br />
Chairpersons: Brunelleschi S. (Novara), Franconi F. (Sassari),<br />
Vella S. (Rome)<br />
THE DETERMINING GENDER: ITALIAN EXPERIENCES<br />
Franconi F. (Sassari)<br />
PRIMARY PREVENTION AND EQUITY<br />
Rosano G. (Milan)<br />
EQUITY IN DAILY HEALTH-CARE<br />
Michieli R. (Florence)<br />
EQUITY IN HOSPITAL HEALTH-CARE<br />
Moretti A. M. (Bari)<br />
REGIONS AND GENDER EQUITY<br />
Giorni L. (Florence)<br />
ROTTAPHARM-MADAUS-<strong>SIF</strong> AWARDS<br />
FINAL TEST<br />
156<br />
SATURDAY, October 17, 2009<br />
Sala Blu – 11.15 am-1.15 pm<br />
Oral Communications<br />
PHARMACOVIGILANCE AND PHARMACOEPIDEMIOLOGY<br />
(SESSION 3)<br />
Chairpersons: Garcia Rodriguez L. (Madrid),<br />
Leone R. (Verona)<br />
11.15 am CARDIOVASCULAR OUTCOMES OF STATIN TREATMENTS<br />
IN GENERAL POPULATION: A 3 YEAR RECORD-LINKAGE<br />
STUDY ON PRESCRIPTION AND HOSPITAL DISCHARGE<br />
DATABASES<br />
Carta P., Poluzzi E., Puccini A., Silvani M., Vaccheri A.,<br />
Montanaro N. (Bologna)<br />
11.30 am ADHERENCE TO EVIDENCE-BASED DRUG THERAPY AFTER<br />
ACUTE MYOCARDIAL INFARCTION: DIFFERENCES IN<br />
PATIENT AND HEALTH CARE CHARACTERISTICS IN A<br />
POPULATION-BASED COHORT IN ROME, ITALY<br />
Kirchmayer U., Belleudi V., Agabiti N., Davoli M., Fusco<br />
D., Stafoggia M., Arcà M., Barone A., Perucci C. (Rome)<br />
11.45 am RISK OF ISCHEMIC STROKE ASSOCIATED WITH<br />
ANTIDEPRESSANT DRUG USE IN ELDERLY PERSONS<br />
Trifirò G., Dieleman J., Sen E., Gambassi G., Caputi A. P.,<br />
Sturkenboom M. (Messina, Rotterdam, Rome)<br />
12.00 pm PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN<br />
PATIENTS RECEIVING RITUXIMAB: A SURVEY ON HIV-<br />
NEGATIVE PATIENTS<br />
Tuccori M., Focosi D., Montagnani S., Blandizzi C., Petrini<br />
M., Del Tacca M. (Pisa)<br />
0.15 pm PERSISTENCE AND ADHERENCE TO ORAL ANTIDIABETIC<br />
THERAPY AMONG ‘NAÏVE’ PATIENTS: A COMPARISON OF<br />
MONOTHERAPY, COMBINATION THERAPY AND FIXED-<br />
DOSE COMBINATION THERAPY<br />
Leoni O., Papagni M., Roi C., Conti V., Pisani S., Oria C.,<br />
Soma R. (Varese)<br />
12.30 pm INCIDENCE OF ADVERSE DRUG REACTIONS (ADRS) IN<br />
HOSPITALIZED CHILDREN IN THE CAMPANIA REGION<br />
Gallo M., Siani P., De Seta L., Maglione U., Saitta F.,<br />
Tarallo L., Vetrano G., Rafaniello C., Ianniello B., Ruggiero<br />
S., Illiano M., Basilicata G., Potenza S., Formica R., Irpino<br />
A., Bonati M., Rossi F., Capuano A. (Naples, Pozzuoli,<br />
157<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
Castellammare di Stabia, Benevento, Milan)<br />
12.45 pm USE OF MEDICINAL PRODUCTS AND DIETARY<br />
SUPPLEMENTS IN A POPULATION OF AMATEUR SWIMMERS<br />
Brossa A., Monico E., Giron M. (Venezia, Padua)<br />
1.00 pm OPIOID CONSUMPTION: INFLUENCE OF LAW CHANGES<br />
AND NEW DRUGS<br />
Bortolami A., Chinellato A., Terrazzani G., Roggeri D.,<br />
Skaper S., Giusti P. (Treviso, Padua)<br />
158<br />
SATURDAY, October 17, 2009<br />
Sala Giardino d’Inverno – 11.15 am-1.15 pm<br />
Oral Communications<br />
RECEPTORS AND SIGNAL TRANSDUCTION MECHANISMS<br />
(SESSION 2)<br />
Chairpersons: Balduini W. (Urbino),<br />
Spampinato S. (Bologna)<br />
11.15 am PPAR- CONTRIBUTES TO THE ANTI-INFLAMMATORY<br />
ACTIVITY OF 17-β-ESTRADIOL<br />
Crisafulli C., Bruscoli S., Mazzon E., Di Paola R.,<br />
Genovese T., Bramanti P., Migliorati G., Cuzzocrea S.<br />
(Messina, Perugia)<br />
11.30 am EXPRESSION OF THE TRANSCRIPTION FACTOR REST AT<br />
DIFFERENT STAGES OF NEURONAL DIFFERENTIATION:<br />
CONTRIBUTION OF PKC AND WNT/β-CATENIN SIGNALING<br />
Baiula M., Bedini A., Carbonari G., Spampinato S.<br />
(Bologna)<br />
11.45 am ROLE OF mGLU2 AND mGLU3 METABOTROPIC GLUTAMATE<br />
RECEPTORS IN MECHANISMS OF NEURODEGENERATION/<br />
NEUROPROTECTION<br />
Di Menna L., Battaglia G., Molinaro G., Caraci F., Copani<br />
A., Bruno V., Nicoletti F. (Pozzilli, Catania, Rome)<br />
12.00 pm CYCLOOXYGENASE-2 MEDIATES HYDROGEN PEROXIDE-<br />
INDUCED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS<br />
Eligini S., Arenaz I., Barbieri S., Faleri M., Crisci M.,<br />
Tremoli E., Colli S. (Milan, Zaragoza)<br />
12.15 pm INVESTIGATION OF HOMOLOGOUS AND HETEROLOGOUS<br />
DESENSITIZATION PROCESSES ACTIVATED BY A<br />
PROLONGED EXPOSURE OF NEURONAL CELLS TO A -<br />
OPIOID AGONIST<br />
Spartà A., Campbell G., Spampinato S. (Bologna)<br />
12.30 pm ACTIVATION OF µ OPIOID RECEPTORS AMELIORATES<br />
MUCOSAL INJURY INDUCED BY INTESTINAL ISCHEMIA<br />
AND REPERFUSION IN MICE<br />
Saccani F., Anselmi L., Jaramillo I., Bertoni S., Barocelli<br />
E., Sternini C. (Los Angeles, Parma)<br />
159<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
SATURDAY, October 17, 2009<br />
Sala Viola – 11.15 am-1.15 pm<br />
Oral Communications<br />
CARDIOVASCULAR AND PULMONARY PHARMACOLOGY<br />
(SESSION 3)<br />
Chairpersons: Cerbai E. (Florence), Squadrito F.<br />
(Messina)<br />
11.15 am BINDARIT, AN INHIBITOR OF MONOCYTE<br />
CHEMOATTRACTANT PROTEIN-1 SYNTHESIS, REDUCES<br />
NEOINTIMA HYPERPLASIA BOTH IN RATS AND IN<br />
HYPERCOLESTEROLEMIC MICE<br />
Ialenti A., Maddaluno M., Grassia G., Mangano G.,<br />
Bartella C., Neri E., De Simone L., Maffia P., Guglielmotti<br />
A. (Naples, Pomezia, Glasgow)<br />
11.30 am POSITIVE MODULATION OF PROSTAGLANDIN E2 AND EP3<br />
ACTIVATION ON PLATELET AGGREGATION<br />
Petrucci G., Rocca B., Patrono C. (Rome)<br />
11.45 am DOXORUBICIN TRIGGERS REPLICATIVE SENESCENCE AND<br />
DEATH OF CARDIAC PROGENITOR CELLS<br />
Piegari E., De Angelis A., Cappetta D., Marino L., Filippelli<br />
A., Berrino L., Martins-Ferreira J., Zheng H., Hosoda T.,<br />
Rota M., Urbanek K., Kajstura J., Leri A., Anversa P., Rossi<br />
F. (Naples, Boston)<br />
12.00 pm KININERGIC RECEPTORS: A NEW PHARMACOLOGICAL<br />
TARGET IN THE CEREBRAL ISCHEMIA- REPERFUSION<br />
PROCESS<br />
Volpe A., Cesare P., Orsini F., Carmignani M. (L'Aquila)<br />
12.15 pm PHYSICAL ACTIVITY AFFECT THE RISK OF RESPIRATORY<br />
TRACT INFECTION<br />
Pannacci M., Lucini V., Caronno A., Scaglione F. (Milan)<br />
12.30 pm SYSTEMIC ADMINISTRATION OF SPHINGOSINE-1-<br />
PHOSPHATE POSITIVELY MODULATES AIRWAYS<br />
REACTIVITY<br />
Roviezzo F., De Gruttola L., Brancaleone V., Bucci M., De<br />
Palma R., D’Agostino B., Cirino G. (Naples)<br />
12.45 pm STUDY OF THE EFFECT OF PPAR LIGANDS ON AN IN VITRO<br />
MODEL OF HOMOLOGOUS DESENSITIZATION OF β2-<br />
ADRENOCEPTORS<br />
Fogli S., Stefanelli F., Breschi M. (Pisa)<br />
160<br />
1.00 pm EFFICACY OF GENISTEIN AGLYCONE ON SOME<br />
CARDIOVASCULAR RISK FACTORS: A FOLLOW-UP STUDY<br />
Marini H., Bitto A., Altavilla D., Polito F., Di Stefano V.,<br />
Minutoli L., Arcoraci V., Adamo E., Caputi A. P., Squadrito<br />
F. (Messina)<br />
161<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
SATURDAY, October 17, 2009<br />
Sala Arancione – 11.15 am-1.15 pm<br />
Oral Communications<br />
PHARMACOLOGY OF CELL DEATH AND PROLIFERATION<br />
(SESSION 2)<br />
Chairpersons: Simonato L. (Ferrara), Vicentini L. (Milan)<br />
11.15 am UP-REGULATION OF DICKKOPF-3 IN ISCHEMIC BRAIN<br />
TISSUES IN EXPERIMENTAL ANIMAL MODELS OF<br />
CEREBRAL ISCHEMIA<br />
Busceti C., Rubattu S., Scarpino S., Biagioni F.,<br />
Mastroiacovo F., Bucci D., Battaglia G., Bruno V., Fornai F.,<br />
Nicoletti F. (Pozzilli, Rome, Pisa)<br />
11.30 am THE mGLU2/3 METABOTROPIC GLUTAMATE RECEPTOR<br />
ANTAGONIST, LY341495, ENHANCES CHEMOSENSITIVITY<br />
OF GLIOBLASTOMA-DERIVED STEM CELLS TO<br />
TEMOZOLOMIDE<br />
Bonelli M., Ciceroni C., Mastrantoni E., Laurenza M.,<br />
Niccolini C., Spinsanti P., Stocchi F., Arcella A., Ricci-Vitiani<br />
L., Oliva M., Nicoletti F., Melchiorri D. (Rome, Pozzilli)<br />
11.45 am HUMAN SMOOTH MUSCLE TSC2 -/- CELLS CAUSE<br />
LYMPHANGIOLEIOMYOMATOSIS-LIKE LUNG DESTRUCTION<br />
IN NUDE MICE. PHARMACOLOGICAL REPAIR<br />
Lesma E., Chiaramonte E., Ancona S., Grande V., Adami<br />
R., Di Giulio A., Gorio A. (Milan)<br />
12.00 pm ACTIVATION OF CORTICOTROPIN RELEASING FACTOR<br />
TYPE 1 RECEPTOR (CRF-R1) INHIBITS CELL GROWTH OF<br />
HUMAN NEUROBLASTOMA CELL LINES VIA THE<br />
MODULATION OF P18 INK4C GENE EXPRESSION<br />
De Simone M., Noviello L., Dello Russo C., Tringali G.,<br />
Mastrella D., Navarra P., Pozzoli G. (Rome)<br />
12.15 pm ADENOSINE RECEPTOR STIMULATION BY<br />
POLYDEOXYRIBONUCLEOTIDE ACTIVATES CELL CYCLE<br />
AND IMPROVES SKIN HEALING IN THE GENETICALLY<br />
DIABETIC MOUSE<br />
Bitto A., Polito F., Irrera N., Minutoli L., Altavilla D.,<br />
Giuliani D., Guarini S., Ottani A., Caputi A. P., Squadrito F.<br />
(Messina, Modena)<br />
12.30 pm ACTIVATION OF MUSCARINIC RECEPTORS STIMULATE<br />
CELL PROLIFERATION IN PRIMARY CULTURES OF HUMAN<br />
DETRUSOR MUSCLE CELLS<br />
162<br />
Arrighi N., Bodei S., Lucente A., Zani D., Simeone C.,<br />
Peroni A., Mirabella G., Cosciani Cunico S., Spano P. F.,<br />
Sigala S. (Brescia)<br />
12.45 pm EFFECTS OF GLUCOSE-REGULATED PROTEIN94 (GRP94)<br />
AND COMPLEXES OF GRP94 WITH IGG ON CELLS OF THE<br />
INNATE AND ADAPTIVE IMMUNITY<br />
Tramentozzi E., Pagetta A., Montopoli M., Zamarchi R.,<br />
Rossi E., Tibaldi E., Finotti P. (Padua)<br />
163<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
SATURDAY, October 17, 2009<br />
Sala Bianca – 11.15 am-1.15 pm<br />
Oral Communications<br />
PHARMACOLOGY OF INFLAMMATION<br />
Chairpersons: Cuzzocrea S. (Messina),<br />
Patrignani P. (Chieti)<br />
11.15 am EVALUATION OF THE POTENTIAL INVOLVEMENT OF<br />
ANGIOTENSIN II IN FUNCTIONAL, BIOPHYSICAL AND<br />
HISTOLOGICAL ALTERATION OF DYSTROPHIC MUSCLE:<br />
EFFECTS OF A CHRONIC TREATMENT WITH THE<br />
ANGIOTENSIN-CONVERTING ENZYME INHIBITOR<br />
ENALAPRIL IN A MOUSE MODEL OF DUCHENNE MUSCULAR<br />
DYSTROPHY<br />
Cozzoli A., Sblendorio V., Capogrosso R., Nico B., Conte<br />
Camerino D., De Luca A. (Bari)<br />
11.30 am EFFECTS OF NSAIDs ON MITOCHONDRIAL METABOLISM<br />
AND GLUTATHIONE LEVELS IN SKELETAL MUSCLE OF<br />
PRESYMPTOMATIC SOD1 G93A TRANSGENIC MICE<br />
Verri M., Pastoris O., Bongiorno A., Bendotti C., Daleno<br />
C., Dossena M. (Pavia, Milan)<br />
11.45 am CRITICAL ROLE FOR THE SPHINGOSINE-1-PHOSPHATE/<br />
SPHINGOSINE KINASE PATHWAY IN ACUTE<br />
INFLAMMATION<br />
De Gruttola L., Brancaleone V., Vellecco V., Bucci M.,<br />
Roviezzo F., Cirino G. (Naples)<br />
12.00 pm HYPERBARIC OXYGEN THERAPY REDUCES TOLL-LIKE<br />
RECEPTORS SIGNALLING PATHWAY IN A RAT MODEL OF<br />
ZYMOSAN-INDUCED MULTIPLE ORGAN FAILURE<br />
SYNDROME<br />
Rinaldi B., Donniacquo M., Imperatore F., Di Paola R.,<br />
Mazzon E., Cuzzocrea S., Luongo C., Rossi C., Di Palma D.,<br />
Sodano L., Rossi F. (Naples, Messina)<br />
12.15 pm AF3442, A NOVEL INHIBITOR OF HUMAN MPGES-1, DOES<br />
NOT REDIRECT PROSTANOID METABOLISM IN HUMAN<br />
WHOLE BLOOD IN VITRO<br />
Bruno A., Coletta I., Polenzani L., Milanese C., Anzellotti<br />
P., Ricciotti E., Dovizio M., Patrignani P. (Chieti, Pomezia)<br />
12.30 pm TRANSCELLULAR METABOLISM OF CYSTEINYL<br />
LEUKOTRIENES IN VIVO<br />
Zarini S., Gijon M., Murphy R., Sala A. (Milan, Denver)<br />
164<br />
12.45 pm ANTI-INFLAMMATORY EFFECTS OF THE NITRIC OXIDE<br />
(NO) RELEASING PRAVASTATIN NCX 6550 IN MONOCYTE/<br />
MACROPHAGES OF HEALTHY DONORS: PPAR-GAMMA<br />
EXPRESSION, NF-KB ACTIVATION AND CYTOKINE<br />
RELEASE<br />
Bardelli C., Amoruso A., Fresu L., Palma A., Ongini E.,<br />
Brunelleschi S. (Novara, Milan)<br />
1.00 pm THE 5-LIPOXYGENASE INHIBITOR ZILEUTON SUPPRESSES<br />
PROSTAGLANDIN BIOSYNTHESIS BY INHIBITION OF<br />
ARACHIDONIC ACID RELEASE IN MACROPHAGES<br />
Rossi A., Pergola C., Koeberle A., Bramanti P., Cuzzocrea<br />
S., Werz O., Sautebin L. (Naples, Messina, Tuebingen)<br />
165<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
SATURDAY, October 17, 2009<br />
Sala Verde – 11.15 am-1.15 pm<br />
Oral Communications<br />
PHARMACOLOGY OF METABOLISM, ENDOCRINE SYSTEM<br />
AND ERECTILE DYSFUNCTION (SESSION 2)<br />
Chairpersons: Cirino G. (Naples), Sigala S. (Brescia)<br />
11.15 am DIFFERENT ANTIOXIDANT DEFENSE IN POORLY<br />
CONTROLLED TYPE 2 DIABETIC PATIENTS WITH AND<br />
WITHOUT COMPLICATIONS<br />
Bigagli E., Raimondi L., Bardini G., Rotella C., Lodovici M.<br />
(Florence)<br />
11.30 am MUSCLE EXPRESSIONS OF MGF, IGF-I, AND MYOSTATIN<br />
IN INTACT AND HYPOPHYSECTOMIZED RATS: EFFECTS OF<br />
RHGH AND TESTOSTERONE ALONE OR COMBINED<br />
Bonomo S., Rigamonti A., Giunta M., Locatelli L., Molinari<br />
F., Müller E., Cella S. (Milan)<br />
11.45 am EFFECTS OF A NEW SYMBIOTIC FORMULATION,<br />
FLORTEC®, IN A MODEL OF INSULIN RESISTANCE AND<br />
NONALCOHOLIC STEATOHEPATITIS IN YOUNG RATS<br />
Iacono A., Mattace Raso G., Esposito E., D'Agostino G., Di<br />
Costanzo M., Berni Canani R., Calignano A., Meli R.<br />
(Naples, Messina)<br />
12.00 pm TESTOSTERONE REGULATES 5-LIPOXYGENASE VIA ERK<br />
AND CAUSES GENDER-SPECIFIC DIFFERENCES IN<br />
LEUKOTRIENE BIOSYNTHESIS<br />
Pergola C., Dodt G., Rossi A., Neunhoeffer E., Lawrenz B.,<br />
Northoff H., Samuelsson B., Rådmark O., Sautebin L.,<br />
Werz O. (Tuebingen, Naples, Stockholm)<br />
12.15 pm TESTOSTERONE AMELIORATES SEXUAL AND METABOLIC<br />
PROFILE IN AN ANIMAL MODEL OF METABOLIC SYNDROME<br />
Filippi S., Vignozzi L., Morelli A., Chalvamane A., Fibbi B.,<br />
Vannelli G., Forti G., Maggi M. (Florence)<br />
12.30 pm UROTENSIN II: A NOVEL TARGET IN HUMAN CORPUS<br />
CAVERNOSUM<br />
Mitidieri E., d'Emmanuele di Villa Bianca R., Coletta C.,<br />
Grassia G., Roviezzo F., Grieco P., Novellino E., Imbimbo<br />
C., Mirone V., Cirino G., Sorrentino R. (Naples)<br />
12.45 pm HYDROGEN SULPHIDE AS A MEDIATOR OF HUMAN<br />
CORPUS CAVERNOSUM<br />
166<br />
d'Emmanuele di Villa Bianca R., Mitidieri E., Coletta C.,<br />
Maffia P., Fusco F., Mirone V., Sorrentino R., Cirino G.<br />
(Naples)<br />
1.00 pm ESTROGENS ABOLISH THE TNF--INDUCED DECREASE IN<br />
LEUKOCYTE EXPRESSION OF CD36, A CLASS B<br />
SCAVENGER RECEPTOR INVOLVED IN THE CLEARANCE OF<br />
β-AMYLOID<br />
Giunta M., Rigamonti A., Bonomo S., Müller E., Cella S.<br />
(Milan)<br />
167<br />
SATURDAY, October 17, 2009
SATURDAY, October 17, 2009<br />
SATURDAY, October 17, 2009<br />
Sala Rossa – 11.15 am-1.15 pm<br />
Oral Communications<br />
PHARMACOLOGY AND EXPERIMENTAL AND CLINICAL<br />
TOXICOLOGY<br />
Chairpersons: Cantelli Forti G. (Bologna),<br />
Marinovich M. (Milan)<br />
11.15 am IDENTIFICATION OF GENETIC MARKER FOR EARLY<br />
DETECTION OF COLORECTAL CANCER<br />
Maffei F., Carbone F., Cantelli Forti G., Festi D., Vestito<br />
A., Hrelia P. (Bologna)<br />
11.30 am CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED<br />
PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL<br />
STUDY IN THE MOUSE<br />
Carozzi V., Canta A., Oggioni N., Chiorazzi A., Meregalli<br />
C., Sala B., Cavaletti G. (Monza)<br />
11.45 am BILIRUBIN AND NITRIC OXIDE INTERACTION: THE<br />
FORMATION OF A NEW CHEMICAL ENTITY<br />
Mancuso C., Barone E., Trombino S., Cassano R., Guido<br />
P., Sgambato A., Picci N. (Rome, Rende)<br />
12.00 pm EFFECTS OF NON PLANAR POLYCHLORINATED BIPHENYL<br />
CONGENERS (PCB 101, PCB 180, AND PCB 153) ALONE OR<br />
MIXED IN J774A.1 MACROPHAGE CELL LINE:<br />
MODIFICATION OF APOPTOTIC AND INFLAMMATORY<br />
PATHWAYS<br />
Esposito E., Ferrante M., Iacono A., Bilancione M.,<br />
Mattace Raso G., Meli R. (Messina, Naples)<br />
12.15 pm A NEW MODEL OF BINGE EATING IN FEMALE RATS:<br />
EFFECT OF SIBUTRAMINE, FLUOXETINE, TOPIRAMATE AND<br />
MIDAZOLAM<br />
Cifani C., Micioni Di Bonaventura M., Polidori C., Melotto<br />
S., Ciccocioppo R., Massi M. (Camerino)<br />
12.30 pm MICE LACKING FATTY ACID AMIDE HYDROLASE (FAAH -/- )<br />
SHOWED INCREASED SEROTONERGIC<br />
NEUROTRANSMISSION AND REDUCED EMOTIONAL<br />
REACTIVITY<br />
Laconca L., Cassano T., Morgese M., Macheda T., Cuomo<br />
V., Piomelli D. (Rome, Foggia, Irvine)<br />
168<br />
12.45 pm ROLE OF SIRT1 IN HUMAN ENDOTHELIAL CELLS DURING<br />
AGING AND OXIDATIVE STRESS<br />
Simeon V., Conti V., Corbi G., Stiuso P., Dicitore A.,<br />
Russomanno G., Filippelli W., Ferrara N., Filippelli A.<br />
(Naples, Campobasso)<br />
1.00 pm EFFECTS OF RESVERATROL IN AGING: AN IN VITRO<br />
STUDY IN HUMAN FIBROBLASTS<br />
Pitozzi V., Jacomelli M., Mocali A., Cifola I., Battaglia C.,<br />
Beltrame L., Mulinacci N., Dolara P., Giovannelli L.<br />
(Florence)<br />
169<br />
SATURDAY, October 17, 2009
Index of Authors<br />
and Chairpersons
Abbadessa G. 54 108<br />
Abbracchio MP. 9 33 47 52 68<br />
101<br />
Abrignani S. 30<br />
Adami M. 105<br />
Adami R. 30 162<br />
Adami S. 23<br />
Adamo E. 161<br />
Addabbo F. 76<br />
Addis A. 24<br />
Adornetto A. 63<br />
Adorni MP. 99 100<br />
Affatato A. 128<br />
Agabiti N. 157<br />
Agabiti Rosei E. 121<br />
Agati L. 101<br />
Agnati L. 32<br />
Agostini S. 51 71 105<br />
Aguglia E. 94<br />
Aguiari G. 41<br />
Aiello M. 13<br />
Albano G. 120<br />
Albertin G. 99<br />
Alboni S. 38 74<br />
Aldinucci A. 117<br />
Aldinucci C. 103<br />
Alemà S. 105<br />
Alfano S. 7<br />
Alfarano C. 101 102<br />
Alfieri A. 100 114<br />
Alghisi M. 58<br />
Allegra M. 114<br />
Allegrini G. 128 146<br />
Alloatti G. 76<br />
Alloisio S. 42 45<br />
Altavilla D. 31 61 72 86 87<br />
104 107 114 161 162<br />
Altavilla G. 33<br />
Altomare E. 117<br />
Alunno A. 116<br />
Amadio M. 86 105<br />
Amadori A. 50<br />
Amadori D. 135 146<br />
Amadoro G. 36<br />
Amantea D. 9 33<br />
Amatori F. 146<br />
Ambretti S. 111<br />
Ambrosi G. 32<br />
Amoroso S. 44 61<br />
Amoruso A. 114 116 136 165<br />
Anaelle D. 119<br />
Anastasi E. 49<br />
Ancona S. 48 162<br />
Andeotti C. 58<br />
Andreini I. 59<br />
Andreoli C. 59<br />
Andreoli N. 32<br />
Anelli C. 102<br />
Angeli A. 108<br />
Angelini S. 128<br />
Annunziato L. 9 63<br />
Anselmi L. 159<br />
Antonelli T. 44<br />
Antonioli L. 71 81 136<br />
Antonucci F. 68<br />
Antonuccio P. 107<br />
Antonuzzo A. 146<br />
Anversa P. 78 160<br />
Anzellotti P. 100 115 136 164<br />
Apolloni S. 68<br />
Appendino G. 12 14<br />
Arcà M. 157<br />
Arcangeli S. 44<br />
Arcaro G. 120<br />
Arcella A. 162<br />
Arcoraci T. 122 124 125<br />
Arcoraci V. 121 161<br />
Arena S. 14<br />
Arenaz I. 159<br />
Armentero M. 32<br />
Armida M. 68<br />
Armogida M. 33<br />
Arnaboldi L. 102<br />
Arnoletti E. 76<br />
Aronica E. 48<br />
Arrighi N. 49 163<br />
Arrigoni E. 126<br />
Ascierto P. 47<br />
Ascione B. 50<br />
Assael B. 108<br />
Autore G. 48 57 107<br />
Avallone R. 107<br />
Avato P. 31<br />
Aviello G. 72 105<br />
Avoli M. 35<br />
Awwad O. 81<br />
Badiali L. 35<br />
Baetta R. 102<br />
Bagetta G. 5 9 30 33 39<br />
50 74<br />
Baiardi P. 120 122<br />
Baiguera C. 58<br />
Baiula M. 75 159<br />
Bajetto A. 48<br />
Balboni G. 51 149<br />
Baldelli P. 4<br />
Balduini W. 8 49 159<br />
Balestrieri E. 67<br />
Ballabeni V. 34 114<br />
Ballerini C. 117<br />
Ballerini P. 36<br />
Balsamo A. 76 98<br />
Banaudi E. 98<br />
Banchelli G. 124<br />
Banfi C. 101 102<br />
Bani D. 103 137<br />
Banni S. 36<br />
Banti I. 112<br />
Baraldi E. 122<br />
Baraldi M. 30 71 107<br />
Baraldi PG. 41 42 81 111 146<br />
Baraldi S. 81<br />
Baraldo M. 54 117 118<br />
Barbaro G. 35<br />
Barbera C. 127<br />
Barberi L. 31<br />
Barberis A. 86 110 112 126<br />
Barbierato M. 41 45<br />
Barbieri F. 48<br />
Barbieri R. 42<br />
Barbieri S. 159<br />
Barbiero V. 4<br />
Barcella S. 101 102<br />
Bardelli A. 14<br />
Bardelli C. 114 116 136 165<br />
Bardini G. 166<br />
Barile C. 111<br />
Barletta M. 128<br />
Barlocco E. 118<br />
Barocelli E. 34 114 159<br />
Barone A. 157<br />
Barone E. 123 168<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Barrese V. 45 46<br />
Barrosi C. 122<br />
Bartella C. 160<br />
Bartoli F. 127<br />
Bartolini A. 37 51 52 149<br />
Bartolone S. 114<br />
Bartoloni Bocci E. 116<br />
Bartorelli A. 76<br />
Baruchello R. 147<br />
Basilicata G. 140 157<br />
Basolo F. 101<br />
Bassi A. 59<br />
Bassi MT. 63<br />
Basso D. 14<br />
Bastianelli A. 7<br />
Battaglia C. 169<br />
Battaglia F. 4<br />
Battaglia G. 7 15 34 37 48<br />
49 66 130 159 162<br />
Bazzu G. 4 34<br />
Bedini A. 75 159<br />
Bedussi F. 49<br />
Belardo G. 47<br />
Belfiore D. 59<br />
Belladonna ML. 42 66<br />
Bellantonio P. 37<br />
Bellantuono C. 119<br />
Bellantuono S. 58<br />
Belleudi V. 157<br />
Bellini G. 63<br />
Bellini M. 15<br />
Bellosta S. 102<br />
Belluardo N. 7<br />
Beltrame L. 169<br />
Benarese M. 9 58<br />
Benassi L. 58<br />
Benatti C. 38 74<br />
Bendotti C. 164<br />
Benedetti F. 134<br />
Benedusi A. 47<br />
Benelli A. 87<br />
Benetti E. 98<br />
Benfante R. 127<br />
Benfenati E. 138<br />
Benfenati F. 4<br />
Benfenati V. 45<br />
Bennett G. 149<br />
Benvenuti S. 58<br />
Bereshchenko O. 7<br />
Berlinguer Palmini R. 38<br />
Berliocchi L. 50<br />
Bernabucci M. 37<br />
Berni Canani R. 166<br />
Bernini F. 21 99 100<br />
Berrino L. 42 76 78 101 103<br />
160<br />
Berry A. 41<br />
Bersan E. 39<br />
Berta G. 100 112 126<br />
Bertario L. 14<br />
Bertazzoni Minelli E. 110 152<br />
Bertocchi I. 39 109<br />
Bertolaso L. 127<br />
Bertoldo A. 47<br />
Bertolini A. 28 35 107<br />
Bertolotti P. 32<br />
Bertoni L. 87<br />
Bertoni S. 34 114 159<br />
Bezanilla F. 46<br />
Bhargava A. 52<br />
Biagi C. 79 111 119<br />
Biagi GL. 58<br />
Biagioli T. 117<br />
Biagioni F. 15 37 38 49 130<br />
162<br />
Bianchi G. 23 132<br />
Bianchi R. 42 66<br />
Bianchini P. 42<br />
Bianchini R. 66 116<br />
Bianco F. 68<br />
Bianco G. 48 57 107<br />
Bianco S. 128<br />
Biasco G. 14<br />
Biel M. 136<br />
Bifari F. 39<br />
Bigagli E. 102 166<br />
Biggio G. 4 61 94<br />
Bilancione M. 168<br />
Billington R. 43 50<br />
Bin A. 71 105<br />
Biondi F. 73<br />
Bisignano C. 124<br />
Bisignano G. 124<br />
Bisoffi G. 119<br />
Bistoni O. 116<br />
Bitto A. 31 61 72 86 87<br />
104 107 114 161 162<br />
Bizzozero L. 7<br />
Blandini F. 32<br />
Blandizzi C. 15 71 81 101 104<br />
107 120 121 122 136<br />
157<br />
Blasevich M. 36<br />
Blasi F. 39<br />
Blasio A. 38<br />
Blom J. 74<br />
Bocci E. 63<br />
Bocci G. 110 128 146<br />
Boda E. 33<br />
Bodei S. 49 163<br />
Boehmer F. 43<br />
Bogani P. 76<br />
Bogliolo V. 29<br />
Bogo M. 41<br />
Bolego C. 100 110 136<br />
Bolognini D. 8<br />
Bombelli R. 120<br />
Bonaiuto A. 114<br />
Bonaldo S. 117<br />
Bonamassa B. 58<br />
Bonanno G. 4 29 30<br />
Bonati M. 120 157<br />
Bondioli L. 107<br />
Bonelli M. 63 162<br />
Bonetti B. 39<br />
Bongiorno A. 164<br />
Bonifacino T. 4 29 30<br />
Bonifazi D. 120<br />
Bonini S. 7<br />
Bonito M. 106<br />
Bono G. 14<br />
Bonomo S. 166 167<br />
Bononi A. 111<br />
Boraso M. 130<br />
Borea PA. 41 42 63 81 111<br />
134 146<br />
Borgognoni L. 76<br />
Borracci P. 59<br />
Borrelli F. 72 105<br />
Borroni B. 130<br />
Borsellino L. 79<br />
Bortolami A. 118 157<br />
Bortolotto V. 7 36<br />
Bortolotto ZA. 144<br />
Boscia F. 38<br />
Bottai D. 29 30<br />
Bottein M. 39<br />
Botticelli A. 61 98<br />
Bottinelli R. 33 99<br />
Bozzo L. 117<br />
Braconi S. 36 55<br />
Braga PC. 97 110<br />
Braghiroli D. 30<br />
Bramanti P. 30 32 49 74 113<br />
130 159 165<br />
Brambilla M. 76<br />
Brancaleone V. 30 76 98 99 160<br />
164<br />
Brancolini C. 139<br />
Bravaccio C. 140<br />
Brera F. 36<br />
Breschi MC. 76 98 112 160<br />
Bresciani E. 108<br />
Brewer J. 103<br />
Brignoli O. 121<br />
Brini A. 126<br />
Brioschi M. 102<br />
Brivio I. 98 102<br />
Brocca L. 33<br />
Brocca Cofano E. 33<br />
Broccardo M. 51 71 105<br />
Broccoli M. 71<br />
Brossa A. 158<br />
Brun P. 105<br />
Brunelleschi S. 66 97 114 116 136<br />
156 165<br />
Brunelli S. 63<br />
Brunello N. 25 28 38 74<br />
Brunetta E. 117<br />
Bruni E. 58<br />
Bruni P. 68<br />
Bruno A. 14 100 164<br />
Bruno C. 82<br />
Bruno V. 7 15 28 34 35<br />
37 48 49 66 130<br />
159 162<br />
Bruscagin S. 127<br />
Bruscoli S. 7 159<br />
Brusselle G. 140<br />
Bruzzone F. 42<br />
Buccella S. 36 81<br />
Buccellati C. 98 100 102 110<br />
Bucci D. 7 15 37 49 130<br />
162<br />
Bucci M. 30 76 98 99 113<br />
160 164<br />
Buchholz F. 43<br />
Bucolo C. 86<br />
Bueno L. 51<br />
Buerger E. 50<br />
Buffo A. 9 33<br />
Buonocore G. 8 49<br />
Burbiel J. 101<br />
Buriani A. 48<br />
Busceti C. 7 15 37 38 48<br />
49 66 130 162<br />
Buzzega D. 32<br />
Cabella C. 102<br />
Cabras M. 30<br />
Caciagli F. 36 81<br />
Caffino L. 55<br />
Caggia F. 38 74<br />
Calabresi L. 99 136<br />
Calapai G. 47 49 55 59 114<br />
119 121 122 148<br />
Calciano S. 45<br />
Caldarelli A. 38 43<br />
Calderone V. 76 98<br />
Calia G. 34<br />
Caliari A. 120<br />
Calignano A. 52 62 86 149 166<br />
Calmieri G. 25<br />
Calò G. 35 61<br />
Calò M. 86<br />
Calo' G. 37<br />
Calvo PL. 127<br />
Calzavara E. 55 114<br />
Camarda V. 35 37<br />
Cambiaghi M. 4<br />
Camera M. 76<br />
Camerino G. 33 97 99<br />
Camici M. 68<br />
Caminiti R. 30 32 113<br />
Cammarota S. 140<br />
Campana G. 86 108<br />
Campbell G. 159<br />
Campesi I. 76<br />
Campioli E. 107<br />
Campodonico F. 112<br />
Campolongo P. 4<br />
Canali E. 101<br />
Canali R. 124<br />
Canaparo R. 127<br />
Canarile L. 7<br />
Canavesi M. 102<br />
Cancelliere C. 14<br />
Candeletti S. 51 54 130<br />
Canestrelli M. 51<br />
Cangemi L. 54<br />
Canistro D. 58<br />
Cannarile L. 66<br />
Cannarsa R. 54<br />
Cannazza G. 30<br />
Cannella M. 48<br />
Cannella N. 36 55<br />
Cannone G. 108<br />
Canonico PL. 7 23 28 34 38<br />
42 43 50 94 133<br />
Canta A. 168<br />
Cantarutti L. 118 122<br />
Cantelli Forti G. 14 59 81 128 147<br />
168<br />
Cantoni O. 7 49 50<br />
Canu B. 110 128<br />
Canu S. 76<br />
Canzoniero L. 108<br />
Caparrotta L. 111 123<br />
Capasso A. 28 31 57 86 107<br />
Capasso F. 105<br />
Capasso R. 72 105<br />
Capecchi PL. 81<br />
Capeci W. 44<br />
Capodanno P. 121<br />
Capogrosso R. 164<br />
Capone M. 14 100 136<br />
Caponnetto C. 30<br />
Caporali S. 108<br />
Capozzo M. 126 128<br />
Cappelani A. 30<br />
Cappellacci L. 112<br />
Cappetta D. 78 160<br />
Cappiello L. 36<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Cappuccio I. 63 112 130<br />
Caprini M. 45<br />
Capuano A.ro 52 149<br />
Capuano A.sa 120 121 140 157<br />
Capucci A. 93<br />
Caputi AP. 3 31 55 59 65<br />
72 79 86 89 95<br />
96 104 108 114 119<br />
121 141 157 161 162<br />
Caputi F. 130<br />
Caputo A. 33<br />
Caraci F. 25 35 61 130 159<br />
Carbonara G. 45<br />
Carbonari G. 159<br />
Carbone F. 58 168<br />
Carelli S. 29 47<br />
Cariboni A. 38<br />
Caricasole A. 10 40<br />
Carle F. 141<br />
Carloni S. 8 49<br />
Carlotti M. 112<br />
Carlucci A. 63<br />
Carmignani M. 160<br />
Carnevale G. 30 71 87<br />
Carnì A. 55 114<br />
Carnuccio R. 48 99 114 115<br />
Carocci A. 46<br />
Carone C. 32<br />
Caronno A. 127 160<br />
Carovani M. 52<br />
Carozzi V. 168<br />
Carrara M. 48<br />
Carraro L. 34<br />
Carratù MR. 59<br />
Carretta MT. 103<br />
Carrì MT. 68<br />
Carta A. 68<br />
Carta M. 82<br />
Carta P. 157<br />
Carta S. 55<br />
Carunchio I. 36<br />
Caruso A.ra 130<br />
Caruso A.lo 63<br />
Caruso ML. 104<br />
Casagrande C. 102<br />
Casale F.ca 53 150<br />
Casale F.co 140<br />
Casarin E. 48<br />
Casazza S. 30<br />
Caselli G. 104<br />
Casolini P. 105<br />
Cassano R. 168<br />
Cassano T. 15 33 37 44 61<br />
168<br />
Castagliuolo I. 71 105<br />
Castaldo P. 44<br />
Castelletti C. 141<br />
Castellsague J. 140<br />
Castiglia S. 98 137<br />
Castiglioni L.ra 100<br />
Castiglioni L.na 103<br />
Castrichini M. 81<br />
Cataldi M. 35 44<br />
Cataldo S. 35<br />
Catania MA. 119<br />
Catapano A. 21<br />
Caterino L. 120<br />
Cathala A. 28<br />
Cattabeni F. 82 130<br />
Cattaneo D. 73<br />
Cattaneo M. 6<br />
Cattaneo MG. 63<br />
Cattaneo MT. 119<br />
Cavaletti G. 135 168<br />
Cavaliere F. 5 30 74<br />
Cavallero A. 44 45<br />
Cavalli R. 112<br />
Cavani F. 87<br />
Cavazza C. 3<br />
Cavina C. 54<br />
Cavone L. 38 117<br />
Cazzato D. 7<br />
Cecchi E. 124<br />
Ceci A. 120 122 135<br />
Celano M. 111<br />
Celia C. 111<br />
Cella S. 86 166 167<br />
Cerbai E. 45 58 78 93 99<br />
101 136 140 160<br />
Cereda C. 28<br />
Cerioni L. 7 49 50<br />
Cerretani D. 47 123<br />
Ceruti S. 52 68<br />
Cerveri G. 94<br />
Cervetto C. 42 45<br />
Cervone C. 101<br />
Cesare P. 160<br />
Cetti E. 57<br />
Chalvamane A. 166<br />
Chen J. 29<br />
Chiamulera C. 39<br />
Chiaramonte E. 48 162<br />
Chiaravalli A. 105<br />
Chiarugi A. 9 39 59 117 139<br />
Chiechio S. 52<br />
Chiesa G. 102<br />
Chiesa R. 126<br />
Chinellato A. 118 157<br />
Chini J. 137<br />
Chiodi V. 29 68<br />
Chiorazzi A. 168<br />
Chiozzi P. 68<br />
Chirafisi J. 59 103 124<br />
Chisari M. 101<br />
Ciammola A. 48<br />
Ciana P. 145<br />
Cianchi C. 123<br />
Cianchi F. 146<br />
Cianci S. 37 61<br />
Ciapparelli A. 127<br />
Ciaramella N. 14<br />
Ciardiello F. 42<br />
Ciarletta M. 38<br />
Ciarmiello A. 48<br />
Cicala C. 100 114<br />
Ciccarelli R. 36 81<br />
Cicchetti A. 22<br />
Ciccocioppo R. 35 36 55 58 168<br />
Ciceroni C. 112 162<br />
Cifani C. 36 58 130 168<br />
Cifola I. 169<br />
Cignarella A. 100 136 145<br />
Cigognini D. 30<br />
Cilio MR. 46<br />
Cillo B. 121<br />
Cimino F. 59 103 124<br />
Cimino M. 9<br />
Cinci L. 103 137<br />
Ciociaro A. 50<br />
Ciofi L. 112 127<br />
Ciotti MT. 36<br />
Cipolla G. 120<br />
Cipollaro M. 103<br />
Cippitelli A. 55<br />
Cippone V. 108<br />
Cipriani S. 33 68 130<br />
Cipriano M. 29 71<br />
Ciriana O. 66<br />
Cirino G. 27 30 76 98 99<br />
113 160 164 166 167<br />
Citraro R. 31 36<br />
Clavenna A. 120<br />
Clementi E. 7 41 44 63 68<br />
73 119<br />
Clementi S. 55<br />
Clerici M. 29<br />
Clini E. 13<br />
Cobellis G. 103<br />
Cocchi D. 86 108<br />
Cocci A. 79<br />
Coccurello R. 58<br />
Coinu R. 76<br />
Cojutti PG. 28 54 117 118<br />
Colaianna M. 39 68<br />
Colangeli R. 37<br />
Colao A. 140<br />
Colapicchioni C. 63<br />
Colasanti T. 50<br />
Coletta C. 113 115 166 167<br />
Coletta I. 164<br />
Colli S. 159<br />
Collingridge G. 144<br />
Collino M. 98 103 137<br />
Colombano G. 50<br />
Colombo L. 52<br />
Colucci M. 53 105 106<br />
Colucci R. 15 71 81 101 136<br />
Coluccia A. 59<br />
Comi G. 120<br />
Concas A. 4 85<br />
Condorelli F. 42 43 50<br />
Conforti A. 79 119<br />
Consoli A. 95<br />
Consoli G. 127<br />
Conte J. 107<br />
Conte MA. 126 128<br />
Conte Camerino D. 33 42 45 46 82<br />
97 99 104 107 108<br />
135 164<br />
Conti V.no 122 157<br />
Conti V.ia 14 169<br />
Copani A. 35 52 61 130 159<br />
Coppini R. 45<br />
Coppo L. 102 103<br />
Coppo M. 7<br />
Corallini A. 33<br />
Corasaniti MT. 5 9 30 39 50<br />
74<br />
Corbi G. 169<br />
Corbo F. 46<br />
Cordeddu L. 36<br />
Cordiano C. 127<br />
Corrao G. 141<br />
Corsaro A. 61<br />
Corsi L. 30 71<br />
Corsi M. 7<br />
Corsini A. 16 99 102<br />
Corsini D. 38<br />
Corti C. 7<br />
Corti F.co 57<br />
Corti F.ca 33<br />
Coruzzi G. 105<br />
Cosciani Cunico S. 49 163<br />
Cosco D. 111<br />
Cosentino M. 14 103 117 120 141<br />
Cosentino S. 101<br />
Cosi C. 38<br />
Cosottini M. 120<br />
Costa B. 11<br />
Costa F. 15<br />
Costa G. 58<br />
Costa L. 50 124<br />
Costa N. 53<br />
Costante G. 111<br />
Costantini D. 79 80 121<br />
Costantino L. 35 107<br />
Costantino M. 123<br />
Costantino S. 101<br />
Costanza T. 82<br />
Cotelli F. 57<br />
Cotrufo M. 103<br />
Cozzi A. 38<br />
Cozzoli A. 164<br />
Cozzolino M. 68<br />
Crema F. 71 104 120<br />
Cricelli C. 95<br />
Crisafulli C. 113 116 159<br />
Crisci M. 159<br />
Crispo G. 53<br />
Cristalli G. 81<br />
Cristani M. 59 122 124<br />
Cristino L. 31 61<br />
Crociara P. 7<br />
Crosio C. 39<br />
Crupi D. 122<br />
Crupi R. 4<br />
Cucchiaroni ML. 33<br />
Cucinotta D. 95<br />
Culici M. 97 110<br />
Cunha R. 29<br />
Cunningham K. 28<br />
Cuomo O. 9 63<br />
Cuomo R. 71<br />
Cuomo V. 3 4 15 33 37<br />
39 44 57 58 61<br />
70 168<br />
Cusinato F. 47<br />
Cutroneo P. 79 80 121<br />
Cuzzocrea S. 11 30 32 62 66<br />
68 74 113 116 130<br />
145 159 164 165<br />
D’Alessandro N. 110<br />
Da Settimo F. 81<br />
D'Acunto C. 49<br />
D'Addario C. 51 130<br />
Daffara F. 110<br />
Daghini E. 101<br />
Dagostino C. 53 150<br />
D'Agostino B. 77 160<br />
D'Agostino G. 52 62 86 149 166<br />
D'Agostino M. 111<br />
Dahl M. 127<br />
Dal Ben D. 81<br />
Dal Sasso M. 97 110<br />
Daleno C. 164<br />
D'Alessandro N. 147<br />
D'Alimonte I. 36<br />
D'Amato F. 58<br />
D'Ambrosi N. 68<br />
Damiano V. 42<br />
D'Amico M.le 36 101<br />
D'Amico M.ia 45<br />
D'Amore V. 37<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Danesi R. 18 73 110 112 126<br />
127 128 146 152<br />
D'Anna R. 87<br />
D'Antico S. 127<br />
D'Aquila P. 29 30<br />
D'Arcangelo M. 146<br />
D'Arrigo C. 61 74<br />
Davoli M. 157<br />
D'Avolio A. 110<br />
de Abajo F. 142<br />
De Angelis A.la 78 160<br />
De Angelis A.io 120<br />
De Bellis M. 46<br />
De Benedictis L. 97<br />
De Bernardi S. 103<br />
De Bona P. 35<br />
De Chiaro M. 52<br />
De Corato A. 52 149<br />
De Dominici M. 50<br />
De Fazio P. 31<br />
De Fazio S. 31<br />
De Feo M. 103<br />
De Filippis D. 29 38 71<br />
De Francia S. 54 98 108 110 118<br />
De Gaetano G. 6<br />
De Gasparo M. 100<br />
De Gennaro Colonna<br />
V.<br />
103<br />
De Girolamo L. 126<br />
De Gruttola L. 76 98 99 160 164<br />
De Guglielmo G. 35 55<br />
De Iudicibus S. 127<br />
De Leon J. 74<br />
De Luca A. 46 164<br />
De Luca M. 58<br />
De Luise C. 140<br />
De Man J. 71<br />
De Manzoni G. 127<br />
De Martino F. 98 110<br />
De Martino G. 120<br />
De Mattei M. 63<br />
De Novellis V. 52 149 150<br />
De Palma C. 63<br />
De Palma R. 160<br />
De Petrocellis L. 63<br />
De Ponti F. 71 79 110 118 134<br />
De Portu S. 140<br />
De Rosa G. 14<br />
De Sarro A. 122<br />
De Sarro GB. 31 36 48 118<br />
De Seta L. 157<br />
De Simone L. 114 160<br />
De Simone ML. 162<br />
De Stefano D. 48 99 114 115<br />
De Vita T. 49<br />
Debetto P. 22 34 41 45 118<br />
Decimo I. 39<br />
Decorti G. 127<br />
Del Grosso E. 43<br />
Del Lungo M. 99 136<br />
Del Senno L. 41<br />
Del Tacca M. 15 71 81 101 110<br />
Del Viscovo A.<br />
112 119 120 121 122<br />
127 128 134 136 146<br />
157<br />
108<br />
Delbarba A. 32<br />
Delfino D. 116<br />
Della Casa L. 36<br />
Dellarole A. 7 36<br />
Delle Donne D. 121<br />
Dello Russo C. 52 74 149 162<br />
Dell'Osso L. 127<br />
Dell'Ovo V. 38 39<br />
Demma I. 104<br />
D'Emmanuele di V.B.<br />
R.<br />
113 115 166 167<br />
Denis-Donini S. 7 36<br />
Desaphy JF. 33 82 135<br />
Desole M. 4 39<br />
Devecchi E. 36<br />
Dever G. 103<br />
Di Bella O. 121<br />
Di Benedetto M. 54<br />
Di Braccio M. 114<br />
Di Carlo F. 54 86 98 100 108<br />
110 112 118 126<br />
Di Cesare Mannelli L. 37 52<br />
Di Costanzo A. 37<br />
Di Costanzo F. 134<br />
Di Costanzo M. 166<br />
Di Desidero T. 110 128<br />
Di Febbo C. 100 136<br />
Di Filippo C. 36 101<br />
Di Francesco C. 58<br />
Di Francesco L. 115<br />
Di Gennaro A. 98<br />
Di Giannuario A. 53 105 106<br />
Di Girolamo F. 53<br />
Di Giulio AM. 29 30 47 48 162<br />
Di Giuseppe D. 102 103<br />
Di Iorio P. 36 81<br />
Di Liberto V. 7<br />
Di Luca M. 28 38 82 130<br />
Di Maio G. 120<br />
Di Maio M. 132<br />
Di Marco R. 37 66<br />
Di Marzo V. 29<br />
72<br />
31 52 61 63<br />
Di Menna L. 159<br />
Di Nardo R. 120<br />
Di Nicolantonio F. 14<br />
Di Noto A. 121<br />
Di Palma D. 164<br />
Di Paola R. 30 66 113 116 130<br />
Di Paolo A.<br />
159 164<br />
112 127 128 146<br />
Di Paolo M. 122<br />
Di Pirro M. 124<br />
Di Renzo G. 9<br />
Di Ronza C. 101<br />
Di Sante M. 7<br />
Di Scipio F. 100 112 126<br />
Di Serio C. 102<br />
Di Simplicio P. 102 103<br />
Di Sotto A. 58 124<br />
Di Stefano A. 103<br />
Di Stefano V. 31 61 72 86 104<br />
Di Viesti V.<br />
107 114 161<br />
30<br />
Di Virgilio F. 68<br />
Diamanti D. 40<br />
Dianzani C. 66<br />
Diaspro A. 42<br />
Diaz F. 74<br />
Diaz Acedo C. 118 119<br />
Dicitore A. 169<br />
Diddi G. 124<br />
Dieguez C. 107<br />
Dieleman J. 140 158<br />
Digennaro C. 33 99<br />
Digiacomo M. 76 98 112<br />
Dimonte V. 118<br />
Dinardo M. 33 97 99<br />
Dinarello C. 139<br />
D'Incau P. 79 119<br />
Ding L. 43<br />
Dipasquale P. 58 61<br />
Distasi C. 38<br />
Dixon D. 14<br />
Dobrowolny G. 33<br />
Dodt G. 166<br />
Dolara P. 169<br />
Domenici MR. 29 68<br />
Donati C. 68<br />
Donati M. 79 119<br />
Donato V. 7<br />
Donato Di Paola E. 31<br />
Donniacuo M. 164<br />
Donnini S. 49 57 63 99<br />
Dore R. 4<br />
Dorent R. 102<br />
Dorigo P. 111 123<br />
Dossena M.ta 32<br />
Dossena M.ia 164<br />
Dovio A. 108<br />
Dovizio M. 14 45 115 164<br />
Drago F. 25 31 64 74 86<br />
129 151<br />
Dragoni S. 59<br />
Dubois-Dauphin M. 130<br />
Duranti E. 81 101 136<br />
Dusonchet L. 112<br />
Eandi M. 127<br />
Economidou D. 36 55<br />
El Khoury A. 83<br />
Elif F. S. 158<br />
Eligini S. 159<br />
Enea D. 56<br />
Epis R. 82 130<br />
Era D. 128<br />
Erich G. 7<br />
Ermito S. 103<br />
Errico F. 144<br />
Errico S. 35<br />
Esculapio P. 54<br />
Esposito A. 108<br />
Esposito E.ga 9<br />
Esposito E.la 30 32 66 74 86<br />
113 116 130 149 166<br />
168<br />
Esposito G. 29 38 71<br />
Eutamene H. 51<br />
Eva C. 39 85 109<br />
Evangelista S. 99<br />
Evangelista V. 100 136<br />
Failli P. 101<br />
Falchi M. 97<br />
Falcioni ML. 57<br />
Falcone A. 128 146<br />
Falcone D. 48<br />
Falcone S. 63<br />
Faleri M. 159<br />
Fallarini S. 117 127<br />
Fallarino F. 42 66<br />
Falzoni S. 68<br />
Fandriks L. 100<br />
Fanò G. 81<br />
Fantò F. 118<br />
Fantozzi R. 14 19 24 98 123<br />
137 140<br />
Fantucci P. 33<br />
Faraco G. 9 39<br />
Fardone E. 37<br />
Farisello P. 4<br />
Fattore L. 70<br />
Fava C. 100 136<br />
Fava G. 119<br />
Favari E. 99 100<br />
Fazio F. 37 66<br />
Fazio N. 82<br />
Fazzini A. 124<br />
Fedele E. 44 45<br />
Fedeli A. 36<br />
Feliciello A. 9 63<br />
Felisi M. 120 122<br />
Fellin R. 68<br />
Ferketich A. 56<br />
Ferraguti F. 37<br />
Ferrajolo C. 140<br />
Ferran S. 118<br />
Ferrante A. 29 68<br />
Ferrante M. 168<br />
Ferrantini C. 45<br />
Ferrara F. 120<br />
Ferrara N. 169<br />
Ferraraccio F. 36 101<br />
Ferrari A. 28 107 123<br />
Ferrari D. 68<br />
Ferrari F. 38<br />
Ferrari M. 14<br />
Ferrari Toninelli G. 7<br />
Ferrario S. 119<br />
Ferraro L. 44 70<br />
Ferraro R. 100 136<br />
Ferrazzi E. 127<br />
Ferrazzin F. 79<br />
Ferreira S. 29<br />
Ferreri A. 124<br />
Ferretti C. 127<br />
Ferretti M. 87<br />
Ferretti R. 68<br />
Ferri A. 68<br />
Ferri C. 122<br />
Ferri N. 102<br />
Ferrigno A. 32 48<br />
Ferroni S. 45<br />
Feruglio M. 54 117<br />
Festa M. 7 31 49<br />
Festi D. 168<br />
Fiacchi P. 111<br />
Fiaschi A. 31 47 123<br />
Fibbi B. 166<br />
Filaferro M. 32 35 51 130<br />
Filippazzi V. 119<br />
Filippelli A. 73 78 123 160 169<br />
Filippelli W. 169<br />
Filippi S. 166<br />
Fimognari C. 147<br />
Fine M. 82<br />
Finetti F. 63<br />
Finicelli M. 103<br />
Fink M. 113<br />
Finocchi P. 68<br />
Finotti P. 163<br />
Fiorani M. 49<br />
Fioravanti A. 110 128 146<br />
Fiore G. 47 123<br />
Fioretti MC. 42 66<br />
Fiorini S. 37<br />
Fiorito S. 59<br />
Firenzuoli F. 124 148<br />
Fischetti C. 35<br />
Fisher T. 43<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Fitzgerald G. 14<br />
Flammini L. 34<br />
Flonta S. 14<br />
Floreani M. 111<br />
Florio C. 38 59<br />
Florio T. 34 47 48 63<br />
Focosi D. 120 157<br />
Fogli E. 81 111<br />
Fogli S. 112 160<br />
Folco G. 13 27 98 100 102<br />
110<br />
Folino A. 100 101 126<br />
Fontana A. 146<br />
Fontana E. 146<br />
Foresti G. 26<br />
Forgione L. 120<br />
Formentini L. 59<br />
Formica R. 120 140 157<br />
Fornai F. 15 37 162<br />
Fornai M. 71 81 101 136<br />
Fornarelli A. 38<br />
Fornasari D. 14 127 143<br />
Forni F. 35 107<br />
Forstermann U. 64<br />
Forte A. 103<br />
Forte M. 120<br />
Forti G. 166<br />
Fortinguerra S. 48<br />
Fortuna A. 86<br />
Fossati G. 139<br />
Fourrier-Réglat A. 118 119 140<br />
Fracchiolla G. 45 97 108<br />
Franceschi L. 28<br />
Franceschini G. 136<br />
Franceschini L. 121<br />
Francese MT. 7 34 36<br />
Franchetti P. 112<br />
Franchi S. 149<br />
Franchini C. 46 82<br />
Franchitto A. 124<br />
Franco G. 59<br />
Franco R. 33<br />
Franconi F. 76 86 145 156<br />
Frattini P. 45<br />
Fresta M. 111<br />
Fresu L. 114 116 136 165<br />
Frigeri C. 51 130<br />
Frigerio E. 108<br />
Frigo G. 71 104 105 120<br />
Froldi G. 111 123<br />
Frosali S. 103<br />
Frosini M. 59<br />
Fu J. 61<br />
Fucile C. 105 112 121 128<br />
Fulle S. 81<br />
Fumagalli F. 55<br />
Fumagalli G. 39<br />
Fumagalli M. 9 52<br />
Furlanut M. 28 54 117 118<br />
Fusco D. 157<br />
Fusco F. 167<br />
Gabbianelli R. 57<br />
Gabrielli N. 101<br />
Gaetani S. 37 58 61<br />
Gagliardi S. 97<br />
Gagliostro M. 121<br />
Gaion R. 71 100 105 110 136<br />
Gala R. 9<br />
Galantucci M. 31 61 98<br />
Galderisi U. 78 103<br />
Galdi M. 120<br />
Galeazzi M. 81<br />
Galeotti N. 51 149<br />
Galiotto M. 39<br />
Gallelli L. 48<br />
Galli A. 130<br />
Galli C.io 108<br />
Galli C.za 146<br />
Galli CL. 130 138 148<br />
Galli L. 146<br />
Galli U. 50<br />
Gallicchio M. 14<br />
Gallo E. 124<br />
Gallo F. 128<br />
Gallo M. 120 140 157<br />
Galluzzi P. 57<br />
Galuppo M. 30 32 74 116<br />
Gamabaro A. 119<br />
Gambaccini D. 15<br />
Gambardella L. 76 101<br />
Gambassi G. 158<br />
Gangemi S. 117<br />
Garcia Rodriguez LA. 142 157<br />
Gardoni F. 38 82 130<br />
Gareri P. 31<br />
Gargiulo L. 100 114<br />
Gariboldi M. 30 111 146<br />
Garozzo D. 35<br />
Garside P. 103<br />
Garzia A. 29<br />
Gass P. 83<br />
Gatta L. 149<br />
Gatti M. 48<br />
Gatti R. 99<br />
Gattorno M. 19<br />
Gaviraghi G. 3 10<br />
Géloen A. 110 126<br />
Gelosa P. 9 100<br />
Gemignani G. 112<br />
Geminiani E. 30 71<br />
Genazzani A. 14 28 38 43 50<br />
126<br />
Genedani S. 32<br />
Gennarelli M. 143<br />
Genovese T.na 30 32 66 68 74<br />
113 116 130 159<br />
Genovese T.so 120<br />
Gentile M. 121<br />
Genuardi M. 146<br />
George A. 99<br />
Geppetti P. 12 76 134 141<br />
Gerace E. 38<br />
Gerli R. 116<br />
Gerlini G. 76<br />
Gervasi N. 29<br />
Gessi S. 41 42 63 81 111<br />
146<br />
Geuna M. 14<br />
Geuna S. 126<br />
Ghè C. 76<br />
Ghelardini C. 37 51 52 149<br />
Ghezzi A. 120<br />
Ghezzi S. 108<br />
Ghi P. 7<br />
Ghisu N. 15 71 81 136<br />
Ghizzardi P. 114<br />
Giaccone M. 127<br />
Giachetti A. 49 57<br />
Giacobbe D. 81<br />
Giambelli R. 83<br />
Gianchecchi E. 81<br />
Gianni L. 132<br />
Giannini E. 51 61 149<br />
Giannuzzi V. 33 42<br />
Giaquinto C. 122<br />
Giaroni C. 71 104 105<br />
Giberti C. 128<br />
Gijon M. 164<br />
Gini R. 118<br />
Giocaliere E. 124<br />
Giommoni F. 124<br />
Giordano C. 149 150<br />
Giordano E. 36<br />
Giordano G. 50<br />
Giorgi G. 31 47 55 57 118<br />
122<br />
Giorgio C. 114<br />
Giorni L. 26 156<br />
Giovannelli L. 169<br />
Giovannini L. 36 114<br />
Giovannini MG. 68 130<br />
Giovannini M. 108<br />
Giovinazzo C. 125<br />
Giovino C. 115<br />
Giraldi T. 126 128 146<br />
Girelli S. 8 49<br />
Giron M. 71 105 158<br />
Girotto S. 122<br />
Giudice S. 58<br />
Giudici D. 45<br />
Giuffrida A. 33 39<br />
Giuffrida M. 35<br />
Giuggioli D. 123<br />
Giuli C. 105<br />
Giuliani D. 31 61 72 98 104<br />
114 162<br />
Giuliani G. 47<br />
Giuliani P. 36<br />
Giunta M. 166 167<br />
Giustetto M. 82<br />
Giusti P. 4 22 41 45 99<br />
118 157<br />
Giustina A. 108<br />
Giustini Saffi E. 119<br />
Gnemmi I. 42<br />
Gobbetti T. 114<br />
Goffredo B. 150<br />
Goglia F. 108<br />
Gomaraschi M. 136<br />
Gomez R. 107<br />
Gomez-Reino J. 107<br />
Gori G. 121<br />
Gori L. 124<br />
Gorini A. 36<br />
Gorio A. 29 30 47 48 162<br />
Govoni S. 45 57 86<br />
Gradini R. 37 49 130<br />
Gradnik R. 3<br />
Gramegna G. 33 42 97<br />
Granata A. 99 102<br />
Granato R. 140<br />
Grande V. 48 162<br />
Grandi D. 104<br />
Grant W. 113<br />
Grassi MC. 56<br />
Grassia G. 99 114 160 166<br />
Greco A. 86<br />
Gregg E. 59<br />
Gregori D. 141<br />
Gregotti C. 48<br />
Grelli S. 67<br />
Grieco P. 98 99 114 166<br />
Grifantini M. 112<br />
Grigoletto J. 4 34<br />
Grilli MG. 7 34 36 51 54<br />
88<br />
Grilli M. 32 45<br />
Grimaldi A. 49<br />
Grimaldi G. 140<br />
Grohmann U. 42 66<br />
Grolla A. 43 50<br />
Grossi L. 100 136<br />
Grossi M. 103<br />
Gruber S. 83<br />
Guadagni F. 53<br />
Guadagno F. 72<br />
Gualeni A. 29<br />
Gualillo O. 107<br />
Guarini S. 31 61 72 98 104<br />
114 162<br />
Guasti L. 103<br />
Guatteo E. 33<br />
Guaza C. 11<br />
Gudermann T. 12<br />
Gueli M. 147<br />
Guerrini R. 35 37 61 104<br />
Guerrini U. 9<br />
Guglielmotti A. 160<br />
Guida F. 52 149<br />
Guidarelli A. 49 50<br />
Guidi A. 36 114<br />
Guido P. 123 168<br />
Guidobono F. 86<br />
Guidolin D. 99<br />
Guidotti G. 74<br />
Guillaume Y. 140<br />
Gulmez S. 140<br />
Gurwitz D. 118<br />
Gusella M. 14 111 127<br />
Haag M. 140<br />
Hallberg A. 100<br />
Hauer D. 4<br />
Haverkamp H. 140<br />
Hayden M. 48<br />
Hen R. 4<br />
Hiberg F. 90<br />
Hilgemann D. 82<br />
Hippisley-Cox J. 118 119<br />
Hodge J. 102<br />
Hosoda T. 160<br />
Hrelia P. 14 57 58 59 81<br />
128 138 146 147 168<br />
Hutter-Paier B. 32<br />
Iaccarino C. 39<br />
Iacobelli M. 119<br />
Iacono A. 62 86 149 166 168<br />
Ialenti A. 47 99 113 114 160<br />
Ianaro A. 41 47 99 113 114<br />
Iannello C. 121<br />
Ianniello B. 121 140 157<br />
Iannone A. 36<br />
Iannone M. 111<br />
Iannotti F. 45 46<br />
Ibrahim T. 146<br />
Idzko M. 68<br />
Illiano ML. 157<br />
Imbesi S. 117<br />
Imbimbo B. 32<br />
Imbimbo C. 166<br />
Imperadore G. 119<br />
Imperatore F. 164<br />
Improta G. 51 71 105<br />
Incerti M. 34<br />
Inta I. 9<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Ipata P. 68<br />
Irpino A. 120 157<br />
Irrera N. 31 72 86 104 107<br />
114 162<br />
Isabella L. 119<br />
Isola L. 105<br />
Isola S. 117<br />
Iuvone T. 11 29 38 71<br />
Izzo A. 72 105<br />
Jacomelli M. 169<br />
Jaconi M. 78<br />
Jahnel U. 133<br />
Jaramillo I. 159<br />
Jasmin L. 52<br />
Jochem J. 98<br />
Kajstura J. 78 160<br />
Kallupi L. 35<br />
Kallupi M. 36 55<br />
Kasper S. 43<br />
Kempen H. 99<br />
Kirchmayer U. 157<br />
Kittler R. 43<br />
Klersy C. 141<br />
Kloting I. 36<br />
Koch S. 43<br />
Koeberle A. 113 165<br />
Kofalvi A. 29<br />
Kors J. 118 119<br />
Kortesca L. 37<br />
Koukopoulos A. 74<br />
Krampera M. 39<br />
Krause K. 61 130<br />
Kroemer G. 48<br />
La Motta C. 81<br />
La Rana G. 52 62 86 149<br />
La Rovere R. 81<br />
La Torre M. 124<br />
La Villa G. 103<br />
Labbadia A. 101<br />
Labbozzetta M. 147<br />
Laconca L. 37 61 168<br />
Laferla F. 37<br />
Laffi G. 103<br />
Laghezza A. 97 108<br />
Laghi Pasini F. 81<br />
Lago F. 107<br />
Lagomarsino F. 32 45<br />
Lamba S. 14<br />
Lambertucci C. 81<br />
Lanas A. 142<br />
Landini I. 146<br />
Landucci E. 38<br />
Lanni A. 108<br />
Lanni C. 57<br />
Lanzetta R. 113<br />
Lanzi C. 103 137<br />
Lanzillotta A. 9 32<br />
Lapi F. 79 80 119 121 124<br />
141<br />
Lapucci A. 112<br />
Lariccia V. 82<br />
Lars P. 118<br />
Lasorsa D. 97<br />
Lastella M. 112 127 146<br />
Latina V. 59 115<br />
Latorre R. 45<br />
Lattanzi R. 51 149<br />
Laurenza M. 162<br />
Lawrenz B. 166<br />
Lawson J. 14<br />
Lazzerini P. 81<br />
Lecca D. 9<br />
Lecca S. 55<br />
Lecchini S. 14 71 103 104 105<br />
120<br />
Ledda F. 76 97<br />
Leggio GM. 28 31<br />
Legnaro M. 103<br />
Lentini G. 46 82<br />
Lenzi M. 147<br />
Leo G. 32<br />
Leone L. 101<br />
Leone R. 79 119 123 157<br />
Leoni O. 79 119 121 157<br />
Leprince J. 42<br />
Leri A. 78 160<br />
Lesaffre E. 140<br />
Lesma E. 48 162<br />
Letari O. 104<br />
Lettieri B. 101 121<br />
Leung E. 42 81 111<br />
Leurs R. 105<br />
Levantesi G. 100 136<br />
Liantonio A. 33 42 97<br />
Lin M. 82<br />
Linari G. 71 105<br />
Linden J. 130<br />
Liquori G. 120<br />
Lisi L. 52<br />
Livi U. 117<br />
Livrea MA. 114<br />
Llaguno M. 82<br />
Lluis C. 33<br />
Locatelli L. 166<br />
Locatelli V. 108<br />
Lodovici M. 102 166<br />
Lofaro A. 123<br />
Lograno M. 99<br />
Loiodice F. 45 97 108<br />
Loizzo A. 86 108<br />
Loizzo S. 86 108<br />
Lombardi G. 117 127<br />
Londero M. 127<br />
Longhi R. 68<br />
Longini M. 49<br />
Longo A. 39 109<br />
Longo V. 58<br />
Lopa S. 126<br />
Lopez M. 107<br />
Loraschi A. 14 120 141<br />
Lorenzi T. 71 104<br />
Lorenzini S. 81<br />
Loupakis F. 128<br />
Loza M. 118<br />
Lu B. 56<br />
Lubrano V. 58<br />
Luccini E. 31 44 45<br />
Lucente A. 163<br />
Luchicchi A. 55<br />
Luciani S. 47<br />
Lucignani G. 29<br />
Lucini V. 160<br />
Lui R. 29<br />
Luisetti M. 27<br />
Lungarella G. 27<br />
Luo H. 101<br />
Luongo C. 101 164<br />
Luongo L. 63 149 150<br />
Lupi P. 124<br />
Luppino MR. 140<br />
Lysenko V. 110 126<br />
Maat-Schieman M. 48<br />
Mac Lennan S. 81 111<br />
Maccari F. 32<br />
Maccarrone M. 70<br />
Maccarrone P. 108<br />
Macchi B. 67<br />
Macchia M. 112<br />
Maccio L. 28<br />
Macheda T. 33 37 168<br />
Maciocco E. 4<br />
Maclennan S. 42 111<br />
Madaschi L. 29<br />
Maddaluno M. 99 114 160<br />
Maffei F. 58 168<br />
Maffezzini M. 112<br />
Maffia P. 99 103 160 167<br />
Maggi A. 3 145<br />
Maggi F. 120<br />
Maggi M. 166<br />
Magi S. 44 82<br />
Magistro L. 79<br />
Maglione U. 157<br />
Magliulo L. 127<br />
Magnani E. 33<br />
Magnetti C. 118<br />
Magnoni C. 58<br />
Magro L. 79 80<br />
Mai A. 112<br />
Maida S. 50<br />
Maiello F. 72<br />
Mainardi P. 31<br />
Maio R. 103 117<br />
Maione F. 105<br />
Maione S. 52 61 63 149 150<br />
Maione T. 37<br />
Maiorca S. 103<br />
Mairesse J. 34<br />
Malcangio M. 149<br />
Malesci A. 141<br />
Malinverno M. 82<br />
Mallei A. 4 83<br />
Malorgio F. 100<br />
Malorni W. 50 76 101<br />
Malpeli G. 39<br />
Mammola C. 124<br />
Manarini S. 100 136<br />
Mancardi D. 110 126<br />
Mancari F. 124<br />
Mancinelli R. 81<br />
Mancuso C. 123 168<br />
Mancuso M. 123<br />
Mandalari G. 124<br />
Mangano G. 160<br />
Mannaioni G. 38<br />
Mannari C. 36 114<br />
Mannino E. 48<br />
Mannucci C. 47 55 59 114<br />
Mannucci E. 101 102<br />
Mannucci PM. 153<br />
Manoni M. 137<br />
Mantovan T. 33<br />
Mantovani L. 95<br />
Marabese I. 52 149<br />
Marcello E. 82 130<br />
Marchesi M. 102<br />
Marchet S. 71 104 105<br />
Marchetti P.lo 147<br />
Marchetti P.ro 98<br />
Marchetti R. 56<br />
Marchi M. 32 45<br />
Marchi S. 15<br />
Marchiafava M. 38<br />
Marcoli M. 42 45<br />
Marfella R. 36 101<br />
Marfia G. 29<br />
Margaritis A. 103<br />
Margutti P. 50<br />
Mariani P. 124<br />
Marini H. 86 87 161<br />
Marini V. 105 112 128<br />
Marino F. 14 117 120<br />
Marino L. 78 101 160<br />
Marino M. 76<br />
Marino S. 86 101 110 112 126<br />
Marinos L. 112<br />
Marinovich M. 57 130 138 168<br />
Marolda R. 36<br />
Maroni L. 103<br />
Marra C. 115<br />
Marra F. 29<br />
Marra R. 31<br />
Marte A. 44 45<br />
Martelli A.ma 76 98<br />
Martelli A.ta 105 112 119 121 128<br />
Martelossi S. 127<br />
Martignoni E. 14<br />
Martinelli E. 42<br />
Martinez A. 33<br />
Martini C. 9<br />
Martini M. 14<br />
Martino A. 127<br />
Martins-Ferreira J. 160<br />
Martire A. 29 68<br />
Martire M. 45<br />
Martorana M. 122 124 125<br />
Marzani B. 47<br />
Marzocchi B. 49<br />
Marzocco S. 48 57<br />
Marzola E. 37<br />
Mascagni P. 139<br />
Mascarin A. 99<br />
Mascolo N. 100 105 106<br />
Maselli MA. 104<br />
Maselli R. 48<br />
Masi A. 38<br />
Masi G. 128<br />
Masini E. 103 137<br />
Massacesi L. 117<br />
Massaro A. 59<br />
Massei J. 127<br />
Massi M. 35 36 55 58 104<br />
130 168<br />
Massi P. 8 113<br />
Mastino A. 67<br />
Mastrangelo S. 124<br />
Mastrantoni E. 162<br />
Mastrantonio T. 37<br />
Mastrella D. 162<br />
Mastriota M. 53 105 106<br />
Mastrofrancesco L. 97<br />
Mastroiacovo F. 15 37 49 162<br />
Mastroianni R. 103 137<br />
Matarrese P. 50<br />
Mathè A. 83<br />
Matrisciano F. 38 130<br />
Mattace Raso G. 30 86 98 166 168<br />
Mattatelli A. 101<br />
Matteis M. 77<br />
Matteoli M. 68<br />
Matteucci C. 67<br />
Matthews L. 41<br />
Mattioli F. 105 112 119 121 128<br />
Maura G. 42 45<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Mauro N. 108<br />
Mavilio D. 117<br />
Maxwell S. 64<br />
Mazzaglia G. 79 95 118 140 141<br />
Mazzanti G. 58 124 148<br />
Mazzei T. 17 65 79 84 135<br />
146<br />
Mazzini G. 57<br />
Mazzolini S. 63<br />
Mazzon E. 30 32 68 113 116<br />
130 159 164<br />
Mazzotta MC. 42 45<br />
Mcgaugh J. 4<br />
Mcinnes I. 103<br />
Medico E. 14<br />
Meini B. 120<br />
Melani A. 68 130<br />
Melchiorre M. 136<br />
Melchiorri D. 38 49 63 112 130<br />
162<br />
Meldolesi J. 60<br />
Mele A. 45 108<br />
Mele P. 39 109<br />
Meli M. 112<br />
Meli R. 32 62 74 86 149<br />
166 168<br />
Mello T. 130<br />
Melloni E. 29<br />
Melotti P. 108<br />
Melotto S. 58 168<br />
Memo M. 7 57<br />
Menard S. 132<br />
Menarini M. 29 30<br />
Mencacci C. 94<br />
Mendlewicz J. 38<br />
Meneghini V. 34<br />
Meneguz A. 138<br />
Meneguzzi A. 100 136<br />
Menichetti F. 65 112<br />
Menna A. 141<br />
Menon D. 111<br />
Mercanti G. 118<br />
Mercatali L. 146<br />
Mercogliano A. 121<br />
Mercuri N. 33 144<br />
Meregalli C. 168<br />
Merighi S. 41 42 63 81 111<br />
146<br />
Merli D. 29<br />
Merlicco A. 59 81<br />
Merlino A. 110 126<br />
Merlo S. 34 50 101<br />
Mesenzani O. 38<br />
Messina A.ea 58<br />
Messina A.la 35<br />
Messina S. 31<br />
Metere A. 101<br />
Mey V. 127<br />
Mhillaj E. 54<br />
Micale V. 31 74<br />
Miceli F. 46<br />
Miceli N. 47<br />
Micheli L. 57 122 123<br />
Michieli R. 156<br />
Micioni Di<br />
Bonaventura M.<br />
36 58 168<br />
Micò U. 61<br />
Miele E. 4<br />
Migheli R. 34 39<br />
Migliardi G. 61<br />
Miglio G. 98<br />
Migliorati G. 159<br />
Migliori M. 36<br />
Migliozzi A. 52 61 149<br />
Milanese C. 164<br />
Milanese M. 4 29 30<br />
Milano L. 28 57 107<br />
Milano W. 28 57 107<br />
Minciullo P. 117<br />
Mini E. 90 146<br />
Minocci D. 127<br />
Minotti G. 132<br />
Minutoli L. 31 61 72 86 104<br />
Minutolo A.<br />
107 114 161 162<br />
67<br />
Minuz P. 100 136<br />
Mirabella G. 163<br />
Miracapillo R. 24<br />
Miragoli L. 102<br />
Mirandola P. 42 146<br />
Miremont-Salamé G. 119<br />
Mirone V. 166 167<br />
Missale C. 49<br />
Mitidieri E. 113 166 167<br />
Mitreva R. 37<br />
Mocali A. 169<br />
Mocenni C. 55<br />
Mochly Rosen D. 49<br />
Modde C. 30<br />
Modena J. 111<br />
Mognetti B. 86 101 110 112 126<br />
Moilanen E. 64 129<br />
Moison D. 28<br />
Mokhles M. 140<br />
Moles A. 58<br />
Molinari F. 166<br />
Molinari S. 35<br />
Molinaro G. 7 34 35 159<br />
Molinaro P. 9<br />
Mollace V. 53 150<br />
Molokhia M. 118 119<br />
Molteni R. 30 111 146<br />
Monaco F. 127<br />
Moncada S. 63<br />
Moneti G. 124<br />
Monfardini S. 58<br />
Monica D. 14<br />
Monico E. 158<br />
Monina G. 141<br />
Monopoli A. 115<br />
Montagnani M. 76 97<br />
Montagnani S. 120 122 157<br />
Montanaro N. 79 111 119 141 157<br />
Montecucco C. 22<br />
Montefrancesco G. 31 47 55<br />
Monteleone D. 122 124 125<br />
Monti E. 30 111 146<br />
Monti M. 49<br />
Montopoli M. 111 123 163<br />
Montuschi P. 13 97<br />
Moore N. 119 140<br />
Morabito G. 103 124<br />
Morandi S. 59<br />
Morando S. 45<br />
Morbidelli L. 63 99<br />
Morelli A. 166<br />
Morelli M. 58<br />
Moreno M. 108<br />
Mores N. 35<br />
Moretta V. 100 136<br />
Moretti AM. 156<br />
Moretti S. 121<br />
Moretti U. 79 110 119<br />
Morganti M. 146<br />
Morgese MG. 33 37 39 168<br />
Morgillo F. 42<br />
Morini G.ni 34<br />
Morini G.na 104<br />
Morlacchi S. 7<br />
Moro E. 71 104 120<br />
Moro F. 101<br />
Moro M. 30<br />
Moroni F. 38 39 59 117<br />
Morrone L. 5 30 39 74<br />
Morroni F. 59<br />
Mortola D. 79<br />
Moschini M. 79 124<br />
Mosillo P. 112<br />
Mossotti M. 117<br />
Mostallino MC. 4<br />
Motola D. 79 80 110 111 119<br />
121<br />
Moyanova S. 37<br />
Muccioli G. 76<br />
Mudò G. 7<br />
Müller E. 166 167<br />
Mueller J. 43<br />
Mugelli A. 21 58 64 76 78<br />
79 93 97 101 121<br />
124 134 136<br />
Mulinacci N. 169<br />
Mulle C. 82<br />
Muller C. 101<br />
Muntoni E. 127<br />
Mura E. 45<br />
Mura ML. 4<br />
Muraca M. 150<br />
Murphy R. 164<br />
Murru L. 4<br />
Musante V. 5 40<br />
Musarò A. 33<br />
Musazzi L. 4<br />
Muscatello MR. 61 74<br />
Muscoli C. 53 150<br />
Muserra G. 122<br />
Musilli C. 76 97 99<br />
Mussa M. 118<br />
Musso A. 34<br />
Mussoni L. 102<br />
Musumeci T. 61<br />
Naccari C. 59 117<br />
Nacci C. 76<br />
Nanetti A. 111<br />
Napoli C. 146<br />
Napolitano M. 47<br />
Nappi G. 14 28<br />
Nargi E. 36<br />
Nasca C. 38<br />
Naselli F. 29<br />
Nassi A. 111<br />
Nasuti C. 57<br />
Natale G. 81<br />
Natale M. 81<br />
Navarra M. 47 49 55<br />
Navarra P. 20 26 51 52 54<br />
74 133 149 162<br />
Navarria A. 74<br />
Negri L. 149<br />
Negro A. 4 34 41<br />
Nencini C. 57 122 123<br />
Nencini P. 56<br />
Neri E. 114 160<br />
Neugebauer V. 52<br />
Neunhoeffer E. 166<br />
Ngomba R. 34 37<br />
Nicchia G. 45<br />
Niccolini C. 63 162<br />
Nico B. 164<br />
Nicolai R. 52<br />
Nicoletti F. 7 13 15 34 35<br />
37 38 48 49 51<br />
52 54 61 63 66<br />
91 112 130 144 159<br />
162<br />
Nicoll D. 82<br />
Nicolucci A. 89 95<br />
Nicora E. 30<br />
Nicotra A. 51 149<br />
Nieri P. 127<br />
Nisi A. 14<br />
Nisoli E. 32<br />
Nisticò R. 33 144<br />
Nisticò G. 150<br />
Nistri A. 81<br />
Nizzari M. 34<br />
Nobile M. 42 45<br />
Nobili B. 63<br />
Nobili S. 146<br />
Nocentini G. 22 66 116<br />
Nolfe G. 57<br />
Northoff H. 166<br />
Nosi D. 68<br />
Notarbartolo M. 147<br />
Notartomaso S. 37 66<br />
Novelli A. 84<br />
Novelli G. 73<br />
Novellino E. 98 166<br />
Novellino L. 68<br />
Noviello L. 162<br />
Nunziata A. 59 128<br />
Oberto A. 39 109<br />
Oberwinkler J. 12<br />
Oddo S. 37<br />
Oggioni N. 168<br />
Ogren S. 130<br />
Ohara P. 52<br />
Oldrini R. 71 104 105<br />
Oliva MA. 162<br />
Oliveira J. 118<br />
Olivieri D. 13<br />
Ongini E. 165<br />
Opri S. 79 80 121<br />
Orabona C. 42<br />
Oria C. 157<br />
Orlandi P. 110 128 146<br />
Orlando R. 38 130<br />
Orlotti D. 77<br />
Orobello S. 48<br />
Orsetti M. 7<br />
Orsini F. 160<br />
Ortona E. 50<br />
Oselladore B. 99<br />
Oteri A. 119 121 122<br />
Ottani A. 31 61 72 98 104<br />
114 162<br />
Ottaviani S. 49<br />
Ottobrini L. 29<br />
Pacini A. 52<br />
Padovani A. 130<br />
Padovano V. 68<br />
Padrini R. 14 111 127 136<br />
Padula R.sa 120<br />
Padula R.ta 122<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Pagani F. 86<br />
Pagano C. 118<br />
Pagano I. 79<br />
Pagetta A. 163<br />
Pagliaro L. 96<br />
Pagliaro P. 54 100 101<br />
Palanza P. 39 85 109<br />
Palazzo E. 52 61 149<br />
Palfi S. 10<br />
Pallotta M. 66<br />
Pallottino S. 49<br />
Palma A. 114 116 136 165<br />
Palmery M. 54<br />
Palmieri G. 25 154<br />
Palmigiano A. 35<br />
Palomba L. 7 50<br />
Palumbo C. 87<br />
Pandolfo G. 61 74<br />
Pani L. 94<br />
Panmand D. 81<br />
Pannacci M. 127 160<br />
Pannini S. 118<br />
Pantaleo M. 14<br />
Panza E. 45 46<br />
Panza L. 117<br />
Paoletti A. 124<br />
Paoletti R. 16<br />
Paolini M. 58 71<br />
Paolino D. 111<br />
Paolisso G. 36<br />
Papagni M. 157<br />
Papi L. 146<br />
Papi M. 128<br />
Pappalardo G. 35<br />
Parente L. 7 49<br />
Parenti A. 76 97 99<br />
Pariente A. 119 140<br />
Parini A. 78<br />
Parini F. 118<br />
Parisi A. 100 114<br />
Parolaro D. 8 113<br />
Parolini C. 102<br />
Parravicini C. 33<br />
Pascale A. 86 105<br />
Pascotto A. 140<br />
Pasini F. 111 127<br />
Paskow-Rozas M. 43<br />
Pasqualetti G. 127<br />
Pasquariello S. 56<br />
Passalacqua M. 29<br />
Passarello F. 31<br />
Pastorino M. 34<br />
Pastoris O. 164<br />
Patacchini R. 12<br />
Patacchioli F. 108<br />
Paterniti I. 30 32 74<br />
Patrignani P. 6 14 100 115 136<br />
142 164<br />
Patrono C. 6 113 116 134 153<br />
160<br />
Pattarozzi A. 48<br />
Pecoraro S. 112<br />
Pedata F. 33 68 130<br />
Pederzoli F. 32<br />
Pedrazzi M. 29<br />
Pedrelli M. 99<br />
Pelà M. 35<br />
Pelaia G. 48<br />
Pelicci P. 139<br />
Pelin M. 59<br />
Pellati F. 58<br />
Pellegrini-Giampietro<br />
D.<br />
9 28 38<br />
Pellegrino M. 33 99<br />
Pelosi V. 100 136<br />
Pengo V. 14<br />
Penna C. 54 101<br />
Pepeu G. 10 47 91<br />
Pepponi R. 29<br />
Pera A. 127<br />
Perez-Otaño I. 82<br />
Pergola C. 113 165 166<br />
Pergolizzi S. 47<br />
Perissoud D. 108<br />
Pero G. 36<br />
Peroni A. 163<br />
Perrone Filardi P. 93<br />
Perrotta C. 7 68<br />
Perrotta S. 63<br />
Perucca E. 31<br />
Perucci C. 157<br />
Pessina F. 58<br />
Pessina G. 103<br />
Petrella A. 7 49<br />
Petrella C.la 36 51 71 105<br />
Petrella C.io 28 57 107<br />
Petrelli F. 9<br />
Petrillo MG. 66 116<br />
Petrini M. 120 157<br />
Petroni A. 36<br />
Petrosino S. 31 63 72<br />
Petrucci G. 35 160<br />
Pezzatini S. 99<br />
Pèzzola A. 68<br />
Pezzolla F. 104<br />
Pfister P. 102<br />
Piacentini P. 24<br />
Pianezzola C. 14<br />
Piazza E. 119<br />
Piazza PV. 28 62<br />
Picci N. 168<br />
Piccinin S. 144<br />
Piccinni C. 79<br />
Piccione F. 54 98 108 110 118<br />
Piccirilli S. 33<br />
Picco W. 112<br />
Piegari E. 42 78 101 160<br />
Pieraccini G. 124<br />
Pieratti A. 55 114 122<br />
Pieretti S. 53 105 106<br />
Pieri M. 36<br />
Pierno S. 33 99<br />
Pietrangelo T. 81<br />
Pietrini G. 68<br />
Pignataro B. 35<br />
Pignataro G. 9<br />
Pignieri A. 100<br />
Pillolla G. 55<br />
Pini L. 51<br />
Pinna A. 58<br />
Pinna C. 102 136<br />
Pinto A. 48<br />
Piomelli D. 61 168<br />
Pippi F. 57<br />
Pirillo A. 102<br />
Pirovano M. 127<br />
Pirro E. 98 110 118<br />
Pisani S. 157<br />
Pisoni S. 63<br />
Pistarà V. 61<br />
Pistis M. 55<br />
Pisu M. 4<br />
Pitozzi V. 169<br />
Pittaluga A. 5 33 40 45 144<br />
Pittelli M. 59<br />
Pizzi M. 9 32 41 44 58<br />
74<br />
Pizzolo G. 39<br />
Plebani M. 14<br />
Poggesi C. 45<br />
Poggi L. 102<br />
Polenzani L. 164<br />
Polidori C. 36 168<br />
Polidori P. 24<br />
Polillo M. 112 127<br />
Polimeni G. 79 119<br />
Polimeno T. 120<br />
Polito F. 31 72 86 104 107<br />
114 161 162<br />
Pollio G. 40<br />
Poluzzi E. 79 110 111 157<br />
Polzonetti V. 43<br />
Poma P. 147<br />
Pompella G. 81<br />
Popoli M. 4 83<br />
Popoli P. 29 68<br />
Popolo A. 48<br />
Porreca E. 100 136<br />
Portaleone P. 54<br />
Portigliatti Barbos M. 86 110 112<br />
Possenti R. 36 71<br />
Possidente M. 59<br />
Postiglione A. 120<br />
Potenza M. 97<br />
Potenza R. 68<br />
Potenza S. 80 120 140 157<br />
Pouladi M. 48<br />
Pozzan T. 60<br />
Pozzesi N. 116<br />
Pozzi S. 136<br />
Pozzoli C. 105<br />
Pozzoli G. 162<br />
Preciosa M. C. 119<br />
Preda S. 45<br />
Preti D. 41 81<br />
Preziosi P. 20 96<br />
Priora R. 102 103<br />
Procino G. 97<br />
Proudlove C. 24<br />
Puccetti P. 42 66<br />
Puccini A. 157<br />
Puggioli C. 111<br />
Puggioni G. 34<br />
Pugi A. 124<br />
Pugliese A. 130<br />
Puri PL. 139<br />
Putaturo I. 120<br />
Putignano A. 146<br />
Puxeddu E. 111<br />
Quadrato G. 7<br />
Quaglia F. 115<br />
Quintieri L. 111<br />
Quon M. 97<br />
Rabasca A. 120<br />
Racagni G. 4 25 55 83<br />
Racanicchi L. 111<br />
Racca S. 54 108 110<br />
Racchi M. 57<br />
Radaeli E. 118<br />
Radice S. 119<br />
Rådmark O. 166<br />
Rafaniello C. 120 121 140 157<br />
Ragazzi E. 111<br />
Ragusa S. 50<br />
Raimondi L. 101 102 166<br />
Raimondo S. 126<br />
Raiteri L. 31 44 45<br />
Raiteri M. 4 5 40 45<br />
Ramadori A. 81<br />
Ramsdell J. 39<br />
Ranghino G. 33<br />
Rapposelli S. 76 98<br />
Raschi E. 79 110<br />
Rasini E. 103<br />
Rassu C. 30<br />
Rastaldo R. 100<br />
Rastrelli F. 121<br />
Rattazzi L. 98<br />
Ravaioli A. 128<br />
Ravaioli E. 146<br />
Ravizza R. 30 111 146<br />
Ray D. 41<br />
Rea G. 120<br />
Reboldazzi G. 14<br />
Rebulla P. 30<br />
Recchia G. 73<br />
Regoli D. 35 37 61<br />
Reinscheid R. 37<br />
Remelli R. 40<br />
Renna G. 59<br />
Renzi P. 86<br />
Resca E. 87<br />
Riccardi C. 3 7 22 66 116<br />
Ricciardi E. 124<br />
Ricciardi S. 127<br />
Ricciotti E. 115 164<br />
Ricci-Vitiani L. 112 162<br />
Richelmi P. 32 48<br />
Rigamonti A. 166 167<br />
Rigamonti E. 102<br />
Riganti L. 68<br />
Riggi C. 98<br />
Righetti C. 58<br />
Righetti L. 37 58 61<br />
Rinaldi B. 14 164<br />
Rinaldi M. 28<br />
Riozzi B. 7 15 37 48 49<br />
Riozzo B. 48<br />
Ripamonti E. 30<br />
Risè P. 108<br />
Riso C. 121<br />
Riva B. 50<br />
Riva M. 55<br />
Rivasi F. 28<br />
Rivolta A. 80 121<br />
Rizzardini G. 155<br />
Rizzarelli E. 35<br />
Rizzi A. 35 37 61<br />
Rizzi L. 108<br />
Rizzi N. 145<br />
Rizzo M. 53 150<br />
Rizzo V. 32 48<br />
Rizzuto E. 33<br />
Robbiano L. 128<br />
Roberto G. 119<br />
Rocca B. 6 108 160<br />
Rocchitta G. 34 39<br />
Rodolico G. 103<br />
Roggeri D. 157<br />
Roi C. 157<br />
Rolland J. 108<br />
Roma G. 114<br />
Romagnoli R. 41 81<br />
Romanelli L. 54<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Romanelli M. 136<br />
Romano A. 37 58 61<br />
Romano B. 72 105<br />
Romano MR. 99<br />
Romano M. 35<br />
Romano S. 36 81<br />
Romaudi P. 51<br />
Rombola' L. 5 30 39 74<br />
Romei C. 31 44 45<br />
Romeo C. 107<br />
Romualdi P. 54 130<br />
Romussi G. 106<br />
Ron M.C. H. 118<br />
Ronchetti S. 66 116<br />
Ronda N. 99<br />
Rondina M. 111<br />
Roozendaal B. 4<br />
Rosa AC. 24 98 140<br />
Rosa P. 7 9 33 68<br />
Rosano G. 156<br />
Rosato A. 111<br />
Rossi And. 45<br />
Rossi AM. 127<br />
Rossi Ant. 113 165 166<br />
Rossi CR. 111<br />
Rossi C. 52 101 164<br />
Rossi Ele. 36<br />
Rossi Eli. 163<br />
Rossi F.ca 52 63<br />
Rossi F.co 3 14 21 36 42<br />
77 78 80 93 101<br />
103 120 121 140 149<br />
150 154 157 160 164<br />
Rossi G. 15<br />
Rossi M. 118<br />
Rossi T. 58<br />
Rota M. 78 160<br />
Rotella C. 166<br />
Rotiroti D. 39 50 150<br />
Rovati L. 151<br />
Roviezzo F. 30 76 98 99 160<br />
164 166<br />
Rubattu S. 162<br />
Ruberti G. 3<br />
Rubino T. 70<br />
Rugani I. 101<br />
Ruggeri B. 35 55<br />
Ruggieri V. 35 51 130<br />
Ruggiero F. 14<br />
Ruggiero S. 120 140 157<br />
Runci F. 31<br />
Ruozi B. 35 107<br />
Russier J. 59<br />
Russo A. 79 119<br />
Russo C. 34<br />
Russo D. 111<br />
Russo E. 31 36<br />
Russo GA. 55 114<br />
Russo GT. 95<br />
Russo M. 14 77<br />
Russo R.to 52 62 86 149<br />
Russo R.sa 42<br />
Russo R.io 57<br />
Russo R.la 5 30 50 74<br />
Russomanno G. 14 169<br />
Rustichelli C. 107<br />
Ruzza C. 35 37<br />
Ruzza P. 111<br />
Saccani F. 34 159<br />
Sacchetto V. 41 81 111<br />
Sacerdote P. 66 133 149<br />
Sacripanti C. 79<br />
Saffi-Giustini E. 26<br />
Saija A. 59 103 117 122 124<br />
125<br />
Saiko P. 112<br />
Saitta F. 157<br />
Sakurada S. 39<br />
Sala A. 13 97 98 100 110<br />
146 164<br />
Sala B. 168<br />
Sala C. 82<br />
Sala P. 14<br />
Salamone P. 100 112 126<br />
Sale P. 63 112<br />
Salomone S. 101<br />
Salsini L. 137<br />
Salt T. 61<br />
Salvadori S. 35 37 44 51 61<br />
149<br />
Salvicchi A. 37 51 149<br />
Salvo F. 119 121 140<br />
Salvucci C. 55<br />
Samuelsson B. 166<br />
Sances G. 28<br />
Sandrini M. 51<br />
Sanna E. 4<br />
Sansò M. 114<br />
Santini R. 57<br />
Santolini I. 34 37<br />
Santoro C. 63<br />
Santoro L. 48<br />
Santoro V. 61 74<br />
Santosuosso U. 103<br />
Santuccio C. 121<br />
Sanvito P. 136<br />
Sanz J. 68<br />
Sanzone S. 43<br />
Sapino S. 112<br />
Saponaro G. 81<br />
Sapone A. 58<br />
Saraceno C. 130<br />
Sarnico I. 9 32 58<br />
Sartiani L. 58 78 99 136<br />
Sartori ML. 108<br />
Sasso O. 52 62 86 149<br />
Sassone J. 48<br />
Saura J. 33<br />
Sautebin L. 113 119 123 140 165<br />
166<br />
Savino R. 48<br />
Savio S. 54<br />
Sblendorio V. 164<br />
Sbrilli M. 122<br />
Scaccianoce S. 38 61 103 130<br />
Scafuro A. 52<br />
Scafuro M. 52<br />
Scaglione F. 17 84 92 127 155<br />
160<br />
Scalori V. 36 114<br />
Scarpa R. 120<br />
Scarpino S. 162<br />
Scarselli P. 37<br />
Scartabelli T. 38<br />
Schade R. 140<br />
Schelling G. 4<br />
Schembri L. 103<br />
Schiavon S. 14<br />
Schiavone N. 37<br />
Schiavone S. 61 130<br />
Schillani G. 126 128<br />
Schintu N. 68<br />
Schipani G. 120<br />
Schuemie M. 140<br />
Schwaninger M. 9<br />
Scicchitano F. 31<br />
Sciulli M. 14<br />
Scognamiglio M. 120<br />
Scordo MG. 127<br />
Scorrano L. 63<br />
Scorziello A. 63<br />
Scott B. 118<br />
Scotto S. 79 80<br />
Scuderi C. 11 29 38 71<br />
Secci P. 4<br />
Secondo A. 108<br />
Segura Garcia C. 31<br />
Sekar D. 57<br />
Selvi E. 81<br />
Serafini L. 3<br />
Serpe L. 127<br />
Serra G.no 29 30 74<br />
Serra G.ia 29<br />
Serra MG. 4 28 85<br />
Serra PA. 4 34<br />
Serratosa J. 33<br />
Sessa A. 119<br />
Severi P. 5<br />
Severini C. 36 71<br />
Severino L. 57<br />
Sgambato A. 168<br />
Sganga G. 65<br />
Sgaragli G. 58<br />
Shen C. 82<br />
Shohreh R. 35<br />
Siani P. 157<br />
Siano C. 28 57 107<br />
Sibilia V. 86<br />
Siciliano R. 123<br />
Sigala S. 49 118 121 163 166<br />
Signorini S. 14<br />
Sili M. 38<br />
Silvana Antonietta R. 118<br />
Silvani M. 111 157<br />
Silvano E. 36<br />
Silvestri E. 108<br />
Simeon V. 169<br />
Simeone C. 49 163<br />
Simeoni S. 108<br />
Simioni C. 42 146<br />
Simonato L. 162<br />
Simonato M. 33 130<br />
Simoni D. 147<br />
Simonyi A. 34<br />
Sinagra G. 136<br />
Sinforiani E. 57<br />
Sinigaglia L. 23<br />
Siniscalco D. 63 149 150<br />
Sipione S. 48<br />
Sirabella R. 9<br />
Sirchia S. 48<br />
Sironi L. 9 100<br />
Sirtori C. 102<br />
Sitia S. 103<br />
Skaper S. 11 41 45 157<br />
Smits R. 105<br />
Sobrado M. 49<br />
Sodano L. 164<br />
Soffia S. 41 45<br />
Soldovieri M. 46<br />
Solenghi E. 104<br />
Soleti A. 71<br />
Solinas M. 8<br />
Solito R. 57<br />
Soma R. 157<br />
Sorato E. 99<br />
Sorce S. 130<br />
Sorrentino R. 113 115 166 167<br />
Sortino M. 28 34 50 61 101<br />
Sosa S. 59<br />
Sottosanti L. 79 80 121<br />
Soukupova M. 52<br />
Soverchia L. 35 55<br />
Spaccapelo L. 28 107 123<br />
Spagnolo L. 121<br />
Spallino A. 97 110<br />
Spampinato S.ti 75 82 86 108 159<br />
Spampinato S.na 34 50<br />
Spampinato U. 28<br />
Spano PF. 9 28 49 58 88<br />
118 121 163<br />
Sparatore B. 29<br />
Spartà A. 159<br />
Spatz L. 4<br />
Speciale A. 59 103 124<br />
Spina E. 4 25 61 74 118<br />
121 126 143<br />
Spinazzi R. 99<br />
Spinelli C. 121<br />
Spinelli G. 121<br />
Spinelli V. 99<br />
Spinsanti P. 7 49 112 162<br />
Spissu Y. 34<br />
Spissy Y. 39<br />
Sportiello L. 119 140<br />
Sprengel R. 39 109<br />
Sprio A. 100 112 126<br />
Squadrito F. 31 61 72 86 87<br />
104 107 114 160 161<br />
162<br />
Squitieri F. 48<br />
Stafoggia M. 157<br />
Stanco D. 126<br />
Stanga S. 57<br />
Steardo A. 38<br />
Steardo L. 11 29 38 71<br />
Stefanelli E. 3<br />
Stefanelli F. 160<br />
Stefani S. 84<br />
Steinkühler C. 139<br />
Stella G. 14<br />
Sternini C. 159<br />
Stiaccini G. 36 114<br />
Stievano L. 127<br />
Stillitano F. 58 78<br />
Stiuso P. 169<br />
Stocchi F. 162<br />
Stocco G. 127<br />
Stocker R. 100<br />
Stopponi S. 55<br />
Storto M. 7 37 48 49<br />
Straface E. 76 101 145<br />
Stricker B. 3 140<br />
Strippoli A. 122<br />
Strongoli M. 150<br />
Sturkenboom M. 118 119 122 140 141<br />
157<br />
Sturla C. 110<br />
Suffredini S. 58 78<br />
Sullo N. 77<br />
Summa M. 5 40<br />
Suto T. 18<br />
Svelto M. 97<br />
Index of Authors and Chairpersons
Index of Authors and Chairpersons<br />
Tabrizi M. 81 111 146<br />
Tacchi R. 28 107 123<br />
Tacchi S. 38<br />
Tacconelli S. 14 100<br />
Taddei R. 112<br />
Taddei S. 101 136<br />
Tagliafico E. 38<br />
Taglialatela M. 41 44 45 46 82<br />
Tamburella A. 31 74<br />
Tamiazzo L. 108<br />
Tanganelli S. 70<br />
Tarallo L. 157<br />
Tarantini F. 102<br />
Tarditi A. 40<br />
Tardito D. 4 83<br />
Targa M. 41<br />
Tari D. 121<br />
Tarozzi A. 59<br />
Tarquini R. 103<br />
Tarquinio M. 76<br />
Tascedda F. 38 74<br />
Tascini C. 112<br />
Tassorelli C. 39<br />
Tebano MT. 29<br />
Tempia F. 33<br />
Terenius L. 130<br />
Terrazzani G. 118 157<br />
Terrazzino S. 28<br />
Tersigni M. 41 47 113 114<br />
Terstappen G. 10 40<br />
Terzolo M. 110<br />
Terzuoli E. 99<br />
Tesoriere L. 114<br />
Tessari M. 58<br />
Testai L. 76 98<br />
Testi A. 121<br />
Theodorou V. 51<br />
Theoharides T. 64<br />
Thiemermann C. 98<br />
Thurmond R. 137<br />
Tibaldi E. 163<br />
Tiezzi S. 55<br />
Togna A. 59 103 115<br />
Togna G. 59 103 115<br />
Tognolini M. 114<br />
Tolomeo M. 112<br />
Tomaino A. 122 124 125<br />
Tomasini MC. 44<br />
Tomasoni L. 103<br />
Tonelli F. 146<br />
Tonini M. 26 104 107<br />
Tontodonati P. 100 136<br />
Torella M. 63<br />
Torelli E. 36<br />
Toro A. 14<br />
Torri S. 98<br />
Torsello A. 108<br />
Torta R. 143<br />
Torti F. 102<br />
Tosca N. 119<br />
Tosi A. 41 63<br />
Tosi G. 35 107<br />
Tosi L. 141<br />
Toso S. 111<br />
Tozzi MG. 68<br />
Trabace L. 31 39 61 68 97<br />
130<br />
Trabattoni D. 76<br />
Trabucco A. 37<br />
Traficante A. 7<br />
Traini C. 130<br />
Tramentozzi E. 163<br />
Trapasso E. 47 49 111<br />
Trapella C. 35 37<br />
Travelli C. 43 50<br />
Traversa G. 142<br />
Traversa MV. 47<br />
Traversa U. 38<br />
Trefiletti G. 103 115<br />
Treglia M. 149<br />
Tremoli E. 6 9 76 100 101<br />
102 113 116 159<br />
Trenti A. 47<br />
Trevisan L. 41<br />
Trevisani M. 12<br />
Trevisi L. 47<br />
Trezza V. 4<br />
Tricarico D. 45 108<br />
Trifirò G. 118 119 140 158<br />
Trincavelli L. 9<br />
Trinchera M. 71<br />
Tringali G. 52 74 149 162<br />
Tripodi F. 14<br />
Trisolini P. 104<br />
Troiani T. 42<br />
Trombetta D. 59 117 124<br />
Trombino S. 168<br />
Tron G. 50<br />
Tubaro A. 39 59<br />
Tucci P. 39 130<br />
Tuccori M. 71 79 80 119 120<br />
121 122 157<br />
Tulipano G. 108<br />
Tullio F. 54 101<br />
Turiel M. 103<br />
Turola E. 68<br />
Turolo L. 100<br />
Turrini E. 14<br />
Turriziani B. 112<br />
Tursi V. 117<br />
Ubaldi M. 35 55<br />
Uberti D. 57<br />
Uccelli A. 30 45<br />
Uliva C. 103 137<br />
Ungaro F. 115<br />
Urbanek K. 78 160<br />
Urbinati S. 21<br />
Ursino MG. 71<br />
Ursino MR. 49<br />
Usiello A. 144<br />
Vacca C. 42 66<br />
Vaccheri A. 111 157<br />
Vacirca D. 50<br />
Vairetti M. 32 48<br />
Valanzano R. 146<br />
Valbusa G. 102<br />
Valensisi C. 38 74<br />
Valente M. 34<br />
Valenti G. 97<br />
Valenti L. 118<br />
Valenti M.co 141<br />
Valenti M.ta 8 113<br />
Valenza M. 38<br />
Valeri A. 58<br />
Valeri P. 54 105<br />
Valeria S. 63<br />
Valerio A. 32<br />
Vallarino M. 42<br />
Valli M. 128<br />
Valoti M. 58 59<br />
Van Camp G. 140<br />
Van Der Lei J. 118 119<br />
Van Luijtelaar G. 34 37<br />
Van Rijn C. 37<br />
Van Soest E. 140<br />
Vandelli M. 35 107<br />
Vannacci A. 79 124<br />
Vannelli G. 166<br />
Vannucchi M. 68<br />
Varani K. 41 42 63 81 111<br />
146<br />
Varano G. 5 30 74<br />
Vara-Rivera H. 82<br />
Varro A. 136<br />
Vasina V. 71<br />
Vaudry H. 42<br />
Vecchio I. 150<br />
Vegeto E. 145<br />
Vegezzi G. 114<br />
Veglio V. 112<br />
Vehramme K. 140<br />
Velardi E. 7<br />
Velazquez C. 102<br />
Vella S. 156<br />
Vellecco V. 30 76 98 99 164<br />
Velo G. 80 140<br />
Venco A. 103<br />
Venegoni M. 79 80 121<br />
Ventrice D. 53 150<br />
Ventura A. 127<br />
Venturini F. 24<br />
Veratti E. 58<br />
Verderio C. 9 52 69<br />
Vergoni A. 35 107<br />
Verhamme K. 140<br />
Verri M. 164<br />
Vestito A. 168<br />
Vestri A. 141<br />
Vetrano G. 157<br />
Viale G. 35<br />
Viana M. 28 127<br />
Viano I. 92 110<br />
Vicentini L. 63 162<br />
Vietri M. 124<br />
Viggiano D. 45 46 63<br />
Vighi G. 122<br />
Vignoli M. 146<br />
Vignozzi L. 166<br />
Villa D. 76<br />
Villa G. 52 68<br />
Villa R. 36<br />
Vincenzi F. 41 63<br />
Vinci M. 103 137<br />
Virdis A. 101 136<br />
Virgili F. 124<br />
Vita G. 4 117<br />
Vitale G. 51 130<br />
Vitalone A. 124<br />
Vitelli M. 101<br />
Vitiello S. 62<br />
Viviani B. 130<br />
Vivoli E. 37 51 149<br />
Vollmayr B. 83<br />
Volontè A. 141<br />
Volontè C. 68<br />
Volpe A. 160<br />
Volpi C.la 66<br />
Volpi C.ia 42 66<br />
Volpi N. 32<br />
Volpini R. 81<br />
Vona R. 76<br />
Vukojevic V. 130<br />
Werz O. 113 165 166<br />
Wickham M. 124<br />
Wilke B. 36<br />
Windisch M. 32<br />
Wurth R. 48<br />
Yaradanakul A. 82<br />
Zaffaroni M. 120<br />
Zaffe D. 61 98<br />
Zamarchi R. 163<br />
Zambon C. 14<br />
Zammataro M. 52<br />
Zanardi A. 45<br />
Zanette C. 38 59<br />
Zanetti E. 71 104 105<br />
Zanettini R. 140<br />
Zangaglia R. 14<br />
Zani D. 49 163<br />
Zaninetti R. 38<br />
Zanoli P. 30 71 87<br />
Zanoncelli A. 58<br />
Zanoni A. 127<br />
Zanotti I. 99<br />
Zappettini S.na 4 29 30<br />
Zappettini S.ia 32 45<br />
Zappia M. 96<br />
Zara G. 127<br />
Zarini S. 164<br />
Zavatti M. 30 71 87<br />
Zecchin D. 14<br />
Zeng H. 114<br />
Zheng H. 160<br />
Zianni E. 38 130<br />
Ziche M. 49 57 63 99 113<br />
116<br />
Zoccali R. 74<br />
Zoli M. 32 45<br />
Zona C. 36<br />
Zoppellaro C. 71 105<br />
Zotti M. 31<br />
Zuccato C. 10<br />
Zucchini S. 33 130<br />
Zusso M. 34 41 45<br />
Index of Authors and Chairpersons
kidstudio<br />
Società Italiana<br />
di Farmacologia<br />
34° Congresso Nazionale<br />
della Società Italiana di Farmacologia<br />
<strong>PROGRAMMA</strong><br />
14-17 ottobre 2009<br />
Rimini, Palacongressi